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Abstract 
Introduction 
The quality of life following an intensive care admission has become an important and topical issue. 
Early intervention in intensive care (ICU) to potentially improve physical and psychological 
outcomes is becoming more accepted but the evidence has not been evaluated. Patients with sepsis 
syndromes especially can have poor outcomes for physical function, quality of life and survival post 
intensive care but the safety and efficacy of early physical rehabilitation remain unexplored. The 
overall aim of this thesis is therefore to evaluate the capacity of early exercise to modulate critical 
illness outcomes particularly in sepsis syndromes. To address this, a systematic review and meta-
analysis, a randomised controlled trial and two pilot trials were undertaken. 
 
Methods 
A systematic review was conducted to evaluate the evidence for exercise in critically ill patients. By 
further performing a meta-analysis, the review was able to critically appraise the effect of ICU 
exercise in critically ill patients in ten randomised controlled trials. Pertinent outcomes measuring 
the short and long-term effects of ICU exercise included quality of life, physical function, 
peripheral muscle strength, respiratory muscle strength, length of hospital and ICU stay, ventilator-
free days and mortality.  
 
A prospective double blinded randomised controlled trial of early ICU physical rehabilitation versus 
usual care was conducted in fifty mechanically ventilated critically ill adults with sepsis syndromes.   
Physical function and exercise capacity tests were performed on discharge from ICU using The 
Acute Care Index of Function and The Physical Function ICU Test. Muscle strength was measured 
using the Medical Research Council Scale. The psychological component was tested using The 
Hospital Anxiety Scale and Health-Related Quality of Life was tested at six months post discharge 
using the Short Form-36. Secondary measures included inflammatory biomarkers; Interleukin-6, 
Interleukin-10 and Tumour Necrosis Factor-α, Plasma Lactate and Fat Free Mass. Oxidative Stress 
was investigated by samples of Mitochondrial DNA. Tissue oxygenation (StO2), was measured by 
Near Infra-Red Spectroscopy. Tissue microcirculation pre and post passive physical rehabilitation 
was measured using Orthogonal Spectral Imaging.  
 
Results 
For the systematic review, from 3126 screened abstracts, ten randomised controlled trials and five 
reviews were found. Two reviewers abstracted data and assessed quality independently. Effect sizes 
and 95% confidence intervals were calculated. The mean PEDro score was 5.4. Overall there was a 
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significant positive effect favouring physical therapy for the critically ill to improve the quality of 
life (g=0.40, 95%CI 0.08, 0.71), physical function (g=0.46, 95%CI 0.13, 0.78), peripheral muscle 
strength (g=0.27, 95%CI 0.02, 0.52), and respiratory muscle strength (g=0.51, 95%CI 0.12, 0.89). 
Length of hospital (g=-0.34, 95%CI -0.53,-0.15) and ICU stay (g=-0.34, 95%CI -0.51,-0.18) 
significantly decreased and ventilator free days increased (g=0.38, 95%CI 0.16, 0.59) following 
physical therapy in the ICU. There was no effect on mortality.  
 
A significant increase in patient self-reported physical function (81.8±22.2 versus 60.0±29.4, 
p=0.04) and role physical (61.4±43.8 versus 17.1±34.4, p=0.005) for the SF-36 at six months, was 
found in the exercise group. The mean change of Interleukin-10 was significantly higher in the 
exercise group (1.8 pg/ml, 180% versus 0.9pg/ml, 90%, p=0.04). There was no significant 
difference between groups for functional tests, lactate, pro-inflammatory cytokines, muscle 
strength, fat free mass or hospital anxiety.  
 
For the measure of oxidative stress, at week 1, there was no change in the mtDNA/nDNA ratio 
following ICU exercise in the intervention group (0.74). In contrast, the ratio in control group 
changed from (0.69 to 0.78, 13%). The ratio following ICU exercise in the intervention group 
changed from (0.74 to 0.59, -20%) and control group from (0.78 to 0.51, -35%) at Week 2.  
 
A trend of increased tissue oxygenation StO2 during hyperaemia was found post exercise (p=0.06). 
Baseline StO2 to Hyperaemia StO2 showed a high percentage change from baseline from 2.6 to 6.2 
on Day 2 post exercise. No statistical significance was reached pre and post exercise for 
microvascular flow index and capillary density but trends of improved capillary density was noted 
(2.46±1.04, 3.70±1.04, p=0.06). 
 
Conclusion  
Overall the systematic review and meta-analysis revealed strong evidence favouring early 
rehabilitation in intensive care in general ICU patients including significant positive effects for 
quality of life, physical function, peripheral and respiratory muscle strength, increasing ventilator 
free days and decreasing hospital and ICU stay. However, further controlled trials of better quality 
and larger sample sizes are required to verify the strength of these tentative associations.          
 
The clinical trial produced evidence that early physical rehabilitation in intensive care resulted in 
improved self-reported physical function and role physical for health-related quality of life. Within 
one week of ICU admission, ICU exercise induced systemic anti-inflammatory effects and did not 
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worsen plasma lactate levels in sepsis syndromes. A possible trend towards favourable effects on 
pro-inflammatory cytokines if confirmed would support a role for early physical rehabilitation. The 
effect of early exercise in ICU can improve tissue oxygenation and should be further investigated. 
No oxidative stress resulted with early ICU physical rehabilitation but further investigations are 
required.  
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CHAPTER 1  
Thesis Overview 
1.1 Statement of Problem  
With increased survival from an intensive care admission, optimisation of recovery is an important 
objective. While there is increased awareness of the importance of early rehabilitation in the 
intensive care unit (ICU), the strength of the existing evidence and the optimal approach has not yet 
been defined and is based on expert consensus [1]. Furthermore, early physical rehabilitation for 
patients such as those with sepsis syndromes is still regarded as potentially causing harm and 
remains controversial [2]. In addition, the short-term systemic effects of early exercise from 
admission in acute disease processes are still unknown and require exploration in order to advocate 
safe management. 
1.2 Justification for Research 
There has been increasing interest in a possible role for early rehabilitation [3-9] in preventing Post 
Intensive Care Syndrome (PICS) [10] in the critically ill. In particular, Intensive Care Unit 
Acquired Weakness (ICU-AW) has become a common problem in mechanically ventilated patients 
[11, 12]. Although the etiology of this weakness is multifactorial, muscle injury from systemic 
inflammation along with deconditioning from immobilisation are principal contributors [13-15]. 
The introduction of exercise during early critical illness is targeted to alleviate illness severity and 
long-term debility. As exercise intervention remains unexplored in aggressive inflammatory 
conditions such as sepsis syndromes, there is lack of strong evidence for benefits of its 
implementation early. Additionally, some disease presentations can involve microcirculatory 
dysfunction and oxidative stress. Currently, it is not known if early exercise would worsen these 
presentations. Mechanisms of effects of early rehabilitation in critical illness are still needing 
detailed definition to assist with the development of physiotherapy programs with greater efficiency 
and impact [16]. By exploring these factors, we would be better able to propose that early exercise 
in acute diseases such as sepsis is safe with clinical benefit. 
1.3 Aims of Thesis 
The first aim of this thesis was to systematically review the published literature and evaluate the 
evidence on physical rehabilitation practices in the ICU during critical illness. This encompasses 
work that determines the effects of ICU physical rehabilitation through a meta-analysis of 
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randomised controlled trials. Secondly, the thesis aimed to evaluate the physical, psychological and 
physiological effects of early ICU physical rehabilitation during critical illness targeting patients 
with sepsis syndromes. In addition, the thesis also aimed to be the first to report on the effect of 
exercise on oxidative stress and tissue oxygenation. The specific aims and hypotheses of the Thesis 
are detailed in Chapter 3. In this thesis, the term “physical rehabilitation” is used as an overall term 
to define specific types of physical exercise strategies including electrical muscle stimulation, 
passive range of motion, active range of motion, resisted exercises, tilt table therapy, sitting out of 
bed, sitting over edge of bed, transfers, ambulation and other mobilisation techniques that involves 
physical movements as part of therapy.  
1.4 Orientation of Thesis 
The thesis has been classified into three sections and includes nine chapters overall.  
Section 1 comprising of Chapters 1and 2 provides foundation and background literature for the 
research.  
 
Chapter 1 is the introduction to the thesis and an overview of the thesis. Chapter 2 provides a 
substantial literature review on the prevalence and manifestation of ICU acquired weakness during 
critical illness and specific literature pertaining to the presentation of sepsis syndromes upon which 
the studies comprising the thesis were based and reviews the evidence and rationale on physical 
rehabilitation strategies and techniques used in the ICU during critical illness. 
 
Section 2 comprising of Chapters 3, 4 and 5 presents the approach to address the main aims of this 
thesis.  
 
Chapter 3 details aims and hypotheses of the thesis. Chapter 4 addresses the first aim of the thesis 
with systematically reviewing the current physical rehabilitation practices for the critically ill in the 
ICU using a meta-analysis. Chapter 5 attends to the second aim of the thesis detailing the methods 
and materials and includes the protocol manuscript of the randomised controlled trial.  
 
Section 3 presents results and derives conclusions from the prospective randomised controlled trial 
and discusses the clinical significance of the thesis in Chapters 6, 7, 8 and 9.  
 
Chapter 6 presents the results of the research in terms of the physical, psychological and 
physiological effects of early physical rehabilitation in sepsis. Chapter 7 presents the results of the 
research investigating the effects of early physical rehabilitation and oxidative stress using 
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mitochondrial DNA in sepsis. Chapter 8 presents the results of the research investigating the 
effects of early physical rehabilitation in sepsis on tissue oxygenation and microcirculation. 
Chapter 9 summarises the research findings, discusses strengths and limitations of the research 
findings and discusses the recommendations for clinical practice and implications for future 
research.  
 
This thesis presents one systematic review including a meta-analysis, one methodological paper 
reporting the research protocol and three experimental studies comprising of a randomised 
controlled trial and two smaller pilot trials. Five manuscripts have been generated and incorporated 
into chapters of this Thesis:  
 
1. Kayambu G, Boots RJ, Paratz JD. Physical therapy for the Critically Ill in the ICU: A 
Systematic Review and Meta-Analysis. Crit Care Med. 2013 Jun;41(6):1543-54. doi: 
0.1097/CCM.0b013e31827ca637 (Incorporated into Chapter 4). 
 
2. Kayambu G, Boots RJ, Paratz JD. Early Rehabilitation in Sepsis: A Prospective Randomised 
Controlled Trial investigating Functional and Physiological Outcomes The i-PERFORM Trial 
(Protocol Article). BMC Anesthesiol. 2011 Oct;11:21. doi: 10.1186/1471-2253-11-21 
(Incorporated into Chapter 5). 
 
3. Kayambu G, Boots RJ, Paratz JD. Early Physical Rehabilitation in Intensive Care Patients with 
Sepsis Syndromes – A Pilot Randomised Controlled Trial. Intensive Care Medicine 2015 
May;41(5), doi: 10.1007/s00134-015-3763-8. (Incorporated into Chapter 6). 
 
4. Kayambu G, Boots RJ, Pfluger C, Lin CY, Paratz JD. Early Exercise in Intensive Care does not 
appear to Cause Oxidative Stress in Patients with Sepsis Syndromes (Incorporated into Chapter 
7). 
 
5. Kayambu G, Boots RJ, Paratz JD. Early Exercise in Intensive Care shows Trends of 
Improvement in Tissue Microcirculation and Oxygenation in Patients with Sepsis Syndromes 
(Incorporated into Chapter 8). 

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CHAPTER 2  
Review of Literature  
2.1 Critical Illness  
With healthcare advances, short-term mortality from critical illness related to severe sepsis and 
septic shock is declining in Intensive Care Unit (ICU) patients [17]. However, ICU associated 
factors such as immobility, dependence on mechanical ventilation, infection, delirium and sepsis are 
contributors to long-term complications of critical care [18]. As a result, long-term mortality of ICU 
patients is increasing ranging between 26% to 63% [19] and survivors are left with a legacy of 
longstanding physical, neurocognitive and quality of life impairments [20, 21]. This may then lead 
to chronic critical illness which is a discrete and complex syndrome of physiologic abnormalities, 
organ dysfunction, and neuroendocrine and immunologic dysfunction [22]. 
 
Effects of Prolonged ICU Stay 
An estimated 2% to 11% of critically ill patients require prolonged stays in the ICU which accounts 
for 25 to 45% of total ICU days [23]. In addition to the debilitative effects of the disease on skeletal 
muscles, heavy sedation and bed rest are known contributors to prolonged stays in mechanically 
ventilated ICU patients [24-27]. Survivors of prolonged intensive care stays, exhibit severe 
psychological and physical problems [28] and have an impaired quality of life up to one year 
following discharge from the hospital [29] (Figure 2.1). In a recent conference [30], the term “Post 
Intensive Care Syndrome” was derived in consensus to describe new or worsening impairments in 
physical, psychological and cognitive status arising after critical illness and persisting beyond acute 
care hospitalisation [10]. 
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Figure 2.1 Patient and ICU risk factors for long-term physical complications [18]  
Reproduced from Desai SV, Law TJ, Needham DM. Long-term complications of critical care. Critical Care 
Medicine 2011; 39(2):371-379 with permission from Wolters Kluers HealthLippincott Williams & 
Wilkins©. 
2.2 ICU Acquired Weakness 
Intensive care unit acquired weakness has been recognised as a persistent complication in survivors 
of critical illness which can result in prolonged functional decline and decreased quality of life [20, 
21]. Reasons for the development of ICU acquired weakness are multifactorial. Due to different risk 
factors, terminology and clinical outcomes, this severe ICU syndrome previously lacked a clear 
definition [31, 32].  
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Definition of ICU Acquired Weakness 
Currently, a new diagnosis and classification to aid in clear and consistent identification of critically 
ill patients presenting with ICU-AW in the ICU has been proposed [31]. “ICU Acquired Weakness” 
is defined based on diffuse, symmetric, generalised muscle weakness. Global estimation of muscle 
strength can be detected by physical examination using the Medical Research Council (MRC) 
sumscore ranging from 0 to 60. A MRC sumscore of <48 or a mean MRC of <4 per muscle group is 
used to define ICU-AW [27, 32-34]. Depending on electrophysiological or histological findings, 
ICU-AW can be further subclassified with documented axonal polyneuropathy as “Critical Illness 
polyneuropathy (CIP), documented myopathy as “Critical illness Myopathy (CIM) and the 
occurrence of both of these conditions as “ Critical Illness Neuro Myopathy (CINM)” [35] (Figure 
2.2).   
 
 
Figure 2.2 Clinical, electrophysiological and histological features of ICU-AW [36]  
Reproduced from Lee CM, Fan E. ICU-acquired weakness: what is preventing its rehabilitation in critically 
ill patients? BMC Med 2012; 10(115) with copyrights from BioMed Central Ltd.  
 
Contributing Factors to ICU-AW 
The adverse effects of bed rest and immobility have been well documented in the literature both in 
ICU and non-ICU populations and may act as contributing factors to ICU-AW. Myopathic changes 
leading to skeletal muscle atrophy are known consequence of prolonged bed rest following critical 
illness for both the peripheral and respiratory muscles [13]. Inactivity reduces muscle strength by 1-
1.5% daily [37, 38] while specific immobilisation can result in up to 5-6% of significant loss in 
strength per day [39]. After one week of bed rest, postural muscle strength decreases in healthy 
volunteers by 10% [40]. Myosin isoforms change from slow to fast twitch fibres and muscle 
metabolism changes from predominantly using fatty acids to glucose resulting in decreased protein 
synthesis [41, 42] which all affects muscle contraction.  
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Figure 2.3 Process of weakness deriving from muscle unloading [13]  
Reproduced from Chambers M, Moylan J, Reid M. Physical Inactivity and muscle weakness in the critically 
ill. Crit Care Med 2009;37(10):S337-S346 with permission from Wolters Kluers HealthLippincott Williams 
& Wilkins©. 
 
In critical illness, the additional factors of multi-organ failure [43], mechanical ventilation [44], 
drugs such as corticosteroids and muscle relaxants [45], inflammatory cytokines [46] and catabolic 
processes [47] all contribute to the progression of muscle weakness. The onset can be rapid. A 
reduction in evoked skeletal muscle force has been noted as early as 24 hours after the onset of 
sepsis and multi-organ failure [43]. Short durations of immobility increases skeletal muscle 
vulnerability to atrophy and the loss of muscle mass  reducing muscle strength [43] (Figure 2.3).  
2.3 Sepsis Syndromes 
Definition of Sepsis  
Almost a quarter of critically ill patients who suffer prolonged ICU stay are either admitted with or 
develop sepsis; a severe, specific inflammatory response to infection, during the course of their stay 
in the ICU [48]. Physiological responses to inflammation in addition to the presence of a suspected 
or proven infection present an internationally accepted definition for “Sepsis” [49, 50]. As the 
disease progresses, the syndromes presented are termed severe sepsis and septic shock [51] (Table 
2.1).    
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Table 2.1 Criteria for SIRS and sepsis syndromes ( modified from Dellinger et al [51] )  
 
HR; Heart Rate, RR; Respiratory Rate; WCC; White Cell Count, T; Temperature, SIRS; Systemic 
Inflammatory Response Syndrome, SABP; Systolic Arterial Blood Pressure. 
 
Pathophysiologically, the activation of antigen-presenting immune cells occurs upon an infection 
[52] followed by immune mechanisms such as cytokine liberation, endothelium and complement 
activation and release of oxygen radicles. Cytokines; Tumour Necrosis Factor–alpha (TNF-α), 
Interleukin-6 (IL-6) and Interleukin-1 (IL-1) and complement factors C3a and C5a facilitate 
inflammation [53]. This is followed by the up regulation of key anti-inflammatory cytokines such as 
Interleukin-10 (IL-10) and Tumour Necrosis Factor-β (TNF-β) as a protective response to 
leucocytosis or acute organ failure that might develop [52]. Eventually, this may lead to hypo-
inflammatory states that can result in nosocomial infection, chronic multiple organ failure leading to 
prolonged ICU stay and increased mortality [54-56]. 
 
Effects of Sepsis  
Sepsis is the leading cause of death in critically ill patients and is associated with multi organ failure 
[52, 57]. The increasing incidence of sepsis syndromes causes a substantial burden for health care 
systems [58, 59]. Increasing disease severity correlates with increasing mortality, rising from 25-
30% for severe sepsis and up to 40-70% for septic shock [60]. The ongoing mortality may be up to 
2 years beyond the 28-day in-hospital mortality and decrements in quality of life [61]. While, more 
than 70% of patients with sepsis or multi-organ failure suffer prolonged neuromuscular weakness 
[62], 5 to 10 percent of survivors become chronically critically ill with profound global weakness 
[63], reduced skeletal muscle force and consequent fatigue [43] which can result in the debilitation 
of physical function. The consequent decrease in endurance of respiratory muscles [44], necessitates 
prolonged mechanical ventilation contributing to 37% of ICU resources [64]. 
 
Syndrome Criteria Mortality 
Systemic Inflammatory 
Response Syndrome (SIRS) any 
two or more of the following 
criteria 
 HR>90bpm 
 RR>20/min or PaO2<32mmHg 
 WCC<4 x 109 cells/L or > 12 x 109 cells/L or  
>10% immature bands 12,000 
 T>380C or < 360C  
 
Sepsis  SIRS + proven infection 15% 
Severe sepsis  Sepsis + failure of one or more organs 20% 
Septic shock  Severe sepsis + cardiovascular failure despite 
adequate fluid resuscitation (usually SABP < 
90mmHg or >40mmHg from baseline) 
45% 
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Systemic inflammatory processes can aggravate and accelerate the rate of muscle wasting in 
addition to the immobility associated with sepsis in its early stages. Muscle wasting and activity 
intolerance occur early in sepsis and prolongs the recovery from critical illness [65]. There is 
evidence that specific decreases in muscle mass and muscle force occur in sepsis syndromes of both 
peripheral and respiratory muscles caused by a variety of mechanisms [66]. A combination of the 
catabolic effects of the major illness stress response [67], poor nutrition [68], systemic 
inflammation [46], immobility [69] result in the loss of large amounts of muscle mass. This is 
thought due to proteolysis [47] which manifests as specific critical care weakness syndromes [70].  
 
While early exercise can be hypothesised to prevent muscle mass loss and the development of 
weakness syndromes, it is equally important to establish that early movements or exercise in sepsis 
does not result in increased oxidative stress, fatigue or cause further substantial tissue injury. 
2.4 Sepsis Induced Myopathy and Myoneuropathy 
Myopathy is likely to manifest as the major feature of ICU-AW and precedes polyneuropathy in 
patients with CINM [71]. In CIM, predominant Type II (Fast Twitch) muscle fibre atrophy is seen 
within muscle tissue and patchy loss of thick myosin filaments is visible. In contrast, CINM is 
characterised by non-excitable muscle membrane (Figure 2.4). These factors may contribute to 
ICU-AW. Loss of muscle mass and thick muscle filaments decreases muscle force and non-
excitable muscle membrane may fail to generate muscle contractions.  
 
While these mechanisms are speculated, the causes of sepsis-induced myopathy and myoneuropathy 
still remain inconclusive [66]. It is hypothesised that the prevention of excessive proliferation of 
pro-inflammatory cytokines [46], proteolytic pathways and the avoidance of marked increase in 
free-radical generation [72] can diminish the catabolic skeletal muscle changes in sepsis [47]. The 
mechanisms behind these are still speculative based on possible risk factors [70, 73]. However, 
inflammation and immobilisation have been found to be significant, independent risk factors in the 
development of critical illness polyneuromyopathy [62]. Intervention with exercise to prevent this 
condition therefore warrants exploration. 
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Figure 2.4 Mechanisms of dysfunction in critical illness polyneuromyopathy [74]  
Reproduced from Pati S, Goodfellow J, Lyadurai S. Approach to critical illness polyneuropathy and 
myopathy. Postgrad Med J 2008;84(993):354-360 with permission from BMJ Publishing Group Ltd. 
2.5 Systemic Inflammatory Response  
2.5.1 Cytokine Modulation  
Inflammatory biomarkers can be used to identify disease severity in sepsis [75]. Pathogens in the 
bloodstream elicit the inflammatory process releasing pro-inflammatory cytokines, IL-1, IL-6 and 
TNF-α. This inflammatory cascade is illustrated in Figure 2.5. This acute rise in these cytokines 
occurs as result of the immune response to sepsis which then releases other mediators causing 
subsequent multiorgan tissue damage and dysfunction and death. Interleukin-10 is an anti-
inflammatory cytokine which is known to prevent proteolysis [76] . 
 
There is an established association between pro-inflammatory cytokines and skeletal muscle 
weakness and wasting in diseases such as Chronic Obstructive Pulmonary Disease (COPD) [77, 
78]. A similar effect would be expected in sepsis. In particular, pro-inflammatory cytokines; 
Interleukins-1 alpha and beta (IL-1α and IL-1β), IL-6 and TNF-α are associated with muscle and 
myocyte degeneration, muscle atrophy and subsequent inhibition of protein synthesis [79] and that 
can result in muscle mass loss and force [43] (Figure 2.6). Therefore defining the state of the 
inflammation in a study of exercise in the critically ill is important.  
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Figure 2.5 Inflammatory cascade in sepsis [80]  
 
Reproduced from Pedersen BK, Febbraio MA. Muscle as an Endocrine Organ: Focus on Muscle-Derived 
Interleukin-6 with copyrights from Physiological Reviews 2008;88(4):1379-1406. 
 
However, the greater inflammatory response in sepsis syndromes than is present in stable COPD 
may be associated with greater and possibly irreversible proteolysis [66]. Furthermore, the unloaded 
muscles of bed ridden patients, contribute to an additional decrease in protein synthesis and 
increased  protein degradation via proteolytic pathways or apoptosis [81]. Several cytokines have 
been studied in critical illness; the roles of IL-6 and IL-10 are of particular interest with their 
associations with sepsis pathogenesis, morbidity and mortality. IL-6, IL-10 and IL-1β correlate with 
the severity of sepsis and the evolution of organ failure as measured by the Sequential Organ 
Failure Assessment (SOFA) score and mortality [75]. 
 
Interleukin 6 (IL-6)  
In sepsis, persistent elevation of circulating levels of Interleukin-6 has been linked to elevated 
mortality [82] and correlates with poor outcomes [83]. Interleukin-6 has been implicated in the  
promotion of  infiltration of myocytes with additional inflammatory factors such as prostaglandins 
leading to inhibition of protein synthesis and apoptosis [81]. This has been shown to result in the 
loss of muscle mass and contractile force in animal studies [62].   
Time 
Plasma 
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Cross-talk between muscle and immune cells in pathologic conditions such as sepsis allows muscle 
repair and regeneration following acute skeletal muscle injury initially. In immobility, the immune 
system is stimulated mediating inflammation. Myokines are recently recognised as potential 
candidates for treating metabolic diseases through their ability to increase glucose uptake, and 
improve lipolysis [84]. With exercise, the skeletal muscle expresses several myokines such as IL-6, 
IL-8 and Interleukin-15 (IL-15) and brained derived neurotrophic factor (BDNF). IL-6 as a myokine 
is known to increase up to 100-fold in the circulation during physical exercise [80]. However, in 
immobility due to prolonged ICU bedrest, this may not happen affecting the local signal in its 
ability to increase glucose uptake and fat oxidation [85]. In addition to the inflammatory process of 
sepsis, the immunological side effects of immobility may be further detrimental. 
 
Tumour Necrosis Factor (TNF-)  
Elevated levels of circulating Tumour Necrosis Factor- occurs in sepsis and septic shock [86]. 
TNF- causes cytopathic changes via receptor mediated signalling pathways and is present in high 
concentrations in both blood [87] and tissues [88] in sepsis. Excessive levels of TNF- can cause 
heightened inflammatory reactions and tissue injury and it is associated with mortality in septic 
patients. This cytokine is considered linked to the development of cachexia [46] along with IL-6. 
TNF- and IL-1 have been shown to be released in large quantities within in systemic inflammation 
[89] aggravating the inflammatory process. In muscles, TNF- overexpression causes skeletal 
myopathy and endothelial dysfunction, leading to myocyte apoptosis and decreases in skeletal 
muscle mass with subsequent weakness [90]. In an animal model, TNF- decreased the force of 
contraction [91] with catabolic effects. This leads to protein loss and disruption of myogenesis [92]. 
TNF- by inducing apoptotic cell death can result in the skeletal muscle wasting that occurs in 
chronic diseases [93] which has been associated with a significant impairment of functional work 
capacity [94]. 
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Figure 2.6 Mechanisms and consequences of metabolic response to critical illness [79]  
Reproduced from Hadley JS, Hinds CJ. Anabolic strategies in critical illness. Curr Opin, Pharmacol 2002; 
2(6):700-707 with permission from Elsiever©. 
2.5.2 Hyperlactaemia  
Hyperlactaemia [95] is a marker of disease severity in patients with sepsis syndromes [96] with 
clearance of lactate often impaired [97]. Accelerated aerobic glycolysis induced by sepsis-
associated hyperlactaemia has been proposed as a more likely explanation for sepsis-associated 
hyperlactaemia [98]. Increased lactate comes from a combination of increased membrane glycolysis 
for sodium pumping through the inflammatory signalling [99] and reduced lactate clearance by the 
liver and also immobilised skeletal muscle. Lactate is an important energy transfer metabolite and 
“Cori cycle” used by many tissues avoid unnecessary oxidative metabolism [100]. Approximately 
half of available lactate is disposed off via oxidation at rest, and 75 to 80% during exercise [101]. In 
exercising human skeletal muscle simultaneous lactate uptake and release by muscle can occur 
[102] and hence reduce the lactate uptake in immobilised skeletal muscle. Lactate can be 
metabolised by the liver and the kidney either by direct oxidation or as a source of glucose. 
Hyperlactaemia in sepsis is due to the high widespread membrane inflammatory assault coupled 
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with the impairment of hepatic metabolism. In sepsis, the amount of lactate not oxidised or 
converted into plasma glucose, however, remains substantial (approximately 30%) and becomes a 
substrate for glycogen synthesis by the liver and the kidney. Hepatic mitochondria however are far 
more susceptible to damage and the toxicity of hyperglycaemia may have illustrated this which was 
not measured in this study [103]. 
As clearance represents the removal of a substance from a unit of volume over a unit of time, 
typically expressed in millilitres per minute, logically, it is impossible to know if the rate and/or 
amount of decline in by sepsis-associated hyperlactaemia is due to increased removal, decreased 
production, dilution because of fluid administration during resuscitation or all the above in variable 
combinations. Moreover, increased lactate production can remain concealed by increased utilisation 
in septic patients, suggesting that a normal blood level of lactate does not prove that its metabolism 
is normal [104].   
Importantly however, as lactate is an important energy transfer metabolite, circulating lactate will 
reflect the balance between production versus clearance to indicate fluxes in oxidative metabolism 
for monitoring effects of exercise in critically ill patients.  
2.5.3 Oxidative Stress 
Oxidative stress and systemic inflammation 
Oxidative stress occurs in many ICU syndromes and diseases, including sepsis [105]. In sepsis, 
increased Reactive Oxygen Species (ROS) [106] or decreased antioxidant defences [107] occur in 
tissues. Sepsis can activate various cells such as macrophages, neutrophils, endothelial and 
epithelial cells causing the release of a number of mediators including cytokines. This sequence of 
activity leads to immune cell activation with the release of ROS. The amount of oxidants drastically 
increases with the induction of immune response. Tumour Necrosis Factor- can induce oxidative 
burst in neutrophils and activate the production of ROS in patients with systemic infection [108]. 
When this response is overstimulated, it may a widespread inflammatory disease systemic infection 
in distal organs resulting in Multi-Organ System Failure (MOSF) and eventual death [109].  
 
Oxygen-derived free radicals play an important role in the development of disease in critically ill 
patients. When free radical production exceeds the antioxidant capacity to buffer oxidants, oxidative 
stress occurs [110]. Under physiological conditions, a homeostatic balance exists between the 
formation of reactive oxygen species and their removal by antioxidant compounds [111]. Oxidative 
stress occurs when this balance is disrupted. Excessive production of ROS such as superoxide, 
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hydrogen peroxide and hydroxyl radicals; or inadequate antioxidant defences by changes in 
superoxide dismutase, catalase, vitamins C and E and glutathione contribute to this imbalance 
[112]. During oxidative stress in sepsis, ROS and Reactive Nitrogen Species (RNS) can mediate 
tissue injury by altering cellular signal transduction and gene activation [113]. The expression and 
control of the immuno-inflammatory response by cytokines is therefore affected [114]. Oxidation of 
DNA and proteins along with membrane damage due to lipid peroxidation, result in alterations to 
membrane permeability, modification of protein structure causing proteolysis and functional 
changes [115]. In particular, oxidative damage to mitochondrial membrane can occur which can 
lead to mitochondrial damage such as mutations in Mitochondrial DNA (mtDNA) and resultant 
apoptosis ultimately producing cell death [72]. 
 
Oxidative stress and skeletal muscle atrophy  
 
Figure 2.7 Mechanism of reactive oxygen species causing muscle atrophy [116]  
Reproduced from Powers S, Smuder AJ, Criswell D. Mechanistic links between oxidative stress and disuse 
muscle atrophy. Antioxid Redox, Signal 2011;15(9):2519-2528 with permission from Mary Ann Liebert Inc. 
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Oxidant activity increases during periods of mechanical unloading such as during prolonged 
immobilisation or bedrest [117]. Oxidative injury occurs during periods of disuse of locomotor 
skeletal muscles [117] and in the unloaded diaphragm during prolonged mechanical ventilation 
[118, 119]. Oxidative stress is an important atrophic stimulus in unloaded muscle [120]. It promotes 
atrophy by modifying redox-sensitive processes in the muscle fibres [111, 113]. Excessive free-
radical generation plays a pivotal role in the induction of sepsis-induced myopathy [66] but at 
present, the specific ROS mechanism to cause atrophy is not clearly known (Figure 2.7). 
Overproduction of ROS can result from a variety of stressors including physical exercise though 
this is non-specific to critically ill patients [121]. Nursing practices such as suctioning, turning and 
positioning as part of daily ICU management [72] during critical illness have been hypothesised to 
release ROS potentially aggravating cellular destruction and increasing mortality risks [122]. For 
patient safety, it is important to establish if early exercise in critical illness does contribute to 
significant oxidative stress and the potential for harm. 
 
Mitochondrial Bioenergetic Failure in Sepsis  
In patients with sepsis, an association has been found between antioxidant depletion, mitochondrial 
dysfunction, oxygen consumption and organ failure [105]. In sepsis, oxidative phosphorylation 
within the mitochondria is interrupted resulting in the inability of the cell to use molecular oxygen 
for Adenine-TriPhosphate (ATP) production, despite oxygen availability [123]. This impaired tissue 
oxygen utilisation causes mitochondrial damage in the absence of hypoxia and leads to decreased 
cellular ATP production. Bioenergetic failure has been hypothesised to be part of the mechanism 
underlying multiple organ failure and death [124, 125].  
 
Depletion of Mitochondrial DNA in Sepsis  
The mitochondrial genome is highly susceptible to oxidative stress.In a rat model of sepsis, 
mtDNA damage and deletion accompanied by decreased mtDNA transcription, preceded 
bioenergetics failure and the restoration of mtDNA integrity appeared linked to mitochondrial 
biogenesis [126]. Tissue mitochondria density is correlated with its energy requirements and can be 
measured as the number of copies of mtDNA per cell. In sepsis, it has been suggested that oxidative 
stress in the mitochondria may affect changes in mtDNA quantity [127, 128], in addition to 
mutations and deletions (Figure 2.8). Mitochondrial DNA may be a useful marker of survival in 
critically ill patients as found in oncology patients [129].  
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Figure 2.8 Mechanisms of mitochondrial damage during sepsis [130] 
Reproduced from Hoffmann S, Crouser E. Mitochondrial Mechanisms of Organ Dysfunction During Sepsis. 
Advances in Sepsis 2007;6(1):2-9 with copyrights from Remedica Medical Education and Publishing Ltd. 
 
Immobilisation during sepsis can result in dramatic decreases in mitochondrial content in both 
locomotive and respiratory muscles which can cause inadequate energy to activate the muscle 
[131]. The role of early recruitment of muscles to prevent this has not been tested. It has been 
established that in septic patients, the skeletal muscle ATP concentrations and mitochondrial 
activity are both significantly reduced in non-survivors [124]. Changes such as mutations and 
depletions in muscle mtDNA content occurs over time during critical illness. Peripheral blood 
mtDNA content which is a systemic representation of energy consumption may allow a convenient 
measure of global oxidative stress [132, 133].  
 
Copy numbers of mtDNA in Peripheral Blood White Cells (PBWC) are affected by oxidative stress 
[134]. Mitochondrial DNA changes are classically studied in skeletal muscle tissue, but recent 
observations suggest that PBWC may be useful and informative especially in sepsis [135]. The 
human leukocyte represents a useful target cell for the study of the relationship between the 
alteration of mtDNA copy number and the change of antioxidant and prooxidant status. Sampling is 
straightforward. Moreover, mitochondrial respiratory function and antioxidant capability of 
immuno-competent cells are considered to be factors which determine the ability of leukocytes to 
cope with the oxidative stress [136]. As PBWC mtDNA levels increase with exercise in normal 
subjects, thereby possibly supplying more energy [137], it can be speculated that similar effects 
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would follow acute exercise in sepsis patients. Surviving septic patients demonstrate longitudinal 
increases in mtDNA levels in their blood [135]. This may act as a marker for energy consumption 
associated with exercise in early sepsis. However, mtDNA changes in PBWC may be specific and 
may not correlate with changes in the various organs [138].  
2.5.4 Microcirculatory Compromise 
In sepsis, the dysfunction of the microcirculatory network is a pivotal element in the pathogenesis 
of the disease and the development of organ failure [139]. The normal microcirculation consists of 
the capillaries, arterioles and venules (< 100μm diameter) and distributes oxygen and nutrients to 
the tissues to maintain organ function. Blood flow through the microcirculation is severely 
disrupted in sepsis [140] (Figure 2.9). Experimental models of sepsis have demonstrated impaired 
microcirculatory flow velocity, stasis, increased heterogeneity of regional perfusion and a low 
density of perfused capillaries [141-144]. This shunting increases non-nutritive blood flow in all 
tissues at the expense of nutritive capillary flow [145]. Strategies to promote the microcirculatory 
flow could include increasing driving pressure at the entrance of the microcirculation or 
vasodilation to decrease the capillary afterload [146].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9 Microcirculatory dysfunction during sepsis [140]  
Reproduced from Ince C. The microcirculation is the motor of sepsis. Critical care 2005;9(4):S13-S19 with 
copyrights from BioMed Central Ltd. 
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2.5.5 Modulating Risk Factors for the Prevention of Sepsis-Induced Myopathy  
Any intervention that can modulate risk factors that result in detrimental effects of sepsis-induced 
myopathy will be critical to the overall management of patients presenting with sepsis syndromes. 
Preliminary evidence suggests that early exercise can modify inflammatory biomarkers in critically 
ill patients [147-149]. Prevention of harm from exercise for example oxidative stress or 
hyperlactaemia is also important. The following sections will review the literature for the early 
physical rehabilitation in the ICU as an intervention for improving outcomes and avoiding injurious 
effects in sepsis syndromes.   
2.6 Implementation of Early ICU Physical Rehabilitation in Critical Illness 
The benefits of an early rehabilitation program in an adult-based ICU can potentially generate 
financial savings which can be generated through reduction in overall ICU expenses, ICU length of 
stay, annual number of ICU readmissions and reduction in rehabilitation costs [150]. Hence, interest 
in administering a physical rehabilitation program in the ICU has increased. However, the value of 
an early ICU exercise program for the critically ill remains a clinical question with work thus far 
being observational [151, 152], retrospective [153, 154] or simple experiments [155-160]. Chapter 4 
will review the randomised controlled trials in the area of early exercise in ICU. Despite increasing 
interest in early ICU exercise, the there is little robust research largely limited by casemix 
complexity and diagnostic diversity in the critically ill.  
Expert opinions in recent years have only highlighted the lack of evidence for early ICU physical 
rehabilitation implementation. Despite this, early mobility is being used as a primary intervention 
for the critically ill ICU patient with interdisciplinary consensus amongst intensivists [3, 9, 161], 
physiotherapists [162] and registered nurses [163]. Evidence is needed to ensure that treatment 
regimes are optimal and limit risks to the patients before the comprehensive introduction of such 
approaches. 
 
Intensive Care Rehabilitation  
Presently the term intensive care unit rehabilitation covers a large variety of clinical practices. 
Survivors of critical illness experience physical, cognitive and mental health impairments. This has 
been termed post intensive care syndrome [164] (Figure 2.10). 
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Figure 2.10 Post Intensive Care Syndrome (PICS) conceptual diagram [164]  
Reproduced from Needham DM, Davidson J, Cohen H et al. Improving long-term outcomes after discharge 
from intensive care unit: Report from a stakeholders' conference. Crit Care Med 2012;40(2):502-509 with 
permission from Wolters Kluers Health, Lippincott Williams & Wilkins©. 
 
This framework highlights the importance of categorising the various aspects of rehabilitation that 
maybe required for the recovery from critical illness by an ICU survivor. While it is important to 
acknowledge the cognitive and mental health rehabilitation of critically ill patients in the ICU, there 
are very few studies [165, 166]. Specifically, physical rehabilitation can constitute strategies such 
as positioning, stretching, electrical muscle stimulation, range of motion exercises, resistive 
exercises, arm or leg ergometry, walking, mobilisation activities and aerobic training [167]. 
Physical rehabilitation will be relevant to and will constitute the main scope of this thesis. 
 
Safety of early ICU physical rehabilitation 
The safety of early physical exercise in the ICU has remained a concern in the absence of evidence. 
Criteria for the safe commencement of a physical rehabilitation program in critical illness are not 
established and current approaches tend to be conservative [168, 169]. A strategy of daily 
interruption of sedative infusions in mechanically ventilated ICU patients has been shown to reduce 
ventilation time and ICU length of stay [170] and increase return to function and ventilator free 
days [158, 171]. This practice can potentially also encourage increased interaction and participation 
in physical rehabilitation.  
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2.7 Physiological Effects of Early ICU Physical Rehabilitation Strategies 
Strategies of early physical therapy have been tested in specific groups of critically ill patients. All 
existing studies are presented in Table 2.2. The assessed endpoints of the effects of early physical 
rehabilitation in these clinical trials are summarised.  
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Table 2.2 Summary of clinical trials of early physical rehabilitation in intensive care  
Study Design n Sample Enrolment Intervention Intervention Group ICU Outcomes 
Denehy et al 2013 [166] RCT 150 ICU  
Critically Ill 
ICU stay > 5 days Mobilisation PT  
15 minutes/day 
↑ 6MWD  
Winkelman 2012 [147] Prospective 75 MSICU  MV > 48 hours Exercise 20 minutes/day 
 2 or more days 
↑ Anti-inflammatory cytokine IL-10,                 
↓ ICULOS* 
Nordan-Craft et al [172] Case series 19 ICU MV ≥ 7 days, ICU-
AW 
Progressive mobilisation 
30 minutes x 5 days/week 
↑ Strength, ↑ Functional Scores 
Montagnani 2011 [173] Retrospective 56 MICU 
tracheostomy 
MV weaning > 
7days 
Mobilisation, ergometer  
6 days/week 
↓ Dyspnea*, ↑ FIM scores** 
Morris 2011[153] Retrospective 258 ICU with RF MV requirement Mobilisation 7 days/week ↓ HOS ReADM* 
 
Yang et al 2010 [174] 
 
Prospective 126 Respiratory Care 
Centre 
MV > 14 days PROM and Progressive 
mobilisation 
↑BI, ↑TOMV 
Bourdin et al 2010[5] Prospective 20 MICU   
≥ 7 days 
MV ≥ 48 hours Functional mobility ↑ Heart and Respiratory Rate*,          
↓ Oxygen saturation* 
Polman et al 2010[175] Retrospective 49 MICU MV 24-72 hours Functional mobility ↑ Functional mobility 
↓ FIM Assistance 
Needham et al 2010[160]  
 
Case controlled 57 MICU MV ~ 1.5 days Functional mobility ↓ ICULOS, ↓ HOSLOS, ↑ Functional 
mobility**  
Zanni 2010[152] Observational 
pilot 
32 MICU MV ≥ 4 days Functional mobility ↓ UL and LL weakness *,↑ Physical 
function** 
Burtin et al 2009[176]  RCT 90 ICU > 7days Day 5 in ICU PROM/AROM, Cycle 
Ergometry 5 days/week 
↓ ICULOS, ↑QOL**, ↑ 6MWD*,↑ 
Quadriceps muscle force* 
Malkoc 2009[159]  Cohort  510 MICU Not reported Mobilisation Chest PT ↓ ICULOS*↓ TOMV* 
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Schweikert et al 2009[171]  RCT 104 ICU  
Critically Ill 
MV <  72hrs  PT / OT daily ↓ ICULOS, ↑ HOSLOS, ↓ 
Mortality*, ↑ VFD*, ↓ TOMV*, ↑ 
Function**, ↓ Delirium duration 
Paratz 2009[149] Pilot 20 MSICU MV > 48hrs Proactive rehabilitation ↓ ICULOS, ↓ TOMV, ↑ FFM**,↑ 
Physical function 
Thomsen et al 2008[158] Prospective 
Pre-post Cohort  
104 MSICU with RF 10 days after ICU 
admission  
Functional mobility and 
Ambulation 
↑ Standing and ambulating* 
McWilliams 2008 [155] Case Series 65 MICU ICU day 5 PROM to Ambulation ↓ ICULOS 
Morris et al 2008[177] Prospective 
cohort 
330 MICU with RF 48hrs of Intubation  Mobilisation program  
7 days/week 
↓ ICULOS*,↓ HOSLOS**,↓ 
Mortality, ↓ TOMV,↑ Function** 
Bailey et al 2007[157] Prospective 
Cohort   
103 RICU with RF 10 days after ICU 
admission 
x2 PT daily 
Functional mobility and 
Ambulation  
↑ Distance ambulated 
Chiang et al 2006[178] RCT 39 46-52 days after 
start of PPV 
Intubated > 14 days Limb strengthening, 
Mobilisation, Ambulation  
↑ VFD, ↑ Quads strength* 
↑ MIP, ↑ FIM** 
Porta et al 2005[179] RCT 66 Weaned from  
MV > 48 to 96 hrs 
>  48 hrs after IPPV General physiotherapy  
45 minutes/day x 6 weeks 
↓ Fatigue*, ↑MIP**,↑ Physical 
function** 
Martin 2005[154] Retrospective 
Case series 
49 RF ≥ 2 failed 
weaning 
~ 18 days after PPV PROM /AROM 
Mobilisation 
Cycle ergometer 
↓ TOMV, ↑MNIP**, ↑ FIM**, ↑ UL 
and LL Strength 
Zafiropoulos 2004[156] Prospective 
Pre post 
17 SICU MV Mobilisation therapy ↑ VE**  
Stiller et al 2004 [180] Prospective 31 ICU ICU admission Mobilisation therapy ↑ HR and Bp* 
Delany et al 2003[181] RCT 64 ICU Post-operative  Immediate post- 
operative 
Incentive Spirometer,  
Mobilisation, ambulation 
↓ HOSLOS*, ↓ QOL 
Nava et al 1998[182] RCT 80 COPD and RF 3-5 days after ICU 
admission  
PROM, Mobilisation, 
Cycle ergometer  
↓ ICULOS, ↑ MIP*, ↑ 6MWD**,          
↑ Survival days 
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*p<0.05 and **p <0.01; ReADM, Readmission; MSICU, Medical Surgical Intensive Care Unit; MICU, Medical Intensive Care Unit;  SICU, Surgical 
Intensive Care Unit; RICU, Respiratory Intensive Care Unit; MV, Mechanical Ventilation; UL, Upper Limb; LL, Lower Limb; PPV, Positive Pressure 
Ventilation; VE, Minute Ventilation; MIP, Maximal Inspiratory Pressure; FIM, Functional Independence Measure; 6MWD, 6 Minute Walk Distance; 
HOS, Hospital; VFD, Ventilator Free Days; TOMV, Time of Mechanical Ventilation; MNIP, Maximal Negative Inspiratory Pressure; RF, Respiratory 
Failure; RCT, Randomised Controlled Trial ; ICULOS, ICU Length of Stay; ICUHOS, Hospital Length of Stay; PROM, Passive Range of Motion; 
AROM: Active Range of Motion; HR, Heart Rate; Bp, Blood Pressure; IPPV; Intermittent Positive Pressure Ventilation; BI,  Barthel  Index; COPD, 
Chronic Obstructive Pulmonary Disease; FFM, Fat Free Mass, QOL, Quality of Life; PT, Physical Therapy; OT, Occupational Therapy.
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2.7.1 Passive Movements 
Passive movements of the limbs involve repeated movements of a joint to maintain movement 
range. Stretching along with passive range of motion is known to maintain muscle length and 
prevent contracture formation [183]. The stretch reflexes stimulate 1a fibres causing increased 
activation of the muscle. This intervention has been demonstrated to improve the ratio of anti to 
pro-inflammatory cytokines [148] and prevent protein degradation in immobilised critically ill ICU 
patients [184]. Continuous passive motion or passive stretch, respectively, can prevent or reduce 
muscle atrophy [184, 185].  
2.7.2 Electrical Muscle Stimulation  
Electrical muscle stimulation (EMS) therapy creates passive contraction of skeletal muscles through 
the use of low-voltage electrical impulses via electrodes on target muscle groups. Electrical 
simulation is capable of increasing muscle oxidative properties by mimicking repetitive muscle 
contractions during mild exercise, with improvement in intramuscular blood flow, maximal muscle 
force output and force endurance [186] with minimal cardiorespiratory stress or patient 
participation. Electrical muscle stimulation to major muscle groups such the rectus femoris has been 
demonstrated to preserve muscle mass by about 40% [16], improve microcirculation through 
reperfusion rate by about 5% [187] potentially improving muscle oxygenation in the critically ill. 
Table 2.3 summarises the clinical trials investigating the effects of EMS in critically ill patients. 
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Table 2.3
 
Summary of clinical trials of electrical muscle stimulation in intensive care [195] 
ALM, Active Limb Mobilisation; BLt, Bilateral; ULt, Unilateral; MRC, Medical Research Council; EMS, Electrical Muscle Stimulation; E, EMS group; C, Control 
group; MF, Medium Frequency; HF, High Frequency; Hz, Hertz; μs, microseconds.
Study Control Intervention EMS parameters Outcomes 
Angelopoulos et al [188] - EMS to vastus lateralis, vastus 
medialis, peroneus longus muscles 
(BLt): 30 min/day  
Frequency:  75 Hz / 45Hz 
Pulse duration:  400 μs 
Intensity: motor threshold 
Endothelial reactivity and Vascular 
Reserved in both MF and HF 
improved (p < 0.05)  
Gerovasili et al [16] Usual care Usual care + EMS to quadriceps and 
peroneus longus (BLt):  
55 minutes/day × 8 days 
Frequency: 45 Hz 
Pulse duration: 400 μs 
Intensity: 37-38 mA (mean) 
Rectus femoris and vastus 
intermedius thickness decreased less 
for E than C (p < 0.05); d = 0.11-0.39 
(small-moderate) 
Gruther et al [189] Sham EMS EMS to quadriceps (BLt):  
30-60 minutes/day × 5 days/week  
× 4 weeks 
Frequency: 50 Hz 
Pulse duration: 350 μs 
Intensity: tolerance 
Quadriceps thickness increased only 
for E (long-term patients)  
(p < 0.13);d = 0.36 (moderate) 
Karatzanos et al [190] Usual care Usual care + EMS to quadriceps and 
peroneus longus (BLt):  
55 minutes/day × 7 days/week  
until ICU discharge 
Frequency: 45 Hz 
Pulse duration: 400 μs 
Intensity: motor threshold 
MRC scores for wrist flexion, hip 
flexion, ankle dorsiflexion (p < 0.05) 
and knee extension (p < 0.01) were 
greater for E  
Poulsen et al [191] Contralateral 
side acted as 
control 
EMS to quadriceps (ULt):  
60 minutes/day × 7 days 
Frequency: 35 Hz 
Pulse duration: 300 μs 
Intensity: motor threshold +50%  
Quadriceps volume decreased for 
both C and E, with no difference 
between sides (p = 0.1) 
Rodríguez et al.[192] Contralateral 
side acted as 
control 
EMS to biceps brachii and quadriceps 
(ULt): 2 × 30 minutes/day × 13 days 
Frequency: 100 Hz 
Pulse duration: 300 μs 
Voltage: 20-200 V 
MRC scores for elbow flexion  
(p = 0.005) and knee extension (p = 
0.034) were greater for E than C.  
Routsi et al [193] Usual care Usual care + EMS to quadriceps and 
peroneus longus(BLt):55 minutes/day  
× 7 days/week until ICU discharge 
Frequency: 45 Hz 
Pulse duration: 400 μs 
Intensity: motor threshold 
Global MRC score was greater for E 
than C (p = 0.04) 
Zanotti et al [194] ALM: 5 
days/week  
× 4 weeks 
ALM + EMS to quadriceps and glutei 
(BLt): 25-30 minutes/day  
× 5 days/week × 4 weeks 
Frequency: 8-35 Hz 
Pulse duration: 250-350 μs 
Intensity: motor threshold 
MRC score increased more for E than 
C (p < 0.02); d = 1.44 (large) 
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2.7.3 Active Upper Limb Movements 
Active upper limb exercise is administered as a supported arm exercise, using arm ergometry or as 
an unsupported arm exercise, using free weights or active range of motion. However, the potential 
benefits of an upper limb exercise program in critically ill patients have received limited 
investigation. Three clinical trials investigated supported arm exercise [154] or unsupported arm 
exercise [178, 182] as a component of whole body physical therapy. Although it is not possible to 
independently evaluate the contribution of arm exercise, all three studies provide support for 
benefit. In particular, an increase of 1 point in upper extremity motor strength score was associated 
with a near 7 day reduction in weaning time [154]. In another RCT [179], Maximal Inspiratory 
Pressure (MIP) improved by about 20% and dyspnea and muscle fatigue decreased by about 30% 
after supported arm training. Resisted upper limb exercise has also been demonstrated to increase 
the trans-diaphragmatic pressure (Pdimax) with the potential to prevent loss of strength in the 
respiratory muscles [196]. This may improve weaning from the mechanical ventilator. In summary, 
the independent benefit of arm exercise is difficult to evaluate. Upper limb exercises are probably 
more effective and beneficial when included in whole body rehabilitation. The application of 
resistive exercises is dependent on cardiovascular function [197] and has only been tested in non-
critically ill patients [198, 199]. 
2.7.4 Cycle Ergometry  
Motorised cycle ergometry for passive movements is becoming increasingly feasible for sedated, 
immobile patients with severe critical illness and plays a role in preserving muscle architecture 
[184]. The safety, feasibility and efficacy of active cycle ergometry in the ICU setting has been 
evaluated in a recent randomised controlled trial [176]. Quadriceps force improved by near 15%, 6-
minute walk distance by almost 30% with both of these parameters contributing to overall improved 
benefits to physical function and quality of life [176]. This trial investigated an early exercise 
approach in the critically ill but the use of cycle ergometry limited the independent benefit 
assessment of the components of the exercise therapies. There has been only been four 
investigations of cycle ergometry in the critically ill population [176, 200-202]. 
2.7.5 Tilt Table Therapy  
Tilt tables in the ICU are used to assist critically ill patients into standing. It is used as a technique 
to minimise the adverse effects of prolonged immobilisation such as orthostatic hypotension, 
reduced oxygen consumption, venous pooling, reduced lung volumes, impaired gas exchange, 
muscle atrophy, joint contractures, peripheral nerve injuries, and pressure areas [203]. Early 
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rehabilitation including tilting is also recommended for chronically critically ill patients to improve 
functional outcome following discharge from intensive care [204]Tilt table therapy has also shown 
to increase minute ventilation, oxygen saturation and spontaneous tidal volumes all of which were 
sustained after intervention [205]. However, at present there is no evidence for the medium or long-
term benefits of this intervention.   
2.7.6 Mobilisation with Mechanical Ventilation 
Early mobilisation can be initiated when patients are hemodynamically stable to include progressive 
therapeutic activities such as bed mobility exercises, sitting on the edge of the bed, standing, 
transferring to a chair and ambulation which may require the use of special equipment and 
continued cardiovascular monitoring [206]. Such active mobilisation in intensive care has been 
associated with a decreased risk of readmission to ICU [207]. In a novel study, early physical and 
occupational therapy in critically ill patients who were mechanically ventilated and had sedation 
interrupted every morning for a sequential mobilisation protocol achieved activity levels early and 
showed no major adverse events. Improved return to premorbid independent functional status at 
hospital discharge and reduced ventilator time by approximately 48 hours were evident from the 
early mobility regimen [171]. There is at present no direct evidence that early mobilisation is 
beneficial for patients with sepsis syndromes despite its recommendation in academic reviews [4, 
9]. Some improvements in ICU, hospital and patient outcomes have been found in observational 
prospective studies [157, 158] and in limited randomised controlled trials [171, 176, 181, 208, 209] 
but only in the general ICU population.   
2.8 Potential Role of Early Exercise in Preventing Detrimental Effects of Sepsis 
The application of early ICU physical rehabilitation strategies has become more common in the 
ICU critically ill population but is yet to be specially assessed in patients with sepsis syndromes. 
Conservatively, simple passive movements [184] and electrical muscle stimulation [187, 193, 210] 
as a precursor to active mobilisation can induce microcirculatory changes that may attenuate the 
anti-inflammatory effects in early sepsis. The roles of pro-inflammatory cytokines, mitochondrial 
changes and muscle proteolysis in causing sepsis-induced myopathy are hypothesised from animal 
models [66, 72] but remain to be tested in humans. It is postulated that exercise can modulate 
cytokine levels [211], ROS production [120] and ATP levels [131] in patients with sepsis. In 
conjunction with an early mobility protocol, ambulation during mechanical ventilation in the early 
stages of critical illness is becoming widely practiced [6, 8, 157], especially with interruption of 
sedation [158, 170, 171]. However, this remains to be tested in patients with sepsis syndromes.  
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2.9 Summary 
Sepsis is the leading cause of death in critically ill patients and is associated with multi organ 
failure. Survivors of intensive care present with severe physical, neurocognitive and quality of life 
impairments but patients with sepsis are particularly at risk because of the systemic inflammatory 
processes that aggravate and accelerate the rate of muscle wasting in addition to the immobility 
associated with the disease in its early stages. Consequent physical debilitation prolongs the 
recovery and return to function. Early exercise may prevent the detrimental effects of sepsis. 
Currently, there is increasing interest and studies in the area of ICU physical rehabilitation in 
critically ill patients.  
 
Hence, to determine the evidence in this area, a systematic review of the literature will be 
conducted. Upon establishing the evidence, an investigation of the effects of early physical 
rehabilitation in sepsis will be conducted. Furthermore, short-term systemic effects of exercise in 
the ICU remain to be defined. The physiological mechanisms of exercise strategies in the early 
stages of inflammatory conditions on oxidative stress, disease severity and microcirculatory 
alterations need to be identified. Exploring these pertinent factors in response to exercise can 
contribute to determining the safety of early physical rehabilitation in sepsis syndromes. This thesis 
aimed to address these gaps identified in the literature. The specific aims of the thesis are presented 
in Chapter 3. 
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SECTION 2 
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CHAPTER 3  
Aims and Hypotheses 
3.1 Main Aim of Research 
This thesis presents research that principally aimed to establish if early ICU physical rehabilitation 
specifically in sepsis can improve physical, psychological and physiological outcomes during 
critical illness. To achieve this, a Systematic Review and Meta-Analysis, a Randomised Controlled 
Trial (RCT) and two Pilot Trials developed from the RCT were conducted. 
3.2 Specific Aims of Research 
The specific aims of the research presented in this thesis were to; 
 
i. To systematically review published literature to evaluate the evidence for physical 
rehabilitation during critical illness – The Systematic Review and Meta-Analysis. 
 
ii. To evaluate the effects of early physical rehabilitation in an intensive care unit using a 
prospective double blinded randomised controlled trial to investigate the physical, 
physiological and psychological outcomes in the critically ill population; specifically in 
patients with sepsis syndromes – The i-PERFORM Trial.  
 
The primary aims of the “i-PERFORM Trial” were to investigate the long-term physical effects 
hypothesising that an early targeted physical rehabilitation program in patients with sepsis 
syndromes in the ICU will achieve a higher functional level and an improved quality of life. The 
secondary aims were to determine the short-term physical, psychological and physiological effects 
of early targeted ICU physical rehabilitation during sepsis. The physiological effects assessed were 
changes in inflammatory biomarkers, fat free mass, plasma lactate levels, mitochondrial DNA 
levels, muscle oxygenation and microcirculation.  
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3.3 Hypotheses 
The Primary Hypothesis of the study states that; 
 
Early targeted physical rehabilitation in ICU patients with sepsis syndromes using a daily exercise 
session of at least 30 minutes compared to a standard care group will; 
 
H1.  
i) Detect a 60% difference in physical function between groups using the functional 
assessment scores of the Acute Care Index of Function [212] at ICU discharge and  
ii) Detect a 15% difference in quality of life between groups using the SF-36 Medical Short 
Form Questionnaire [165] assessed at 6 months post ICU discharge. 
 
with the secondary supporting hypotheses of the study stating that this will; 
 
H2. Detect an 8% difference in fat free mass between groups using the Bioelectrical Impedance 
Spectroscopy [149] measured weekly.  
H3.  Detect a 16% difference in pro-inflammatory and 22% increment in anti-inflammatory 
cytokines between groups in arterial blood [149] measured pre and post exercise. 
H4. Detect a 40% difference in arterial plasma lactate levels [213] between groups measured pre 
and post exercise.  
H5. Detect a 10% difference in the overall score of the Physical Function ICU Test [214] and 
10% difference in muscle strength by using the Medical Research Council Score [215] 
between groups at ICU discharge.  
H6. Detect a 30% difference in hospital anxiety between groups using the Hospital Anxiety 
Score [216] at ICU discharge. 
H7.  Detect a 30% difference in mitochondrial DNA levels [137] between groups in the 
peripheral arterial blood measured weekly. 
H8.  Detect a 9% difference in peripheral muscle tissue oxygenation using the Near Infrared 
Oxygenation [187] and a 40% difference in microcirculation using Orthogonal Spectral 
Polarisation Microscan [217] measured pre and post exercise intervention.  
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3.4 Focus of Research 
The thesis includes research that will focus on the effects of early physical rehabilitation in 
critically ill patients particularly those with sepsis syndromes. While rehabilitation is comprised of 
physical, psychological and social restoration, this thesis solely focuses on physical rehabilitation 
with outcomes that include measures of physical, psychological and physiological outcomes that are 
practical and achievable in a single centre study of critically ill patients. In addition, the short-term 
physiological effects of early physical rehabilitation in critical illness will provide further insight 
into the safety and clinical applicability of such treatments in the ICU. 
 
In recent years, clinical trials have attempted to investigate various short-term and long-term effects 
of physical rehabilitation for the critically ill in the intensive care unit. While these studies 
contribute to new evidence, they have not been assessed systematically for methodological 
robustness, clinical relevance or applicability.  
 
The following chapter, Chapter 4, addresses the first aim of the thesis and presents the systematic 
review and meta-analysis manuscript entitled “Physical Therapy for the Critically Ill in the ICU: A 
Systematic Review and Meta-Analysis”. 
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CHAPTER 4  
Systematic Review and Meta-Analysis 
4.1 Overview 
To address the first aim of this thesis; published literature was systematically reviewed to evaluate 
the evidence for physical rehabilitation during critical illness. Pertinent outcomes measuring the 
short and long-term effects of ICU exercise were assessed in the meta-analysis which included; 
quality of life, physical function, peripheral muscle strength, respiratory muscle strength, length of 
hospital and ICU stay, ventilator-free days and mortality.  
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4.2 Manuscript 1 (Systematic Review and Meta-Analysis) 
 
The manuscript entitled “Physical Therapy for the Critically Ill in the ICU: A Systematic Review 
and Meta-Analysis” has been published in Critical Care Medicine. 
 
The final publication is available at Wolters Kluwer Health via: Kayambu G, Boots RJ, Paratz JD. 
Physical Therapy for the Critically Ill in the ICU: A Systematic Review and Meta-Analysis. Crit 
Care Med. 2013; Jun;41(6):1543-54. doi: 10.1097/CCM.0b013e31827ca637 (Impact Factor 6.124). 
 
This manuscript was reviewed by an external statistician for its methodological and statistical 
content and peer-reviewed.  
 
The manuscript is presented as submitted for publication. The numbering of pages are in 
accordance with the overall format of the Thesis. The references are found at the end of this 
manuscript and have been configured to fit the overall style of the Thesis. 
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Abstract  
Objective 
The purpose of this systematic review was to review the evidence base for exercise in critically ill 
patients.  
 
Data Sources and Study Selection 
Using keywords Critical care AND Physical therapy and related synonyms, randomised controlled 
trials, meta-analyses and systematic reviews were identified through electronic database searches 
and citation tracking. Clinical trials with outcomes of mortality, length of hospital and intensive 
care unit (ICU) stay, physical function and quality of life, muscle strength and ventilator free days 
were included.  
 
Data Extraction and Synthesis  
Two reviewers abstracted data and assessed quality independently. Effect sizes and 95% confidence 
intervals were calculated. From 3126 screened abstracts, ten randomised controlled trials and five 
reviews were found. The mean PEDro score was 5.4. Overall there was a significant positive effect 
favouring physical therapy for the critically ill to improve the quality of life (g=0.40, 95%CI 0.08, 
0.71), physical function (g=0.46, 95%CI 0.13, 0.78), peripheral muscle strength (g=0.27, 95%CI 
0.02, 0.52), respiratory muscle strength (g=0.51, 95%CI 0.12, 0.89). Length of hospital (g=-0.34, 
95%CI -0.53,-0.15) and ICU stay (g=-0.34, 95%CI -0.51,-0.18) significantly decreased and 
ventilator free days increased (g=0.38, 95%CI 0.16, 0.59) following physical therapy in the ICU. 
There was no effect on mortality.  
 
Conclusion  
Physical therapy in the ICU appears to confer significant benefit in improving quality of life, 
physical function, peripheral and respiratory muscle strength, increasing ventilator free days and 
decreasing hospital and ICU stay. However, further controlled trials of better quality and larger 
sample sizes are required to verify the strength of these tentative associations.          
 
Keywords  
Critical Care, Exercise, Mobilisation, Intensive care, Physical Therapy, Review      
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Introduction 
Over the last twenty years, advances in critical care management have increased survival following 
intensive care admission [1].While traditionally, the measure of the quality of critical care has 
focused on mortality outcomes, recently, there has been an awareness that functional status and 
health-related quality of life post critical illness are also important [2]. 
 
From recent literature and observational studies it has become apparent that survivors of critical 
illness experience poor physical, functional and cognitive outcomes often lasting for years [3-8]. 
This has been termed post intensive care syndrome (PICS) [2]. This can result in major impacts on 
the health and productivity of survivors and carers, return to work rates, as well as the availability 
of intensive care and hospital beds, surgical waiting lists and health care costs [9]. 
 
One aspect of PICS is weakness, termed intensive care unit acquired weakness (ICU-AW), may be 
present in 25-60% of mechanically ventilated patients [10, 11]. Although the etiology of this 
weakness is multifactorial and poorly understood, evidence suggests that muscle injury from 
systemic inflammation along with deconditioning from immobilisation is responsible [12-14].  
 
As exercise in other populations has been shown to improve strength and function, decrease 
inflammation [15-17] and affect oxidative stress [18-21] it has been suggested that early physical 
therapy of ICU patients may prevent or reverse some physical impairments that are present. There 
has been a surge in interest in this intervention in recent years [22-28] and it is important to review 
the existing studies in this area to gauge the quality of evidence and identify research gaps for future 
studies.  
 
Materials and Methods 
A systematic review of the published literature was conducted to investigate the effects of ICU 
physical therapy following critical illness. Although there is increasing published literature on this 
topic, it was decided a priori to restrict to and include all prospective controlled studies, both 
randomised controlled trials (RCTs) and quasi RCTs as they represent the highest order of clinical 
trials for evidence based practice. Existing meta-analysis and systematic reviews were also included 
and reviewed. 
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Search Strategy 
A comprehensive search strategy of the electronic databases Ovid MEDLINE (1980 to Jan 2012), 
PubMed (1980 to Jan 2012), CINAHL (1982 to Jan 2012) and the Cochrane Database (1992 to Jan 
2012) was conducted. The keywords or search terms were as follows: (Intensive Care OR Critical 
care) AND (Physical therapy OR Mobilisation OR Exercise OR Physiotherapy OR Mobility). For 
the purpose of this review we defined Physical Therapy as activities such as positioning, stretching, 
electrical muscle stimulation (EMS), range of motion exercise, resistive exercises, ergometry, 
walking, splinting, mobilisation activities and aerobic training [29]. The RCTs included were 
required to describe a comparison group that did not receive or minimally received physical therapy 
in contrast to the intervention group. Language limits were set to include English, French, Chinese 
and Tamil.  
 
Selection Criteria 
Clinical trials selected for the meta-analysis were confined to those investigating physical therapy 
within in the ICU. Outcomes of interest were peripheral muscle strength, respiratory muscle 
strength, physical function, quality of life, ventilator free days, length of stay in hospital and ICU in 
days and incidence of mortality. In order to calculate Hedges’g effect size (g) and 95% confidence 
intervals, the studies were required to report means, standard deviations and sample size.  To assess 
eligibility, two investigators (GK and JP) independently retrieved and examined the titles and 
abstracts of the studies with a third investigator (RB) consulted in case of disagreement. To identify 
additional studies, citation-tracking of reference lists of retrieved articles was conducted. The 
following chart illustrates the article selection process (Figure 4.1). 
 
Assessment of Methodological Quality  
The quality of the methodological features of the 10 RCTs [30-39] were independently assessed and 
scored using the Physiotherapy Evidence Database (PEDro) Scale [40]. This is a reliable instrument 
for rating quality of RCTs [41], based on a 0-10 point scale, with a higher score reflecting well-
designed trials. The quality of the systematic reviews was independently assessed and scored using 
the Revised Assessment of Multiple Systematic Reviews (R-AMSTAR) for grading clinical 
evidence [42]. Following independent scoring and assessment of RCTs and systematic reviews, 
both reviewers discussed and verified the results. The Cohen’s Kappa (k) (inter-observer reliability) 
was used to assess the two investigators (GK and JP). Consensus was achieved with open 
discussion involving the third reviewer for the final review process. The quality scoring for the 
included studies is shown in Table 4.1. 
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Data Extraction and Analysis 
Two reviewers (GK and JP) independently performed and then cross-checked the data with regard 
to study design, intervention and outcome measures. The parameters of the outcomes measures of 
interest were collected from each RCT and summarised (Table 4.2). Data was analysed using 
Comprehensive Meta-Analysis software Version 2.0 [43]. To evaluate the effects of exercise on 
critically ill ICU patients on continuous outcomes; peripheral and respiratory muscle strength, 
physical function, quality of life, ventilator free days, length of hospital and ICU stay, Hedges’g 
effect size (g) and 95% confidence interval (based on means and standard deviations) were 
calculated between groups receiving physical therapy and the control groups at endpoint. Calculated 
effects denoted associations between ICU physical therapy and corresponding outcome measures. 
The strength of the effect sizes were interpreted with values less than 0.2 as ‘no’ effect, more than 
0.2 as ‘small effect’, more than 0.5 as ‘moderate’ effect and more than 0.8 as ‘large’ effect [44]. 
Odds ratios were calculated for dichotomous data such as mortality comparisons. The data was 
pooled using the fixed effects model, however when heterogeneity was statistically significant (Q 
statistic, p< 0.001), the data was reanalysed using the random effects model [45]. Pooled data for 
overall effect sizes were carefully evaluated due to inherent variations in interventions and 
endpoints. Forest plots were constructed for selected outcome measures (Figure 4.2).  
 
Based on the criteria of excellence of systematic reviews that resulted in the 11 domains examined 
by R-AMSTAR, the overall score on the R-AMSTAR was used to assign a grade of systematic 
review quality and clinical relevance with a possible maximum score of 44. A conventional cut-off 
point of 22 was used to indicate that on average only two criteria for each of the 11 domains were 
satisfied [42].  
 
Results 
Searches from the database identified 3126 articles. Applying the exclusion criteria, over 3000 
articles were ineligible on the basis of being case-control, pre-post, abstract only, observational and 
retrospective studies or narrative reviews. Of 101 articles remaining, 37 articles were retained based 
on title and abstract. After review of full content, a further twenty publications comprising non-
randomised trials and reviews were excluded. Seventeen RCTs [30-39, 46-52] met the inclusion 
criteria. Seven RCTs [46-52] were then removed from the final selection for review; three were not 
ICU trials [47-49], one was not a physical therapy trial (46), one had no physical therapy 
intervention comparisons [50] and two reported non-usable information by outcome for this meta-
analysis [51, 52].  
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Methodological quality  
The Kappa level of agreement between reviewers on PEDro quality scoring was 0.89. A mean 
PEDro Score of 5.4 (median 5, range of 4 to 8) was obtained for the 10 RCTs evaluated (Table 
4.1). Of the 10 trials [30-39] all except one [30] performed random allocation to treatment group. 
All trials reported between group statistical comparison and point measures and measures of 
variability. Only 4 trials [31, 32, 37, 38] reported concealed allocation. Four trials [30, 31, 34, 38] 
performed intention to treat analysis, three trials [31, 35, 37] reported assessor blinding and one trial 
[37] reported subject blinding. The difficult problem of therapist blinding was apparent as this was 
not reported in the methodology of all the included trials.  
 
Demographics 
The patient case mix largely included critically ill patients with a range of causes of admission to 
intensive care. Patient type, illness or severity, overall mean age and range in years, sample size, 
gender ratio, type of intensive care unit, type of physical therapy personnel and type of outcome 
measures were summarised (Table 4.3). The total sample size of all ten trials was (n=790 [range: 
24-140]) after accounting for dropouts. The overall mean age for the trials for control vs. exercise 
group was (59.3 vs. 63.6) years. The overall percentage of male: female ratio for control vs. 
exercise group was (69:31 vs. 73:27). Two trials recruited patients in mixed ICUs [30, 32], one in a 
medical unit [31], three in surgical units [33, 34, 38] and four in respiratory units [35-37, 39].  
 
Intervention 
Exercise interventions reported in the RCTs covered a wide range of techniques. Specifically, 
physical therapy strategies used in the trials varied in type, duration, frequency and intensity. In 
some trials patients in the intervention arms received a physical therapy package with treatment 
strategies progressing from passive or active limb mobilisation to ambulation based on their level of 
co-operation and strength. In other trials patients received only specific treatment strategies such as 
EMS or ergometry. Control groups treatments varied largely between trials ranging from no sham 
treatment to general or standard physical therapy. Six trials [30, 33, 34, 37-39] failed to provide 
sufficient information on the type of personnel involved in their studies with one trial [37] stating 
that a member of the physical therapy team was involved. Four trials [31, 32, 35, 36] indicated that 
intervention groups received ICU exercise treatments by a physical therapist; one of these trials [31] 
used both physical and occupational therapy. Endpoint measures of tested outcomes for the trials 
were compared at variable time points as reported in Table 4.4.  
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Effect on Peripheral Muscle Strength  
General peripheral muscle strength was measured in five trials [30-32, 35, 37] with the use of the 
Medical Research Council (MRC) scale (0-5) [53], the Medical Research Council (MRC) Score 
[54] or hand-held dynamometry. Data were pooled using a fixed effects model (Q=0.46, p=0.50) 
from two trials [30, 31] that used MRC Scores. A small but significant positive effect was found for 
general peripheral muscle strength using the MRC Score (pooled Hedges’g=0.27, 95%CI, 0.02, 
0.52, n=244 [127,117]) following ICU physical therapy (Figure 4.2).  
 
Of the five trials, three trials [31, 32, 35] specifically used a hand-held dynamometer to gauge 
muscle strength at ICU discharge. Quadriceps strength measured using this technique indicated 
significant correlations between changes in lower limb strength and ambulation (r=0.40) in one trial 
(32). The effect size for handgrip strength using this technique was calculated from two RCTs [31, 
32]. Data were pooled using a fixed effects model (Q=0.01, p=0.93).The effect size analysis (pooled 
Hedges’g=0.07, 95%CI -0.23, 0.38, n=194 [100, 94]) revealed no significant effect of physical 
therapy in critically ill patients on handgrip strength. 
 
Effect on Respiratory Muscle Strength  
Respiratory muscle strength was measured using maximal inspiratory pressures (MIP) in two trials 
[35, 36]. Data were pooled using a fixed effects model (Q=0.25, p=0.62). The overall effect size on 
respiratory muscle strength calculated from these two trials indicated a significant moderate effect 
favouring ICU physical therapy (pooled Hedges’g=0.51, 95% CI 0.12, 0.89, n=105 [53, 52]) 
(Figure 4.2). 
 
Effect on Physical Function  
Two trials [31, 35] reported outcomes using the Barthel Index of Activities of Daily Living (BI) 
[55] score as an assessment tool for physical function and pooled effect size was calculated (31, 35). 
Data were pooled using a fixed effects model (Q=0.44, p=0.51). The overall effect size on physical 
function outcomes indicated a significant small effect, favouring physical therapy for critically ill 
patients (pooled Hedges’g=0.46, 95%CI 0.13, 0.78, n=143 [74, 69]) (Figure 4.2). 
 
Effect on Ventilator Free Days  
Effect on time on mechanical ventilation duration was identified from three trials [30-32] reporting 
number of days alive and breathing without assistance (ventilator free days) during the length of 
stay in the hospital and ICU during the course of critical illness. Data were pooled using a fixed 
effects model (Q=1.51, p=0.47). The overall effect size calculated from these three trials [30-32] 
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revealed a significant small effect in improving ventilator free days favouring ICU physical therapy 
(pooled Hedges’g=0.38, 95%CI 0.16, 0.59, n=334 [172, 162]) (Figure 4.2). 
 
Effect on Health-related Quality of Life  
Health-related quality of life was examined in two trials [32, 38] using the Medical Outcomes Study 
36-Item Short Form (SF-36) survey score. Data was pooled using the fixed effects model (Q=1.23, 
p=0.27). The overall effect size for health-related quality of life calculated from two RCTs (32, 38) 
was small but significant favouring ICU physical therapy (pooled Hedges’g=0.40, 95%CI 0.08, 
0.71, n=154 [78, 76]) (Figure 4.2). 
 
Effect on Length of Hospital Stay  
The length of stay in the hospital in number of days following ICU physical therapy was examined 
in five trials [31-34, 38] with data pooled using a fixed effects model (Q=4.37, p=0.36). There was 
a small reduction in the length of hospital stay with exercises for the critically ill while in the ICU 
(pooled Hedges’g=-0.34, 95%CI -0.53,-0.15, n=441 [226, 215]) (Figure 4.3).  
 
Effect on Length of ICU Stay  
Six trials [30-34, 39] were analysed investigating the length of stay measured in number of days in 
the intensive care unit following ICU physical therapy with data pooled using a fixed effects model 
(Q=1.44, p=0.92). All studies found a small reduction in ICU length of stay and reported a 
significant small effect (pooled Hedges’g=-0.34, 95%CI -0.51,-0.18, n=597 [285, 312]) (Figure 
4.3). 
 
As three trials [33, 34, 38] included in this analysis investigated post-operative patients, another 
sub-analysis excluding these studies was pooled and it was found that the reduction in ICU length 
of stay (pooled Hedges’g = -0.31, 95%CI-0.51,-0.12, n=414[192, 222]) remained significant but the 
effect on hospital length of stay (pooled Hedges’g =-0.20, 95%CI-0.43,0.13, n=194[100, 94]) was 
no longer apparent. 
 
Effect on Mortality  
Hospital mortality was investigated in 3RCTs [31, 32, 39] with data were pooled using a fixed 
effects model (Q=1.71, p=0.64). There was no effect of ICU physical therapy for critically ill 
patients on mortality (OR= 1.0, 95%CI 0.54, 1.85, n=274 [120, 154]) (Figure 4.4). 
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In summary, there was a significant positive effect favouring ICU physical therapy for the critically 
ill to improve peripheral and respiratory muscle strength, quality of life, physical function, increase 
ventilator free days, reduce hospital and ICU length of stay. However, there was no mortality 
benefit. 
 
Clinical Relevance of Systematic Reviews 
Five reviews [56-60] and one narrative review [61] were identified. The narrative review was 
excluded in the analysis. While the reviews reported search strategies they were essentially 
narrative reviews with all research designs included, no independent assessment, and no scoring or 
comment on the quality of the studies.  
 
Discussion 
Early physical therapy in intensive care is increasingly recommended [27, 28, 62, 63] and this 
review has found preliminary evidence that there are beneficial effects on muscle strength, physical 
function, health-related quality of life, ventilator free days and length of stay in the ICU and 
hospital. While this meta-analysis suggests that ICU physical therapy as a ‘program package’ is 
beneficial, further studies are warranted to distinguish the effects of specific physical therapy 
strategies and to elucidate the mechanisms responsible for effectiveness. 
 
Essentially as the procatabolic nature of acute critical illness is understood physical therapy efforts 
have been directed at minimizing proteolysis and increasing protein synthesis. In addition to the 
increase in inflammatory mediators following catastrophic illness, an actual proinflammatory state 
develops with bed rest, with increased production of reactive oxygen species (ROS), and a decrease 
in anti-oxidative defences [64]. One of the theories for the success of early exercise following 
critical illness or trauma is a decrease in the inflammatory load i.e. a decrease in pro (Interleukin-6) 
and increase anti (Interleukin-10) inflammatory cytokines [65]. Interventions analysed in this study 
have been shown in both critically ill and other populations counteract to protein catabolism in 
skeletal muscles [52, 66] and improve microcirculation [51]. 
 
Although peripheral muscle strength is regarded as a surrogate measure, weakness has been highly 
correlated with increased duration of mechanical ventilation [54], increased length of stay in 
intensive care and increased hospital mortality [67]. Maintaining or improving muscle strength 
appeared correlated significantly with functional measures [35].  
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This meta-analysis also demonstrated that ICU physical therapy increased ventilator free days 
which is known to be strongly associated with decreases in mortality [68]. Overall, seven trials [30-
34, 38, 39] included in the meta analysis indicated small effects in either reducing ICU or hospital 
length of stay potentially related to improved muscle strength and functional ability. Length of stay 
both in the ICU and hospital are important performance indicators related to the use of critical care 
resources. 
 
Health-related Quality Of Life (HrQOL) represents an important patient focused outcome (69). 
Upon ICU or hospital discharge, the failure to return to premorbid independent function can result 
in carer dependency and associated societal stresses. Despite the use of varied exercise protocols 
including bedside cycling [32] and walking [38], overall, this meta-analysis showed significant 
improvements in HrQOL of critically ill patients at hospital discharge following the implementation 
of physical therapy in the ICU. Although improvements in HrQOL are fundamental, they not 
related to physical recovery alone as cognitive function can be a contributor, not tested in this meta-
analysis. 
 
Even though this meta-analysis has produced favourable findings towards implementation of 
physical therapy in the ICU, clinical trial findings used in the analysis can be considerably 
critiqued. It is important to note that EMS differs from other physical therapy strategies and 
primarily has a more direct physiological effect. Furthermore, blinding was not observed in this 
study, weakening its findings [30]. Although ergometry showed improvement in lower limb muscle 
strength [32], delayed end point measures may not reflect the true effect of ergometry use in the 
ICU. Sedation interruption prior to administering physical therapy is not a common ICU practice 
which used in this study [31] may have magnified the overall effect size in improving physical 
function and strength and length of stay in the hospital and ICU. The variability in type, intensity 
and duration of interventions across trials could not allow us to quantitate the passive or active 
therapy required to produce the positive effects elucidated in this meta-analysis. 
 
Although “early ICU exercise” is still not clearly defined, initiation of physical therapy or the use of 
EMS or passive ranging within a few days of ICU admission, are strategies performed earlier than 
conventional start of exercises normally upon weaning of sedation or mechanical ventilation [51, 
52, 70]. As physical therapy is a “complex healthcare intervention”, future clinical trials should 
model, validate and describe exercise interventions using the MRC complex intervention 
framework [71]. This approach will help address the safe application of early exercises in critically 
ill patients especially in those presenting with sepsis syndromes.  
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Limitations 
This meta-analysis has some limitations. Firstly, there is inherent variability of patient case mix in 
the trials compared and thus factors such as covariates and risk stratification were not accounted for 
in the overall analysis. This must be taken into account before generalising findings of this review 
to the critically ill population. Secondly, due to the heterogeneity of outcome measures utilised, in 
some cases often meta-analyses comprised only two to three studies. Therefore, results of these 
analyses should be considered with caution. In addition, the outcome measures within the pooled 
trials varied in timing and type. Thirdly, the reliability of the overall pooled effects also needs to be 
carefully considered as a wide range of interventional measures in terms of type, intensity and 
duration were used across trials.  
 
Lastly, the randomised controlled trials included in these analyses were not large and had a number 
of methodological shortcomings with reduced quality scoring that were not taken into account in the 
overall analysis. Biases within individual studies (e.g. dropouts) were acknowledged but not 
addressed in the actual aggregation of data as a sensitivity analysis could not be performed due to 
insufficient information from the trials.  
 
Further research 
Even though it is apparent that ICU physical therapy appears to confer benefits it is imperative that 
future clinical trials investigate physical therapy in the ICU on a larger scale with stringent 
methodological standards to provide conclusive evidence on the positive effects of its 
implementation to the critically ill population. It is also important to investigate other mechanisms 
such as the ideal dose and timing of exercise, the effect of exercise on specific conditions and the 
mechanisms of specific interventions.  
 
Conclusion 
Physical therapy in the ICU can be seen as an important component of critical care management. 
Current evidence suggests that ICU physical therapy reduces ICU and hospital length of stay, 
increases number of ventilator free days, improves peripheral and respiratory muscle strength, 
physical function and health-related quality of life. Future research on ICU physical therapy should 
investigate short-term effects as well as related long-term outcomes to advocate the efficacy of early 
exercise in critical illness. 
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Figure 4.1 PRISMA flow diagram 
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Figure 4.2 Meta analysis and pooled effect sizes (Hedges’g) on physical function, quality of life, 
muscle strength, ventilator free days for physical therapy or standard care in the ICU *p≤ 0.05 and 
**p≤ 0.01 
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Figure 4.3 Meta analysis and pooled effect sizes (Hedges’g) on length of hospital and intensive 
care stay for physical therapy or standard care in the ICU *p≤ 0.05 and **p≤ 0.01 
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Figure 4.4 Odds ratio on mortality for physical therapy or standard care in the ICU 
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Table 4.1 PEDro quality scoring of randomised controlled trials  
 
Randomised Controlled 
Trials 
PEDro Categories 
PEDro 
SCORE 
Random 
allocation 
Concealed 
allocation 
Baseline 
similarity 
Subject 
blinding 
Therapist 
blinding 
Assessor 
blinding 
Measures 
of key 
outcomes 
> 85% of 
subjects 
Intention 
to treat 
Between 
group 
statistical 
comparison 
Point 
measures 
and 
measures 
of 
variability 
Routsi et al 2010(30) × × √ × × × × √ √ √ 4 
Schweickert et al 2009(31) √ √ √ × × √ √ √ √ √ 8 
Burtin  et al 2009(32) √ √ × × × × × × √ √ 4 
Muehling et al 2009(34)  √ × √ × × × √ √ √ √ 6 
Muehling  et al 2008(33)  √ × √ × × × √ × √ √ 5 
Chiang et al 2006(35)  √ × √ × × √ × × √ √ 5 
Porta  et al 2005(36)  √ × √ × × × √ × √ √ 5 
Zanotti  et al 2003(37) √ √ × √ × √ √ × √ √ 7 
Delaney  et al 2003(38) √ √ √ × × × × √ √ √ 6 
Nava  1998(39) √ × √ × × × × × √ √ 4 
Percentage Overall (%) 90 40 80 10 0 30 50 40 100 100  
 
 
 
 
 
 
Legend:  √ PEDro criteria met    × PEDro criteria not met 
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Table 4.2 Summary of randomised controlled trials investigating ICU physical therapy in the critically ill 
 
Study 
 
n 
Sample 
population 
Control 
Arm 
Exercise  
Arm 
 
Duration/ 
Frequency/ 
Intensity 
       Physical        
       Therapy  
       Initiation  
Results and Significant 
Outcome 
Routsi et al 2010  
(30) 
 
 
 
140 Day 2 of 
admission  
(APACHE  
≥ 13) 
No sham EMSa EMS  Daily :  
EMS to LLb  
55 minutes at 
45Hz 
Day 2 of ICU 
admission 
↑ MRCc Score  
   (58 vs. 52; p=0.04)  
↑ Ventilator free days  
   (4 vs. 6days; p=0.003) 
↓ Weaning period 
   (1 vs. 3 days; p=0.003) 
Schweickert et al 2009 
(31) 
104 
 
Sedated with 
MVd < 72 hrs 
(Barthel Index 
score ≥70) 
Standard care PTe 
and OT f 
as ordered by 
primary care team  
 
PROMg 
AROMh 
Transfers 
Bed mobility  
Sitting up 
ADLi 
Sit to stand 
Gait training 
Early mobilisation 
(sedation 
interrupted) 
PT and OT: 
Daily 
PROM:  
x 10  
 
Day of enrolment  
MV < 72 hrs  
 
↑ Return to functional 
independence  
   (59% vs.35%; p=0.02) 
↓ Duration of delirium  
   (2 vs. 4 days; p=0.02)  
↑ Ventilator free days 
   (23.5 vs. 21.1 days; p=0.05)  
 
 
 
Burtin et al 2009  
(32) 
90 
 
Prolonged ICU 
stay ≥ 7 days  
Daily standardised 
PROM and 
AROM of  
ULj and LL for  
5 days/week  
 
PROM  
AROM         
Ergometer  
Ambulation 
Ergometer:  
20 minutes/day 
ROM:  
5 days/week 
 
On cardio-
respiratory stability  
 
↑ 6MWDk 
   (196 vs. 143m; p<0.05)  
↑ SF36l  
   (21 vs. 15; p<0.01) 
↑ Quadriceps force  
   (2.4 ± 0.6 N.kg-1 vs.  
    2.0 ± 0.8 N.kg-1; 
p=0.11)  
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Muehling et al 2009 
(34)  
 
 
101 Indications for 
elective open 
aneurysm repair  
Mobilisation  
PODm 1 
Early mobilisation 
 
 
 
Daily POD 0  
 
 
 
 
↓ Postoperative ventilation  
   (6.1% vs. 32%; p=0.002)  
↓ Postoperative complications  
   (16% vs. 36%; p=0.039)  
↓ Postoperative hospital stay  
   (10 vs. 11 days; p=0.016) 
Muehling et al 2008 
(33) 
 
 
 
 
82 Indications for 
elective open 
aneurysm repair  
 
Mobilisation  
POD1 
Early mobilisation 
 
 
 
 
 
 
Daily POD 0  ↑ Postoperative ventilation in  
   control group      
   (33.3% vs. 5.4%; p=0.011)  
↓ LOSn in ICU  
   (41 vs. 20hours)  
↓ Rate of postoperative 
complications  
   (16.2% vs. 35.7%; p=0.045)  
Chiang et al 2006 
(35) 
39 Prolonged  
MV > 14 days  
 
Only verbal 
encouragement for 
mobilisation but 
not routinely 
performed  
 
Limb 
strengthening 
Diaphragmatic 
exercises  
Bed mobility 
Transfers 
Standing 
Ambulation 
Physical 
training:  
6 weeks x 
5/week 
ROM:  
10 x 2 sets 
 
As early as patients 
could tolerate  
 
↑ Respiratory and limb muscle   
   strength 3rd and 6th weeks  
↑Total BIo and FIMp scores     
   intervention group 
↑ FIM mobility scale by 80%   
   intervention group (p=0.001) 
 
Porta et al 2005 
(36) 
66 Weaned from 
MV  
> 48 to < 96 
hours 
 
General 
physiotherapy   
45 minutes/day for 
6 weeks 
 
General 
Physiotherapy  
(Chest 
Physiotherapy  
PROM  
AROM 
Mobilisation 
Ambulation) 
Arm ergometer 
 
Chest therapy: 
15 minutes  
ROM:  
30 minutes 
Mobilisation: 
15minutes 
Ambulation: 
15minutes 
- Graded 
according to 
level of patient 
activity  
96hrs after weaning 
from MV  
 
↑ Exercise capacity (IT) 
   (7.3 vs. 2.6W; p=0.003)  
↑ Endurance test (ET)  
   (8 vs. 4mins; p=0.021)  
↑ MIPq  
   (43 ± 19 cmH2O to  
    52 ± 20 cmH2O; 
p<0.001) 
   (37 ± 14 cmH2O to  
    42 ± 15 cmH2O; 
p=0.003)   
↓ IT workload dyspnea  
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UL cycling:  
20 minutes/day x 
15 sessions 
   (4.6 ± 2.5 to  
3.4 ± 2.7; p=0.005) 
   (5 ± 3.2 to  
3.5 ± 2.5; p=0.009)  
↓ IT peripheral muscle fatigue  
   (6.3 ± 2.5 to  
4.1 ± 2.8, p=0.001) 
↓ ET dyspnea  
   (4.7 ± 2.8 to  
2.6 ± 2.2, p=0.007)  
↓ ET muscular fatigue  
   (5.6 ± 2.6 to  
3.4 ± 2.4; p=0.002)  
Zanotti et al 2003 
(37) 
 
 
 
 
 
 
24 30 days bed 
bound with 
chronic 
hypercapnic 
respiratory 
failure MV 
with marked 
hypotonia and 
atrophy 
Active limb 
mobilisation 
(ALM)  
 
ALM  
EMS to LL 
 
 
ALM/EMS: 
5 days/week x  
4 weeks 
30 days after bedrest  
 
↑ Muscle strength overall 
  (1.8 ± 0.7 to  
3.4 ± 0.7; p<0.05) 
↑ Muscle strength intervention 
group 
   (2.1 ± 1.0 to  
1.3 ± 0.8; p=0.02)  
↓ Days transfer from bed to 
chair  
   (10.8 ± 2.4 vs.  
    14.3 ± 2.5; p=0.001) 
Delaney et al 2003  
(38) 
 
64 Undergoing 
laparotomy and 
intestinal or 
rectal resection 
Traditional post- 
operative care 
 
 
Incentive 
spirometry  
Sit out of bed 
Ambulation 
Ambulation: 60 
metres x 5 
 POD 1  
 
 
 
↓ LOS in hospital  
   (5.4 vs. 7.1 days; p=0.02)  
 
 
Nava 1998  
(39)  
80 COPDr and 
episode of 
acute 
respiratory 
failure  
 
Standard medical 
therapy and basic 
ambulation 
program  
 
PROM  
AROM 
Postural training 
Cough education 
Respiratory 
muscle training 
Physical 
Therapy:  
30 - 45minutes x 
2 daily  
Lower limb 
exercises:                 
Within first 24 hrs 
after admission  
 
↑ 6MWD (p<0.001) 
↑ MIP intervention group 
   (45 to 61cmH2O; p<0.05)  
↓ 6MWD HRs  
   (128 to 100 beats/min; 
p<0.01) 
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Treadmill walking  
Ambulation 
Leg ergometer  
Stair climbing 
 
30 minutes x 2 
daily x 3 weeks   
↓ Dyspnea (p<0.01)  
 
Legend: aEMS=Electrical Muscle Stimulation, bLL=Lower Limb, cMRC=Medical Research Council, dMV=Mechanical Ventilation, 
ePT=Physiotherapy, fOT=Occupational Therapy, gPROM=Passive Range of Motion, hAROM=Active Range of Motion, iADL=Activities of Daily 
Living, jUL=Upper Limb,         k6MWD=6 Minute Walk Distance, lSF36=Short Form 36 Questionnaire, mPOD=Post Operative Day, nLOS=Length of 
Stay, oBI=Barthel Index Activity of Daily Living, pFIM=Functional Independence Measure, qMIP=Maximal Inspiratory Pressure, rCOPD=Chronic 
Obstructive Pulmonary Disease, sHR=Heart Rate 
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Table 4.3 Demographics of studies included in the meta analysis  
 
Study 
Sample 
Size 
 
Patient Type/ Severity/ 
Illness 
Mean Age ±Standard 
Deviation/range, Yrs 
Male : Female Ratio, [%] 
Intensive 
Care 
Type 
Physical 
Therapy 
Personnel 
Outcome 
Measures 
 
 (Control/ 
Exercise) Control Exercise Control Exercise 
   
Routsi et al  
2010(30) 
140 
(72/68) 
APACHE II  58 ±         18 
49:23, [68:32] 
61 ±        19 
     46:22, [68:32] 
ICUa Not  
stated 
MVb weaning period,  
LOSICUc, MRCd, 
TOMVe 
18±5 18±4 
Schweickert  et al 
2009(31) 
104 
(55/49) 
APACHE II 54.4(46.5-66.4) 
26:29, [41:59] 
57.7(36.3-69.1) 
26:23, [58:42] 
MICUf PTg & 
OTh 
ICU Delirium, Hand-
grip, Barthel Index, 
Mortality, Ambulation   
LOSICU, LOSHOSPi, 
MRC, TOMV 
19.0(13.3-
23.0) 
20.0(15.8-
24.0) 
Burtin  et al  
2009(32) 
 
90 
(45/45) 
APACHE II 57 ± 17 
26:10, [72:28] 
56       ±          16 
22:9, [71:29] 
SICUj 
MICU 
PT Quadriceps force,  
Hand-grip,  
Berg Balance, 
SF36k,LOSICU, 
LOSHOSP, 6MWDl, 
TOMV 
25±4 26±6 
Muehling  et al  
2009(34)  
 
 
 
 
 
 
101 
(51/50) 
ASA III 68(52-84) 
47:3, [72:28] 
67(40-81) 
46:3, [94:6] 
SICU Not  
stated 
Mortality,  
Postoperative 
ventilation,  
& complications, 
Perioperative outcomes, 
LOSICU, LOSHOSP 
34 32 
 
 
Muehling  et al  
2008(33)  
82 
(42/40) 
ASA III 68(52-84) 
39:3, [93:7] 
67(40-81) 
34:3, [92:8] 
SICU Not  
stated 
Mortality,  
Postoperative ventilation  
LOSICU, LOSHOSP  
34 32 
 
 
 
                                               
93 
 
 
 
Legend: aICU=Intensive Care Unit, bMV=Mechanical Ventilation, cLOSICU=ICU Length of Stay, dMRC=Medical Research Council, eTOMV=Time 
on Mechanical Ventilation, fMICU=Medical Intensive Care Unit, gPT=Physiotherapy, hOT=Occupational Therapy, iLOSHOSP=Hospital Length of 
Stay, jSICU= Surgical Intensive Care Unit, kSF36=Short Form 36 Questionnaire; l6MWD=6 Minute Walk Distance, mRCC=Respiratory Care Centre, 
nRICU=Respiratory Intensive Care Unit, oRHDU=Respiratory High Dependency Unit, pMGPQ=McGill Pain score Questionnaire,  qCQOL=Cleveland 
Global Quality of Life, rFEV1=Forced Expiratory Volume at end of 1st second, sFVC=Forced Vital Capacity 
 
 
 
 
 
 
Chiang  et al  
2006(35)  
39 
(19/20) 
Multisystem Failure n(%) 79(72.5-82.8) 
12:3, [80:20] 
75(63.0-80.3) 
12:5, [71:29] 
RCCm PT Respiratory and 
peripheral muscle 
strength,  
BI,FIM, Ambulation 
TOMV 
2(13.3) 2(1.8) 
Porta  et al  
2005(36)  
66 
(34/32) 
Long-term mechanical 
ventilation 
72 ± 5 
23:11, [68:32] 
70 ± 6 
22:10, [69:31] 
 
RICUn PT Arm exercise test, 
Inspiratory muscle 
strength 
Zanotti  et al  
2003(37) 
24 
(12/12) 
Hypercapnic respiratory 
failure 
65 ± 4 
8:4, [67:33] 
66 ± 8 
9:3, [75:25] 
RHDUo Member 
of 
physical 
therapy  
team 
Peripheral muscle 
strength,   
Cardiorespiratory 
function,  
Transfer Ability 
Delaney  et al  
2003(38) 
64 
(33/31) 
ASA III 42 ± 13 
21:12, [64:36] 
51 ±         17 
21:10, [68:32] 
SICU Not  
stated 
Pain score,  
MGPQp, CGQLq, SF36 7 12 
Nava  et al  
1998(39) 
80 
(20/60) 
Acute respiratory failure 67 ± 9 
38:22, [63:37] 
65 ± 6 
13:7, [65:35] 
RICU Not  
stated 
Respiratory muscle 
strength,  
Dyspnea score, 
LOSICU, FEV1r, FVCs, 
6MWD 
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Table 4.4 Endpoint measures of outcomes included in the meta analysis 
Randomised Controlled 
Trials 
Outcome measures tested in 
Meta Analysis 
End points  
(DC=Discharge) 
Control Group 
Mean [SD] / 
Median [Range] 
Treatment Group 
Mean [SD] / 
Median [Range] 
Significance  
between 
groups 
Physical Function  
Schweickert et al 2009(31) Barthel Index 
Activities of Daily Living Score 
Hospital DC 55[0-58]  75[7.5-95]  p=0.05 
Chiang et al  2006(35) 3rd  and 6th week 0.0[0.0-8.8] 35[20-55] p<0.05 
Quality of Life 
Burtin et al 2009(32) Medical Outcomes Study 36-Item 
Short Form Score 
Hospital DC 15[14-23] 21[18-23] p<0.01 
Delaney et al  2003(38) Day 10, 30 & 
Hospital DC 
66 ± 24.3 64.8 ± 23.4 p>0.05   
Peripheral Muscle Strength 
 Routsi et al 2010(30)  Medical Research Council Score 
 
ICU DC 52[2-60] 58[33-60] p<0.05 
Schweickert et al 2009(31) Hospital DC 48[0-58]  52[25-58]  p>0.05 
Respiratory Muscle Strength 
Chiang et al 2006(35) Maximal Inspiratory Pressure 3rd  and 6th week 30[25.0-42.0] cmH2O 60[40.5-71.5] cmH2O p<0.05 
Porta et al  2005(36) Not mentioned 42 ± 15 mH2O 52 ± 20 cmH2O p>0.05  
Ventilator-Free Days 
Routsi et al 2010(30)  Number of ICU days without 
mechanical ventilation 
ICU DC 6[0-41] days 4[0-16] days p<0.01 
Schweickert et al 2009(31) 1st 28 hospital days  21.1[0.0-23.8] days 23.5[7.4-25.6] days p=0.05  
Burtin et al  2009(32)  ICU DC 34 days 30 days p>0.05 
Length of Hospital Stay 
Schweickert et al 2009(31) Number of days for length of stay 
in the hospital 
 
 
 
Hospital DC 12.9[8.9-19.8] days 13.5[8.0-23.1] days p>0.05   
Burtin et al  2009(32) Hospital DC 40[28-49] days 36[28-47] days p>0.05   
Muehling et al 2009(34)  Hospital DC 11[8-45] days 10[6-49] days p<0.05 
Muehling et al 2008(33)  Hospital DC 11[8-24] days 10[8-49] days - 
Delaney et al  2003(38)  Hospital DC 7.1 ± 4.8 days 5.4 ± 2.5 days p<0.05 
Length of Intensive Care Stay 
Routsi et al 2010(30) Number of days/hours for length 
of stay in the intensive care unit 
ICU DC 22[2-92] days 14[4-62] days p>0.05  
Schweickert et al 2009(31) ICU DC 7.9[6.1-12.9] days 5.9[4.5-13.2] days p>0.05  
Burtin et al  2009(32) ICU DC 14[8-26] days 11[5-21] days p>0.05  
Muehling et al 2009(34) ICU DC 32[12-293] hrs 20[14-336] hrs p>0.05  
Muehling et al 2008(33)   ICU DC 41[12-129] hrs 20(14-336] hrs - 
Nava et al  1996(39)   ICU DC 33.2 ± 11.7 days 38.1 ± 14.3 days p>0.05 
95 
 
4.3 Review of Additional Papers since completion of Systematic Review 
Since the systematic review was published, a number of new studies have been published in this 
area investigating physical therapy or exercise for the critically ill in the ICU. An additional search 
was performed on 5th November 2014 and seven new randomised trials relevant to this topic were 
retrieved. In addition there were ten new systematic reviews published. There has been a surge in 
the investigation of early physical rehabilitation techniques; particularly in the use of passive 
rehabilitation techniques and electrical muscle stimulation in intensive care units. The new papers 
are briefly summarised in the following sections. 
 
4.3.1 Randomised Trials 
Seven randomised trials have been reported to be conducted in the past eighteen months since the 
review of 10 RCTS that were analysed in our Systematic Review and Meta-Analysis published in 
June 2013. Except for one ICU trial that investigated the effects of progressive rehabilitation on 
critically ill patients, other trials particularly investigated the use of EMS on critically ill patients in 
the ICU, however not all of them have fulfilled the allocation concealment, blinding, addressing 
outcome data according to “Cochrane Risk of Bias Tool for Randomised Controlled Trials” or the 
“Physiotherapy Evidence Database Scale”.     
 
Denehy and colleagues (2013) aimed to investigate the effectiveness of an exercise rehabilitation 
program commencing during ICU admission and continuing into the outpatient setting. Using a 
single-center, assessor-blinded, randomised controlled trial, one hundred and fifty participants were 
stratified and randomised to receive usual care or intervention if they were in the ICU for 5 days or 
more. The intervention group received intensive exercises in the ICU and the ward and as 
outpatients. Participants were assessed at recruitment, ICU admission and hospital discharge and at 
3, 6 and 12-month follow-up. Six-Minute Walk Test (6MWT), Timed Up and Go Test and the 
Physical Function in ICU Test were used to evaluate physical function. Patient-reported outcomes 
were measured using the Short Form 36 Health Survey and Assessment of Quality of Life 
Instrument. No differences were found in demographic and hospital data, including acuity and 
length of acute hospital stay, APACHE II score, hospital length of stay, primary outcome of 6MWT 
or any other outcomes at 12 months after ICU discharge. Further exploratory analyses only showed 
the rate of change over time and mean between-group differences in 6MWT from first assessment 
were greater in the intervention group [166]. 
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For trials investigating the use of EMS as a rehabilitative tool on critically ill patients, Gruther and 
colleagues (2010) found the effects of EMS on muscle layer thickness on knee extensor muscles in 
intensive care unit patients and found it to be a useful adjunct in preventing muscle wasting 
in intensive care unit long-term patients. In this randomised controlled, double blinded pilot trial, 33 
intensive care patients were stratified into 2 groups; 17 acute patients (< 7 days) and 16 long-
term patients (>14 days). Both groups were randomised to a stimulation group or a sham 
stimulation group. Electrical stimulation was applied to knee extensor muscles for a period of 4 
weeks (session time 30-60 minutes, 5 days/week). Ultrasound measurements were performed before 
and after the stimulation period to quantify muscle layer thickness of knee extensor muscles. This 
study found long-term patients who were stimulated (+4.9%) showed a significant (p=0.013) 
increase in muscle layer thickness compared with sham-stimulated patients (-3.2%)  [189]. 
 
On the contrary, Poulsen and colleagues (2011) investigated the early effects of electrical muscle 
stimulation on quadriceps muscle volume in patients with septic shock and found that the loss 
of muscle mass was unaffected by the use of EMS despite daily application. This was the first trial 
to isolate eight patients diagnosed with sepsis for the investigation of the effect of a single 
rehabilitative tool. The study was randomised with the intervention group using a single-legged 
exercise design with the contralateral leg serving as a paired control. 
Electrical muscle stimulation was applied on the intervention side for 7 consecutive days and for 60 
minutes per day on the randomised quadriceps muscles. Over 7 days, the volume of the 
quadriceps muscle on the control thigh decreased by 16% (4-21%, p=0.03) corresponding to a rate 
of 2.3% per day. The volume of the stimulated muscle decreased by 20% (3-25%, p=0.04) 
corresponding to a rate of 2.9% per day (p=0.12 for the difference in decrease). There was no 
difference in muscle volume between the stimulated and non-stimulated thigh at baseline (p=0.10) 
or at day 7 (p=0.12). This study observed a marked decrease in quadriceps volume within the first 
week of intensive care for septic shock [191].  
 
Karatzanos and colleagues (2012) studied the effects electrical muscle stimulation on strength of 
various muscle groups in critically ill patients. One hundred forty-two consecutive patients were 
randomly assigned to the EMS or the control group. EMS sessions were applied daily on vastus 
lateralis, vastus medialis, and peroneus longus of both lower extremities. Muscle strength was 
evaluated with the Medical Research Council scale. Handgrip strength assessment was also 
measured. Twenty four patients in the EMS group and 28 patients in the control group were 
evaluated. The use of EMS resulted in higher MRC scores (p ≤ 0.05) in wrist flexion, hip flexion, 
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knee extension, and ankle dorsiflexion. The EMS group had higher muscle strength (p < 0.01) in the 
lower limbs and overall. Handgrip strength correlated (p ≤ 0.01) with the muscle strength of the 
upper and lower extremities and the overall MRC scores. Therefore, this study demonstrated that 
EMS had beneficial effects on the strength of critically ill patients and may also 
affect muscle groups not involved in EMS presenting itself as a potential effective means 
of muscle strength preservation rehabilitation strategy [190].  
 
Angelopoulos and colleagues (2013) compared the effects on microcirculation 
using medium and high frequency currents of a single EMS session. Patients in the intensive care 
with systemic inflammatory response syndrome or sepsis of three to five days duration 
and patients with ICU-AW were studied. A single 30-minute EMS session was applied to the lower 
limbs bilaterally using current of increasing intensity. Thirty-one patients were randomly assigned 
to either the high-frequency (HF) (75 Hz, pulse 400 μs, cycle 5 seconds on - 21 seconds off) or the 
medium frequency (MF) (45 Hz, pulse 400 μs, cycle 5 seconds on - 12 seconds off) protocol. 
Peripheral microcirculation was monitored at the thenar eminence using near-infrared spectroscopy 
to obtain tissue oxygen saturation (StO2) before and after the session. Local microcirculation of the 
vastus lateralis was also monitored. In the HF protocol, peripheral microcirculatory parameters; 
thenar O2 consumption rate (%/minute) from 8.6 ± 2.2 to 9.9 ± 5.1 (p = 0.08), endothelial reactivity 
(%/second) from 2.7 ± 1.4 to 3.2 ± 1.9 (p = 0.04), vascular reserve (seconds) from 160 ± 55 to 
145 ± 49 (p = 0.03). In the MF protocol, thenar oxygen consumption rate (%/minute) from 8.8 ± 3.8 
to 9.9 ± 3.6 (p = 0.07), endothelial reactivity (%/second) from 2.5 ± 1.4 to 3.1 ± 1.7 (p = 0.03), 
vascular reserve (seconds) from 163 ± 37 to 144 ± 33 (p = 0.001). Both protocols showed a similar 
effect demonstrating that a single EMS session affected local and systemic skeletal muscle 
microcirculation and that medium and high frequency currents were equally effective [188].  
 
Abu-Khaber and colleagues (2013) furthered this area of research by assessing the effect of 
electrical muscle stimulation on prevention of ICU-AW and in facilitating the weaning from 
mechanical ventilation in critically ill patients. Using a prospective, randomised, placebo-controlled 
trial, 80 critically ill patients on mechanical ventilation for more than 24 hours were randomly 
categorised into two groups; 40 patients received conventional lines of treatment only (control 
group) and 40 patients received in addition one daily session of EMS (EMS group). Assessment of 
occurrence of ICU-AW was done using the MRC scale which is a method for clinical assessment of 
muscle strength. Muscle strength did not show any significant difference between the two groups in 
the first 3 days post mechanical ventilation. On day 4, MRC mean value was 46.86 ± 10.88 in the 
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EMS group versus 43.70 ± 9.32 in the control group (p = 0.041). At 3 weeks, MRC mean value was 
29.67 ± 8.87 in the EMS group versus 19.60 ± 4.34 in the control group (p = 0.037). Significant 
difference was also noted in the duration of mechanical ventilation as the mean value in the EMS 
group was 9.01 ± 8.01 days versus 11.97 ± 8.07 in the control group (p = 0.048). This study 
concluded that although EMS could not prevent the occurrence of ICU-AW in critically ill 
mechanically ventilated patients it still could minimise the degree of muscular weakness and help 
facilitate weaning from mechanical ventilation [210].  
 
Recently, Kho and colleagues (2014) conducted a randomised pilot study of EMS versus sham 
applied to 3 bilateral lower extremity muscle groups for 60 minutes daily in the intensive care unit. 
Adults who were receiving mechanical ventilation within the first week of ICU stay and who could 
transfer independently from bed to chair before hospital admission were enrolled. The primary 
outcome was lower extremity muscle strength at hospital discharge using Medical Research Council 
score (maximum, 30). Secondary outcomes at hospital discharge included walking distance and 
change in lower extremity strength from ICU awakening. For EMS versus sham, mean (SD) lower 
extremity strength was 28 (2) versus 27 (3), p = 0.072. Among secondary outcomes, EMS versus 
sham patients had a greater mean (SD) walking distance (514 [389] vs 251 [210] feet, p = 0.050) 
and increase in muscle strength (5.7 [5.1] versus 1.8 [2.7], p = 0.019). In this pilot randomised trial, 
EMS did not significantly improve leg strength at hospital discharge [218].  
 
Information on ongoing trials were sought from electronic trial registries; Clinicaltrials.gov 
(http://clinicaltrials.gov/) and ANZCTR (http://www.anzctr.org.au/). Currently, there are 22 trials in 
progress examining physical therapy or exercise for patients in the intensive care unit.  
4.3.2 Systematic Reviews 
To our knowledge, there has been no meta-analysis that analysed the highest order of clinical trials 
(randomised controlled trials) performed in the area of research for physical rehabilitation in the 
critically ill. While there were new reviews reported in search strategies, they were essentially 
narrative reviews with all research designs included, no scoring or comment on the quality of the 
studies. However, a recent systematic review in the Cochrane Database, evaluated randomised 
controlled trials to examine the effect of any intervention in intensive care on the incidence of 
CIP/CIM in ICU patients [219]. This review found moderate quality evidence for a potential benefit 
of early rehabilitation on CIP/CIM and very low quality evidence suggesting no effect of EMS on 
CIP/MIP, although data were prone to bias for the effect of EMS.  
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One new systematic review [220] in the area of early mobilisation in the ICU graded the quality of 
the trials while another review [221] performed a review of RCTs on interventions to improve 
physical function but failed to assess the quality of the trials. Two reviews [222, 223] were narrative 
although they provided a comprehensive list of all the trials. Two systematic reviews [195, 224] 
summarised trials and their quality for the use of EMS as a rehabilitative tool in the ICU. Three 
other reviews [225-227] were narrative in nature. 
4.4 Summary 
The systematic review and meta-analysis of randomised controlled trials presented in this chapter 
indicated physical therapy in the ICU confers benefits for the critically ill patient. The evidence 
from the meta-analysis indicated that ICU exercise reduces ICU and hospital length of stay, 
increases the number of ventilator free days, improves peripheral and respiratory muscle strength, 
improves physical function and health related quality of life. While these were positive findings, the 
effects were small to moderate. By critically assessing the methodology of the trials, the review was 
able to conclude that future trials require more stringent methodological standards to provide more 
conclusive evidence on the effect of ICU exercise. Protocols of exercises including the ideal 
intensity and timing and the mechanisms of these effects in specific conditions during critical illness 
are yet to be explored. 
 
The exercise trials in this review included a large casemix of critically ill patients but was able to 
support the use of supervised exercise to reduce ICU length of stay and increase ventilator free days 
while demonstrating beneficial effects on peripheral and respiratory muscle function, physical 
function and quality of life despite the greatly varied methodologies used in the available studies. 
Diagnostic criteria are one of the determinants of poor outcome post ICU with sepsis syndromes 
repeatedly demonstrating poor outcomes particularly in the physical domain [228]. The toxic 
combination of sepsis and critical illness/multi-organ failure leads to severe, new and enduring 
impairments which often persist for years. However patients with sepsis syndromes, especially 
septic shock, often have high acuity of illness and require heavy sedation which makes 
implementation of rehabilitation difficult. While investigating benefit, we also need to consider 
safety and optimal doses of exercise in these critically ill patients.  
 
Further limitations of the published systematic review include that it does not provide a meta-
analysis of a single pathology. It includes an analysis of wide range of intensive care conditions as 
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is the nature of critical care admissions and it is important to note that the results of the effects of 
the outcomes cannot be entirely specific to a single condition. 
 
Although the Pedro scoring criteria was employed to analyse the RCTs, it is important to note that 
such criteria for studies is not linear and hence missing factors such as lack of blinding, concealed 
allocation or random allocation may have much greater bias effects than others depending on the 
nature of the work in each RCT. This can impact on the methods, populations recruited, measures 
and outcomes employed in the study potentially biasing the effect positively or negatively. 
 
The next chapter, Chapter 5, will present the protocol for a randomised controlled trial on acute 
critically ill patients with sepsis syndromes investigating both efficacy and safety of an early 
physical rehabilitation program: “A prospective randomised controlled trial investigating functional 
and physiological outcomes; i-PERFORM trial”.  
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CHAPTER 5  
Methodology 
5.1 Overview 
To address the second aim of this thesis; a methodologically stringent randomised controlled trial 
was conceptualised and designed to investigate early physical rehabilitation in a critically ill 
population of patients with sepsis syndromes in intensive care.  
 
The purpose of this chapter is to describe the methodology and materials used in the i-PERFORM 
trial and presents the trial protocol manuscript. Details of methodological work provided by the 
PhD Candidate, Geetha Kayambu are reported. A description of methods that were modified from 
the protocol published has been included in this chapter. Recruitment commenced in December 
2010 and ended in August 2012. Final follow up of all participants was completed in May 2013. 
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5.2 Contribution to Trial by PhD Candidate 
As the principal investigator of the i-PERFORM trial, Geetha Kayambu contributed to the 
development of the structure and content of the research protocol, including novel components of 
the research which consisted of the investigation of effects of early ICU physical rehabilitation on 
mitochondrial DNA, plasma lactate, muscle oxygenation and tissue microcirculation. Geetha 
Kayambu introduced the investigation of novel measures; mitochondrial DNA, plasma lactate, 
tissue microcirculation during early ICU physical rehabilitation for the conduct of the i-PERFORM 
trial to physiotherapists at the Cardiorespiratory Meeting, Australian Physiotherapy Association, 
2010. 
 
Trial registration and ethics approvals 
Geetha Kayambu obtained clinical trial registration for the study with the                             
Australian and New Zealand Clinical Trials Registry (Trial Registration: ACTRN12610000808044)                            
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12610000808044       
and ethics approval for the conduct of the research with the Human Research Ethics Committee              
(HREC/10/QRBW/279) at Royal Brisbane and Women’s Hospital and the Medical Research Ethics 
Committee at The University of Queensland (2010001178). She also sought the approval of the 
Queensland Civil and Administrative Tribunal for the study (CRL018-10). Geetha Kayambu 
sourced and applied for internal and external grants to support the conduct of the i-PERFORM trial. 
 
Screening and recruitment 
Geetha Kayambu performed recruitment tasks which included screening of patients for the trial 
using Intellivue Clinical Information Portfolio (ICIP) ICU database and directly at ICU medical 
rounds, introducing the study to the ICU consultants, registrars and staff nurses and obtaining 
written consent from next of kin of potential participants for recruitment. Geetha Kayambu was the 
research physiotherapist providing early targeted physical rehabilitation program to the recruited 
participants in the intervention group in the ICU as per protocol. 
 
Data collection 
Geetha Kayambu collected all ICU demographic data from Intellivue Clinical Information 
Portfolio. All demographic data were directly stored in softcopies. Geetha Kayambu passed a 
formal clinical competency assessment in the ICU to obtain arterial blood from the arterial line of 
participants in the ICU and collected blood for the i-PERFORM trial. Geetha Kayambu remained 
blinded to the serially coded arterial blood samples which were only analysed after completion of 
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the ICU trial. Geetha Kayambu centrifuged, aliquotted and stored all blood samples for analysis, 
performed all associated data entry and all data management and statistical analysis tasks with a 
statistician.  
 
Geetha Kayambu sourced and obtained contacts of scientists and experts who assisted in the 
preparation, extraction and analysis of inflammatory biomarkers and mitochondrial DNA. Upon 
completion of the ICU trial, Geetha Kayambu assisted in laboratory analysis of the inflammatory 
biomarkers and mitochondrial DNA content. Geetha Kayambu worked closely with laboratory 
scientists from the University of Queensland Centre for Clinical Research and the University of 
Queensland School of Chemistry and Molecular Biosciences and contributed significantly in the 
preparation, extraction and analysis of mitochondrial DNA in peripheral blood obtained from the i-
PERFORM trial. Geetha Kayambu underwent formal training by scientists to use SYBR green real-
time PCR (RT-PCR ABI ViiA7) and the RT-PCR epMotion 5075 Robot machines. Geetha 
Kayambu worked with laboratory research personnel from the University of Queensland Centre for 
Clinical Research, Cardinal Bioresearch and The Abacus Laboratory for the analysis of 
inflammatory biomarkers in arterial blood collected from the i-PERFORM trial. 
 
For the pilot trials, Geetha Kayambu performed the muscle oxygenation measurements using the 
Near Infrared Oxygenation Monitor (NIRO) and microcirculation measurements using the 
Orthogonal Polarisation MicroScan (OPS). Geetha Kayambu remained blinded to all data which 
were serially coded and performed the analysis of the stored data at completion of the ICU trial. 
 
Data Storage 
All measurable outcome data were serially coded and documented in hardcopies developed for the 
purpose of the trial and transferred to softcopies for data and statistical analysis. All data were kept 
under lock and key for data protection and confidentiality. All documentation used for the i-
PERFORM trial are found under the Appendices section of the Thesis. 
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5.3 Manuscript 2 (Protocol Article) 
The manuscript entitled “Early rehabilitation in sepsis: a prospective randomised controlled trial 
investigating functional and physiological outcomes The i-PERFORM Trial (Protocol Article)” has 
been published in the BioMed Central Anesthesiology. 
 
The final publication is available at BioMed Central via: Kayambu G, Boots RJ, Paratz JD. Early 
rehabilitation in sepsis: a prospective randomised controlled trial investigating functional and 
physiological outcomes The i-PERFORM Trial (Protocol Article). BMC Anesthesiol. 2011 Oct 
31;11:21. doi: 10.1186/1471-2253-11-21 (Impact Factor 1.33). 
 
The manuscript is presented as submitted for publication, except for tables and figures and 
references that have been configured to fit the overall style of the Thesis. The numbering of pages 
are in accordance with the overall format of the Thesis. The references are found at the end of this 
manuscript.  
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Abstract 
Introduction Patients with sepsis syndromes can have worse outcomes for physical function, 
quality of life and survival. Early intensive care rehabilitation can improve the outcome in general 
Intensive Care Unit (ICU) patients, however no investigations have specifically looked at patients 
with sepsis syndromes. The ‘i-PERFORM Trial’ will investigate if early targeted rehabilitation is 
both safe and effective in patients with sepsis syndromes admitted to ICU. 
 
Methods/Design A single-centred blinded randomised controlled trial will be conducted in 
Brisbane, Australia.  Participants (n=252) will include those ≥ 18 years, mechanically ventilated for 
≥ 48 hours and diagnosed with a sepsis syndrome. Participants will be randomised to an 
intervention arm which will undergo an early targeted rehabilitation program according to the level 
of arousal, strength and cardiovascular stability and a control group which will receive normal care.  
 
The primary outcome measures will be physical function tests on discharge from ICU (The Acute 
Care Index of Function and The Physical Function ICU Test). Health related quality of life will be 
measured at six months post discharge with the Short Form-36 and the psychological component 
will be tested using The Hospital Anxiety and Depression Scale. Secondary measures will include 
the inflammatory biomarkers; Interleukin-6, Interleukin-10 and Tumour Necrosis Factor - α, 
peripheral blood mitochondrial DNA content and lactate, fat free muscle mass, tissue oxygenation 
(StO2) and microcirculatory flow.   
 
Discussion The ‘i-PERFORM Trial’  will determine whether early rehabilitation for patients with 
sepsis is effective at improving patient outcomes with functional and physiological parameters 
reflecting long and short-term effects of early exercise and its safety in its application in critical 
illness. 
 
 
 
 
 
 
 
 
 
Trial Registration: ACTRN12610000808044 
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Introduction 
Critical Illness and trauma are the primary sources of intensive care unit admissions. An estimated 
2% to 11% of these patients require prolonged stays in the ICU which accounts for 25-45% of total 
ICU days [1]. Survivors of intensive care, especially those with a prolonged stay, may exhibit 
severe psychological and physical problems [2] and have a lower health related quality of life up to 
one year following discharge from the hospital [3]. Almost a quarter of these patients are either 
admitted with or develop sepsis i.e. a severe, specific inflammatory response to infection,  during 
the course of their stay in the ICU with major immediate and long-term effects on morbidity and 
mortality [4]. Patients with sepsis can have a worse outcome both in terms of overall functioning 
and mortality rates [5].There is evidence that specific decreases in muscle mass and muscle force 
occur in sepsis syndromes caused by a variety of mechanisms [6]. This has major effects on the 
health and productivity of survivors as well as ultimately the impact on the availability of ICU and 
hospital beds, surgical waiting lists, health costs and society. 
 
Hypothesising that light to moderate exercise can partially reverse this condition without causing 
harm to critically ill patients, several exercise trials conducted in general intensive care patients 
have indicated positive findings that early intervention with exercise is able to prevent critical 
illness weakness syndromes, loss of muscle mass, decrease duration of mechanical ventilation 
length of hospital and ICU stay and improve overall quality of life [7]. Specifically however, it is 
important to investigate early rehabilitation in patients with sepsis syndromes as the inflammatory 
process in sepsis can aggravate and accelerate the rate of muscle wasting in addition to the 
immobility associated with the disease in its early stages. It is equally important to ensure that early 
exercise in sepsis does not result in oxidative stress or cause substantial tissue injury potentially 
worsening the inflammatory reaction. The physiological reasons for improvement or adverse effects 
require investigation (Figure 5.1). 
 
Sepsis Syndrome 
Sepsis is a systemic inflammatory response associated with an infectious insult. It is the leading 
cause of death in critically ill patients and is often associated multi organ failure [8]. The 
inflammatory cytokines associated with sepsis such as Interleukin 6 (IL-6), Interleukin 10 (IL-10) 
and Interleukin 1β (IL-1β) are found to be correlated with the severity of the disease, the evolution 
of organ failure as measured by the SOFA score and mortality [9]. Physiological responses to 
inflammation as described in Table 1 in addition to the presence of a suspected or proven infection 
has been an internationally accepted definition for “Sepsis” [8, 10]. Increasing sepsis severity 
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correlates with increasing mortality, rising from 25-30% for severe sepsis to 40-70% for septic 
shock [10, 11].  
 
Systemic Inflammation and Proteolysis 
The aggressive inflammatory process that occurs during sepsis also affects muscle force, mass and 
ultimately functional outcome [12, 13]. Persistent elevation of circulating levels of Interleukin-6 
(IL-6) have been known to infiltrate myocytes with inflammatory factors such as prostaglandins 
leading to proteolysis, myocyte degeneration, and muscle atrophy [14]. Tumour Necrosis factor - 
(TNF-) overexpression in sepsis is linked to the development of cachexia [15] through endothelial 
dysfunction, leading to myocyte apoptosis, reduction in skeletal muscle mass, weakness and 
myopathy. It has been hypothesised that prevention of excessive release of pro-inflammatory 
cytokines [15], and activation of proteolytic pathways leading to limitation of free-radical 
generation [16] may inhibit the catabolic skeletal muscle changes in sepsis [17] and thus critical 
illness weakness syndromes.  
 
Inflammatory Biomarkers and Exercise  
Interleukin 10 (IL-10); an anti-inflammatory cytokine is thought to inhibit proteolysis [18] while 
low levels have been postulated to lead to excessive inflammation and muscle damage [19]. IL-10 is 
known to attenuate the synthesis of TNF- surface receptor and its suppressive effects may be 
beneficial in pathology that results from inflammatory dysregulation such as in sepsis.  
 
A number of studies [20-22] have shown that aerobic and resisted exercise in healthy and other 
diseased populations such as in chronic heart failure alters pro-inflammatory cytokines specifically 
decreasing IL-6 and TNF- and increasing IL-10. Simple physical exercises such as repetitive 
passive muscle stretches have been shown to decrease pro-inflammatory cytokine (IL-6), increased 
anti-inflammatory cytokine (IL-10) and improved the IL-10/TNF- ratio in chronic critically ill 
patients [23]. The use of electrical muscle stimulation on major muscle groups has been shown to 
attenuate the production of TNF- [24]. It is therefore important to investigate the effect of exercise 
on IL-10 in sepsis.  
 
Our pilot study tested 20 patients with sepsis syndromes randomised into a treatment (proactive 
rehabilitation) and a control group. The trial demonstrated significant decreases (-7.2%) in the 
percentage fat free mass in the control group with no decreases in the intervention group. 
Significant increases in IL-10 (mean difference 12.1 (SE +/- 2.1) (p<0.01) were found in the 
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treatment group. Clinically relevant findings from this study indicate early exercise reduces loss of 
muscle mass in sepsis [25].  
 
Oxidative stress 
Oxygen-derived free radicals play an important role in the development and progression of disease 
in critically ill patients resulting in increases in the level of Reactive Oxygen Species (ROS) [26] or 
decreases in antioxidant defences [27] causing oxidative stress [28]. ROS can play a pivotal role in 
stimulating the inflammatory system by causing an increase in cytokines (e.g. Interleukins and 
TNF-).  Both cytokines and ROS can enter the circulation and mediate systemic inflammatory 
responses linked with clinical conditions [29] which are inter-related in causing muscle proteolysis 
resulting in the induction of sepsis-induced myopathy [6]. 
 
In patients with sepsis, antioxidant depletion has been found to be associated with mitochondrial 
dysfunction where oxidative stress generates bioenergetic failure [30] which may affect changes in 
mitochondrial DNA quantity [31], as well as increase mutations or deletions. This has been 
hypothesised to be part of the mechanism underlying multiple organ failure and death [32, 33].  
 
Oxidative stress also acts as an atrophic stimulus in an unloaded muscle [34] promoting wasting by 
modifying redox-sensitive processes in its muscle fibres such as during periods of disuse in 
locomotor skeletal muscles [35] and the unloaded diaphragm during prolonged mechanical 
ventilation [36, 37]. Currently, however, there is no published data on the effects of exercise on 
oxidative stress on the critically ill population particularly in sepsis. 
 
Illness Severity 
Hyperlactaemia is a marker of illness severity in sepsis [38, 39]. During early sepsis, perturbation of 
glycolytic mechanisms can occur. In septic shock, high concentrations of circulating adrenaline can 
drive large quantities of lactate out of skeletal muscles, overwhelming lactate clearance mechanisms 
with resultant, Hyperlactaemia [40, 41]. The effect of light exercise on lactate clearance 
mechanisms in early sepsis remains to be investigated. 
 
Microcirculation and Muscle Oxygenation  
Sepsis impairs microcirculatory function causing tissue hypoxia [42]. This combined with blood 
flow diversion from less important tissues to vital organs [43] promotes decreased muscular oxygen 
extraction [44]. However, the use of electrical stimulation [45] on major muscle groups and a 
physical exercise rehabilitation program in chronic heart failure patients [46] have demonstrated 
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short-term beneficial systemic effects on the microcirculation. The effect of early activity on 
microcirculation in patients with sepsis should be further investigated. 
 
Early Rehabilitation may Modulate Detrimental Effects of Sepsis  
The roles of pro-inflammatory cytokines, mitochondrial changes and muscle proteolysis in causing 
sepsis-induced myopathy in critically ill patients are hypothesised from animal models [6, 14]. It is 
postulated that exercise can modulate cytokine levels [47], ROS production [48] and ATP levels 
[49] in patients with sepsis. In conjunction with an early mobility protocol, ambulation during 
mechanical ventilation in the early stages of critical illness is becoming widely practiced [50-52], 
especially with interruption of sedation [53-55]. Conservatively, simple passive movements [56] 
and neuromuscular electrical stimulation [45] as a precursor to active mobilisation can induce 
microcirculatory changes that may attenuate the anti-inflammatory effects in early sepsis.  
 
Overall, early rehabilitation in critical illness seems to show reduced time on the ventilator, 
improved quality of life and reduced hospital and ICU stay [7] but this is not specific to sepsis. 
Furthermore, the short-term systemic effects of exercise for ICU patients remain highly speculative 
and debatable. The impact of exercise in the early stages of critical illness on effects such as 
oxidative stress and microcirculatory alterations have been unexplored and speculated from other 
populations. Exploring these physiological factors in response to exercise can contribute to 
determining the safety of early rehabilitation in sepsis.  
 
Hypothesis and Aims 
The primary research hypothesis of the “i-PERFORM Trial” is that patients with defined sepsis 
syndromes [57] in the ICU who participate in an early targeted rehabilitation program will have 
improved physical function and an improved quality of life. The secondary hypotheses is that there 
will be systemic effects underlying primary improvements which will include; increased fat free 
mass; decreased pro-inflammatory and increased anti-inflammatory cytokines; increased peripheral 
blood mitochondrial DNA content and reduced plasma lactate levels; and improved tissue 
oxygenation and microcirculation flow.  
 
Materials and Methods 
Methods and Design 
The i-PERFORM Trial is a prospective double blinded randomised controlled trial (RCT) in 
patients with sepsis syndromes randomised into an early rehabilitation intervention arm or a control 
arm during the course of ICU stay. All outcomes will be measured by a blinded assessor from the 
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research team. This study is being conducted in a quaternary level general Intensive Care Unit at the 
Royal Brisbane and Women’s Hospital (RBWH), Brisbane, Queensland, Australia. The Human 
Research Ethics Committee at RBWH and the Medical Research Ethics Committee at The 
University of Queensland have approved this study. The study protocol is registered with the 
Australian New Zealand Clinical Trials Registry (ANZCTR). Figure 5.2 illustrates the 
methodology design for this RCT through recommendations from CONSORT (Consolidated 
Standards of Reporting Trials) Statement. 
 
Inclusion Criteria 
To be eligible for recruitment in the study, participants must be aged 18 years and above; ventilated 
for ≥ 48 hours; diagnosed with a sepsis syndrome or have a high clinical suspicion of sepsis [57] 
Table 5.1. Patients with head injuries, burns, spinal injuries, and multiple fractured lower limbs 
requiring specific rehabilitation regimes and patients with septic shock who are unresponsive to 
maximal treatment and those who are moribund or have an expected mortality within 48 hours will 
be excluded. 
 
Recruitment, Randomisation and Blinding 
Eligible patients will be identified and consent will be sought by the chief and principal 
investigators, with next of kin or substitute decision maker. Participants recruited will be 
randomised into control and intervention arms using computer generated randomization; 
http://www.randomization.com/. The randomization sequence will be generated and re-identifiable 
serial numbers will be assigned by a research personnel not involved in the study. They will be 
concealed from consent designee research staff for group allocation to prevent selection bias and 
protected by an electronic password. Participants, substitute decision makers and outcome assessors 
will be blinded to group allocation to avoid influence over treatment effect. Blinding of the treating 
physiotherapist and health care providers cannot be ensured due to the nature of the research 
intervention. 
 
Demographics  
Patient demographic information will be collected at baseline (recruitment) and ICU and hospital 
discharge and will include; age, gender, primary reason for readmission to ICU, Acute 
Physiological and Chronic Health Evaluation (APACHE II) [58], Sequential Organ Failure 
Assessment (SOFA) score [59], Charlson Comorbidity Index [60], time on mechanical ventilation, 
length of ICU and hospital stay, readmissions to ICU and 90-day mortality. 
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Intervention Arm 
Participants randomised to the intervention arm of the trial will undergo a specific targeted 
rehabilitation program prescribed by the treating ICU physiotherapist for 30 minutes, one to two 
times daily until discharge from the ICU within 48 hours of the diagnosis of sepsis (Early 
Intervention Arm). The rehabilitation program will comprise of passive or active range of motion 
exercises, resistive exercises, electrical muscle stimulation to major muscle groups, leg or arm 
ergometry, sitting out of bed, tilt tabling therapy and ambulation with assistance. The rehabilitation 
strategy for the participants in the intervention arm has been carefully planned with consideration 
for different levels of cardiovascular stability, ability of the patient to co-operate, and existing 
evidence regarding rehabilitation techniques and mobilisation strategies in intensive care. It will be 
administered and progressed by the discretion of the physiotherapist, according to individual acuity 
of illness and level of co-operation as based on the Ramsay sedation score which will account for 
the intervention progression stages. If the patient deteriorates, a lower level of activity will be given. 
Table 5.2 summarises the intervention strategies. 
 
Control Arm  
Participants allocated to the control arm will receive standard ICU care. The participants 
randomised to this group will not receive active rehabilitation from the research team, i.e. will not 
be given targeted exercises early in their disease process upon recruitment. However, they will 
continue to receive simple and less regular mobilisation activities from other sources, as part of the 
usual ICU care such as sitting out of bed or ambulation immediately prior to discharge from the 
unit. The time involved in these activities and the type of activities performed will be recorded and 
compared between groups.  
 
Safety and Withdrawal criteria  
A safety audit will be completed on patients in the rehabilitation group to monitor any adverse 
events [61] during rehabilitation. Data will be gathered from the patient’s IntelliVue bedside 
monitor MP70 (Phillips) every 10 seconds and printed out for 10 minutes prior, during and post 
rehabilitation. The intra-arterial line will be zeroed 10 minutes prior to exercise. A withdrawal 
criterion with a checklist of adverse events will be used for the clinical decision of withdrawal or 
modification of exercise intervention. 
 
Primary Outcome Measures 
All primary outcomes will be measured at baseline (recruitment) and at ICU discharge and quality 
of life at 6 months post discharge. The primary outcome measures will report the level of physical 
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functioning and quality of life (long-term effects) of the participants. Physical function will be 
measured using the Acute Care Index of Function (ACIF) and the Physical Function ICU Test 
(PFIT).  
 
The ACIF will essentially rate simple physical function (transfer bed to chair, sit to stand 
independently) of the patient on leaving the ICU [62]. The PFIT is a newly developed clinical tool 
for testing functional strength and endurance capacity in ICU patients. It consists of a battery of 
tests assessing endurance, muscle strength, cardiovascular capacity and functional ability which are 
domain representative of physical function and specific for the use of higher functional assessment 
in the critically ill [63]. These have been chosen as corresponding measuring instruments as they 
have demonstrated reliability, validity and responsiveness in the ICU population [63, 64]. 
 
Quality of life will be measured at 6 months post discharge using the Short-Form-36 (SF-36) Heath 
Questionnaire. Information from the next of kin will be used to provide proxy scores which have 
been demonstrated to have good reliability and validity [65]. 
 
The constructs of psychological well-being will be measured using anxiety subscale of the Hospital 
Depression and Anxiety Subscale (HADS) as psychological wellbeing is known to be highly 
correlated to functional physical outcomes [66]. 
 
Secondary Outcome Measures 
The secondary outcome measures will report on the physiological factors (short-term effects) 
illustrating underlying mechanisms of early intervention undertaken in the study. Blood samples 
(8ml) will be obtained from the patients’ arterial line, for the analysis of cytokines, plasma lactate 
and mtDNA levels pre and post intervention during the trial. All blood samples taken will be 
centrifuged (Spintron GT-25E/LL, Australia) for 15 minutes at 3000rpm, within 20 minutes of 
collection. Plasma from the whole blood for the cytokine analysis and peripheral blood 
mononuclear cells (PBMC) forming the buffy coat pellet for DNA isolation will be stored at -800C.  
 
Inflammatory Biomarkers 
Biomarkers will be measured before intervention and 30 minutes post intervention daily (week 1) 
and thereafter twice weekly (till ICU discharge). The acute inflammatory response of early exercise 
in sepsis will be measured by changes in levels of pro-inflammatory cytokines (IL-6 and TNF-α) 
and anti-inflammatory cytokines (IL-10). IL-6, IL-10 and TNF-α will be measured from plasma 
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samples with the Milliplex cytokine panels from Millipore (Billerica, MA, USA) using a Luminex 
100 assay, with an inter and intra-assay CV < 7%.  
 
Muscle Mass 
Fat free mass will account for muscle mass (lean tissue) measured at baseline (week 0) and weekly 
thereafter (till ICU discharge) using the Multi-Frequency Bioelectrical Impedance Spectroscopy 
(BIS) Machine (ImpediMed SFB7, ImpediMed Ltd, Brisbane, Australia). Measurements will be 
taken at a standardised time of the day as practicable for validity [67] and at standardised 
anatomical landmarks for reproducibility of results [68]. Pairs of gel electrodes will be placed on 
the hand and foot on the right side of the body with the participant positioned in supine. ICU 
monitoring will continue during measurement without interference [69]. An estimate will be made 
of the critically ill patients’ fluid balance. Urinary catheters will be emptied, prior to measurement. 
If subjects are known to have ascites, a pleural effusion or a renal replacement therapy, 
measurements will not be done. Percentage fat free mass will be measured in triplicate and analysed 
to reflect if proteolysis had occurred and resulted in the loss of muscle mass [70]. 
 
Oxidative Stress Markers 
Oxidative stress will be determined through changes in mitochondrial DNA levels.  Mitochondrial 
DNA copy number in the PBMC will be measured by determining relative amounts of 
mitochondrial to nuclear DNA using quantitative real-time PCR. Mitochondrial DNA (mtDNA) 
levels in the peripheral blood will be measured at baseline (week 0) and weekly thereafter (till ICU 
discharge). Total DNA from the blood sample will be extracted from the buffycoat using a DNA 
Analysis Kit (Machery Nagel Blood XL, Germany) and mtDNA quantity will be analysed using 
SYBR Green Master Mix Real Time PCR kit (Applied Biosystems, Warrington, United Kingdom). 
Triplicate analysis of blood samples will be conducted and trends of longitudinal increases in 
mitochondrial DNA levels will be reported. 
 
Illness Severity 
Plasma lactate levels will be measured before intervention, 5 and 30 minutes post intervention with 
arterial blood using a standard bench top Arterial Blood Gas Analyser (ABL 700 Series gas 
Machines, RADIOMETER, Copenhagen, Denmark). Lactate concentration trends will be used to 
analyse lactate clearance rates [71] as a marker of illness severity.  
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Muscle oxygenation and Microcirculation  
Muscle oxygenation and microcirculatory changes will be measured using the Near Infrared 
Oxygenation (NIRO) Monitor and the Orthogonal Polarization Spectral (OPS) Microscan 
respectively.  
 
Muscle (tissue) oxygenation will be measured pre and post intervention daily using the NIRO 
(NIRO-200, Hamamatsu, Japan) with a probe placed on a peripheral muscle to detect levels of 
muscle oxygenation (StO2) following acute exercise [72]. Muscle oxygen consumption will be 
further analysed through induced ischemia and reactive hyperaemia [73]. A pneumatic cuff will be 
placed above the elbow and inflated to 50mmHg above the patient’s systolic blood pressure and the 
occlusion will be retained for 3 minutes inducing local ischemia. StO2 will be recorded 
continuously for 3 minutes before, during and after arterial occlusion [44].  
 
Improvements in microcirculation following acute exercise will be measured pre and post 
intervention session once weekly using the OPS MicroScan (Microvision Medical Inc, Wallingford, 
PA,USA) with a non-invasive probe placed in the sub-lingual space to detect functional capillary 
density and blood flow velocity as indicators of microcirculatory function [74] using video images. 
Five video sequences per patient will be graded by 3 independent observers and assigned a flow 
velocity score to each of the 4 quadrants of each image [75]. Capillary density will be calculated 
using superimposed calibrated grid of vertical and horizontal lines on the images of number of 
small (<20 μm) vessels crossing the lines of the grid divided by the total length of the lines, yielding 
the number of small vessels per millimetre [76]. An average of these 5 readings will be calculated 
for discrete capillary density value for each time point at which imaging was performed.  
 
Confounding Variables  
Critical illness neuropathy and myopathy is a possible feature of critically ill patients. Formal tests 
to establish critical illness neuropathy or myopathy can be painful, invasive, time consuming and 
expensive [6]. Such formal diagnosis would not affect any pertinent findings in this trial. Basic 
physiotherapy assessment muscle testing done as part of regular intervention assessment using the 
Medical Research Council or Manual Muscle Test will detect any possible development of 
weakness without requirements for formal diagnosis and is accepted as configuration of critical 
illness polyneuromyopathy [77]. 
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Sample size 
Clinically important difference and the standard deviation estimates used in our sample size 
calculations were based on a previous clinical trial [64]. Sample size was calculated from the ACIF 
[62] for hypothesis testing with a type I error rate of 0.05 and 0.025 with Bonferroni adjustment and 
type II error rate of 0.20 (80% power). A minimum of 35 per group (70 total) is required to detect a 
minimum clinical difference (effect size) of 0.7 for physical functional outcomes which will yield 
clinically significant results for the main hypothesis achievable by intervention. Projection of the 
sample size after adjusting for attrition or withdrawal rates, participation refusals and possible death 
due to sepsis; based on admission and mortality rates in the RBWH ICU, 126 patients per group 
(252 in total) will be required.   
 
A smaller number of patients will undergo mtDNA, tissue oxygenation and microcirculatory 
measurements as these will be tested as pilot investigations. To test these secondary hypotheses, a 
minimum of 58 per group is required to detect a minimum clinical difference of 0.8 for clinically 
significant changes in mitochondrial DNA [78], a minimum 91 per group is required to detect a 
clinical difference of 0.4 and 59 per group is required to detect a minimum clinical difference of 0.7 
for clinically significant changes in tissue oxygenation [45] and microcirculation [46] respectively, 
all corrected for with Bonferroni adjustment of 0.025. 
 
Data Management and Statistical Analysis 
A baseline comparison using both student t-tests and chi-square for equal proportions of 
demographic data will be done between groups at enrolment. Data will be analysed using SPSS 
Version 17.0. The distribution, range of scores and heterogeneity will be examined for participants 
in both groups. Mean changes scores, standard deviations and 95% confidence intervals will be 
calculated and specific analysis detailed under each outcome measure will be performed. Repeated 
measures, between/within analysis of variance (ANOVA) will be performed to investigate for the 
main effects of time and group. Post hoc analyses will then be performed to ascertain where the 
differences occur. A Bonferroni correction will be used as the post hoc measure as there are 
multiple outcome measures. Analysis will be by both intention to treat and per protocol method. 
Any violations of the protocol will be noted. Statistical significance will be set at p<0.05 and 
p<0.025 (two-tailed). All efforts will be taken to avoid missing data but if it occurs a carry forward 
imputation will be done and linear mixed modelling will be used for overall analysis. Reasons for 
loss of follow up will be recorded.  
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Discussion 
The i-PERFORM Trial is an original study in investigating early rehabilitation in septic patients. 
Fully powered to be a larger trial from the pilot study, this RCT has been modified to include 
detailed and intensive interventional measures and further outcome measures; SF-36, PFIT, plasma 
lactate, mitochondrial DNA, muscle oxygenation and microcirculation dynamics. 
 
Controversies still exist with regards to the implementation of early exercise in critically ill patients 
despite growing evidence in the literature [7, 79]. Introducing early rehabilitation in patients with 
sepsis syndromes is challenging and the direct physiological implications are unknown. Novel 
findings from the i-PERFORM Trial involving physiological markers of oxidative stress and 
microcirculation will translate better understanding of the short-term systemic effects of early 
exercise in critical illness. The mechanisms and associations between early exercise and the 
inflammatory effects of sepsis explored in this trial will implicate on future rehabilitation 
management of septic patients in intensive care units. 
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Key Messages 
 
 The i-PERFORM RCT will determine whether early targeted rehabilitation will achieve a 
higher functional level and an improved quality of life in patients with sepsis. 
 
 Participants in the intervention arm will receive early, targeted, individualised rehabilitation 
program comprising of passive, active and resisted exercises, electrical stimulation to major 
lower limb muscles, sitting out of bed with exercises and tilt-tabling to improve orthostatic 
reflexes, ergometry exercises for upper and lower limbs and ambulation. 
 
 Physical functional capacity, quality of life, psychological wellbeing, inflammatory 
biomarkers, oxidative stress markers, illness severity, muscle oxygenation and microcirculation 
will be assessed using standard instruments at specific times before, during and after exercise 
sessions. 
 
 Short-term systemic findings from early rehabilitation in sepsis will be novel and will translate 
better understanding of the acute effects of early exercise in critical illness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 119 
 
References 
 
1. Williams TA, Ho KM, Dobb GJ, Finn JC, Knuiman M et al. Effect of length of stay in 
intensive care unit on hospital and long-term mortality of critically ill adult patients. British 
Journal of Anaesthesia 2010;104(4):459-464. 
2. Hurel D, Loirat P, Saulnier F, Nicolas F, Brivet F. Quality of life 6 months after intensive 
care: results of a prospective multicentre study using a generic health status scale and a 
satisfaction scale. Intensive Care Med 1997;23(3):331-337  
3. Pettila V, Kaarlola A, Mäkeläinen A. A Health related quality of life of multiple organ 
dysfunction patients after one year after intensive care. Intensive Care Med 
2000;26(10):1473-1479. 
4. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F et al. Incidence, risk factors, 
and outcome of severe sepsis and septic shock in adults. A Multicentre prospective study in 
intensive care in adults. JAMA 1995;274(12):968-974. 
5. Heyland D, Hopman W, Coo H, Tranmer J, McColl M. Long term health related quality of 
life in survivors of sepsis. Short Form 36: a valid and reliable measure of health related 
quality of life. Crit Care Med 2001;28(11):3599-3605. 
6. Callahan LA, Supinski GA. Sepsis-induced myopathy. Crit Care Med 2009;37(10):S354-
367. 
7. Kress JP. Clinical trials of early mobilization of critically ill patients. Crit Care Med 
2009;37(10 Suppl):S442-447. 
8. Lever A, Mackenzie I. Sepsis: Defintiion, epidemiology and diagnosis. BMJ 
2007;335(7625):879-932. 
9. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF et al. Cytokine profiles as markers 
of disease severity in sepsis: a multiplex analysis. Crit Care 2007;11(2):R49. 
10. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and 
organ failure. Chest Surgery Clinics of North America 1992;101(6):1481-1483. 
11. Lever A, Mackenzie I. Management of Sepsis. BMJ 2007;335:929-932. 
12. Winkelman C. Inactivity and Inflammation: Selected cytokines as biologic mediators in 
muscle dysfunction during critical illness. AACN Clinical Issues 2004;15(1):74-82. 
13. Eikermann M, Koch G, Gerwig M, Ochterbeck C, Beiderlinden M et al. Muscle force and 
fatigue in patients with sepsis and multiorgan failure. Intensive Care Med 2006;32(2):251-
259. 
 120 
 
14. Fink H, Helming M, Unterbuchner C, Lenz A, Neff F et al. Systemic inflammatory response 
syndrome increases immobility-induced neuromuscular weakness. Crit Care Med 
2008;36(3):910-916. 
15. Sharma R, Anker S. Cytokines, apoptosis and cachexia: The potential for TNF antagonism. 
Int J Cardiol 2002;85(1):161-171. 
16. Goodyear-Bruch C and Pierce JD. Oxidative Stress in Critically Ill patients. American 
Journal Critical Care 2002;11(6):543 - 551. 
17. Klaude M, Fredriksson K, Tjäder I, Hammarqvist F, Ahlman B et al. Proteasome proteolytic 
activity in skeletal muscle is increased in patients with sepsis. Clinical Science 
2007;112(9):499-506. 
18. Oberholzer A, Oberholzer C, Moldawer LL. IL-10: A complex role in the pathogenesis of 
sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 
2002;30(1):S58-S63. 
19. Lyons A, Goelbel A, Mannick JA, Lederer JA. Protective effects of early interleukin-10 
antagonism on injury-induced immune dysfuntion. Arch Surg 1999;134(12):1317-1324. 
20. Gielen S, Adams V, Möbius-Winkler S, Linke A, Erbs S et al. Anti-inflammatory effects of 
exercise training in the skeletal muscles of patients with chronic heart failure. J Am Coll 
Cardiol 2003;42(5):861-868. 
21. Vivodtzev I, Pépin J, Vottero G, Mayer V, Porsin B et al. Improvement in quadriceps 
strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely 
deconditioned and malnourished COPD. Chest 2006;129(6):1540-1548. 
22. Nuhr MJ, Pette D, Berger R, Quittan M, Crevenna R et al. Beneficial effects of chronic low-
frequency stimulation of thigh muscles in patients with advanced chronic heart failure. Eur 
Heart J 2004;25(2):136-143. 
23. Winkelman B. Cytokines in chronically ill patients after activity and rest. Bio Res Nurs 
2007;8(4):261-271. 
24. Karavidas AI, Raisakis KG, Parissis JT, Tsekoura DK, Adamopoulos S et al. Functional 
electrical stimulation improves endothelial function and reduces peripheral immune 
responses in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 
2005;13(4):592-597. 
25. Paratz J, Lipman J, Boots R, Lingwood B. Early exercise attenuates inflammation and loss 
of muscle mass. Australian and New Zealand Intensive Care Society, Perth October 2009. 
26. Oldham KM, Bowen PE. Oxidative stress in critical care: is antioxidant supplementation 
beneficial? J Am Diet Assoc 1998;98(9):1001-1008. 
 121 
 
27. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH et al. Total Vitamin C, 
ascorbic acid and dehyroascorbic acid concentrations in plasma in critically ill patients Am J 
Clin Nutr 1996;63(5):760-765. 
28. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact 
on muscle force production. Physiol Rev 2008;88(4):1243-1276. 
29. Espat NJ, Nelson WS. Oxygen free radicles, oxidative stress and antioxidants in critical 
illness. Support Line 2000;22:11-20. 
30. Callahan L, Stofan D, Szweda L, Nethery D, Supinski G. Free radicals alter maximal 
diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis. Free Radic 
Biol Med 2001;30(1):129–138. 
31. Crouser ED. Mitochondrial dysfunction in septic shock and multiple organ dysfunction 
syndrome. Mitochondrion 2004;4(5-6):729-741. 
32. Brealey D, Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 
2003;5(5):365-371. 
33. Brealey D, Brand M, Hargreaves I, Heales S, Land J et al. Association between 
mitochondrial dysfunction and severity and outcome of septic shock. Lancet 
2002;360(9328):219-223. 
34. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl 
Physiol 2007;102(6):2389-2397. 
35. Kondo H, Nakagaki I, Sasaki S, Hori S, Itokawa Y. Mechanism of oxidative stress in 
skeletal muscle atrophied by immobilization. Am J Physiol Endocrinol Metab 1993;265(6 pt 
1):E839–E844. 
36. Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T et al. Mechanical 
ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased 
proteolytic activity. Am J Respir Crit Care Med 2002;166(10):1369–1374. 
37. Zergeroglu MA, McKenzie MJ, Shanely RA, Van Gammeren D, DeRuisseau KC et al. 
Mechanical ventilation-induced oxidative stress in the diaphragm. J Appl Physiol 
2003;95(3):1116–1124. 
38. Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC et al. Lactate and glucose 
metabolism in severe sepsis and cardiogenic shock. Crit Care Med 2005;33(10):2235-2240. 
39. Valenza F, Aletti G, Fossali T, Chevallard G, Sacconi F et al. Review. Lactate as a marker 
of energy failure in critically ill patients: Hypothesis. Crit Care 2005;9(6):588-593. 
40. Daniel A, M, Shizga lH, M, MacLean L, D The anatomic and metabolic source of lactate in 
shock. Surg Gynecol Obstet 1978;147(5):697-700. 
 122 
 
41. Luchette FA, Friend LA, Brown CC, Upputuri RK, James JH. Increased skeletal muscle 
Na+, K+-ATPase activity as a cause of increased lactate production after hemorrhagic 
shock. J Trauma 1998;44(5):796-801. 
42. Hammed SM, Aird WC, Cohn SM. Oxygen delivery. Crit Care Med 2003;31(12 
Supp):S658-667. 
43. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J et al. Early microcirculatory 
perfusion derangements in patients with severe sepsis and septic shock: relationship to 
hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007;49(1):88–98. 
44. Cretuer J. Muscle StO2 in critically ill patients. Current Opinion in Critical Care 
2008;14(3):361-356. 
45. Gerovasili V, Tripodaki E, Karatzanos E, Pitsolis T, Markaki V et al. Short-term systemic 
effect of electrical muscle stimulation in critically ill patients. Chest 2009;136(5):1249-
1256. 
46. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E et al. Physical exercise 
improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm 
Rehabil Prev 2009;29(6):385-391. 
47. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 
2005;98(4):1154-1162. 
48. Fisher-Wellman K, Bloomer RJ. Acute exercise and oxidative stress: a 30 year history. 
Dynamic Medicine 2009;8(1): doi: 10.1186/1476-5918-1188-1181. 
49. Fredriksson K, Rooyacckers O. Mitochondrial function in sepsis: Respiratory muscle versus 
leg muscle. Crit Care Med 2007;35(9):S449-453. 
50. Perme C, Chandrashekar R. Early mobility and walking program for patients in intensive 
care units : Creating a standard of care. Am J Crit Care 2009;18(3):212-221. 
51. Bailey P, Thomsen GE, Spuhler VJ, Blair R, Jewkes J et al. Early activity is feasible and 
safe in respiratory failure patients. Crit Care Med 2007;35(1):139-145. 
52. Hopkins RO, Spulher VJ. Strategies for promoting early activity in critically ill 
mechanically ventilated patients. AACN Clinical Issues 2009;20(3):277-289. 
53. Thomsen GE, Snow GL, Rodriguez L, Hopkins RO. Patients with respiratory failure 
increase ambulation after transfer to an intensive care unit where early activity is a priority. 
Crit Care Med 2008;36(4):1119-1124. 
54. Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ et al. Early physical and 
occupational therapy in mechanically ventilated critically ill patients : a randomised 
controlled trial. Lancet 2009;373(9678):1874-1882. 
 123 
 
55. Kress JP, Polman AS, O’Conner MF, Hall JB. Daily Interruption of sedative infusions in 
critically ill patients undergoing mechanical ventilation. N Engl J Med 2000;342:1471-1477. 
56. Griffiths RD, Palmer TE, Helliwell T, MacLennan P, MacMillan R, R. Effect of passive 
stretching on the wasting of muscle in the critically ill. Nutrition 1995;11(5):428-432. 
57. Dellinger RP, Levy MM CJ, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-
Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, 
Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman 
JL, Vincent JL; International Surviving Sepsis Campaign Guidelines Committee; American 
Association of Critical-Care Nurses; American College of Chest Physicians; American 
College of Emergency Physicians; Canadian Critical Care Society; European Society of 
Clinical Microbiology and Infectious Diseases; European Society of Intensive Care 
Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association 
for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care 
Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of 
Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: International 
guidelines for management of severe sepsis and septic shock. Crit Care Med 
2008;36(1):1394-1396. 
58. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease 
classification system. Crit Care Med 1985;13(10):818-829. 
59. Vincent JL MR, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, 
Thijs LG. The SOFA ( Sepsis related Organ Failure Assessment ) score to describe organ 
dysfunction/failure. Intensive Care Med 1996;22(7):707-710. 
60. Charlson ME, Pompe P, Ales KL, MacKenzie CR. A new method of classifying prognostic 
comorbidity in longitudinal studies: development and validation. J Chronic Dis 
1987;40(5):373-383. 
61. Zeppos L, Patman S, Bernet S, Adsett J, Bridson J et al. Adverse physiological events in 
intensive care-is it an issue? Aust Journal of Physiotherapy 2007;53(4):279-283. 
62. Van Dillen LR, Roach KE. Reliability and validity of the acute care index of function for 
patients with neurologic impairment. Phys Ther 1988;68(7):1098-1101. 
63. Skinner EH, Berny S, Warrillow S, Denehy L. Development of a physical function outcome 
measure (PFIT) and a pilot exercise training protocol for use in intensive care. Crit Care 
Resusc 2009;11(2):110-115. 
64. Roach KE, Ally D, Finnerty B, Watkins D, Litwin BA et al. The relationship between 
duration of physical therapy services in the acute care setting and change in functional status 
in patients with lower extremity orthopaedic problems. Phys Ther 1998;78(1):19-24. 
 124 
 
65. Rogers J, Ridley S, Chrispin P, Scotton H, Lloyd D. Reliability of the next of kins’ estimates 
of critically ill patients' quality of life. Anaesthesia 1997;52(12):1137-1143  
66. Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety 
symptoms among patients. Arch Intern Med 2010;170(4):321-331. 
67. Kushner RF. Bioelectrical impedance analysis: a review of principles and applications. J Am 
Coll Nutr 1992;11(2):199-209. 
68. Lukaski HC, Bolonchuk WW, Hal lCB, Siders WA. Validation of tetrapolar bioelectrical 
impedance method to assess human body composition J Appl Physiol 1986;60(4):1327-
1332. 
69. Lingwood BE, Dunster KR, Ward LC. Cardiorespiratory monitoring equipment interferes 
with whole body impedance measurements. Physiological Measurement 2005;26(2):S235-
S240. 
70. Cornish BH, Ward LC, Thomas BJ, Jebb SA, Elia M. Evaluation of multiple frequency 
bioelectrical impedance and Cole-Cole analysis for the assessment of body water volumes in 
healthy humans. Eur J Clin Nutr 1996;50(3):159-164. 
71. Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P et al. Mild hyperlactatemia in stable 
septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir 
Crit Care Med 1998;157(4 pt 1):1021–1026. 
72. Colier WN, Meeuwsen IB, Degens H, Oeseburg B. Determination of oxygen consumption 
in muscle during exercise using near infrared spectroscopy. Acta Anaesthesiol Scand 
1995;39(Suppl 107):151-155. 
73. Strahovnik I, Podbregar M. Measurement of skeletal muscle tissue oxygenation in the 
critically ill. Signa Vitae 2008;3(1):43-50. 
74. Lindeboom JA, Mathura KR, Ramsoekh D, Harkisoen S, Aartman IH et al. The assessment 
of the gingival capillary density with orthogonal spectral polarization (OPS) imaging Arch 
Oral Biol 2006;51(8):697–702. 
75. De Backer D, Creteur J, Preiser JC. Microvascular blood flow is altered in patients with 
sepsis. Am J Respir Crit Care Med 2002;166(1):98–104. 
76. Abate NL, Trzeciak S. Is impaired capillary perfusion a marker of tissue hypoxia and a 
hallmark of incipient circulatory shock? Crit Care Med 2006;34(2):566–567. 
77. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Zaleski ID et al. Paresis acquired in 
the intensive care unit: A prospective multicenter study. JAMA 2002;288(22):2859-2867. 
78. Lim S, Kim SK, Park KS, Kim SY, Cho BY et al. Effect of exercise on the mitochondrial 
DNA content of peripheral blood in healthy women. Eur J Appl Physiol 2000;82(5-6):407-
412. 
 125 
 
79. Burtin C, Langer D, Troosters T, Hermans G, Decramer M. Early exercise in critically ill 
patients enhances short-term functional recovery. Crit Care Med 2009;37(9):2499-2505. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Impact of delayed ICU rehabilitation in early sepsis.  
This diagram illustrates the sequential impact of delayed rehabilitation for patients with sepsis as a 
result of the inflammatory processes and the detrimental short and long-term outcomes. 
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Figure 5.2 Research methodology sequence diagram.  
The inclusion criteria are as follows: Age ≥ 18 yrs and remain ventilated for ≥ 48 hours; present 
with documented sepsis or high clinical suspicion of sepsis. Patients with head injuries, burns, 
spinal injuries, and multiple fractured lower limbs, those with septic shock unresponsive to 
treatment, moribund or with expected mortality within 48 hours will be excluded. 
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Table 5.1 Criteria for sepsis syndromes.  
This table states the SIRS criteria for sepsis syndromes which includes 2 or more criteria in addition to the presence of a suspected or proven infection 
[51] 
 
Syndrome Criteria Mortality 
Systemic inflammatory response syndrome 
(SIRS) 
Any two or more of the following criteria 
 HR>90bpm 
 RR>20/min or PaCO2 <32mmHg 
 WCC<4 x 109 cells/L or > 12 x 109 cells/L or > 10% immature bands 12,000 
 T> 380 C or <360 C 
 
Sepsis  SIRS + proven infection 15% 
Severe Sepsis  Sepsis + failure of one or more organs 20% 
Septic Shock 
 Severe sepsis + cardiovascular failure despite adequate fluid resuscitation 
(usually SABP<90mmHg or >40mmHg from baseline) 45% 

HR; Heart rate, RR; Respiratory Rate; WCC; White Cell Count; T; Temperature, SIRS; Systemic Inflammatory Response Syndrome, SABP; Systolic 
Arterial Blood Pressure. 
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 Table 5.2 ICU physical rehabilitation program guide for participants in intervention group 
 
 
This chart serves only as a guide for potential patient exercise intervention strategies depending on the level of alertness and medical factors that  
affect the progression of exercise in each individual 
Ramsay 
Sedation 
Scale 
Stages of 
exercise 
progression 
Conditions Type of Intervention Recommended Exercise Prescription 
6-4 Stage 1 Sedated Passive Range of Motion with stretch reflex to upper and lower limbs  
Electrical Muscle Stimulation to major muscle groups  
 
30 Mins /day 
30 Mins /day 
3-2 Stage 2 Inotropic Dependence  Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting up in Bed with assistance as tolerated 
  
10 Mins x 2 /day 
30 Mins /day 
30 Mins x 2 /day 
2 Stage 3 Weight  
Bearing  
Muscle Strength  
Grade < 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed with assistance 
Lower Limb Ergometry 
Tilt Table Therapy  
 
10 Mins x 2 /day 
30 Mins /day 
10 Mins x 2 /day 
60 Mins x 2 /day 
15 Mins x 2 /day 
30 Mins /day 
2 Stage 4 Weight  
Bearing  
Muscle Strength  
Grade > 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical muscle stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed  
Upper Limb Ergometry ( low level resistance ) 
Lower Limb Ergometry  
Ambulation with assistive device and therapist 
10 Mins x 2 /day 
30 Mins /day 
10 Mins /day 
30 Mins /day 
15 Mins /day 
15 Mins x 2 /day 
30 Mins x 2 /day 
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5.4 Additional Protocol Information 
5.4.1 ICU Physical Rehabilitation Program 
The multi-modal approach of physical therapy administered in this study, was developed taking into 
consideration the importance of maintaining strength of specific large muscle groups in the upper 
and lower limbs, for overall return to physical function, of the participating patient, through 
strategically performing early exercise during a critical care admission. The participant’s medical 
condition during the critical illness also had a major role to play in the eventual administration of 
the specific exercise by the therapist and successful execution of the exercise during the 
rehabilitation process.  
 
While rehabilitation strategies for participants in the intervention arm were carefully planned with 
consideration for different levels of cardiovascular stability, extent of overall rehabilitation and 
progression of rehabilitation was dependant on the participants’ medical stability reviewed and 
discussed on a daily basis at ICU medical rounds. During the exercise sessions, each participant 
received individualised rehabilitative strategies as appropriate and encouragement to progress with 
rehabilitation within each exercise session. Any cardiovascular intolerance to progression of 
rehabilitation was noted and exercise was administered accordingly to provide maximum 
rehabilitative benefit during each exercise session for each participant. For rehabilitative techniques 
such as sitting out of bed, tilt table and ambulation i.e. techniques requiring additional manpower to 
the physiotherapist, manual assistance from the staff nurses in charge of the patient was sought. 
Blinding of the nurses to the trial was maintained during this time by not revealing group allocation. 
Electrical Muscle Stimulation was administered using the NMES Machine (Verity Medical Ltd., 
Hampshire, UK).  
 
 
 
 
 
 
 
 
 
Figure 5.3 Neuro Trac electrical muscle stimulation machine for motor point stimulation  
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5.4.2 Medical Research Council Muscle Strength Score 
Muscle strength testing was assessed using the Medical Research Council Score (MRC) [215]. At 
ICU discharge, muscle strength was measured in the four limbs using the MRC score, with values 
ranging from 0 to 60 (normal muscle strength). The movements assessed for upper limbs were; 
shoulder flexion, elbow flexion and wrist flexion and the movements assessed for lower limbs were; 
hip flexion, knee extension and ankle dorsiflexion. The following grading was used to assess each 
of the 3 movements in each limb and was scored from 0-5 based on the patient’s effort.  
5.4.3 Physical Function ICU Test Score 
During the conduct of this trial, the Physical Function ICU Test (PFIT) scoring tool was developed 
and validated (Unpublished) by the authors who developed the PFIT test, in mechanically ventilated 
patients in medical-surgical ICUs [214]. As new and updated information, the new PFIT scoring 
was included and used for data analysis of the i-PERFORM trial for the measurement of physical 
function. The PFIT demonstrated good reliability and was responsive to change. Inter-rater 
reliability for the PFIT was good (intra-class correlation coefficient, 0.996-1.00). Convergent 
validity was present, as a significant moderate correlation was found for the discharge PFIT-s with 
the TUG (r=−0.60, 95% CI=−0.70 to −0.46, P<.001), the 6MWT (r=0.41, 95% CI=0.24 to 0.55, 
P<.001), and the MRC muscle test (rho=0.49, 95% CI=0.33 to 0.62, P<.001, n=105). Low 
correlation was observed between the Body Mass Index (BMI) and the admission PFIT-s scores 
(r=−0.011, 95% CI=−0.18 to 0.16, n=137), demonstrating divergent validity. The PFIT-s measured 
between days 5 to 10 of ICU admission in a sample of participants who were in the ICU for a 
minimum of 5 days was simple, inexpensive, and had high clinical utility. It was shown to measure 
construct, to have validity compared with commonly used functional tests, and to be predictive of 
several important patient parameters related to function [229]. 
5.4.4 Blood and Mitochondrial DNA Analysis 
Upon publication of the trial protocol manuscript, changes were made to type of assays used for the 
analysis of the cytokine (Interleukin-6, Interleukin-10 and Tumor Necosis Factor-α). The VERSA 
Map kits (R&D Systems, Minneapolis, USA) were used as these multiplex kits were equally 
effective as individual assays with lesser cost for the analysis of cytokines on the blood sample 
results. The intra coefficient of variance was < 10% and inter coefficient of variance was < 10% for 
Interleukin-6, Interleukin-10 and Tumor Necrosis Factor-α. 
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Mitochondrial DNA was analysed using a DNA Analysis Kit (Nucleospin Blood XL DNA kit, 
Macherey-Nagel, Germany) as stated in the protocol. However, a buffy coat layer method was not 
used and the samples were frozen in Lithium Heparin tubes until analysis as this method produced a 
better yield of DNA. This method required several stages to process the extracted blood to yield the 
DNA and was performed only after completion of recruitment. 
 
The sequences for nDNA primers used were, R: 5’- CAA CTT CAT CCA CGT TCA CC - 3’, F: 5’ 
- GAA GAG CCA AGG ACA GGT AC – 3’ and the sequences for mtDNA primers were, F: 5’ – 
CCA CGG GAA ACA GCA GTG ATT – 3’, R: 5’ – CTA TTG ACT TGG GTT AAT CGT GTG 
A – 3’ (Integrated DNA Technologies Inc., Illinois, USA). Using SYBR green real-time PCR (RT-
PCR ABI ViiA7, Applied Biosystems, USA) with mitochondrial and nuclear DNA primers, 
samples were tested with RT-PCR epMotion 5075 Robot, USA.  
 
Results were then analysed using SDS software v.2.4 (Applied Biosystems, USA). The relative 
mtDNA content of the peripheral blood white cells was expressed as mtDNA/nDNA ratio. As the 
nDNA copy number per cell was considered constant, alteration of the ratio was attributed to 
changes in mtDNA content.  












 
 
 
Figure 5.4 Determination of mitochondrial DNA content using SYBR green real time PCR and 
Robot  
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5.4.5 Near Infrared Oxygenation Analysis 
Near Infrared Oxygenation (NIRO) a, non-invasive method of analysis of tissue oxygenation from 
the use of a finger probe placed on a peripheral muscle on the arm pre and post acute ICU exercise 
was used as stated in the protocol. The signal estimates skeletal muscle microcirculatory 
oxygenation, and reflects the venous haemoglobin oxygen status. Participants’ brachioradialis was 
used in the event the hypothenar muscle was not accessible. A pneumatic cuff was place above the 
elbow of the arm measured and was inflated to approximately 180mmHg to obtain temporary 
occlusion of the blood supply through the brachial artery for 3 minutes inducing local ischemia and 
released to 0mmHg for active hyperaemia. Tissue oxygenation (StO2) was measured before, during 
and after the occlusion for a time frame of 1 to 3 minutes using the NIRO-100/200 (Hamamatsu 
Photonics K.K., Tokyo, Japan). Interrupted waveforms due to movement or noise artefacts during 
pre and post measures were retaken again for useful information or data.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Determination of muscle (tissue) oxygenation using the on-line data display and analysis 
software for NIRO-100/200 v.1. 
5.4.6 Orthogonal Polarisation Spectral Microscan Analysis 
Orthogonal Polarisation Spectral Microscan (OPS) was used to measure tissue microcirculation pre 
and post ICU exercise, in the sub-lingual space with a non-invasive probe. Participants were already 
under sedation and mechanically ventilated during this procedure. Disposable caps between patients 
were used at the tip of the Light Emitting Probe (LED) probe. Low powered high intensity green 
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LED light emitted provided direct illumination of the microcirculation when penetrating deep into 
the sublingual tissues as the light was absorbed by the haemoglobin of erythrocytes. Three to five 
live magnified video images of the capillary flow were captured for pre and post measures using 
this sidestream dark field imaging. Images were recaptured to obtain images that could produce 
some usable information or data, if the live video sequences were unclear due to artefacts. Video 
images were stored and microvascular flow index and capillary density were analysed using the 
software (Adobe Premiere Elements v.4) accompanying this tool.  
 
Microvasular flow index (MFI) was used to quantify the velocity of microcirculatory perfusion as 
absent (0), intermittent (1), sluggish (2), or normal (3). The average of the predominant flow in each 
of the four quadrants divided over the image was used to calculate MFI [230]. Capillary density was 
calculated using a grid of equidistant vertical and horizontal lines was superimposed on the image. 
The vessel density was calculated as the number of small vessels (< 20 µm) intersecting the lines of 
the grid divided by the total length of the lines yielding the number of small vessels per millimetre 
[231].   
                                                                                    
 
 
 
 
 
 
                                                        
 
 
A                                                                               B 
Figure 5.6 Calculation of changes in tissue microcirculation by determining A) Microvascular flow 
index and B) Capillary density  
5.5 Data Management and Statistical Analysis 
All demographic and hardcopy data of all outcome measures will be entered into PASW statistical 
software (Version 18: SPSS inc. Chicago, IL). All continuous data will be tested for normality. 
Continuous data will be assessed for normal distribution and log transformation of skewed data will 
be attempted to improve distribution. Normal data will be reported as mean ± standard deviations 
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and non-normal data as median (inter-quartile range). Baseline data will be compared within each 
group using independent samples t-tests for continuous variables. Measurable outcomes in number 
of days between groups will be assessed using negative binomial. Chi-squared Test or Fisher’s 
exact test will be used to analyse incident rates. Mean changes at baseline and time intervals 
relevant to each outcome measure will be calculated. Between group analysis at different time 
points will be performed using repeated measures ANOVA with Bonferroni correction. Correlations 
amongst continuous variables will be assessed using Pearson’s correlation and categorical variables 
using Spearman’s correlation.  
5.6 Type of Data Analysis  
An intention to treat analysis will be performed to assess the primary effect of intervention in the 
exercise group following randomisation irrespective of the compliance of the participants during 
intervention or control conditions. Attrition, missing data and death will be monitored and reported. 
A mixed method ANOVA managed other missing data in the case of mortality for comparison 
between/within groups at different time points.   
 
The next chapter, Chapter 6, presents the results of the i-PERFORM trial, the first randomised 
controlled trial to evaluate the short-term; physiological (systemic) and long-term; physical and 
psychological effects of early physical rehabilitation in the intensive care unit in patients with sepsis 
syndromes.  
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CHAPTER 6  
Randomised Controlled Trial 
6.1 Overview  
This chapter reports the results of the main randomised controlled trial; “A Pilot and Explorative 
Investigation into Early Physical Rehabilitation in Intensive Care Patients with Sepsis Syndromes – 
A Randomised Controlled Trial”. This trial is the first to investigate early ICU physical 
rehabilitation in patients presenting with sepsis syndromes. Physical outcomes included physical 
function, muscle strength, exercise capacity and reported quality of life; psychological outcomes 
included hospital anxiety and the short-term physiological outcomes included inflammatory 
biomarkers, plasma lactate and fat free muscle mass. 
 
Two smaller pilot trials developed from the RCT examined the effects of early ICU physical 
rehabilitation on the microcirculation, muscle oxygenation and mitochondrial DNA. Results of 
these two trials are discussed in chapters 7 and 8 and are also reported in the respective manuscripts. 
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6.2 Manuscript 3 (Randomised Controlled Trial) 
The manuscript entitled “A Pilot and Explorative Investigation into Early Physical Rehabilitation in 
Intensive Care Patients with Sepsis Syndromes – A Randomised Controlled Trial” has been 
published in Intensive Care Medicine. 
 
The final publication is available at Springer via: Kayambu G, Boots RJ, Paratz JD. Early Physical 
Rehabilitation in Intensive Care Patients with Sepsis Syndromes – A Pilot Randomised Controlled 
Trial. Intensive Care Medicine. 2015 May;41(5):865-74. doi: 10.1007/s00134-015-3763-8 (Impact 
Factor 5.544). 
 
The manuscript is presented as submitted for publication, except for tables and figures and 
references that have been configured to fit the overall style of the Thesis. The numbering of pages 
are in accordance with the overall format of the Thesis. The references are found at the end of this 
manuscript.  
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Abstract  
Rationale  
Survivors of sepsis syndromes have poor outcomes for physical and cognitive function. No 
investigations of early physical rehabilitation in the intensive care unit have specifically targeted 
patients with sepsis syndromes. 
 
Objective 
To determine if early physical rehabilitation improves physical function and associated outcomes in 
patients with sepsis syndromes.  
 
Methods 
Fifty critically ill adults admitted to a general intensive care unit with sepsis syndromes were 
recruited into a prospective double blinded randomised controlled trial investigating early physical 
rehabilitation.  
 
Measurements 
Primary outcomes physical function (Acute Care Index of Function) and self-reported health-related 
quality of life were recorded at ICU discharge and six months post hospital discharge respectively. 
Secondary measures included inflammatory biomarkers; Interleukin-6, Interleukin-10 and Tumour 
Necrosis Factor-α, blood lactate, fat free muscle mass, exercise capacity, muscle strength and 
anxiety.  
 
Main Results 
A significant increase in patient self-reported physical function (81.8±22.2 versus 60.0±29.4), 
p=0.04) and role physical (61.4±43.8 versus 17.1±34.4, p=0.005) for the SF-36 at six months, was 
found in the exercise group. Physical function scores were not significantly different between 
groups. Muscle strength scores were (51.9±10.5 versus 47.3±13.6, p=0.24) with the standard care 
mean MRC score <48/60. The mean change of Interleukin-10 increased and was significantly 
higher in the exercise group (1.8 pg/ml, 180% versus 0.9pg/ml, 90%, p=0.04). There was no 
significant difference between groups for lactate, Interleukin-6, Tumour Necrosis Factor–, muscle 
strength, exercise capacity, fat free mass or hospital anxiety.  
 
Conclusion  
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Implementation of early physical rehabilitation can improve self-reported physical function and 
induce systemic anti-inflammatory effects. 
 
Keywords: Physiotherapy; Critical Care; Exercise Therapy 
 
Key Messages: 
 
 Early physical rehabilitation in intensive care can improve self-reported physical function in 
patients with sepsis. 
 
 Early physical rehabilitation in intensive care can induce systemic anti-inflammatory effects 
in patients with sepsis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trial Registration: ACTRN12610000808044 
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Introduction 
Sepsis is defined as a powerful systemic response to severe infection. The incidence of severe sepsis 
is estimated between 50 and 100 cases per 100,000 people of the population in developed countries 
[1] with an increased risk of mortality due to early elevated anti-inflammatory activity [2]. 
Associated with this disease burden is the cost of ongoing disability and loss of productivity post 
illness. Patients with sepsis syndromes have significantly worse outcomes particularly in the 
physical and cognitive domains compared to age matched normal [3] and other hospitalized patients 
[4].  
 
There is emerging evidence that early physical intervention in intensive care unit (ICU) can increase 
ventilator free days, improve peripheral and respiratory strength, reduce length of ICU and hospital 
stay [5-7], and improve long–term physical function [8]. There are no randomised prospective trials 
specifically on the effects of exercise in humans with sepsis. Animal models of sepsis have 
indicated that physical exercise post sepsis increased bacterial clearance from blood and organs, 
decreased the release of pro- and anti-inflammatory cytokines and improved survival [9]. 
Additionally, there is evidence for pre conditioning prior to the septic insult with less lung and 
distal organ injury occurring following sepsis [10]. Physical training prior to sepsis prevented 
atrophy, lipid peroxidation and protein oxidation in the skeletal muscles of septic rats [11].  
 
Retrospective cohort analysis found that increased physiotherapy intervention in patients with 
sepsis resulted in less ICU mortality [12]. In the absence of prospective controlled trials specifically 
investigating early exercise intervention in sepsis, we aimed to investigate if early physical 
rehabilitation improved physical function and self-reported health-related quality of life and 
associated secondary outcomes in patients with sepsis syndromes admitted to ICU. 
 
Materials and methods 
A prospective double blinded randomised controlled trial [13] [ACTRN 12610000808044] was 
conducted at a single quaternary level, university affiliated, general ICU at the Royal Brisbane and 
Women’s Hospital, Brisbane, Queensland, Australia. Methodology for this trial is detailed in the 
protocol article [13]. The study was conducted according to CONSORT guidelines [14]. 
Participants, substitute decision makers, outcome assessors and health care personnel except 
treating therapists were blinded to group allocation. 
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Study population 
Participants ≥ 18 years who remained mechanically ventilated  ≥ 48 hours and diagnosed with 
sepsis [15] ( ≥ 2 criteria of a systemic inflammatory response plus proven or strongly suspected 
infection), severe sepsis (sepsis plus organ failure), septic shock (severe sepsis with hypotension not 
responding to fluid management) were enrolled. Patients with head injuries, burns, spinal injuries, 
or multiple fractured lower limbs and those with septic shock who were unresponsive to maximal 
treatment, moribund or had an expected mortality within 48 hours were excluded. Written informed 
consent was obtained according to ethical guidelines. The study was approved by The Human 
Research Ethics Committee at Royal Brisbane and Women’s Hospital and the Medical Research 
Ethics Committee at The University of Queensland.  
 
Participant age, sex, co-morbidities, admission diagnoses, Acute Physiological and Chronic Health 
Evaluation (APACHE II) [16], Charlson Comorbidity Index (CCI) [17], Sequential Organ Failure 
Assessment (SOFA) [18], time on mechanical ventilation, ventilator free days, length of ICU and 
hospital stay, readmissions to ICU and 90 day-mortality in hospital or home were recorded. 
Enrolled participants were randomised into an intervention and standard care arm by computer 
generated randomisation http://www.randomization.com, using concealed allocation (Figure 6.1). 
 
ICU Physical Rehabilitation Program 
Participants in the intervention arm underwent individualised early targeted physical rehabilitation 
program prescribed by the ICU research physiotherapist for 30 minutes, one to two times daily until 
discharge from the ICU within 48 hours of the diagnosis of sepsis (Table 6.1). Physical 
rehabilitation strategies included electrical muscle stimulation, passive range of motion, active 
range of motion, sitting out of bed, transfers, ambulation and other mobilisation techniques as 
appropriate. Targeted muscle groups for EMS were vastus medialis, vastus lateralis, tibialis anterior 
and brachioradialis. A frequency of 40 to 45Hz at 20 to 25 mA with pulse duration at 400 μs of 12 
seconds on and 6 seconds off was used. Participants in the standard care group received standard 
ICU care which included physical therapy strategies provided by the ICU physiotherapist. The 
physical rehabilitation received by both groups was recorded (Figure 6.2). A safety audit was 
completed on patients in the intervention group during treatment. 
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Primary Outcomes 
Participants were assessed objectively for physical function using the Acute Care Index of Function 
(ACIF) [19] and self-reported health related quality of life was measured by the SF-36 Medical 
Short-Form (SF-36) at six months post discharge from hospital [20] by telephone. 
 
Secondary Outcomes 
Secondary measures included exercise capacity using the Physical Functional ICU Test (PFIT) [21], 
overall muscle strength using the Medical Research Council Muscle Score (MRC) [22] and 
psychological outcome using the anxiety subscale of the Hospital Anxiety and Depression Scale 
(HADS) [23] on discharge from ICU.  Pro and anti-inflammatory activity were assessed objectively 
by monitoring cytokines; Interleukin-6 (IL-6), Interleukin-10 (IL-10) and Tumour Necrosis Factor-
α (TNF-α). Plasma Lactate (PL) concentration was assessed to determine whether exercise was 
inducing anaerobic glycolysis. Fat Free Mass (FFM) was assessed for lean tissue muscle mass loss. 
Methodology for these measures is detailed in the protocol article [13]. Reliability, validity and 
responsiveness in the ICU [20, 24] and sepsis population [25, 26] for these measures are specified 
in the protocol article [13].  
 
Sample Size  
Sample size calculations were based on physical function outcome; ACIF using previously 
published minimally clinical important differences and standard deviations 15.4 (SD 17) in an acute 
care trial [27]. A sample size of 35 per group (70 total) was calculated with an effect size of 0.7, 
90% power with a type 1 error rate of 0.05 and 0.025 with Bonferroni adjustment.  
 
Statistical Analysis  
Data were analysed using intention to treat. Non-normal data were log transformed. Data were 
expressed as mean (Standard Deviation) (SD) or median (Inter-Quartile Range) (IQR). Single 
variables were compared using Student’s t-test and dichotomous outcomes were analysed using a 
Chi-squared test or Fisher’s exact test as appropriate. A mixed method ANOVA managed missing 
data and was used to compare between/within groups at different time points. If the overall model 
was significant, multiple comparisons among pairs of means were analysed with post hoc 
Bonferroni correction of the significance level (p<0.025).  
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Results 
Fifty patients (5.2% of those screened) were recruited with 26 and 24 participants randomised to the 
intervention and standard care group respectively during the period of December 2010 to August 
2012 (Figure 6.1). 
 
Demographics, ICU and Hospital Measures 
The demographics of participants in the standard care and intervention groups are reported in Table 
6.2. There were no significant baseline differences between the groups. There was no statistical 
significance between groups for duration of mechanical ventilation, ventilator free days, ICU and 
hospital length of stay, ICU readmission, ICU and 90-day mortality and resuscitation (DNR) status 
(Table 6.2). 
 
Adherence 
There were no withdrawals during the conduct of the trial. All participants adhered and remained 
enrolled in the study for an average of 11.4 days. Figure 6.2 describes the details of the duration 
and number of episodes of exercise interventions administered to both groups. 
 
Physical Function 
A total of 42 participants were assessed for physical function on discharge from ICU using a t-test 
for independent groups. Eight patients were not suitable for assessment due to death in ICU (n=4) 
and for the presence of delirium or reduced level of consciousness (n=4). No differences were found 
in the physical function ACIF final scores (61.1±33.1, vs. 55.0±24.4, p=0.45) and mobility scores 
(39.8±38.2 vs. 34.5±27.1, p=0.67 (Table 6.3). 
 
Health-related Quality of Life  
Thirty participants completed the SF-36 quality of life survey at 6 months post hospital discharge 
over telephone. Sixteen patients were lost to further follow up due to death (n=12), non-contactable 
(n=3) or readmitted to hospital (n=1). An independent t-test comparison between groups found that 
patients in the exercise group self-reported a significant quality of life improvement in the domains 
of physical function (81.8±22.2 vs. 60.0±29.4, p=0.04) and physical role (61.4±43.8 vs. 17.1±34.4, 
p=0.005), compared to those who received standard care. Patient report of emotional role 
(63.6±40.7 vs. 33.3±45.8, p=0.08), vitality (45.9±12.0 vs. 39.2±7.7, p=0.07) and general health 
(50.5±11.9 vs. 41.8 ±11.3, p=0.06) all showed a trend towards statistical significance. Early 
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rehabilitation did not impact on reports of bodily pain, social functioning or mental health (Table 
6.4).  
 
Hospital Anxiety 
Thirty–five participants were able to complete the HAS assessment at ICU discharge. Fifteen 
participants were not successful in testing due to death (n=4); inability to converse or delirium 
(n=11). A t-test for independent groups found no statistically significant changes between mean 
scores with ICU early exercise; however a chi-square crosstabs found that there was a trend for a 
greater number of patients in the intervention group having low levels of anxiety (25% vs. 14%, 
p=0.09) (Table 6.4).   
 
Exercise Capacity and Muscle Strength 
A total of 42 participants were tested for exercise capacity and overall muscle strength at ICU 
discharge. No differences were found in ICU exercise capacity using the interval PFIT score 
(5.6±2.1 vs. 5.4±1.7, p=0.61). Although not statistically significant, the standard care group 
recorded a mean MRC score of less than 48/60 for the MRC scale consistent with the criteria for 
ICUAW [28] (Table 6.3). 
 
Inflammatory Biomarkers 
Interleukin -6 
The pro-inflammatory cytokine; IL-6 was measured on Days 1, 3, 5, 7 upon initiation of the trial 
and ICU discharge. A reduction in IL-6 mean scores was observed in the intervention group pre and 
post exercise across Days 1, 3, 5 and 7 but no statistically significant differences were found 
between groups. There was a trend towards significance for mean change from baseline to ICU 
discharge where the decrease was greater (5.2 pg/ml, 55% vs. 20.4 pg/ml 120%, p=0.07) (Table 
6.5) in the intervention group with a mixed model ANOVA (Figure 6.3). 
 
Interleukin-10                                                                                                                                                         
The anti-inflammatory cytokine; Interleukin-10 was measured on Days 1, 3, 5, 7 and ICU 
discharge. Overall mean change of IL-10 from baseline to ICU discharge was significantly higher in 
the intervention group (1.8 pg/ml, 180% vs 0.9 pg/ml, 90%, p=0.04) (Table 6.5) than in the 
standard care group (Figure 6.3). 
 
Tumour Necrosis Factor-α 
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The pro-inflammatory cytokine; Tumour Necrosis Factor-α was also measured on Days 1, 3, 5, 7 
and ICU discharge. There were statistically significant findings between groups from baseline to 
ICU discharge with a greater percentage decrease in the standard care group (2.5 pg/ml, 100% vs 
2.5 pg/ml, 75%, p<0.01) (Table 6.5) (Figure 6.3). 
 
Fat Free Mass    
Percentage fat free mass was measured at recruitment (n=44), week 1 (n=32) and at ICU discharge 
(n=17). Six patients were ineligible for the use of BIS at recruitment due to missing a limb, 
presence of metal implants or peripheral or generalised oedema. Fat free mass increment at week 1 
was noted but the groups were not significantly different (Figure 6.4a). Percentage changes in fat 
free mass showed increments in both groups at week 1 and reductions at ICU discharge from 
baseline (4.4% vs. 2.5% and -1.2% vs. -5.1%, p=0.93) (Figure 6.4b). 
 
Safety Measures 
Plasma Lactate   
Plasma lactate concentrations were determined pre and post exercise as a safety marker for exercise. 
Lactate showed significant effects for time and decreased in both groups over the course of the 
week (p=0.04). It did not increase post exercise in the intervention group (Table 6.6).  
 
Vital Signs 
As a further measure of safety, arterial blood pressure, heart rate, respiratory rate and oxygen 
saturation were monitored during all sessions of exercise. There were pre-determined alterations 
which would define an adverse event [13]. No session of exercise resulted in an adverse event. 
 
Discussion 
Early physical rehabilitation for critically ill patients with sepsis resulted in a significant health-
related quality of life improvement in self-reported physical function and physical role at six 
months post hospital discharge. In addition, there were trends towards improvement in emotional 
role, vitality and general health and less anxiety on ICU discharge. There were significantly larger 
increases in the early exercise group for the anti-inflammatory cytokine IL-10. There were no 
significant effects on physical function, exercise capacity or fat free mass on discharge from 
intensive care.  
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Previous studies in intensive care have reported positive outcomes for general patients with a 
combined intervention of early rehabilitation [5, 29, 30]. A number of studies have not shown a 
difference between groups [31, 32] but it can be noted that the group of “standard care” received a 
high level of exercise due to existing local practices. Our study differed, in that we investigated a 
discrete group of patients with sepsis syndromes. This group have been shown to have worse 
physical and cognitive deficits than other diagnostic groups in ICU so there may have been more 
potential for improvement [3, 4]. Additionally, we provided intervention such as EMS and passive 
exercise in the early stage when patients were sedated and unable to participate in active movement. 
The dose of early physical rehabilitation provided in this trial that is 30 minutes a day is a feasible 
treatment to be delivered in typical intensive care settings. 
Specific studies have been undertaken utilising EMS with contradictory outcomes [6] with 
preservation of muscle mass found in long stay ICU patients. Studies that targeted patients with 
sepsis [33, 34], did not find preservation of their muscle mass. However, this may have occurred as 
sepsis is a systemic inflammatory disease and exercise lowers overall inflammatory activity, hence 
exercising one part of the body with the other leg serving as a control may not be effective.  
Our study included a high proportion of those receiving EMS or passive exercise when patients 
were high acuity, or when sedation produced a decreased level of co-operation. This was more 
common early in the admission, however some patients deteriorated and passive manoeuvres were 
substituted for more active forms of exercise. We are of the opinion that providing some form of 
exercise at these stages as well as more active interventions produced a higher level of physical 
function overall in the later stages as determined from the improved HrQOL. Recent studies using a 
deeply sedated and mechanically ventilated experimental ICU rat model [35, 36] found preservation 
of muscle mass and muscle force generation after passive mechanical loading.  
In addition, a number of factors in sepsis predispose towards greater potential loss of muscle mass 
and force which were reported as secondary measures in this study. The pro-inflammatory 
cytokines; Interleukin-6 and Tumour Necrosis Factor-α are involved in muscle degradation, 
myocyte degeneration and muscle atrophy, inhibition of protein synthesis and apoptosis [37-41]. 
Significant muscle wasting from bed rest occurs early in critical illness [42] which results from 
increased proteolytic degradation as well as decreased protein synthesis. The anti-inflammatory 
cytokine; Interleukin-10 (IL-10) is considered to inhibit proteolysis [43]. In this study, the rate of 
increase of IL-10 was twice the rate in the exercise group. Although novel and preliminary, this 
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may contribute to some pertinent information relating to the mechanism underlying the effect of 
exercise on the systemic inflammatory response. 
The ACIF score was an objective measurement used to assess basic physical function change at 
ICU discharge (short-term) and the SF-36 assessed self-reported quality of life at six months (long-
term) by telephone. As many subjects were discharged to rural areas a remote form of assessment 
was required at six months. Although the SF-36 indicated increased self-reported physical function, 
we could not conclude that it directly translated into demonstrably improved physical function, as a 
physical function assessment or muscle strength assessment was not performed to confirm this at 
six months. However, a self-perception of improved physical function would assist in increasing 
participation and aid recovery as per the International Classification of Functioning, Disability and 
Health (ICF) [44]. 
 
Previous studies have found a correlation between strength and function [26, 45] in general ICU 
patients, however the timing of the assessment in our study that is on discharge from ICU may have 
influenced the results. The blinded assessor reported that although able to complete a simple 
strength assessment, patients were not able to complete transfers due to problems with initiation of 
movements. Baldwin et al [46] noted the same difficulties in a similar population. Deficits in motor 
control neural programming may have resulted in adequate strength not translating to efficient 
motor functioning and repeating the tests at a later date may have shown significance between 
groups [47]. Additionally we did not see a significant difference in exercise capacity (PFIT) 
consistent with the limitations of this ICU exercise capacity test [48]. 
 
Patients post sepsis syndromes have been reported to have problems with cognition, anxiety, and 
post traumatic syndrome as well as physical problems. We did not specifically address these in this 
study. However, there was a trend towards fewer patients in the intervention group reporting severe 
anxiety and a trend towards a higher score in emotional role (SF-36). Exercise has frequently been 
reported to lessen anxiety [49-51]. A recent study has combined both physical and cognitive 
interventions with no differences found [32]. However, larger numbers may be required to 
demonstrate an effect.  
 
Plasma lactate concentration was used in the study as a safety measure to ensure that exercise did 
not result in clinically significant changes. Pilot data of other secondary outcome measures of 
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mitochondrial DNA, muscle oxygenation and microcirculation obtained during this main 
randomised trial will be reported in future manuscripts. 
 
Limitations 
This original study has some limitations. Firstly, the expected sample size was not reached due to 
time logistics for study completion. In addition, some bias may have been unavoidable in the 
overall analysis of the HrQOL outcomes due to the small sample available at 6 months from early 
deaths. Basic physical function as measured by the ACIF score was not assessed at the long term 
stage. Hospital readmission was not monitored and there was also a lack of baseline data on 
physical function, muscle strength and exercise capacity as is the nature of a critical care admission. 
 
Conclusion 
Early ICU exercise can moderate the detrimental effects of sepsis. It can improve self-reported 
quality of life in the physical domains and induce anti-inflammatory effects. Further research is 
required to look at the detailed mechanisms behind these effects to refine and tailor approaches to 
physical rehabilitation in the critically ill. 
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Figure 6.1 CONSORT recruitment flow diagram 
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Health-Related Quality of Life 
 (n=20)  
 
Deceased (n=3) 
 
Excluded (n=910) 
 
Not >18 years (n=9) 
Not mechanically ventilated (n=271) 
Not met inclusion criteria (n=330) 
 Neurological Injuries (n=224) 
 Traumatic Injuries (n=50) 
 Burn Injuries (n=31) 
 Orthopaedic Injuries (n=25) 
Not Sepsis Syndrome (n=290) 
Declined (n=8) 
Competing Trial (n=2) 
 
Allocation 
Follow-up  
Week 1 
 
Screened  
(Day 2 ICU Admission) 
(n=960) 
Physical Function, Fat Free Mass, 
Exercise Capacity, Muscle Strength, 
Hospital Anxiety 
(n=23) 
 
Deceased (n=3) 
 
Physical Function, Fat Free Mass, 
Exercise Capacity, Muscle Strength, 
Hospital Anxiety 
(n=23)  
 
Deceased (n=1) 
 
Follow-up  
ICU Discharge 
Follow-up  
6 months  
Hospital Discharge 
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Figure 6.2 Total frequency and duration of physical rehabilitation received by participants in 
intervention and standard care groups
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Figure 6.3 Inflammatory biomarker changes with early physical rehabilitation 
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Figure 6.4 Fat free mass changes with early physical rehabilitation in week 1 
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Figure 6.5 Percentage change in fat free mass during ICU stay  
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Table 6.1 ICU physical rehabilitation program guide for participants in intervention group 
Ramsay 
Sedation Scale 
Stages of exercise 
progression Conditions Type of Intervention 
6-4 Stage 1 Sedated Passive Range of Motion with stretch reflex to upper and lower limbs 
Electrical Muscle Stimulation to major muscle groups 
 
3-2 Stage 2 Inotropic Dependence Active Range of Motion / Lightly resisted with upper and lower limb 
Electrical Muscle Stimulation to major muscle groups 
Sitting up in Bed with assistance as tolerated 
 
2 Stage 3 Weight 
Bearing 
Muscle Strength 
Grade < 3 
Active Range of Motion / Lightly resisted with upper and lower limb 
Electrical Muscle Stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed with assistance 
Lower Limb Ergometry 
Tilt Table Therapy 
 
2 Stage 4 Weight 
Bearing 
Muscle Strength 
Grade > 3 
Active Range of Motion / Lightly resisted with upper and lower limb 
Electrical muscle stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed 
Upper Limb Ergometry ( low level resistance ) 
Lower Limb Ergometry 
Ambulation with assistive device and therapist 
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Table 6.2 Demographic clinical characteristics and intensive care unit and hospital measures 
 Intervention (n=26)  Standard Care (n=24) p value 
Age (years)  62.5(30-83) 65.5(37-85)  
Female : Male (%) 8(16):18(36) 10(20):14(28)  
Weight (kg) 74.50(44-130) 79(50-130)  
Height (cm) 171.4(10.1) 170.3(9.2)  
CCI* index  3.0(0-8) 2.0(0-6)  
BMI† (kg/m2)  27.9(17.9-52.6) 28.1(20.5-36.2)  
APACHE‡ II score   28.0(7.6) 27.0(6.8)  
Sepsis Category [n(%)] 
Sepsis 
Severe Sepsis 
Septic Shock 
 
1(3.8) 
6(23.1) 
19(73.1) 
 
1(4.2) 
6(25) 
17(70.8) 
 
SOFA§ Score baseline 11.1(3.2) 10.5(2.5)  
TOMV** (days) 8.0(4-64) 7.0(2-30) 0.22# 
VFD†† (days)   20.0(0-24) 21.0(0-26) 0.71# 
ICU‡‡ length of stay (days)  12.0(4-45) 8.5(3-36) 0.43# 
Hospital length of stay (days) 41(9-158) 45(14-308) 0.80# 
ICU readmission (n[%]) 1(2) 4(8) 0.13 
ICU Mortality (n[%]) 3(12.0) 1(4.0) 0.34 
90-Day Mortality (n[%]) 8(31) 2(8) 0.05 
DNR§§ Status (n[%]) 9(18) 4(8) 0.15 
Data are median (IQR), mean (SD) or n (%), * p<0.05 or **p<0.01 
Binomial Regression# or Chi-squared test, Ventilator free days; from study day 1 to day 28.
                                                 
*Charlson Comorbidity Index
†Body Mass Index
‡Acute Physiology and Chronic Health Evaluation
§Sequential Organ Failure Assessment
**Time on Mechanical Ventilation
††Ventilator Free Days
‡‡Intensive Care Unit
§§Do Not Resuscitate
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Table 6.3 Physical function, exercise capacity and muscle strength outcomes at ICU discharge according to study group 
 
Physical Function Outcomes Intervention (n=19) Standard care (n=23) p value 
 
   
MRC* scores, n=42  51.9(10.5) 47.3(13.6) 0.24 
PFIT† scores, n=42 5.6(2.1) 5.4(1.7) 0.61 
ACIF‡ final score, n=42 61.1(33.1) 55.0(24.4) 0.45 
Mental Status score  79.8(35.8) 82.7(31.6) 0.47 
Bed mobility score  61.1(32.8) 61.1(26.1) 0.99 
Mobility score  38.9(38.2) 34.5(27.1) 0.67 
Data are Mean (SD) *p<0.05 or **p<0.01, Independent Samples T-Test  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
*Medical Research Council
†Physical Function ICU Test
‡Acute Care Index of Function
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Table 6.4 Quality of life and anxiety outcomes according to study group 
Quality of Life Outcome Intervention (n=11) Standard care (n=19) p value 
SF-36* scores, n=30 Mean (SD) Mean (SD)  
Physical Function   81.8 (22.2) 60.0 (29.4) 0.04* 
Role Physical 61.4 (43.8) 17.1 (34.4) 0.005** 
Bodily Pain 70.9 (20.7) 64.7 (22.5) 0.46 
General Health 50.5 (11.9) 41.8 (11.3) 0.06 
Vitality 45.9 (12.0) 39.2 (7.7) 0.07 
Social Functioning 71.6 (37.1) 73.7 (37.2) 0.88 
Role Emotional 63.6 (40.7) 33.3 (45.8) 0.08 
Mental Health 38.6 (11.5) 37.3 (7.4) 0.71 
Anxiety Outcome Intervention (n=16) Standard care (n=19) p value 
HAS†, n=35  n (%) n (%)  
Normal 9(25) 5(14) 0.09# 
Borderline Abnormal 1(3) 6(17)  
Abnormal 6(17) 8(22)  
Data are Mean (SD) or n (%). *p<0.05 or **p<0.01, Independent T-Test and Chi-Square#  
 
 
                                                 
*Short-Form 36 
†Hospital Anxiety Scale 
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Table 6.5 Plasma lactate concentration changes according to study group 
Plasma 
lactate 
(mmol/L) 
Intervention (n=21) Standard care (n=16) p value 
 
Pre Post  Pre Post   
 
Mean (SD) Mean change (% change) Mean (SD) Mean change (% change)  
Day 1 2.07(1.51) 1.83(1.23) -0.24(-11.6) 2.15(1.95) 1.96(1.71) -0.19(-8.8) 0.04* 
Day 2 1.47(0.58) 1.40(0.58) -0.08(-5.4) 1.50(0.77) 1.48(0.74) -0.02(-1.3)  
Day 3 1.53(0.88) 1.54(0.77) 0.01(0.7) 1.59(0.81) 1.66(0.81) 0.07(4.4)  
Day 4 1.50(0.65) 1.50(0.54) 0.00(0) 1.13(0.53) 1.34(0.62) 0.09(7.9)  
Day 5 1.29(0.53) 1.45(0.45) 0.16(12.4) 1.24(0.61) 1.35(0.56) 0.11(8.9)  
Day 6 1.26(0.48) 1.26(0.47) 0.00(0) 1.28(0.64) 1.40(0.61) 0.12(9.4)  
Day 7 1.24(0.43) 1.21(0.45) -0.03(-2.4) 1.19(0.55) 1.23(1.21) 0.04(3.4)  
Data are Mean (SD) *p<0.05 or **p<0.01, Mixed Within/Between Repeated Measures ANOVA  
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6.3 Summary  
The i-PERFORM trial assessed the effect of early (Day 2 ICU admission) physical rehabilitation 
intervention (30-45 minutes, daily sessions at least once per day) on 50 patients with sepsis 
syndromes in the ICU in comparison with patients with sepsis syndromes who did not receive 
targeted early physical rehabilitation. Short-term systemic changes in fat free mass, plasma lactate 
concentration and inflammatory biomarkers were investigated over 7 days for physiological effects 
of early ICU exercise. Long-term physical and psychological changes in function, exercise capacity, 
muscle strength; and anxiety were investigated at ICU discharge and quality of life 6 months after 
hospital discharge.  
A significant quality of life improvement in self-reported physical function and physical role, were 
found at 6 months post hospital discharge by those who underwent early ICU physical 
rehabilitation. Role emotional, vitality and general health all showed trends towards statistical 
significance. There were no major differences with receiving early ICU physical rehabilitation on 
bodily pain, general health, social functioning or mental health.  
The range of pathologies and illness severity may result in mortality differences that could appear 
by chance in ICU for critically ill patients. The overall mortality for this population is reasonable 
and expected. We did not look at the risk of death estimates from the APACHE scoring as the 
illness severity scores at ICU and length of ICU stay of those surviving to six months may not be 
directly comparable. Although we cannot exclude harm, it is possible that a few more survivors in 
the control group were likely equally unwell as those who were in the intervention group but did not 
die perhaps of a different disease recovery pathway. They could also have been less positive at six 
months regarding their physical status resulting in a self-reported poor quality of life score. 
Physical function scores were not significantly different between groups at ICU discharge. Overall 
MRC scores between groups did not reach statistical significance. However, MRC total score for 
the control group reported < 48 indicating presence of ICU-AW without early ICU exercise during 
sepsis syndromes. Circulating plasma lactate showed significant effects for time and decreased in 
both groups over the course of the week (p=0.04). It did not increase post exercise in the 
intervention group. The rate of increase of IL-10 was twice the rate in the exercise group and may 
explain why muscle strength was preserved in this group of patients. This preliminary finding may 
contribute to some pertinent information relating to the mechanism underlying the effect of exercise 
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on the systemic inflammatory response. There was no significant difference between groups for 
lactate, Interleukin-6, Tumour Necrosis Factor–, muscle strength, exercise capacity, fat free mass 
or hospital anxiety.  
This randomised controlled trial has found some benefit in early exercise in patients with sepsis 
syndromes. However, it is vital to ensure that early exercise in sepsis is not harmful. The following 
chapter, Chapter 7, presents the results of the first pilot trial to evaluate the effects of early physical 
rehabilitation on oxidative stress in the intensive care unit in patients with sepsis syndromes. 
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CHAPTER 7  
Pilot Trial 1 
7.1 Overview 
This chapter reports the results of the first pilot trial; “Early Exercise in Intensive Care does not 
appear to cause Oxidative Stress in Patients with Sepsis Syndromes”. This pilot trial is original and 
the first in investigating if early physical rehabilitation in intensive care results in oxidative stress in 
patients presenting with sepsis syndromes. In particular, it is novel in examining the changes in 
copy numbers of mitochondrial DNA as an indicator of oxidative stress. Results of this trial are 
reported and presented in a manuscript. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169 
 
7.2 Manuscript 4 (Pilot Trial 1) 
The manuscript entitled “Early Exercise in Intensive Care does not appear to Cause Oxidative 
Stress in Patients with Sepsis Syndromes” has been prepared for submission to a journal. 
 
The manuscript is presented as prepared for submission to International Journal of Clinical 
Medicine, except for tables and figures and references that have been configured to fit the overall 
style of the Thesis. The numbering of pages are in accordance with the overall format of the Thesis. 
The references are found at the end of this manuscript.  
 
Authors’ contributions 
All authors contributed to the conception and design of the study. Ms Kayambu obtained ethics, 
registered the trial on clinical trials database and performed acquisition of data. Analysis and 
interpretation of data was done by all authors. Ms Kayambu was responsible for drafting and 
writing of manuscript for important intellectual content. All authors revised the manuscript for 
important statistical and intellectual content and approved the final version of the manuscript for 
publication. 
 
Acknowledgements 
Ms Kayambu was supported by a Singaporean Postgraduate Award from The National University 
Hospital. The project was supported in kind by the Burns, Trauma and Critical Care Research 
Centre and University of Queensland Centre for Clinical Research. We would like to thank the 
Royal Brisbane and Women’s Hospital and for the support of facilities to conduct this research.   
 
Conflict of Interest 
The authors have not disclosed any potential conflicts of interest. 
 
 
 
 
 
 
 170 
 
Early Exercise in Intensive Care does not appear to Cause 
Oxidative Stress in Patients with Sepsis Syndromes 
 
Geetha Kayambu, BSc Phyt (Hons)1*, Casey MM Pfluger, BSc App Sci2, Lin CY, BBiotech2, 
Robert J Boots, PhD1,3 and Jennifer D Paratz, PhD1,4 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
1
 Burns, Trauma & Critical Care Research Centre, School of Medicine, The University of 
Queensland, Brisbane, Australia. 
2
 University of Queensland Centre for Clinical Research, The University of Queensland, The Royal 
Brisbane and Women’s Hospital,  Brisbane, Australia. 
3Department of Intensive Care Medicine, The Royal Brisbane and Women’s Hospital,   Brisbane, 
Australia.
4
 Griffith University, Brisbane, QLD 4222, Australia. 
*
 Corresponding author  
Miss Geetha Kayambu 
Burns, Trauma & Critical Care Research Centre 
School of Medicine, The University of Queensland 
Level 7, Block 6 
The Royal Brisbane and Women’s Hospital  
Brisbane, Queensland, Australia 4029 
E-mail: g.kayambu@uq.edu.au 

 171 
 
Abstract 
Introduction  
Critically ill patients with sepsis are prone to oxidative stress. Such oxidative stress may have 
effects on mitochondrial DNA and potentially outcomes. Early exercise in such patients may 
contribute to this effect. 
 
Methods 
Forty-five mechanically ventilated critically ill adults admitted to a general Intensive Care Unit 
(ICU) with sepsis syndromes were recruited into this pilot study as part of a prospective double 
blinded randomised controlled trial investigating early physical rehabilitation in ICU.  
 
Measurements 
Clinical demographic data and relative mitochondrial DNA (mtDNA)/nuclear DNA (nDNA) were 
collected at baseline and thereafter for 2 weeks during ICU admission. 
 
Results 
Healthy controls (n=50) had a mean mtDNA/nDNA ratio of 0.55. There was no significance found 
for time or time and group. At week 1, there was no change in the mtDNA/nDNA ratio following 
ICU exercise in the intervention group (0.74). Week 1(+/- Day 4) mtDNA/nDNA ratio significantly 
correlated with plasma lactate concentration on Day 4 (r=0.39, p=0.04).  
 
Conclusion 
Early exercise in the ICU does not appear to increase oxidative stress in acute sepsis syndromes as 
assessed by mitochondrial DNA. The utility of mtDNA as a marker of oxidative stress and clinical 
outcome requires further investigation  
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Introduction 
Early physical rehabilitation and mobilisation of critically ill patients has recently been recognised 
as an important clinical management [1-5]. Beneficial effects have been found on muscle strength, 
length of stay, functional outcome and health-related quality of life [1]. However, the possible 
harmful effects of early physical rehabilitation in critically ill patients have not been elucidated 
mainly decreasing antioxidant defences, particularly in sepsis syndromes. 
 
Oxidative stress acts as an atrophic stimulus in an unloaded muscle, [6] inducing wasting by effects 
on redox-sensitive processes in muscle fibres during inactivity [7] and in the diaphragm during 
prolonged mechanical ventilation [8, 9]. Increased Reactive Oxygen Species (ROS) [10] cause 
oxidative stress in the critically ill [11] playing a pivotal role to stimulate production of 
inflammatory cytokines resulting in the muscle proteolysis of sepsis-induced myopathy [12]. 
 
Oxidative stress during systemic inflammation results in altered mitochondrial function [13] with 
decreased quantity and increased mutation of mitochondrial DNA [14]. Such changes in the 
mitochondria contribute to the mechanisms of multiple organ failure and cell death [15, 16]. Acute 
exercise may worsen oxidative stress in early stages of critical illness and during systemic 
inflammation. Currently there is no published data on oxidative stress on exercising critically ill 
patients. We aimed to investigate the effects of early physical rehabilitation on oxidative stress in 
critically ill patients with sepsis. 
 
Materials and Methods 
This pilot study was part of a prospective double blinded randomised controlled trial [17] [ACTRN 
12610000808044] conducted at a single quaternary level, university affiliated, general ICU at the 
Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia. Methodology for this trial 
has been detailed previously [17]. The main study was conducted according to CONSORT 
guidelines [18]. Substitute decision makers, outcome assessors and health care personnel except 
treating therapists were blinded to group allocation. 
 
Study population 
Participants aged ≥ 18 years who were predicted to remain in ICU mechanically ventilated for 
greater than 48 hours; diagnosed with sepsis syndromes [19] were enrolled. Head injury, burns, 
spinal injury, or multiply fractured lower limb patients were excluded. Patients with septic shock 
who were unresponsive to maximal treatment, moribund or had an expected mortality within 48 
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hours were also excluded (Figure 7.1). Forty-five patients were enrolled with blood samples from 
fifty healthy controls from The University of Queensland Centre for Clinical Research. 
 
Participant age, sex, co-morbidities, admission diagnoses, Acute Physiological and Chronic Health 
Evaluation (APACHE II) [20], Charlson Comorbidity Index (CCI) [21], Sequential Organ Failure 
Assessment (SOFA) [22], time on mechanical ventilation, ventilator free days, length of ICU and 
hospital stay, readmissions to ICU and 90 day-mortality in hospital or home were recorded. 
Enrolled participants were randomised into an intervention and standard care arm by computer 
generated randomisationhttp://www.randomization.com, using concealed allocation (Figure 7.1).  
 
ICU Physical Rehabilitation Program 
Participants in the intervention arm underwent an individualised early targeted physical 
rehabilitation program prescribed by the ICU research physiotherapist for 30 minutes, one to two 
times daily until discharge from the ICU within 48 hours of the diagnosis of sepsis. Assessment of 
conscious level, acuity of illness, haemodynamic stability and muscle strength dictated the choice of 
intervention for each day (Table 7.1). Physical rehabilitation strategies included electrical muscle 
stimulation (EMS), passive range of motion, active range of motion, sitting out of bed, transfers, 
ambulation and other mobilisation techniques as appropriate. Participants in the standard care group 
received usual ICU care which included physical therapy strategies provided by the ICU 
physiotherapist. The physical rehabilitation received by both groups was recorded (Figures 7.2 and 
7.3). As a further measure of safety, arterial blood pressure, heart rate, respiratory rate and oxygen 
saturation were monitored during all sessions of exercise. There were pre-determined alterations 
which would define an adverse event [17].  
 
Nuclear and Mitochondrial DNA   
Peripheral arterial blood was collected in lithium heparin blood tubes at study entry and once 
weekly until death or discharge from the ICU. The blood tubes were stored frozen at -20 degrees 
until used. Bloods were analysed using a DNA Analysis Kit (NucleoSpin Blood XL DNA kit, 
Macherey-Nagel, German. Using SYBR green real-time PCR (RT-PCR ABI ViiA7, Applied 
Biosystems, USA) with mitochondrial and nuclear DNA primers (Integrated DNA Technologies 
Inc., Illinois, USA),  samples were tested with RT-PCR epMotion 5075 Robot, USA. The sequences 
for nDNA primers used were, R: 5’- CAA CTT CAT CCA CGT TCA CC - 3’, F: 5’ - GAA GAG 
CCA AGG ACA GGT AC – 3’ and the sequences for mtDNA primers were, F: 5’ – CCA CGG 
GAA ACA GCA GTG ATT – 3’, R: 5’ – CTA TTG ACT TGG GTT AAT CGT GTG A – 3’. 
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Results were analysed using SDS software v.2.4 (Applied Biosystems, USA) (Figure 7.4). The 
relative mtDNA content of the peripheral blood white cells was expressed as mtDNA/nDNA ratio. 
As the nDNA copy number per cell was considered constant, alteration of the ratio was attributed to 
changes in mtDNA content.  
 
Plasma Lactate 
Lactate levels were measured from plasma samples (8mls) obtained from the indwelling arterial line 
before intervention and 30 minutes post intervention (ABL 700 Series gas Machines, 
RADIOMETER, Copenhagen, Denmark). Lactate concentration were used as a marker of illness 
severity [23]. 
Sample Size  
Sample size calculations were based on mitochondrial DNA outcome; using previously published 
minimally clinical important differences and standard deviations [24]. A sample size of 16 per 
group (32 total) was calculated for an effect size of 0.8, 90% power with a type 1 error of 0.025 
with Bonferroni correction.  
Statistical Analysis 
Data were analysed using intention to treat. Non-normal data were log transformed. Data were 
expressed as mean (Standard Deviation) (SD) or median (Inter-Quartile Range) (IQR). A mixed 
method ANOVA managed missing data and was used to compare between and within groups at 
different time points. If the overall model was significant, multiple comparisons among pairs of 
means were analysed with post hoc Bonferroni correction of significance level (p<0.025).  
 
Results 
Forty-five patients (4.7 % of those screened) were recruited with 23 and 22 participants randomised 
to the intervention and standard care group respectively during the period of December 2010 to 
August 2012 (Figure 7.1). 
 
The baseline demographics of participants are reported in Table 7.1. There were no differences 
found between the groups for baseline demographics duration of mechanical ventilation, ventilator 
free days, ICU and hospital length of stay, ICU readmission, ICU and 90-day mortality and 
resuscitation (DNR) status. There were no withdrawals during the conduct of the trial. All 
participants adhered and remained enrolled in the trial for an average of 11.2 days. Figure 7.2 and 
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7.3 describe the actual duration and number of episodes of exercise interventions administered to 
both groups. No session of exercise resulted in an adverse event. 
 
Fifteen samples failed to yield mitochondrial DNA. Mitochondrial DNA levels obtained at baseline 
(n=30), week 1 (n=27) and week 2 (n=21). Although values tended to decrease over time and reach 
levels of healthy controls at Week 2, there were no differences in the absolute levels or changes 
over time in the exercise or standard care groups (Table 7.2). At week 1, there was no change in the 
mtDNA/nDNA ratio following physical rehabilitation in intensive care in the intervention group but 
increased 13% in the standard care group. From baseline levels, the mtDNA/nDNA ratios in the 
intervention and standard care groups decreased by 20% and 35% respectively by week 2. No 
changes in the mtDNA/nDNA ratios over time reached statistical significance (Table 7.2 and 7.3, 
Figure 7.5).  
 
There were not differences between the intervention and control group in plasma lactate 
concentrations over time or in the immediate pre/post exercise evaluation. The mean 
mtDNA/nDNA ratio only correlated with plasma lactate concentration on Day 4 (r=0.39, p=0.04) 
with the absolute peripheral blood mitochondrial DNA and lactate concentrations at baseline 
approaching statistical significance (r=0.31, p=0.09) (Table 7.4). 
 
Discussion 
Observations from this novel trial supports the contention that early exercise in critically ill patients 
with sepsis does not cause harm. Mitochondrial DNA is known to increase in the peripheral blood 
during the acute phase of sepsis [25] and was similarly noted in our patient population. As a 
surrogate for oxidative stress, there was no evidence of significant change in mtDNA/nDNA ratio in 
patients who underwent targeted progressive physical rehabilitation within the early days of ICU 
admission. Exercise in this study did not affect plasma lactate. Although nursing practices such as 
suctioning, turning and positioning as part of daily ICU management [26] during critical illness has 
been hypothesised to release ROS potentially aggravating cellular destruction and increasing 
mortality risks, our current study did not show any evidence of exercise-induced oxidative stress in 
critically ill patients in intensive care. Levels of mtDNA/nDNA ratio approximated those of healthy 
controls by the end of the 2nd week in both intervention and standard care groups.  
 
Oxygen-derived free radicals play an important role in the development of disease in critically ill 
patients. When free radical production exceeds the antioxidant capacity to buffer oxidants, oxidative 
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stress occurs [11]. It is known that overproduction of ROS can occur with intense and prolonged 
exercise resulting in oxidative damage to protein and lipids in skeletal muscle cells [27, 28]. As a 
result, oxidation of DNA and proteins along with membrane damage can occur due to lipid 
peroxidation, resulting in alterations to membrane permeability, modification of protein structure 
causing proteolysis and functional changes [29]. As the mitochondrial genome is highly susceptible 
to oxidative stress, oxidative damage to mitochondrial membrane can lead to mutations in 
mitochondrial DNA (mtDNA) and resultant apoptosis, ultimately producing cell death [30].   
 
Aerobic [31-33] and anaerobic [34-36] exercises to the point of exhaustion can contribute to 
increased free radical production. In addition, different exercise protocols may result in varying 
levels of ROS production, as oxidative damage can be both intensity [37, 38] and duration [39] 
dependent. During low-intensity or low-duration protocols, antioxidant defences are usually 
adequate to meet the ROS production. However, as the intensity and duration of exercise increases, 
these defences are no longer adequate and may result in in oxidative damage even in healthy 
athletes [40]. To date, it is unknown what optimal level of exercise can be safely administered based 
on duration, intensity and frequency that will maximise treatment efficacy without inducing 
oxidative stress in a critically ill septic patient. 
 
In sepsis, these defence mechanisms can be compromised. During systemic inflammation, oxidative 
phosphorylation within the mitochondria is interrupted [41] causing mitochondrial dysfunction, 
exacerbating the production of ROS [42]. In a sepsis rat model, mtDNA damage, depletion and 
decreased mtDNA transcription, precede bioenergetics failure and the restoration of mtDNA 
integrity appeared linked to mitochondrial biogenesis [43]. In sepsis, oxidative stress in the 
mitochondria may affect changes in mtDNA quantity [44], in addition to mutations which can 
eventually result in dysfunction of distal organs and multi-organ system failure (MOSF).  Extremely 
low levels of mtDNA might also suggest possible mitochondrial ‘shutdown’ or copy number 
depletion leading to death [45].  
 
Exercise-induced skeletal muscle damage must be prevented in rehabilitation of the critically ill. 
Pilot findings from this study suggest there is a no clear relationship between early ICU physical 
rehabilitation and mitochondrial DNA levels in peripheral blood of patients with sepsis syndromes. 
This supports the safety of early physical rehabilitation in critically ill sepsis patients. Further 
research is required to prove that early ICU physical rehabilitation can inhibit mitochondrial DNA 
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dysfunction and prevent skeletal muscle damage and resultant myopathy in sepsis syndromes 
(Figure 7.6).   
 
Study limitations 
Although the novel findings from this pilot study support the safety of early exercise not to worsen 
oxidative stress in patients with sepsis syndromes, the finding should be interpreted with caution. 
Blood nuclear and mitochondrial DNA levels may be influenced by the degree of sepsis, age and 
pre-existing co-morbidities and time of collection during ICU stay, however our groups were 
comparable in regard to these possible confounders. DNA changes and release may occur in 
different tissues via several mechanisms due to variety of pathogens, types of infection. Different 
leukocyte populations that have not been considered in this study could contribute to a clearer 
understanding of the mechanism of mitochondrial DNA changes in peripheral blood samples.  
 
Conclusion 
In conclusion, this study suggests that early physical rehabilitation is safe and does not appear to 
cause any harm in relation to oxidative stress in critically ill patients. A larger study is required to 
assess for temporal trends on the effects of exercise on oxidative stress. Further investigations are 
required to elucidate the mechanism of oxidative stress the effects of early physical rehabilitation 
during critical illness. 





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
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
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Figure 7.1 CONSORT recruitment flow diagram
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 Figure 7.2 Total duration of physical rehabilitation received by participants in intervention and standard care groups 
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Figure 7.3 Number of physical rehabilitation sessions received by participants in intervention and standard care groups 
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Figure 7.4 Determination of mitochondrial DNA content using SYBR green real time PCR and Robot 
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Figure 7.5 Relative mitochondrial DNA changes with early ICU exercise
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Figure 7.6 Proposed mechanism of effects of early ICU exercise intervention on oxidative stress 
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Table 7.1 Demographic and clinical characteristics and intensive care unit and hospital measures for 
study cohort 
 
 Intervention (n=22) Standard Care (n=23) 
Age (years)  57.9(14.6) 65.0(9.2) 
Female : Male (%) 6(13):16(36) 10(22):13(29) 
Weight (kg) 79.7(24.5) 82.0(22.3) 
Height (cm) 171.6(10.5) 170.1(9.4) 
CCI index  2.0(0-3) 3.0(0-3) 
BMI (kg/m2)  28.0(17.9-28.8) 27.8(20-29.9) 
APACHE II score   28.6(6.1) 27.5(7.6) 
Sepsis Category [n(%)] 
Sepsis 
Severe Sepsis 
Septic Shock 
 
1(2.2) 
5(11.1) 
16(35.6) 
 
1(2.2) 
5(11.1) 
17(37.8) 
SOFA Score baseline 11.1(3.2) 10.5(2.5)  
TOMV (days) 8.0(4-13) 7.0(2-11) 0.30# 
VFD (days)   20.0(0-9) 21(0-9) 0.79# 
ICU length of stay (days)  12.0(4-16) 9.0(3-13) 0.57# 
Hospital length of stay 41.0(9-63) 51.0(14-88) 0.63# 
ICU readmission [n(%)] 1(2) 4(9) 0.35 
ICU Mortality [n(%)] 1(2) 2(4) 0.61 
90-Day Mortality [n(%)] 7(16) 2(4) 0.07 
DNR Status [n(%)] 8(18) 4(8) 0.19 
Data are median (IQR), mean (SD), median (IQR) or n(%). Ventilator free days; from study day 1 
to day 28. 
* p<0.05 or **p<0.01, Negative binomial# or Chi-squared test 
CCI; Charlson Comorbidity Index, BMI; Body Mass Index, APACHE II; Acute Physiology and Chronic 
Health Evaluation, SOFA: Sequential Organ Failure Assessment, TOMV; Time on Mechanical Ventilation, 
VFD; Ventilator Free Days; ICU; Intensive Care Unit, DNR; Do not resuscitate  
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Table 7.2 Blood mitochondrial DNA(mtDNA)/nuclear DNA(nDNA) ratio in standard care versus exercise groups  
Data are Mean (SD) *p<0.05 or **p<0.01, Repeated Measures ANOVA time*group analysis 
Table 7.3 Blood mitochondrial DNA(mtDNA)/nuclear DNA(nDNA) ratio changes in controls vs. exercise groups  
Data are Mean (SD) *p<0.05 or **p<0.01, Independent Samples T-test 
  
 
 
 
 
 
mtDNA/nDNA 
ratio  
Baseline  
Mean (SD), n=30 
Week 1 (Day 4 +/-1) 
Mean (SD), n=27 
Week 2 
Mean (SD), n=21 
 
p value 
 
Healthy 
Controls  
n=50 
Exercise Standard Care Exercise Standard Care Exercise Standard Care 
 
Overall 0.55(0.1),50 0.74(0.3),18 0.69(0.2),12 0.74(0.3),14 0.78(0.5),13 0.59(0.1),13 0.51(0.1),8 0.49 
mtDNA/nDNA 
ratio 
Baseline to Week1(Day 4 +/-1)  
Mean Change (%) p value 
Baseline to Wk2  
Mean Change (%) p value 
Week1(Day 4 +/-1)  to Week 2  
Mean Change (%) p value 
 Exercise Standard Care  Exercise Standard Care  Exercise Standard Care   
Overall 0.00 (0) 0.09(13) 0.20 -0.15(20) -0.18(26) 0.96 -0.15(20) -0.27(35) 0.35 
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Table 7.4 Plasma lactate concentration changes in study groups 
Data are Mean (SD) *p<0.05 or **p<0.01, Repeated Measures ANOVA between groups
Plasma lactate 
(mmol/L) 
Exercise  
Mean (SD) (n=22) Mean change (% change) 
Standard  Care 
Mean (SD) (n=23) Mean change (% change) p value 
 Pre Post  Pre Post   
Day 1 2.09(1.63) 1.92(1.34) -0.24(-11.6) 2.15(1.94) 2.00(1.71) -0.19(-8.8) 0.47 
Day 2 1.50(0.62) 1.41(0.62) 0.09(6) 1.50(0.77) 1.48(0.74) -0.02(-1)  
Day 3 1.56(0.96) 1.52(0.84) 0.04(3) 1.59(0.81) 1.66(0.81) 0.07(4)  
Day 4 1.50(0.67) 1.41(0.53) -0.09(-6) 1.25(0.53) 1.34(0.62) 0.09(7)  
Day 5 1.28(0.55) 1.40(0.48) 0.12(9) 1.24(0.61) 1.35(0.56) 0.11(9)  
Day 6 1.22(0.46) 1.22(0.40) 0(0) 1.28(0.64) 1.40(0.61) 0.12(9)  
Day 7 1.24(0.46) 1.16(0.40) -0.08(-7) 1.19(0.55) 1.23(0.62) 0.04(3)  
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7.3 Summary  
Pilot findings from this study suggest there early physical rehabilitation in intensive care does not 
result in oxidative stress in sepsis syndromes as determined by peripheral blood mitochondrial DNA 
and that the use of peripheral blood mitochondrial DNA quantification as a marker of oxidative 
stress for early physical rehabilitation in intensive care on critically ill patients would require further 
exploration.  
 
Although appropriate, we sampled a population of cells circulating that may be going to or coming 
from sites of inflammation where there could be a mix of young healthy or damaged cells. As we 
could not study a steady state during the course of the illness, it is important to note that the various 
populations of cells that make up this mix will change considerably affecting mitochondrial DNA 
outcomes. 
 
For future research, the differences that exist in mitochondrial content in different cell types and 
ages and whether this alone could explain changes needs to be investigated. It is important to note 
that only excess ROS signalling beyond local control is harmful. While we counted copies of DNA, 
these may not directly measure actual functional activity of these mitochondria and may not 
indicate a reflection of ROS signalling that has reached harmful levels. 
 
It is important to note that peripheral blood white cell mitochondrial DNA and nuclear DNA 
measured as a marker to explore reactive oxygen stress in this study may or may not have any 
reflection on mitochondrial function in any other tissue especially in the skeletal muscle. It can be 
hypothesised that early exercise allowed a beneficial environment allowing the modulating effect of 
skeletal muscle that was not present in the control group. 
 
A larger study is required to confirm these findings. Further investigations are required to elucidate 
the mechanism of oxidative stress and early physical rehabilitation during critical illness. 
 
The next chapter, Chapter 8, presents the results of the second pilot trial; the first to evaluate the 
short-term effects of early ICU physical rehabilitation on muscle oxygenation and tissue 
microcirculation in the intensive care unit in patients with sepsis syndromes.  
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CHAPTER 8  
Pilot Trial 2 
8.1 Overview 
This chapter reports the results of the second pilot trial; “Early Exercise in Intensive Care shows 
Trends of Improvement in Tissue Microcirculation and Oxygenation in Patients with Sepsis 
Syndromes”. This pilot trial is original and the first in investigating if early ICU physical 
rehabilitation results in muscle oxygenation and tissue microcirculation in patients presenting with 
sepsis syndromes. In particular, it is novel in examining the acute changes of tissue microcirculation 
and muscle tissue oxygenation extraction before and after ICU exercise. Results of this trial are 
stated in a draft manuscript prepared for journal submission. 
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8.2 Manuscript 5 (Pilot Trial 2) 
The manuscript entitled “Early Exercise in Intensive Care shows Trends of Improvement in Tissue 
Microcirculation and Oxygenation in Patients with Sepsis Syndromes” has been prepared for 
submission to a journal. 
 
The manuscript is presented as prepared for submission to the journal, except for tables and figures 
and references that have been configured to fit the overall style of the Thesis. The numbering of 
pages are in accordance with the overall format of the Thesis. The references are found at the end of 
this manuscript.  
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Abstract 
Introduction  
Critically ill patients with systemic inflammation have impaired microcirculation and oxygenation 
to vital organs. Early physical exercise strategies may modulate the microcirculation in patients 
with sepsis.  
 
Methods 
Twenty-one mechanically ventilated critically ill adults admitted to general intensive care unit with 
sepsis syndromes were recruited into this pilot study as part of a prospective double-blind 
randomised controlled trial investigating early physical rehabilitation in intensive care.  
 
Measurements 
Clinical data and measurements of tissue oxygenation and microcirculation were collected at 
baseline and thereafter over one week during intensive care admission. 
 
Results 
A trend of increased StO2 for hyperaemia was found following early exercise (p=0.06). There was a 
large StO2 change from baseline to hyperaemic StO2 of 2.6% to 6.2% on Day 2 post exercise. No 
statistical significance was reached pre and post exercise for microvascular flow index but a trend 
for improved capillary density was improved capillary density was noted (2.46±1.04, 3.70±1.04, 
p=0.06). 
 
Conclusion 
Early physical rehabilitation in intensive care shows trends of improved microcirculatory and tissue 
oxygenation alterations in the acute stages of sepsis. Near-infra Red Oxygenation Monitor and 
Orthogonal Spectral Imaging are useful clinical tools to observe the effect of ICU physical 
rehabilitation during critical illness. 
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Introduction 
Intensive care acquired weakness syndrome (ICUAW) is a frequent complication of sepsis and 
attributed to factors such as impaired microcirculation, inflammation and immobilisation. Early 
rehabilitation is now strongly advocated [1-3] and accepted in intensive care [4-6]. However, in the 
critically ill, haemodynamic instability and limited co-operation due to sedation limit beginning 
rehabilitation at an early stage of admission. As majority of proteolysis occurs in the first 48 hours 
following a septic insult [7, 8], methods of rehabilitation not requiring active participation are 
required to assist with limiting muscle loss.     
 
Passive techniques such as manual passive limb movements, continuous passive movement devices 
and electrical muscle stimulation are all methods applicable for early physical rehabilitation. There 
is some preliminary evidence as to benefit in both general intensive care, septic and heart failure 
patient [9-16]. The majority of studies have been completed when the patient has been adequately 
resuscitated and haemodynamically stable. 
 
Sepsis impairs microcirculation flow causing tissue hypoxia [17-19]. Early recruitment of the 
microcirculation using pharmacological means has demonstrated decreased organ failures and 
mortality [20]. Similar effects maybe possible with exercise by stimulation of endothelial Nitric 
Oxide (NO) synthase. There has been preliminary evidence of improvements in the 
microcirculation [11] with physical rehabilitation strategies at late stages of an ICU stay. Passive 
movements and electrical muscle stimulation could theoretically be utilized at an earlier stage of 
sepsis to recruit the microcirculation. 
 
Materials and methods 
Study population 
This pilot study was part of a prospective double blinded randomised controlled trial [21][ACTRN 
12610000808044] conducted at a single quaternary level, university affiliated, general ICU at the 
Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia. The main study was 
conducted according to CONSORT guidelines [22]. Substitute decision makers, outcome assessors 
and health care personnel except treating therapists were blinded to group allocation. The study 
protocol was approved by The Human Research Ethics Committee at Royal Brisbane and Women’s 
Hospital and the Medical Research Ethics Committee at The University of Queensland.  
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Study population 
Participants aged ≥ 18 years who were mechanically ventilated with sepsis syndromes and predicted 
to remain in ICU for more than 48 hours [23] were enrolled. Enrolment exclusions were patients 
with head injuries, burns, spinal injuries, or multiply fractured lower limbs. Patients with septic 
shock who were unresponsive to maximal treatment, moribund or had an expected mortality within 
48 hours were also excluded (Figure 8.1).  
 
Participant age, sex, co-morbidities, admission diagnoses, Acute Physiological and Chronic Health 
Evaluation (APACHE II) [24], Charlson Comorbidity Index (CCI) [25], Sequential Organ Failure 
Assessment (SOFA) [26], time on mechanical ventilation, ventilator free days, length of ICU and 
hospital stay, readmissions to ICU and 90 day-mortality in hospital or home were recorded. Twenty 
one participants from the intervention group who consented for the main study were recruited into 
this pilot study. Sixteen and five participants respectively had measurement of muscle oxygenation 
and microcirculation completed immediately before and after an exercise session (Figure 8.1). 
 
ICU Physical Rehabilitation Program 
Participants underwent individualised early targeted physical rehabilitation program prescribed by 
the ICU research physiotherapist for 30 minutes, one to two times daily until discharge from the 
ICU within 48 hours of the diagnosis of sepsis. Assessment of conscious level, acuity of illness, 
haemodynamic stability and muscle strength dictated the choice of intervention for that day. 
Physical rehabilitation strategies included Electrical Muscle Stimulation (EMS), passive range of 
motion (PROM), active range of motion, sitting out of bed, transfers, ambulation and other 
mobilisation techniques as appropriate. 
In the early stages of physical rehabilitation, EMS was administered using the NMES Machine 
(Verity Medical Ltd., Hampshire, UK) on motor points of Vastus Medialis Oblique, Vastus 
Lateralis, Tibialis Anterior and Brachioradialis of limbs on bilateral sides. Biphasic, symmetric 
impulses in sets of 2 to 3 with 8 repetitions each with a frequency of 40 to 45Hz at 20 to 25 mA, 
pulse duration at 400 μs of 12 seconds on and 6 seconds off were administered for 20 minutes to 
induce visible muscle contractions. Table 8.1 describes the intervention received by each subject 
during intervention. 
 
Muscle Oxygenation 
Near Infra-Red Spectroscopy (NIRO) was used to measure regional tissue oxygenation to provide 
an estimate or indirect measure of microcirculation [11]. Tissue (muscle) oxygenation was 
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measured using a finger probe placed on the hypothenar muscle pre and post ICU physical 
rehabilitation. The signal from the probe estimates skeletal muscle microcirculatory oxygenation, 
and reflects the venous haemoglobin oxygen status. Participants’ brachioradialis was used in the 
event the hypothenar muscle was not accessible. A pneumatic cuff was placed above the elbow of 
the arm used for NIRO measurements and inflated to approximately 180 mmHg to obtain temporary 
occlusion of the blood supply through the brachial artery for 3 minutes inducing local ischemia and 
then totally deflated to cause active hyperaemia. Baseline percentage of oxygenation and 
hyperaemia (StO2%), difference between baseline and maximum (∆StO2), Muscle Oxygenation 
Extraction Rate (MOER%) were measured before, during and after the occlusion for 1 to 3 minutes 
using the NIRO-100/200 (Hamamatsu Photonics K.K., Tokyo, Japan). Measurements and graphs 
were analysed as described previously [21] (Figure 8.4).      
. 
Tissue Microcirculation 
Tissue microcirculation pre and post passive physical rehabilitation was measured using the 
Orthogonal Spectral Imaging OPS (Microvision Medical Inc, Wallingford, PA, USA) with a non-
invasive probe in the sub-lingual space. Participants were under sedation and mechanically 
ventilated during this procedure. Three to five live magnified video images of the capillary flow 
were captured for pre and post measures using sidestream dark field imaging. Images were 
recaptured to obtain images that could produce some usable information or data, if the live video 
sequences were unclear due to artefacts. Video images were stored and microvascular flow index 
and capillary density were analysed using the software (Adobe Premiere Elements v.4) 
accompanying this tool [19].  
 
Microvascular flow index (MFI) was used to quantify the velocity of microcirculatory perfusion as 
absent (0), intermittent (1), sluggish (2), or normal (3). The average of the predominant flow in each 
of the four quadrants divided over the image was used to calculate MFI [27] (Figure 8.5a). 
Capillary density (CD) was calculated using a grid of equidistant vertical and horizontal lines was 
superimposed on the image. The vessel density was calculated as the number of small vessels (< 20 
µm) intersecting the lines of the grid divided by the total length of the lines yielding the number of 
small vessels per millimetre (n/mm) [27] (Figure 8.5b).      
 
Sample Size  
Sample size calculations were based on tissue oxygenation and microcirculation outcome using 
previously published minimally clinical important differences and standard deviations [28]. A 
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minimum sample size of 16 ( 32 in total ) was calculated with an effect size of 0.7, 90% power with 
a type 1 error rate of 0.025 with Bonferroni adjustment.  
Statistical Analysis 
Non-normal data were log transformed. Data were expressed as mean (Standard Deviation) (SD) or 
median (Inter-Quartile Range) (IQR).A mixed method ANOVA managed missing data and was 
used to compare between/within groups at different time points for StO2. If the overall model was 
significant, multiple comparisons among pairs of means were analysed with post hoc Bonferroni 
correction of the significance level (p<0.025). The data derived from the OPS was measured 
pre/post on one occasion and was analysed with a student t-test for paired data. 
 
Results 
Twenty-one patients were recruited during the period of December 2010 to August 2012 (Figure 
8.1). Sixteen and five participants completed measurement of muscle oxygenation and 
microcirculation respectively immediately pre and post physical rehabilitation sessions. 
 
The baseline demographics of participants are reported in (Table 8.2). There were no withdrawals 
during the conduct of the trial. Figure 8.2 and 8.3 describe actual number of sessions and duration 
and of physical rehabilitation interventions administered. As a further measure of safety, arterial 
blood pressure, heart rate, respiratory rate and oxygen saturation were monitored during all sessions 
of exercise. There were pre-determined alterations which would define an adverse event [21]. No 
session of exercise resulted in an adverse event. 
 
Muscle Oxygenation 
Muscle (tissue) oxygenation was measured on Days 1, 2, 3, 5 and 7 pre and post intervention during 
week 1 after recruitment. A trend of increased StO2 for hyperaemia was found post exercise within 
subjects (p=0.06). Percentage changes from baseline StO2 to hyperaemia StO2 indicated return of 
circulation following ischemia where there was a high percentage change from baseline from 2.6 to 
6.2 on Day 2 post physical rehabilitation (Table 8.3 and 8.4). 
 
Tissue Microcirculation  
Tissue oxygenation was measured pre and post ICU physical rehabilitation pre post for week 1. 
From the images captured, MFI and CD were determined. Due to a small sample size, no statistical 
significance was reached pre and post physical rehabilitation for MFI but a trend was found for CD 
(2.46±1.04, 3.70±1.04, p=0.06) (Table 8.5). 
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Discussion 
Intervention with early physical rehabilitation in early sepsis is still controversial and could 
potentially cause oxidative stress or a deficit in overall oxygen delivery. This study found there was 
a trend towards an improvement in microcirculation using both OPS and NIRS. This implies that 
the microcirculation can potentially be recruited with physical rehabilitation early in the ICU 
admission. 
 
Endothelial function plus communication between endothelial cells is altered in sepsis. 
Hypothetically physical rehabilitation could improve increased endothelial nitric oxide synthesis. 
StO2 in particular is an index of endothelial function. An animal model previously found that short-
term physical rehabilitation training in rats, increased endothelial NO synthesis in skeletal muscle 
arterioles and vasodilator responses to Acetylcholine and l-arginine, suggesting enhanced 
endothelium and NO-dependent function [29].  
 
Perfused capillary density has been shown to have the greatest influence on tissue oxygenation [30]. 
This study indicated a trend in capillary density post physical rehabilitation. Many agents have been 
utilised in an effort to recruit the microcirculation, including vasodilators (dopexamine, 
pentoxifylline), blood transfusion and activated protein C. These can potentially result in adverse 
effects in critically ill patients. As physical rehabilitation does not result in hypotension, it may 
prove a safer way to recruit microcirculation. Our data suggests that EMS and PROM both might 
have had a systemic effect on microcirculation [11].  
 
Improvements in microcirculation may be the result of electrical muscle stimulation increasing 
energy consumption, [31] mimicking the effects of exercise [32]. The increase in cardiac output 
during the EMS session is likely to occur [33, 34] due to an increase in sympathetic discharge 
increases oxygen consumption [35, 36]. A bioenergetic pathway could be activated causing an 
improvement in mitochondrial function during the EMS session, contributing to the increased 
oxygen consumption [37].  
 
While evidence exists for the improvement of microcirculation in patients with chronic heart failure 
[28], and less critically ill patients, this study suggests that passive exercise is not only safe in the 
early stages of critical illness but a method that can recruit the microcirculation. This is important 
preliminary information as recruitment of microcirculation has been shown to correlate with 
survival in sepsis [38]. However, it is important to note that the findings may be limited as the 
results may be changes detected of mostly the skin and subcutaneous tissues as skin has 
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physiologically marked hyperaemia ability for heat loss. As the skin was acting as a buffer, changes 
in the skeletal muscle bulk may have been insignificant. Control of activity of the muscle 
component during the test is essential since any activity could change oxygen consumption many 
fold. 
 
This study is a preliminary exploration of the effects of early rehabilitation on the microcirculation.  
It was limited by a small sample size with each patient acting as their own control. Results therefore 
need to be interpreted carefully and a larger study would be required to confirm these effects.  
 
Pilot findings from this study suggest a potential effect of early ICU physical rehabilitation on 
tissue oxygenation and microcirculation. Dynamic variable interpretation using continuous StO2 
monitoring in critically ill patients provide valuable information on microcirculatory compromise in 
patients with sepsis. The time course of these microcirculatory alterations, the dose effects of 
therapeutic interventions and pathophysiological mechanisms of early physical rehabilitation will 
require further research.  
 
Conclusion 
Early physical rehabilitation in intensive care can modulate tissue oxygenation and microcirculation 
impairments during systemic inflammation in critically ill patients. The effects of early physical 
rehabilitation on patient outcome in relation to microcirculatory changes requires further 
investigation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 202 
 
References 
 
1. Lee CM, Fan E. ICU-acquired weakness: what is preventing its rehabilitation in critically ill 
patients? BMC Med 2012;10(115):doi:10.1186/1741-7015-10-115. 
2. Schweickert WD, Kress JP. Implementing early mobilization interventions in mechanically 
ventilated patients in the ICU. Chest 2011;140(6):1612-1617. 
3. Puthucheary ZA, Hart N. Intensive care unit acquired muscle weakness: when should we 
consider rehabilitation? Crit Care 2009;13(4):167:doi: 10.1186/cc7937. 
4. Bailey P, Thomsen GE, Spuhler VJ, Blair R, Jewkes J et al. Early activity is feasible and 
safe in respiratory failure patients. Crit Care Med 2007;35(1):139-145. 
5. Morris PE, Griffin L, Berry M, Thompson C, Hite RD et al. Receiving early mobility during 
an intensive care unit admission is a predictor of improved outcomes in acute respiratory 
failure. Am J Med Sci 2011;341(5):373-377. 
6. Camargo Pires-Neto R, Fogaca Kawaguchi YM, Sayuri Hirota A, Fu C, Tanaka C et al. 
Very early passive cycling exercise in mechanically ventilated critically ill patients: 
physiological and safety aspects--a case series. P LoS One 2013;8(9):e74182. 
7. Tiao G, Fagan JM, Samuels N, James JH, Hudson K et al. Sepsis stimulates nonlysosomal, 
energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J 
Clin Invest 1994;94(6):2255-2264. 
8. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G et al. Acute skeletal 
muscle wasting in critical illness. JAMA 2013;310(15):1591-1600. 
9. Griffiths RD, Palmer TE, Helliwell T, MacLennan P, MacMillan R, R. Effect of passive 
stretching on the wasting of muscle in the critically ill. Nutrition 1995;11(5):428-432. 
10. Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanos E, Politis P et al. Electrical muscle 
stimulation preserves the muscle mass of critically ill patients: a randomised study. Crit Care 
Med 2009;13(5):R161-165. 
11. Gerovasili V, Tripodaki E, Karatzanos E, Pitsolis T, Markaki V et al. Short-term systemic 
effect of electrical muscle stimulation in critically ill patients. Chest 2009;136(5):1249-
1256. 
12. Karatzanos E, Gerovasili V, Zervakis D, Tripodaki ES, Apostolou K et al. Electrical muscle 
stimulation: an effective form of exercise and early mobilization to preserve muscle strength 
in critically ill patients. Crit Care Res Pract 2012;2012(432752):doi:10.1155/2012/432752. 
13. Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolis T et al. Electrical muscle 
stimulation prevents critical illness polyneuromyopathy: a randomised parallel intervention 
trial. Crit Care 2010;14(2):R74:doi: 10.1186/cc8987 
 203 
 
14. Paratz J, Lipman J, Boots R, Lingwood B. Early exercise attenuates inflammation and loss 
of muscle mass. Australian and New Zealand Intensive Care Society, Perth October 2009. 
15. Angelopoulos E, Karatzanos E, Dimopoulos S, Mitsiou G, Stefanou C et al. Acute 
microcirculatory effects of medium frequency versus high frequency neuromuscular 
electrical stimulation in critically ill patients - a pilot study. Ann Intensive Care 
2013;3(1):doi: 10.1186/2110-5820-1183-1139. 
16. Burtin C, Langer D, Troosters T, Hermans G, Decramer M. Early exercise in critically ill 
patients enhances short-term functional recovery. Crit Care Med 2009;37(9):2499-2505. 
17. Farquhar I, Martin CM, Lam C, Potter R, Ellis CG et al. Decreased capillary density in vivo 
in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996;61(1):190-196. 
18. Lam C, Tyml K, Martin C. Microvascular perfusion is impaired in a rat model of 
normotensive sepsis. J Clin Invest 1994;94(5):2077-2083. 
19. De Backer D, Creteur J, Preiser JC. Microvascular blood flow is altered in patients with 
sepsis. Am J Respir Crit Care Med 2002;166(1):98–104. 
20. Trzeciak S, McCoy JV, Phillip Dellinger R, Arnold RC, Rizzuto M et al. Early increases in 
microcirculatory perfusion during protocol-directed resuscitation are associated with 
reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 
2008;34(12):2210-2217. 
21. Kayambu G, Boots RJ, Paratz JD. Early rehabilitation in sepsis: a prospective randomised 
controlled trial investigating functional and physiological outcomes : The i-PERFORM Trial 
(Protocol Article). BMC Anesthesiology 2011;11(21):doi:10.1186/1471-2253-11-21. 
22. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement:updated guidelines for 
reporting parallel group randomised trials. Int J Surg 2011;9(8):672-677. 
23. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM et al. Surviving Sepsis Campaign: 
International guidelines for management of severe sepsis and septic shock. Crit Care Med 
2008;36(1):1394-1396. 
24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease 
classification system. Crit Care Med 1985;13(10):818-829. 
25. Charlson ME, Pompe P, Ales KL, MacKenzie CR. A new method of classifying prognostic 
comorbidity in longitudinal studies: development and validation. J Chronic Dis 
1987;40(5):373-383. 
26. Vincent JL MR, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, 
Thijs LG. The SOFA ( Sepsis related Organ Failure Assessment ) score to describe organ 
dysfunction/failure. Intensive Care Med 1996;22(7):707-710. 
 204 
 
27. Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C. Quantifying bedside-
derived imaging of microcirculatory abnormalities in septic patients: a prospective 
validation study Crit Care 2005;9(6):R601–606. 
28. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E et al. Physical exercise 
improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm 
Rehabil Prev 2009;29(6):385-391. 
29. Sun D, Kaley G, Koller A. Characteristics and origin of myogenic response in isolated 
gracilis muscle arterioles. Am J Physiol 1994;266(3):H1177-H1183. 
30. Edul VS, Enrico C, Laviolle B, Vazquez AR, Ince C et al. Quantitative assessment of the 
microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med 
2012;40(5):1443-1448. 
31. Hamada T, Hayashi T, Kimura T, Nakao K, Moritani T. Electrical stimulation of human 
lower extremities enhances energy consumption, carbohydrate oxidation, and whole body 
glucose uptake. J Appl Physiol 2004;96(3):911-916. 
32. Poole RB, Harrold CP, Burridge JH, Byrne CD, Holt RI. Electrical muscle stimulation 
acutely mimics exercise in neurologically intact individuals but has limited clinical benefits 
in patients with type 2 diabetes. Diabetes Obes Metab 2005;7(4):344-351. 
33. Hanft LM, Korte FS, McDonald KS. Cardiac function and modulation of sarcomeric 
function by length. Cardiovasc Res 2008;1(77):627-636. 
34. Clarke Moloney M, Lyons GM, Breen P, Burke PE, Grace PA. Haemodynamic study 
examining the response of venous blood flow to electrical stimulation of the gastrocnemius 
muscle in patients with chronic venous disease. Eur J Vasc Endovasc Surg 2006;31(3):300-
305. 
35. Tsuchimochi H, Hayes SG, McCord JI, Kaufman MP. Both central command and exercise 
pressor reflex activate cardiac sympathetic nerve activity in decerebrate cats. Am J Physiol 
Heart Circ Physiol 2009;296(4):H11557-11563. 
36. Koba S, Yoshida TF, Hayashi N. Renal sympathetic and circulatory responses to activation 
of the exercise pressor reflex in rats. Exp Physiol 2006;91(1):111-119. 
37. Pimenta Ada S, Lambertucci RH, Gorjao R, Silveira Ldos R, Curi R. Effect of a single 
session of electrical stimulation on activity and expression of citrate synthase and 
antioxidant enzymes in rat soleus muscle. Eur J Appl Physiol 1997;102(1):119-126. 
38. De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D et al. Microcirculatory 
alterations in patients with severe sepsis: impact of time of assessment and relationship with 
outcome. Crit Care Med 2013;41(3):791-799. 
 
 205 
 





















 
 
 
 
 
 
 
 
 
Figure 8.1 CONSORT recruitment flow diagram 
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(i-PERFORM Trial) 
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Excluded (n=910) 
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Not mechanically ventilated (n=271) 
Not met inclusion criteria (n=330) 
 Neurological Injuries (n=224) 
 Traumatic Injuries (n=50) 
 Burn Injuries (n=31) 
 Orthopaedic Injuries (n=25) 
Not Sepsis Syndrome (n=290) 
Declined (n=8) 
Competing Trial (n=2) 
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(n=26)  
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Muscle Oxygenation (NIRO) 
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(n=960) 
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TRIAL 
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(n=17)  
 
Equipment Unavailable (n=1) 
Tissue Microcirculation (OPS) 
(n=7) 
 
Equipment Unavailable (n= 2) 
Baseline  
Pre-Post  
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Figure 8.2 Number of physical rehabilitation sessions received by participants in intervention group 
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Figure 8.3 Total duration of physical rehabilitation received by participants in intervention group 
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Figure 8.4 Calculation of dynamic variables using NIRO; baseline percentage of tissue oxygenation 
(StO2%); hyperaemia (StO2%), difference between baseline and reperfusion (∆StO2%) 
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Figure 8.5 Calculation of changes in sublingual tissue microcirculation by determining A) 
Microvascular flow index and B) Capillary density
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Table 8.1 ICU physical rehabilitation program guide for participants  
Ramsay 
Sedation 
Scale 
Stages of 
exercise 
progression 
Conditions Type of Intervention Recommended Exercise Prescription 
6-4 Stage 1 Sedated Passive Range of Motion with stretch reflex to upper and lower limbs  
Electrical Muscle Stimulation to major muscle groups  
 
30 Mins /day 
30 Mins /day 
3-2 Stage 2 Inotropic Dependence  Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting up in Bed with assistance as tolerated 
  
10 Mins x 2 /day 
30 Mins /day 
30 Mins x 2 /day 
2 Stage 3 Weight  
Bearing  
Muscle Strength  
Grade < 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed with assistance 
Lower Limb Ergometry 
Tilt Table Therapy  
 
10 Mins x 2 /day 
30 Mins /day 
10 Mins x 2 /day 
60 Mins x 2 /day 
15 Mins x 2 /day 
30 Mins /day 
2 Stage 4 Weight  
Bearing  
Muscle Strength  
Grade > 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical muscle stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed  
Upper Limb Ergometry ( low level resistance ) 
Lower Limb Ergometry  
Ambulation with assistive device and therapist 
10 Mins x 2 /day 
30 Mins /day 
10 Mins /day 
30 Mins /day 
15 Mins /day 
15 Mins x 2 /day 
30 Mins x 2 /day 
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Table 8.2  Demographic and clinical characteristics for study cohort 
 NIRO (n=16) OPS  (n=5) 
Age (years)  63.0(30-83) 63.0(56-70) 
Female : Male (%)  3(19):13(81) 1(20):4(80) 
Weight (kg) 75.0(51-130) 74.0(56-125) 
BMI (kg/m2)  29.2(18.5-47.8) 35.4(18.5-75.0) 
APACHE II score   29.9(20-43) 26(19-43) 
SOFA Baseline Score 11.6 (3.6) 11.6 (3.5) 
TOMV (days) 7(4-44) 12(7-20) 
VFD (days)   21(1-24) 16(8-21) 
ICU length of stay (days)  8(4-44) 21(8-26) 
Hospital length of stay (days) 44(9-152) 22(18-94) 
ICU readmission [n (%)] 0 0 
ICU Mortality [n (%)] 0 0 
90-Day Mortality [n (%)] 4(25) 1(20) 
DNR Status [n (%)] 4(25) 1(20) 
Data are median (IQR), mean (SD), median (IQR) or n(%). Ventilator free days; from study day 1 
to day 28. 
* p<0.05 or **p<0.01, Negative binomial# or Chi-squared test 
CCI; Charlson Comorbidity Index, BMI; Body Mass Index, APACHE II; Acute Physiology and 
Chronic Health Evaluation, SOFA; Sequential Organ Failure Assessment, TOMV; Time on 
Mechanical Ventilation, VFD; Ventilator Free Days; ICU; Intensive Care Unit, DNR; Do not 
resuscitate  
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Table 8.3 Muscle (tissue) oxygenation using Near Infrared Oxygenation (NIRO) pre and post exercise 
n=16 
 
Baseline StO2 (%) 
Mean (SD) 
p 
value 
Hyperaemia StO2 (%) 
Mean (SD) 
p 
value 
∆StO2 (%) 
Mean (SD) 
p 
value 
MOER (%) 
Mean (SD) 
p  
value 
 Pre Post  Pre Post  Pre Post  Pre Post  
Day 1 63.7(7.3) 61.7(7.8) 0.63 66.7(8.3) 66.7(6.2) 0.06 20.8(21.5) 19.0(19.0) 0.15 4.3(4.3) 6.7(9.5) 0.99 
Day 2 66.0(11.0) 63.1(9.0)  68.6(11.1) 69.3(9.0)  23.3(14.9) 22.4(15.9)  6.5(5.9) 9.0(5.5)  
Day 3 58.4(4.3) 59.0(8.4)  61.4(3.4) 64.4(6.1)  17.5(15.1) 14.4(17.5)  4.8(3.3) 3.3(3.3)  
Day 7 65.4(4.4) 67.3(2.0)  67.7(4.1) 69.1(1.1)  14.1(10.2) 12.5(12.4)  3.4(2.4) 2.6(2.0)  
 
Table 8.4 Percentage change in muscle (tissue) oxygenation using Near Infrared Oxygenation (NIRO) pre and post exercise 
 
 
Pre Exercise  
Mean (SD) 
% 
Change 
Post Exercise  
Mean (SD) 
%  
Change 
 Baseline StO2 (%) Hyperaemia StO2 (%)  Baseline StO2 (%) Hyperaemia StO2 (%)  
Day 1 63.7(7.3) 66.7(8.3) 3 61.7(7.8) 66.7(6.2) 5 
Day 2 66.0(11.0) 68.6(11.1) 2.6 63.1(9.0) 69.3(9.0) 6.2 
Day 3 58.4(4.3) 61.4(3.4) 3 59.0(8.4) 64.4(6.1) 5.4 
Day 7 65.4(4.4) 67.7(4.1) 2.3 67.3(2.0) 69.1(1.1) 1.8 
 
Data are Mean (SD) *p<0.05 or **p<0.01, Repeated Measures ANOVA 
 
StO2; Percentage of oxygenation in the muscle, ∆StO2; Difference between baseline and maximum, MOER; Muscle Oxygenation extraction rate 
Non-normal Data were log transformed 
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Table 8.5 Changes in tissue microcirculation using Orthogonal Polarisation Spectrum (OPS) pre and post exercise 
Tissue microcirculation, n=5 Pre Exercise  
Mean(SD) 
Post Exercise  
Mean(SD) 
p value 
Microvascular flow index 1.12(0.50) 1.45(0.36) 0.28 
Capillary density 2.46(1.04) 3.70(1.04) 0.06 
Data are Mean (SD) 
*p<0.05 or **p<0.01, Paired T-Test  
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8.3 Summary  
Pilot findings from this study suggest there is a mild relationship between early ICU exercise and 
tissue oxygenation and microcirculation. While there is still no “gold standard” measure of 
monitoring regional circulation during critical illness, observation of tissue oxygenation cannot be 
overlooked especially in a patient performing early exercise in the ICU. Dynamic variable 
interpretation using continuous StO2 monitoring in critically ill patients provide valuable 
information on microcirculatory compromise in patients with sepsis. The time course of these 
microcirculatory alterations and the specific dose of therapeutic interventions such as early physical 
rehabilitation to cause such modulation in the critically ill will require further research. This short-
term systemic effect of ICU exercise suggests that early physical rehabilitation can improve tissue 
oxygenation and possibly microcirculatory disorders during systemic inflammation. Further 
investigations are required to elucidate the mechanism of tissue oxygenation and microcirculation 
and the time and dose of ICU exercise to improve the management of sepsis syndromes. 
 
The last chapter of this thesis, Chapter 9 discusses the findings of the i-PERFORM trial, states the 
limitations of the trial and evaluates the implications for future research and clinical practice. 
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CHAPTER 9  
Discussion 
9.1 Overview 
The clinical research presented in this thesis aimed to investigate whether early physical 
rehabilitation in intensive care would improve outcomes specifically in those with critical illness 
due to sepsis. The systematic literature review and meta-analysis (Chapter 5) reported experimental 
evidence and the magnitude of the effects of ICU exercise in critically ill patients.  
 
The meta-analysis of randomised controlled trials reported small, but significant positive effects 
favouring physical therapy to improve the quality of life, physical function, peripheral muscle 
strength and moderate improvement in respiratory muscle strength in the critically ill. There were 
small reductions in length of hospital and ICU stay with increased ventilator free days. Physical 
rehabilitation however did not affect mortality. The systematic review highlighted limited 
information on inflammatory biomarkers to advance an understanding of the biological mechanisms 
for the positive effects reported in the meta-analysis. Furthermore, there were no trials in specific 
diagnostic groups of critically ill patients such as those with sepsis syndromes.  
 
The i-PERFORM trial (Chapters 6, 7 and 8) is the first prospective interventional randomised trial 
to examine the effects of early physical rehabilitation in the intensive care on proposed physical, 
psychological outcomes and physiological (systemic) biomarkers relevant to sepsis syndromes in 
the broad casemix of  the critically ill population.  
 
This final chapter of the thesis summarises the trial’s key findings and discusses the experimental 
and clinical significance of these, including limitations of the trial. Based on the wider body of 
evidence derived from this research, recommendations for future research and implications for 
clinical practice are also discussed. The final conclusion will summarise the overall implications of 
the clinical research comprising this thesis.  
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9.2 Overall Key Findings  
The meta-analysis reported evidence that;  
1. Physical rehabilitation in intensive care reduced length of stay in intensive care and hospital, 
increased number of ventilator free days, improved peripheral and respiratory muscle 
strength, physical function and health-related quality of life. 
The randomised controlled trial reported that; 
2. Early physical rehabilitation in intensive care did not improve physical function, fat free 
mass and muscle strength at ICU discharge in patients with sepsis. 
3. Early physical rehabilitation in intensive care improves self-reported quality of life in the      
physical domains and induces anti-inflammatory effects and did not worsen the severity of 
illness of a critically ill patient.  
The pilot trials reported that; 
4. Early physical rehabilitation in intensive care does not appear to cause oxidative stress in 
patients with sepsis. 
5. Early physical rehabilitation in intensive care shows trends of changes in tissue oxygenation 
and microcirculation in patients with sepsis.  
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Investigation of Main Hypotheses 
9.2.1 Effect on Physical Function 
Physical function at ICU discharge did not show improvement with early physical rehabilitation in 
this study. Previous studies have found a correlation between strength and function [232, 233] in 
general ICU patients, however the timing of the assessment in our study that is, on the day after 
discharge from ICU, may have influenced the results found in this trial.  
Importantly, there is no clinically specific tool for the assessment of physical function and exercise 
capacity in the ICU for critically ill patients [234]. Although  several physical function assessment 
tools have been developed, validated and proven reliable, the clinical applicability of these 
measures remain far from specific for the accurate assessment of physical function debilitation in 
critically ill patients [235]. While the ACIF was used as the most appropriate tool for the accurate 
assessment of acquired physical dysfunction during critical illness, it may not have had sufficient 
sensitivity to measure physical outcomes in patients with sepsis. The recently developed ‘ICU 
Mobility Scale’ may be a more reliable tool [236].  
Based on well-established evidence from review of randomised trials on exercise and critical illness 
[237], measures of mobility components of physical function in patients were expected to improve 
following early targeted exercises in the ICU in patients with sepsis [238]. However, this change 
was not apparent in this randomised trial. Although able to complete a simple strength assessment, 
patients with sepsis in this study were not able to complete transfers due to problems with initiation 
of movements. Similar difficulties were noted in a comparable population [239]. Deficits in motor 
control neural programming may have resulted in adequate strength not translating to efficient 
motor functioning to explain this phenomenon [240].  
In sepsis, underlying mechanisms causing physical derangements are aggressive as systemic 
inflammatory insults to skeletal muscle occur early and rapidly although this can be independent of 
nutritional uptake [241]. Reduced muscle protein synthesis and an elevation in particular in leg 
protein breakdown results in catabolic states which has direct implications on functional 
compromise [241]. Myopathic damage of this extent may result in that any change in function 
following early physical rehabilitation may only be minimal or insignificant in the ICU as full 
physical recovery may be slow and would require a more sustained program of assessment. In 
addition, sepsis survivors suffer cognitive deficits in learning and memory [242]. This may affect 
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their return to premorbid function independent of maintained motor function and could persist up to 
eight years [228]. Other confounding factors such as the effects of inotropes and sedation need to be 
controlled or interrupted for effective exercise [170, 171]. Therefore, long-term confounding effects 
of physical disability was measured through health-related quality of life at six months upon 
hospital discharge to answer the second main hypothesis of the study. 
9.2.2 Effect on Health related Quality of Life  
Proving one of the main hypothesis of the study, the randomised controlled trial of this thesis found 
that patients self-reported improved health-related quality of life in the SF-36 components for 
physical function and physical role and trends of improvement in vitality, general health and 
emotional role at six months following hospital discharge.  
Survivors from intensive care have a lower health related quality of life reported for up to one year 
from hospital discharge [29]. Patients with sepsis syndromes have significantly worse outcomes 
with lower health related quality of life (HrQOL) [243], particularly in the physical and cognitive 
domains [228] compared to non-septic ICU survivors. 
Although the intervention demonstrated greater self-reported physical function at six months than 
the standard care group, this did not result in significant differences in physical function (ACIF) 
short-term. This implied that early physical rehabilitation program could improve physical function 
at a later stage rather than the short time frame of ICU stay likely due to reasons discussed in the 
previous section. Other aspects of quality of life such as bodily pain and mental status did not 
change and will warrant further research.  
Investigation of Supporting Hypotheses 
9.2.3 Effect on Muscle Strength and Physical Exercise Capacity 
Monitoring muscle strength deficits was not a principal objective of this study, however, the 
prevention of ICU-AW is an important outcome of an exercise trial. Without early physical 
rehabilitation, participants who received only standard care presented with an overall mean MRC 
score of less than 48 indicating distinct ICU-AW [215]. A number of studies have quoted MRC 
Score (<48/60) as defining critical illness weakness syndrome [193, 244]. The use of standardised 
voluntary muscle strength measurement using MRC muscle strength assessment is determined to be 
reliable in critically ill patients in a recent systematic review [245]. A further exploration into the 
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respiratory strength of these patients in addition to peripheral strength would provide more 
information on the effect of early exercise during sepsis. The complicated nature of weakness and 
physical deficits in critically ill patients need to be taken into consideration in ongoing researches 
for assessments of physical function and strength. The timing of strength assessment is also critical. 
Measuring physical exercise capacity in ICU patients remains a challenge [246]. As a new reliable 
and responsive outcome measure, the PFIT tool was used to evaluate exercise capacity of patients 
with sepsis syndromes. However, large differences were not noted between both groups of critically 
ill patients. While PFIT is generally applicable for testing in the ICU population, we may have to 
take into consideration the ceiling and floor effects of the test [229] as inherent limitations of the 
tool. This is important to measure exercise capacity in patients with sepsis syndromes who 
demonstrate severe debilitation in exercise tolerance and weakness. This could have been 
particularly true for the assessment of less simple functional movements; ‘Sit to Stand’ and 
‘Marching on the Spot’ component of the PFIT tool which likely posed a challenge for completion 
in patients whose cognition and motor control was affected and presented at a later stage of the  
systemic inflammatory disease.  
9.2.4 Effect on Fat Free Mass 
Acute muscle wasting is directly correlated with systemic inflammation and patients with multi-
organ failure can suffer muscle loss of more than 15% by the end of the first week of ICU 
admission [241]. In this trial, the early administration of exercise as early as day 2 of ICU 
admission avoided immobility in critically ill patients, potentially avoiding atrophy. However, such 
effects were not seen in the assessment of fat free mass at 7 days, consistent with research in this 
area [191].  
The molecular mechanisms responsible for marked skeletal muscle atrophy reported in critically ill 
patients is fundamentally unresolved. A decline in the magnitude of phosphorylation (activation) of 
signalling proteins is thought to control initiation of muscle protein synthesis in critically ill 
patients. This suppression of anabolic signalling is simultaneous with the upregulation of muscle 
protein breakdown pathways (ubiquitin proteasome complex and cathepsin L) at the level of both 
mRNA and protein expression. Interestingly, these catabolic events are matched by a cellular 
programme of anabolic restoration at the transcriptional level indicating a high molecular plasticity 
in the muscle of critically ill patients [247].  
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Currently, exercise studies in intensive care have not explored changes in anabolic and catabolic 
pathways in detail. Preservation of muscle mass should focus on anabolic restoration through early 
physical rehabilitation strategies. Studies utilising EMS however have found [224] preservation of 
muscle mass in long stay ICU patients but in patients with sepsis [191, 192], such preservation is 
not seen. This may have occurred as sepsis is a systemic inflammatory disease and exercise lowers 
overall inflammatory activity, hence exercising one part of the body with the other leg serving as a 
control may not be effective. Electrical stimulation of motor points of major muscle groups in this 
trial of physical rehabilitation in sepsis did not preserve muscle mass. The timing of assessment 
may have been too early.  
Muscle mass preservation may not be best observed using BIS during early exercise as it is not an 
invasive measure. The use of ultrasonography or muscle histology over time maybe more sensitive 
to assess the morphological changes in musculature. Also, the dosage or frequency of exercise 
needs to be assessed in greater detail as we know that EMS is safe and feasible in patients with 
sepsis [248].  
9.2.5 Effect on Hospital Anxiety 
While early physical rehabilitation may boost confidence in patients at risk of debilitation during 
critical illness, it may also contribute to apprehension to move due to the complex support needed 
for the activity, the physiological effects of workload or pain. The ICU experience can result in 
post-traumatic stress, anxiety and depression [249]. Exercise can positively impact the 
pathophysiological processes of anxiety and reduce anxiety in clinical settings [250-252]. Hence, 
the psychological impact of early physical rehabilitation in patients with sepsis was explored by 
measuring anxiety at ICU discharge.  
Possible mechanisms for anxiolytic effects of exercise have been proposed. Exercise increases 
endogenous opioid activity in the central and peripheral nervous system and may induce a euphoric 
state and reduce pain [253]. Exercise can positively influence surrogate measures of adult 
hippocampal neurogenesis such as β-endorphins, vascular endothelial growth factor, brain-derived 
neurotrophic factor, and serotonin, all of which are thought be common pathophysiologic 
mechanisms for anxiety disorders [254]. Exercise of shorter duration (< 30 minutes) also has shown 
larger effect sizes for anxiety reduction than exercise of longer duration (> 31minutes) [255]. This 
may imply on the dosage ideal for ICU physical rehabilitation.  
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In this randomised trial, without early physical rehabilitation, patients reported trends of more 
anxiety and a trend towards a higher score in emotional role (SF-36) although these did not reach 
statistical significance perhaps due to limited power. While there is limited literature on exercise 
and anxiety and depression in ICU patients, the effects of early exercise on these in sepsis remains 
exploratory.  
9.2.6 Effect on Inflammatory Biomarkers  
From this early exercise intervention study specific to patients with septic syndromes, inflammatory 
biomarker modulation has been observed [147-149]. We were only able to determine trends in pro-
inflammatory cytokines notably IL-6, and TNF-α with early ICU exercise during sepsis. Although, 
a significant increase in anti-inflammatory cytokine, IL-10 was found. 
Systemic inflammation affects muscle force and  mass [43] that ultimately affects return to 
functional independence. Persistent elevation of Interleukin-6 (IL-6) infiltrate myocytes with 
inflammatory factors leading to proteolysis, myocyte degeneration, and muscle atrophy [62]. 
Tumour Necrosis factor - (TNF-) overexpression in sepsis is linked to the development of 
cachexia [46] through endothelial dysfunction, leading to myocyte apoptosis, reduction in skeletal 
muscle mass, weakness and myopathy. The prevention of excessive release of pro-inflammatory 
cytokines [46], and activation of proteolytic pathways leading to limitation of free-radical 
generation [72] may inhibit the catabolic skeletal muscle changes in sepsis [47].  
Trials investigating inflammatory biomarker changes due to movement or exercise in critically ill 
patients are few [147, 149]. In this study, minimal trends in levels of IL-6 and TNF- α are reported 
following early ICU exercise during sepsis. It is unknown if more frequent or increased dosage of 
ICU exercise is required to decrease circulating IL-6 and TNF-α concentrations. However, this 
study does support early exercise potentially having an anti-inflammatory effect with changes in 
circulating Interleukin-10 levels.  
Non-specific inflammatory markers such as CRP were not assessed in the i-PERFORM trial 
however, in a recent trial a direct correlation was found between muscle wasting and both 
inflammation (C-reactive protein) [241]. Progressive physical activity can reduce resting CRP 
levels through multiple mechanisms, causing a decrease in cytokine production by adipose tissue, 
skeletal muscles, endothelial and blood mononuclear cells, improved endothelial function and 
insulin sensitivity, and possibly impose an antioxidant effect [256]. However, these were not seen 
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as important as cytokine changes. Investigation of this and other inflammatory markers of sepsis 
such as IL-1α and IL-β may have added further information regarding the anti or pro inflammatory 
effects of acute exercise during sepsis syndromes.  
9.2.7 Monitoring Illness Severity with Plasma Lactate Changes 
This trial is the first to monitor plasma lactate levels as a marker of the immediate effects of 
physical exercise in critically ill patients as opposed to measuring skeletal muscle lactate commonly 
reported in exercise trials. Plasma lactate concentration was used as a safety measure to ensure that 
exercise did not result in clinically significant anaerobic glycolysis. It was also adopted as it was a 
more clinically feasible approach where it can be performed as a bedside measurement by clinical 
staff. As anticipated, a significant decrease of plasma lactate was noted in all septic patients who 
participated in the trial as the majority of patients improved during the admission.  
The introduction of physical rehabilitation mainly comprising on EMS, passive range of motion and 
sitting up in bed in the early stages did not result in an increase in plasma lactate levels. This 
implied that early physical rehabilitation in the critically ill did not worsen illness severity or cause 
anaerobic glycolysis. As elevated lactate is associated with hospital mortality [257] measuring this 
outcome was critical for the assessment of the safety in implementing early physical rehabilitation 
techniques during sepsis. The novelty of examining lactate in relation to the effects of physical 
rehabilitation in the ICU is unique to this study and suggests the use of this measure in the clinical 
setting for monitoring the systemic effects of exercise during critical illness.  
9.2.8 Monitoring Oxidative Stress with Mitochondrial DNA Changes 
Observations through mitochondrial DNA from this trial supports the safety of early ICU exercise. 
Mitochondrial DNA is known to increase in peripheral blood of ICU survivors during the acute 
phase of sepsis. Circulating plasma and mitochondrial DNA levels in patients with severe sepsis 
and septic shock are known to be significantly higher than healthy controls [258]. We found that 
our patients with a range of severity of sepsis present with high baseline mtDNA/nDNA ratios. On 
the other hand, extremely low levels of mtDNA might suggest possible mitochondrial failure or 
copy number depletion with disease progression. However, due to the small sample size of this 
study, these subgroups of survivors and non-survivors were not investigated. 
Different exercise protocols may result in varying levels of ROS production, as oxidative damage 
can be both intensity [259, 260] and duration [261] dependent. During low-intensity or low-duration 
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protocols, antioxidant defences are usually adequate to meet the ROS production, however as 
intensity and duration of exercise increases, these defences are no longer adequate and may result in 
in oxidative damage as seen in healthy athletes [262]. In addition, during systemic inflammation, 
oxidative phosphorylation within the mitochondria is interrupted [123] causing mitochondrial 
dysfunction which exacerbates the production of ROS [263]. It is unknown what optimal level of 
exercise can be safely administered based on duration, intensity and frequency that will maximise 
treatment without inducing oxidative stress in a critically ill septic patient. However, based on 
descriptive results of the pilot study, we can deduce that early physical rehabilitation of 
approximately 30 minutes once to twice a day does not induce oxidative stress in patients with 
critical illness. 
9.2.9 Effect on Muscle Oxygenation and Tissue Microcirculation   
Improved microcirculation has been noted in critically ill patients after electrical muscle stimulation 
[187] with one recent study which explored the effects of varied frequencies of EMS in sepsis 
patients with ICU-AW [188]. However, to date, this trial is the first to evaluate systemic effects of 
progressive targeted physical rehabilitation on tissue oxygenation and microcirculation in patients 
with sepsis. There was a trend of improved reperfusion rate after the early physical rehabilitation 
sessions which mainly comprised of progressive daily sessions of EMS to major muscle groups, 
PROM to all limbs and early mobilisation in bed e.g. sitting up in bed and active range of motion. 
Microvascular alterations are frequent in patients with sepsis and in this study it was evaluated 
using OPS imaging of the sublingual microcirculation and there was a trend of improved 
microcirculation. 
Several physiological mechanisms may have contributed to this systemic effect on tissue 
oxygenation and microcirculation. At the motor contact point of EMS, endothelial reactivity in a 
peripheral skeletal muscle is known to improve [187] likely due to the muscle-derived cytokine; 
Interleukin-6 which can then release anti-inflammatory biomarker; Interleukin-10 [211]. 
Furthermore, EMS also has the capacity to improve vascular reserve microcirculation which is 
directly related to magnitude of capillary recruitment after a muscle contraction which could be due 
to the sympathetic activation and its effects on vascular tone [264]. 
The effects of vasoactive agents such as noradrenaline, adrenaline, dopamine and dobutamine used 
to support systemic haemodynamics of ICU patients, affect the microcirculation. While these drugs 
are used for vasodilation and to recruit microcirculation, they can cause hypotension. Exercise on 
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the other hand, appears to recruit the microcirculation (which has been shown to improve mortality) 
without decreasing blood pressure [265].      
9.2.10 Effect on ICU and Hospital Measures  
While ICU and 90-day mortality were monitored in the study, the actual causes for mortality were 
not assessed. The high 90-day mortality outcome observed in the exercise participants can be the 
result of these treatment limitations, from clinical assessment of futility upon ICU discharge to the 
wards. However, this was statistically non-significant and reasons for DNR were not followed up. 
The overall mortality for this population is reasonable and expected. We did not look at the risk of 
death estimates from the APACHE scoring as the illness severity scores at ICU and length of ICU 
stay of those surviving to six months may not be directly comparable. It is possible that a few more 
survivors in the control group were likely equally unwell as those who exercised but did not die 
perhaps of a different disease recovery pathway.  
9.3 Limitations  
9.3.1 Sample Size 
The trial had a small sample size. With an overall target of 70 participants, 60 patients were found 
eligible but only 50 were able to be recruited. The identification and recruitment of patients with 
sepsis syndromes suitable for inclusion was much slower than anticipated potentially due to the 
inability to contact relatives for consent and changing practice for mechanical ventilation. 
Competing sepsis trials and the exclusion of head injuries, spinal injuries and orthopaedic 
conditions where early rehabilitation programs were limited are other factors. Reasons for this also 
include the lower incidences of sepsis syndromes in the wider casemix of critical illnesses admitted 
into the ICU. A further cause could have been the fact that the use of mechanical ventilation was 
decreasing and the use of non-invasive ventilation was increasing, so a number of potential 
participants were not eligible.  
In response to the slow recruitment, modifications for recruitment were implemented. In order to 
capture these patients early in the ICU admission, the research team attempted to shortlist and 
approach the patients once they were started on antibiotics for proven infection and were recruited 
once the SIRS criteria were fulfilled resulting in a more streamlined consent process. The 
recruitment period was extended by 6 months. Further extensions to the recruitment were not 
possible due to the time constrains of the PhD scholarship.  
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Despite recruitment not meeting the target sample size, there were no dropouts. However, due to its 
sample size, this trial remains exploratory. The main randomised trial with the two pilot trials 
targeted a special population of critical illness with sepsis syndromes and assessed novel 
rehabilitation interventions and provides valuable and interesting pilot and useful descriptive data 
for future trials and insights into the challenges faced with recruiting a specific critically ill 
population.   
Trial Design 
There are clear implications for this clinical trial, as sepsis can confound into multiple pathologies 
and have multiple pathways of recovery. The variable depths of illness severity confounded by the 
effects of aging during critical illness makes critical care management multi-focal and impacts on 
the trial design and outcomes. This is a limitation of the design of the study as would be the nature 
of an ICU trial involving critically ill patients as we are not dealing with clinical presentations of a 
single pathology with a specific pathway of recovery. 
9.3.2 Outcome Measures 
Heath-related Quality of Life and Physical Function 
Some bias may have been unavoidable in the overall analysis of the HrQOL outcomes due to the 
small increase in death in the intervention group. As in many studies of the critically ill, there was a 
lack of baseline data on physical function, muscle strength and exercise capacity. 
Fat Free Mass 
Bioimpedance spectroscopy was used for measuring fat free mass. To improve its accuracy and 
reliability in measurements, all precautions and contraindications for the use of this equipment were 
followed closely. Muscle measurement with the use of the ultrasonography or the needle biopsy 
could have been more accurate or have provided a histological impression of the cellular muscle 
changes. These techniques were however not clinically acceptable in the critically ill nor affordable 
for this study.   
Cytokines  
The ideal assay tools for cytokine assessment would have been the Millipore Assay Kits, however 
these were not affordable. Versa Map Kits of similar accuracy were used for the analysis of 
Interleukin-6, Interleukin-10 and Tumour Necrosis Factor-α. In order to ensure reliability, 
triplicates of analysis were performed for each cytokine.  
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Mitochondrial DNA  
The resources required for the assessment of mitochondrial DNA were quite specialised and the 
establishment of a team of scientists trained in extracting mitochondrial DNA from blood samples 
and analysing copy numbers with real-time PCR took several months. While these methods were 
performed following accurate protocols aiming to elicit reliable results, there were delays due to 
bedding down the analysis.   
Microcirculation 
Use of the microcirculation probe requires skill for accurate and representative images in a 
mechanically ventilated patient. The images obtained were assessed independently using 
appropriate software and were blinded to the participants. 
Exercise Intervention 
Passive range of motion exercises to the limbs and EMS were the principal contributions to the 
early physical rehabilitation administered. Out of bed mobilisation and ambulation were limited due 
to severity of illness, invasive equipment and inotropic dependence although measures of safety 
through arterial blood pressure, heart rate, respiratory rate and oxygen saturation were monitored 
during all sessions of exercise that was safe and acceptable in the ICU. This could have resulted in 
attenuation of the treatment effects on physical function, cardiovascular and exercise capacity at 
ICU discharge. A more intensive physical rehabilitation program may have been required.  
9.3.3 Prevention of Limitations 
Limitations identified in this trial can be overcome in future clinical trials by: 
 Obtaining a larger sample size with a multi-centred trial. 
 Investigating effects of interruption of sedation for more active forms of early physical 
rehabilitation during ICU admission. 
9.4 Future Research Directions 
Recommendations for future clinical research based on this clinical research include: 
 Larger multi-centred randomised controlled trials measuring the effect of early ICU 
physical rehabilitation in patients with sepsis syndromes. 
 Large clinical trials powered to analyse subgroups of different acuity of sepsis and 
mobilisation status to examine the effects of early physical rehabilitation strategies on 
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oxidative stress, plasma lactate and microcirculation in different severity and 
immobilisation categories of septic patients in the ICU. 
 Clinical trials to examine additional or other oxidative stress biomarkers related to physical 
exercise during critical illness such as malondialdehyde, superoxide dismutase, glutathione 
peroxidase, glutathione reductase and ascorbic acid. 
9.5 Clinical Significance and Recommendations 
Knowledge of information that surfaced in the three original studies of this research thesis provide 
practice changing information to improve clinical practice in the arena of physical therapy for 
critically ill patients. While important effects on self-reported physical function, anti-inflammatory 
effects and the safety of ICU exercise were established, it is important not to overstate the trends of 
pro-inflammatory biomarkers, hospital anxiety and microcirculation. 
 
Electrical stimulation techniques of major muscles and passive range of motion of limbs are well 
tolerated for early physical rehabilitation in patients with sepsis syndromes. A targeted early ICU 
physical rehabilitation program was found not to cause any harm and was tolerated during critical 
illness with preservation of the quality of life upon discharge from the hospital and showed trends in 
emotional role and the reduction of anxiety at ICU discharge. These findings support the 
administration of early physical rehabilitation in the intensive care unit. 
9.6 Conclusion 
In conclusion, there is evidence of small benefits for early physical rehabilitation during sepsis in 
intensive care. Some positive findings and important trends have been found in this novel 
randomised controlled trial. Early physical rehabilitation in intensive care improves long-term self-
reported physical function in quality of life of sepsis survivors. Although no improvements in 
physical function were noted at ICU discharge, physical rehabilitation was well tolerated and 
caused no harm to patients with sepsis syndromes when administered early in intensive care. 
Preliminary changes seen in inflammatory biomarkers and microcirculation suggest that early 
physical rehabilitation in intensive care can attenuate detrimental mechanisms that occur in sepsis 
syndromes. Associations of physical rehabilitation and oxidative stress will require further 
exploration. Further research is required to elucidate all underlying physiological mechanisms. 
Early exercise in intensive care appears to play a subtle but crucial role for the prevention of 
complications to improve physical, physiological and psychological outcomes in critical illness.   
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Appendix A: Consent Form for Participation in Research Trial 
 
 
 
Research Study 
 
Improving Outcomes in Critical Illness: Early Rehabilitation 
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i-PERFORM Trial 
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Principal Investigators Ms Geetha Kayambu  
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Assoc Prof Robert Boots 
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Physiological and Functional Outcomes following  
Early Rehabilitation 
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Division of Critical Care 
Department of Intensive Care Medicine 
 Substitute Decision Maker Information and Consent Form, RBWH 
Version 8, 27th August 2010 250 
 
SUBSTITUTE DECISION MAKER CONSENT FORM 
 
Introduction 
Acting on behalf of the patient, we kindly ask that you read this information sheet about this 
clinical trial. If you are satisfied that it would be in the interest of the patient to participate in 
this trial, please provide your consent on the form provided. We ask this consent from you, as 
the patient is unable to make this decision for him/herself at this time as they are sedated 
and ventilated. Should you have any questions about this trial, or the consent process, please 
do not hesitate to talk to our medical staff or the research co-ordinator. 
 
 
The patient is invited to participate in a study as they are in intensive care. 
Two hundred and fifty two patients will be recruited to participate in this trial at the Royal 
Brisbane and WoŵeŶ͛s Hospital. 
 
 
From this research, the investigators wish to determine which type of exercise in intensive care 
results in less loss of muscle, stronger muscles and earlier discharge from intensive care and 
the hospital. 
 
 
Purpose of Study 
The purpose of this study is to investigate the optimal timing and type of exercise which will 
result in less loss of muscle, stronger muscles and a shortened stay in ICU. 
 
 
Background Information 
The patient is being asked to take part in this study because they have been in intensive care for 
longer than 48 hours. Previous research has shown that a stay in ICU of this period can result in 
weak breathing muscles, loss of overall muscle mass and anxiety. This study aims to see which 
level and type of exercise is best for preventing these problems. 
 
 
Study Design and Procedures 
This trial is being run by the Intensive Care Unit (ICU) in conjunction with the University of 
Queensland. 
 
Whilst they are in intensive care, the patients will receive chest physiotherapy. This is a routine 
procedure and would be done whether or not they are enrolled in the trial. 
 
They will be randomly selected into one of the 2 groups, both of whom will receive exercise 
treatment in the ICU. In one group, earlier rehabilitation will be provided while in the other usual 
are will be received. 
 
They will be sat out in a special chair or a standing table as soon as they have a stable blood 
pressure and heart rate. This will help in their ability to sit and stand when they are weak. They 
may have more intense exercise earlier e.g. a machine which moves their legs, a trainer they can 
do arm exercises on. These are fairly new to ICU. We will make sure that they are well enough to 
do these procedures. Other patients will have a lower level of exercise but will still be sat out of 
bed and given some gentle exercises by the nurses. As soon as they are sent to the ward and leave 
ICU, they will continue the rehabilitation program as appropriate.  
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During their stay in ICU they will undergo the following measurements;  
 
 Answer two short questionnaires to give the investigators information on their quality of 
life prior to this admission. We would ask about 1] anxiety and depression 2] ability to sit, 
stand and move about. This will take 20 minutes. If the patient is still sedated we may need 
to ask you these questions.   
 A measurement of the amount of fat vs muscle tissue in the body using a machine which 
involves placing small electrodes like ECG dots on the arm and leg. This painless test takes 
7 seconds.  
 A recording of the changes in heart rate or blood pressure that occur during the exercise 
periods. This acts as a safety measure. This is taken every 10 seconds.  
 A measurement of the levels of substances or markers in the blood before, after and sixty 
minutes after exercise on two subsequent days. These markers are components in the 
blood used to assess the effects of exercise. This will not be painful as the blood comes out 
through a tube placed in their artery as part of intensive care management. This test only 
takes 5 minutes.  
 A measurement of the muscle oxygenation and blood circulation using external probes and 
does not breech the skin or tissues. This will not be painful and will only take about 10 
minutes. 
 
At the end of the stay in ICU they will be asked to; 
 
 Answer 2 short questionnaires on the anxiety and depression they feel at the time and a 
quality of life questionnaire. This will take 20 minutes. 
 We will perform a test to evaluate their improvement in muscle strength. This test will take 
10 minutes and is painless. 
 We will record the time they were on a breathing machine, their length of stay in the 
ICU and hospital, and if they needed to go back to ICU. 
 
 
At 6 months following discharge, we would telephone the patient to; 
 
 Answer a short questionnaire on quality of life improvements since your discharge. This 
will only take 5 minutes. 
 
 
No further tests, procedures or information will be required after the completion of the 
study. Neither you nor your family will have any cost incurred. 
 
 
Possible Benefits 
There may be no immediate benefit to the patient from this study, however some patients 
may be stronger and have more muscle mass maintained as a result of the study. 
Participation in this research study does not allow you or the patient to receive any 
compensation, or other financial benefit. The results from this study are anticipated to 
benefit future patients. You or the patient may receive information about their health from 
any tests performed in this study. 
 
Storage of Samples 
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The  blood  samples  will  be  kept  in  a  secure  location  and  only  accessed  by scientific staff 
associated with this study. Blood samples will be sent to UQ Researchers for biomarker 
analysis. All of the samples collected throughout this study will be disposed of appropriately after 
analysis. All other patient information data will be filed away for 15 years safely under lock and 
key. Individual patient data will be coded, re-identifiable and only accessible to the main 
investigator of the study. No patient information will be identifiable from the information. 
 
Risks/ Discomforts/ Possible side Effects 
There may be risks to the patient if they participate in this study, but they are minimal. Risks 
are unexpected events that may occur during the time of the treatment. Exercise and 
mobilisation is normally done as a standard treatment in the ICU. The exercises may result in 
too high or low changes in blood pressure or heart rate; however this is unlikely as we will be 
very careful when we introduce the special exercises. The patients will be exercised under a safety 
protocol to prevent from such events occurring and we will continually monitor heart rate and 
blood pressure. For this study, a daily additional blood volume of 16ml (in addition to other 
medical tests) will be drawn during the first week of their recruitment. This will constitute to a 
total additional blood volume of 96ml in the first week. Depending on their length of stay in the 
ICU; an additional 40ml will be drawn weekly till discharge. The total amount of blood 
volume taken for the purpose of this study will comply with guidelines for blood taking and will 
be spread throughout their stay in the ICU and therefore does not pose major risks such as 
extreme changes in blood volume or pressure. In the case of such risks, blood sampling will be 
ceased. All patients are under close medical supervision in the ICU and these risks are small and 
not threatening. 
 
Participation in the Study 
Participation in this trial is purely voluntary. The patient͛s maximum time of involvement in 
this study will follow the total time of his/her length of stay in the ICU. You may refuse for the 
patient to take part in the study or you may stop their participation in the study at any time, 
without penalty or loss of benefits to which they are otherwise entitled. Consent to participate 
in the trial does not exclude the patient from their rights under the law.  
 
Questions 
You are encouraged to ask questions about the study, your rights and the patient͛s rights as 
a participant. If you have any questions, now or later, regarding the nature of this study or your 
patient͛s rights or if you choose to withdraw from the study, please contact Ms Geetha 
Kayambu (Chief Investigator) or Dr Jennifer Paratz (Primary Investigator) or her associates at 
the Royal Brisbane and WoŵeŶ’s Hospital, Department of Intensive Care Medicine, QLD 4029 or 
telephone (07) 3636 1980 or (07) 33465193 who will be happy to answer any concerns. This 
study has been reviewed and approved by the Royal Brisbane and Women͛s Hospital and 
Health Service District Human Research Ethics Committee and the Queensland Civil and 
Administrative Tribunal. Should you wish to discuss the study with someone not directly involved, 
in particular in relation to matters concerning policies, information about the conduct of the 
study or your rights as a participant, or should you wish to make an independent complaint, 
you can contact the secretary or chairperson, Human Research Ethics Committee, Royal Brisbane 
and Women͛s Hospital, Herston, QLD, 4029 or telephone (07) 36365490. 
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Confidentiality and Privacy 
Information obtained from this research study will only be used by the investigating team. The 
identity of all patients who participate in this trial will be kept confidential. No patient͛s name or 
personal information will be identified in any of the data produced. The results of the project 
will be presented at appropriate meetings, conferences and publications. All information from 
this study will be stored in a locked office accessed only by the research co-ordinator associated 
with the trial. All records will be kept for 15 years as per the guidelines for clinical research. No 
information will be disclosed or made publicly available to anybody unless the law requires this 
disclosure. If at any time you wish to access the information collected during this trial please 
feel free to contact Ms Geetha Kayambu at (07) 33465913 or Dr Jennifer Paratz at (07) 3636 
1980 . 
 
 
Signatures 
For the patient to be entered into the study, you must sign and date the signature page; 
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Royal Brisbane and Women’s Hospital Division of Critical 
Care 
Department of Intensive Care Medicine 
 
 
Substitute Decision Maker Consent Signature Form 
 
Declaration of Informed Consent 
I understand the participation in this clinical research is voluntary. I have fully discussed and 
understood the purpose and procedures of this study and have fully reviewed and understood 
the contents of this consent. I have been invited to ask questions about this study and all my 
questions have been answered. 
 
I, the undersigned, 
 
 
 
[Print full name] 
 
hereby declare that, 
 
 
 
I agree that this patient 
 
 
 
[Print patient͛s full name] 
 
(hereinafter referred to as the "patient") can be included in this clinical trial as detailed in this 
document. 
 
 
 
I was informed by of the following: 
[Doctor's name] 
 
a. Ms. Geetha Kayambu received approval from the Royal Brisbane and Women͛s 
Hospital and Health Service District Human Research Ethics Committee and the 
Queensland Civil and Administrative Tribunal to conduct the clinical trial in humans, 
in accordance with the Declaration of Helsinki and the latest statement by the National 
Health and Medical Research Council on Human Experiments and on Scientific Practice. 
b. I am free to withhold my consent to the patieŶt͛s participation in the trial, and I am free 
to terminate the patient͛s participation in the trial at any time. All this without violating 
the patients' right to receive the standard treatment. 
c. The patient͛s identity will be held in confidence. 
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I have received a copy of this information sheet and consent form to keep; 
Relative/Substitute Decision Maker Information and Consent Form Version 6, 1st August, 2010. 
 
My signature on behalf of the patient indicates that I have read and understood the above 
information, talked about the trial with the principal investigator and her staff and have fully 
reviewed and understood the contents of this consent and decided to give my consent to the 
participation of the patient based upon the given information. I have been invited to ask 
questions about this study and all my questions have been answered. I certify that I am the 
legally authorised representative of the participant named above and that I am authorised to 
sign this consent to his/her participation in the medical research study described above. I am 
also authorised to sign this authorisation to release medical records and health information as 
described above. 
 
 
[Name of Legally Authorised Representative] 
 
Relationship to the patient    
 
 
 
  
                       Legally Authorised Representative Signature                                  Date 
  
  _   _    
           [Witness name]       Witness Signature Date 
 
For the Investigator or Designee: 
I certify that I have reviewed the contents of this consent form with the Substitute Decision 
Maker, who signed this consent above, who in my opinion understood the explanation. I 
have explained the known side effects and possible benefits of the research. 
 
I have ensured that the Substitute Decision Maker whose signature is shown above is fully 
informed in accordance with applicable regulations, and that the Human Research Ethics 
Committee will be advised of any adverse reactions that develop from this study. 
 
 
 
[Name of Investigator or Designee] 
 
 
 
                        Investigator or Designee Signature                                     Date 
 
 
 
 
 
 
 
 
 
 
 256 
 
Appendix B: Exercise Prescription Guide 
 
EXERCISE PRESCRIPTION GUIDE FOR PHYSIOTHERAPIST 
This chart serves only as a guide for patient exercise intervention strategies depending on the level of alertness and medical factors that affect 
the progression of exercise in each individual 
 
 
Ramsay 
Sedation 
Scale 
Stages of 
exercise  
progression 
Conditions  Type of Intervention  Recommended Exercise 
Prescription  
6-4 Stage 1 Sedated Passive Range of Motion with stretch reflex to upper and lower limbs  
Electrical Muscle Stimulation to major muscle groups  
30 Mins /day 
30 Mins /day 
3-2 Stage 2 Inotropic 
Dependence  
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting up in Bed with assistance as tolerated 
Sitting on Edge of Bed  
 
10 Mins x 2 /day 
30 Mins /day 
30 Mins x 2 /day 
10 Mins x 2 /day 
 
2 Stage 3 Weight  
Bearing  
Muscle 
Strength  
Grade < 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical Muscle Stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed with assistance 
Lower Limb Ergometry 
Tilt Table Therapy  
 
10 Mins x 2 /day 
30 Mins /day 
10 Mins x 2 /day 
60 Mins x 2 /day 
15 Mins x 2 /day 
30 Mins /day 
2 Stage 4 Weight  
Bearing  
Muscle 
Strength  
Grade > 3 
Active Range of Motion / Lightly resisted with upper and lower limb  
Electrical muscle stimulation to major muscle groups 
Sitting On Edge of Bed 
Sitting Out of Bed  
Upper Limb Ergometry ( low level resistance ) 
Lower Limb Ergometry  
Ambulation with assistive device and therapist 
 
10 Mins x 2 /day 
30 Mins /day 
10 Mins /day 
30 Mins /day 
15 Mins /day 
15 Mins x 2 /day 
30 Mins x 2 /day 
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Appendix C: Physical Function Assessment Form 
                              ACUTE CARE INDEX OF FUNCTION 
RESEARCH SUBJECT IDENTIFICATION CODE  
DATE OF ASSESSMENT  
NAME OF ASSESSOR  
ACIF Test                 BASELINE             DISCHARGE                               
MENTAL STATUS        ( MS ) Yes No MS score 
 
[_____] /   6 
 
1. Verbal commands 
2. Commands 
3. Learning 
4. Safety Awareness  
2 
1 
2 
1 
0 
0 
0 
0 
BED MOBILITY             ( BM ) Unable Dependent Independent BM score 
 
[_____] /  40 
 
5. Roll supine to right 
6. Roll supine to left 
7. Supine to sit 
8. Sit to supine 
0 
0 
0 
0 
4 
4 
4 
4 
10 
10 
10 
10 
TRANSFERS                    ( T ) Unable Dependent Independent T score 
 
 
[_____] /  60 
9.   Bed to chair 
10. Chair to bed 
11. Sit to stand 
12. Sitting balance 
14. Standing balance 
0 
0 
0 
0 
0 
5 
5 
5 
5 
5 
10 
10 
10 
10 
10 
MOBILITY                        ( M ) Unable Dependent Independent M score 
 
[_____] /  70 
 
15. Gait with device 
16. Gait without device 
17. Ascend stairs 
18. Descend stairs 
0 
0 
0 
0 
14 
21 
7 
7 
20 
30 
10 
10 
 
Unable:    
Patient cannot physically assist to perform the activity 
 
Dependent:   
Patient assists to perform the activity but requires physical or verbal assist to complete the activity 
 
Independent:   
Patient performs the activity meeting all stated criteria without verbal or physical assistance] 
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Comments  
*Please refer to the back for Instructions for administration of test 
 
 
ACIF INSTRUCTION SHEET 
 
Mental status evaluation 
 
Guidelines 
 
 Yes = Presence of a defined behaviour 
 No   = Absence of a defined behaviour 
 Verbal Commands: Following verbal commands = Ability to follow commands 
 Ability to learn: Initiation of sequence of steps for simple motor task within 24hrs = Yes 
 Safety awareness: Verbal or physical supervision for patient safety because impaired judgement = No 
 
 
 
1. Ability to follow verbal commands  
 Instruct the patient to perform one of the following simple motor tasks  
a. Close your eyes 
b. Open your eyes 
c. Lift your arm 
d. Lift your leg 
 Task should ďe withiŶ patieŶt͛s Đapaďilities. 
 Command may be given no more than 2 times 
2. Ability to follow commands with visual cueing 
 Instruct the patient to perform on of the above tasks while you simultaneously  
perform the motor task. 
 Command may be given to a maximum of 3 times 
3. Ability to learn 
 Inform the patient that he will be given a task and will be expected to perform  
the task later. 
 Instruct a sequence of steps of motor task to the patient 
 Within 24hrs, ask the patient to perform the motor task without assistance.  
       4.     Safety Awareness 
 Patient requires supervision in performing any functional task for safety to be ensure 
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Appendix D: Fat Free Mass Assessment Form 
 
BIOELECTRICAL IMPEDANCE ANALYSIS 
RESEARCH SUBJECT IDENTIFICATION CODE  
DATE OF ASSESSMENT  
NAME OF ASSESSOR  
Demographics            BASELINE        WEEK ____    
Age of Subject  
Gender of Subject (M/F)  
Weight of Subject (kg)  
Height of Subject (cm)  
BIA Test Calibration Check        
 
BIA Data Record ( Wrist and Foot ) 
  Data 1 
Total Body weight TBW L % 
Extracellular Fluid ECF L % 
Intracellular Fluid ICF L % 
Free Fat Mass FFM kg % 
Fat Mass FM kg % 
Body Mass Index BMI   
Data 2 
Total Body weight TBW L % 
Extracellular Fluid ECF L % 
Intracellular Fluid ICF L % 
Free Fat Mass FFM kg % 
Fat Mass FM kg % 
Body Mass Index BMI   
Data 3 
Total Body weight TBW L % 
Extracellular Fluid ECF L % 
Intracellular Fluid ICF L % 
Free Fat Mass FFM kg % 
Fat Mass FM kg % 
Body Mass Index BMI   
AVERAGE VALUES 
Total Body weight TBW L % 
Extracellular Fluid ECF L % 
Intracellular Fluid ICF L % 
Free Fat Mass FFM kg % 
Fat Mass FM kg % 
Body Mass Index BMI   
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Appendix E: Muscle Strength Assessment Form 
MEDICAL RESEARCH COUNCIL MUSCLE SCORE 
  MRC MUSCLE TEST 
R/L Muscle ICU DAY/DATE AT DISCHARGE 
L Shoulder 
Abduction 
  
L Elbow 
Flexion 
  
L Wrist 
Extension 
  
R Shoulder 
Abduction 
  
R Elbow 
Flexion 
  
R Wrist 
Extension 
  
L Hip 
Flexion 
  
L Knee 
Flexion 
  
L Ankle 
DorsiFlexion 
  
R Hip 
Flexion 
  
R Knee 
Flexion 
  
R Ankle 
DorsiFlexion 
  
 
TOTAL 
  
 Muscle Grading 
 
1. No Movement 
2. Palpable contraction, no visible movement 
3. Movement but only with gravity eliminated 
4. Movement against gravity 
5. Movement against resistance but weaker than normal 
6. Normal power 
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Appendix F:  Exercise Capacity Assessment Form 
PHYSICAL FUNCTION ICU TEST 
RESEARCH SUBJECT IDENTIFICATION CODE  
DATE OF ASSESSMENT  
NAME OF ASSESSOR  
PFIT TEST                                               DISCHARGE    
PFIT RECORDING SHEET 
1. Heart rate  
    (beats per minute) 
Pre test Post test 
 
 
 
 
 2. SpO2 (%) 
 
Pre test Post test 
 
 
 
3. Sit to stand 
    Assistance (circle) 
 
0           1             2 
 
4. Marching on the spot 
4.1 RPE (pre) 
 
4.2 Able? (circle) 
 
4.3 Steps (number) 
 
4.4 Time (seconds) 
 
4.5. RPE (post) 
 
 
Yes               No 
 
 
 
 
 
 
 
5. Strength 
 
5.1 Shoulder flexion 
 
5.2 Knee extension 
 
Left Right 
 
 
 
 
 
 
6. Shoulder flexion 
6.1 RPE (pre) 
 
6.2 Reps (number) 
 
6.3 Seconds 
 
6.4 RPE (post) 
 
 
 
 
 
 
 
 
 
 
 
 
Reason for test non-completion: 
Patient deceased   Patient lost to follow-up                           Other  
Patient refused   Patient confusion             
_________________________
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PFIT INSTRUCTION SHEET 
 
All patients must undergo a practice sit to stand BEFORE being tested with the PFIT. The 
following procedure should be followed for both initial and repeat PFIT testing. 
 
Preparation 
 PATSLIDE patient OOB. 
 Sit patient upright in the chair. 
 The height of the recliner should be as low as able. 
 The patient should be assisted as required to move into a position on the edge of the 
chair that they will be able to attempt the standing position from. 
 Patients should be informed about what the test consists of, and read the standardised 
instructions for the marching on the spot component of the test prior to commencement 
of the test. 
 
Sit to stand component 
 The first component of the PFIT (assistance required to stand) should be recorded first. 
 Ask the patient to stand up.  No assistance should be given unless the patient is unable to 
transfer into the standing position. One person should then assist, and if this is 
insufficient, the second person should then assist to transfer into the standing position. 
 The level of assistance required to transfer from sitting to standing should be recorded as 
0, 1 or 2 people. 
 If the patient is unable to transfer into the standing position with the assistance of 2 
people their level of assistance should be recorded as 5. 
 
Marching on the spot component 
 Once the patient has been assisted into the standing position, the marching on the spot 
component of the PFIT should be recorded as soon as possible. 
 IŶstruĐt the patieŶt that wheŶ Ǉou tell theŵ to ͚“tart͛, Ǉou waŶt theŵ to ŵarĐh oŶ the 
spot as long as they possibly can as you discussed prior to standing. 
 Instruct the patieŶt to ͚“tart͛ ŵarĐhiŶg oŶ the spot aŶd reĐord the Ŷuŵďer of steps takeŶ 
;1 step = wheŶ the patieŶt͛s foot ;left or rightͿ ĐoŶtaĐts the grouŶdͿ aŶd the tiŵe takeŶ 
(in seconds). 
 Give standardised encouragement every 10 seconds. 
 Once the patient stops for longer than two seconds (i.e. no new steps in two seconds), 
the test should be ceased and the patient assisted (as required) to return to the sitting 
position in the chair. 
 ‘eĐord the patieŶt͛s ‘PE at ĐoŵpletioŶ of the MO“ ĐoŵpoŶeŶt. 
 If the patient is unable to march on the spot, the number of steps taken and time taken 
should be recorded as 0. 
 
Upper limb and lower limb strength component 
 Once the patient has returned to the sitting position, bilateral shoulder flexion and 
bilateral knee extension strength testing should be performed once the patient has had 
ample time to rest. 
 If the patient is unable to sit out of bed, muscle strength testing should be performed 
with the patient in supine.  For shoulder flexion strength testing, the patient must be sat 
as upright as possible. 
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 Muscle strength should be graded according to the Oxford scale: 
0 = no muscle contraction 
1 = flicker of muscle contraction 
2 = active movement range across gravity 
3 = active movement through range against gravity 
4 = active movement through range against some resistance 
5 = active movement through range against full resistance 
 
 Bilateral shoulder flexion should be performed first. Free active movement should be 
assisted first, and then resistance applied through range, resisted at the elbow where 
resistance is required.  Muscle strength should be recorded for each arm. 
 Knee extension should be resisted at the ankle where resistance is required for 
assessment.  Muscle strength should be recorded for each leg.  If being performed in 
supine, inner range knee extension will be assessed by quads over fulcrum with 
resistance applied at the ankle as required. 
 
Upper limb endurance component 
 Finally, the bilateral upper limb endurance component should be tested. 
 In the sitting position, the patient should start with their hands resting on their knees. 
 Patients should be informed that once instructed to start, they should raise both hands 
above their head as high as they can. 
 Patients should be instructed with standardised instructions (upper limb endurance 
component). 
 IŶstruĐt the patieŶt to ͚“tart͛ aŶd reĐord the Ŷuŵďer of tiŵes theǇ perforŵ ďilateral 
shoulder flexion (1 repetition = bilateral shoulder flexion > 90 degrees) and the time they 
exercise for (in seconds).  Where patients are unable to perform bilateral shoulder flexion 
(i.e. due to lines, fractures, etc), unilateral shoulder flexion should be recorded. 
 Give standardised encouragement every 10 seconds  
 Once the patient stops for longer than two seconds (i.e. no new repetitions in two 
seconds) or shoulder flexion is below the required 90 degrees elevation, the test should 
be ceased. 
 If the patient is unable to complete the upper limb endurance component shoulder 
flexion repetitions and time should be recorded as 0. 
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Standardised instructions for PFIT (marching on spot component) 
͞OŶĐe Ǉou are iŶ the staŶdiŶg positioŶ, we will ask Ǉou to ŵarĐh oŶ the spot.  We would like Ǉou 
to march on the spot for as long as you can.  We are going to record how long you walk for and 
how many steps you do.  This test is designed to record your maximum exercise ability, so it is very 
iŵportaŶt that Ǉou ŵarĐh oŶ the spot for as loŶg as Ǉou possiďlǇ ĐaŶ.͟ 
 
If applicable (i.e. retest), then: 
͞Last tiŵe Ǉou perforŵed the test, Ǉou ŵarĐhed for … aŶd did …. steps." 
 
Give standardised encouragement every 10 seconds: 
͞Keep goiŶg for as loŶg as Ǉou ĐaŶ,͟ ͞You͛re doiŶg well͟, ͞Well doŶe͟ 
 
 
Standardised instructions for PFIT (upper limb endurance component) 
͞We would like Ǉou to lift Ǉour haŶds up and down above your head for as long as you can.  We 
are going to record how long you can do this for and how many repetitions that you do.  This test 
is designed to record your maximum exercise ability, so it is very important that you lift your arms 
up aŶd dowŶ for as loŶg as Ǉou possiďlǇ ĐaŶ.͟ 
 
If applicable (i.e. retest), then: 
͞Last tiŵe Ǉou perforŵed the test, Ǉou eǆerĐised for …. aŶd did …. repetitioŶs.͟ 
 
Give standardised encouragement every 10 seconds: 
͞Keep goiŶg for as loŶg as Ǉou ĐaŶ͟, ͞You͛re doiŶg well͟, ͞Well doŶe͟ 
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Appendix G: Hospital Anxiety Assessment Form 
 HOSPITAL ANXIETY SCALE 
RESEARCH SUBJECT IDENTIFICATION CODE  
DATE OF ASSESSMENT  
NAME OF ASSESSOR  
HAS Test                            DISCHARGE    
Please read each item below and tick the box that comes closest to how you have been feeling 
this past week.      
A1 I feel tense or 'wound up'  Tick Score 
  Most of the time  3 
  A lot of the time  2 
  From time to time, occasionally  1 
  Not at all  0 
  A2 I get a sort of frightened feeling as if something awful is about to happen  Tick Score 
  Very definitely and quite badly  3 
  Yes, but not too badly  2 
  A little, but it doesn't worry me  1 
  Not at all  0 
  A3 Worrying thoughts go through my mind  Tick Score 
  A great deal of the time  3 
  A lot of the time  2 
  From time to time, but not too often  1 
  Only occasionally  0 
 A4 I can sit at ease and feel relaxed  Tick Score 
  Definitely  0 
  Usually  1 
  Not Often  2 
  Not at all  3 
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  A5 I get a sort of frightened feeling like 'butterflies' in the stomach  Tick Score 
  Not at all  0 
  Occasionally  1 
  Quite Often  2 
  Very Often  3 
 A6 I feel restless as I have to be on the move  Tick Score 
  Very much indeed  3 
  Quite a lot  2 
  Not very much  1 
  Not at all  0 
 A7 I get sudden feelings of panic  Tick Score 
  Very often indeed  3 
  Quite often  2 
  Not very often  1 
  Not at all  0 
  
 
 
HADS SCORING SHEET  
Scoring (Add the As = Anxiety).   
The ranges below will mark the level of Anxiety 
Enter Total 
Score Below 
Tick the range below appropriate according to total score calculated 
 
  
0-7 = N   
8-10 = BABN   
11-21 = ABN   
 
 
 
*Adapted and modified for the purpose of i-PERFORM Trial  
Zigmond and Snaith (1983) 
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Appendix H: Health Related Quality of Life Assessment Form 
 
SF-36 MEDICAL SHORT FORM QUESTIONNAIRE 
RESEARCH SUBJECT IDENTIFICATION CODE  
DATE OF ASSESSMENT  
NAME OF ASSESSOR  
 
 Please answer the 36 questions of the Health Survey completely, honestly, and without    
 interruptions. 
 
GENERAL HEALTH 
GH1  In general, would you say your 
health is 
Excellent Very Good 
 
Good 
 
Fair 
 
 Poor
HEALTH TRANSITION 
HT1  Compared to one year ago, how would you rate your health in general now? 
 Much better now than one year ago 
 Somewhat better now than one year ago 
 About the same as one year ago 
 Somewhat worse now than one year ago 
 Much worse than one year ago
PHYSICAL FUNCTIONING 
The following questions are about activities you might do during a typical day. Does YOUR 
HEALTH NOW LIMIT YOU in these activities? If so, how much? 
PF1  VIGOROUS activities, such as running, lifting heavy objects, participating in 
strenuous sports 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF2  MODERATE activities, such as moving a table, pushing a vacuum cleaner, bowling, 
or playing golf 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF3  Lifting or carrying groceries 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF4  Climbing SEVERAL flights of stairs 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF5  Climbing ONE flight of stairs 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF6  Bending, kneeling, or stooping 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF7  Walking MORE THAN a mile 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF8  Walking SEVERAL blocks 
Yes, limited a lot Yes, limited a little No, not limited at all 
PF9  Walking ONE block Yes, limited a lot           Yes, limited a little        No, not limited at all 
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PF10  Bathing or dressing yourself 
Yes, limited a lot Yes, limited a little No, not limited at all 
ROLE PHYSICAL 
During THE PAST 4 WEEKS, have you had any of the following problems with your work 
(including your work outside the home and housework) or other regular daily activities AS A 
RESULT OF YOUR PHYSICAL HEALTH? 
RP1  Cut down the amount of time you spent on work or other activities Yes No 
RP2  Accomplished less than you would like Yes No 
RP3  Were limited in the kind of work or other activities Yes No 
RP4  Had difficulty performing the work or other activities 
(for example, it took extra effort) 
Yes No 
ROLE EMOTIONAL 
During the PAST 4 WEEKS, have you had any of the following problems with your work or 
other regular daily activities AS A RESULT OF ANY EMOTIONAL PROBLEMS (such as feeling 
depressed or anxious)? 
RE1  Cut down the amount of time you spent on work or other activities Yes No 
RE2  Accomplished less than you would like Yes No 
RE3  Didn't do work or other activities as carefully as usual Yes  No 
SOCIAL FUNCTIONING 
SF1  During the PAST 4 WEEKS, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, 
friends, neighbours or groups? 
 Not at all Slightly Moderately Quite a bit Extremely
BODILY PAIN 
BP1  How much bodily pain have you had during the PAST 4 WEEKS? None Very Mild Mild Moderate Severe Very Severe 
BP2  During the PAST 4 WEEKS, how much did PAIN interfere with your normal work 
(including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
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VITALITY and MENTAL HEALTH 
For each question, please give the answer that comes closest to the way you have been 
feeling. How much of the time during the PAST 4 WEEKS; 
VT1  Did you feel full of life? 
 All of the time Most of the time 
 Some of the time A little bit of the time
 
 A good bit of the time 
 None of the time
MH1  Have you been a very nervous person? 
 All of the time Most of the time 
 Some of the time A little bit of the time
 
 A good bit of the time 
 None of the time
MH2  Have you felt so down in the dumps that nothing could cheer you up? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
MH3  Have you felt calm and peaceful? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
VT2  Did you have a lot of energy? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
MH4  Have you felt downhearted and blue? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
VT3  Did you feel worn out? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
MH5  Have you been a happy person? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
VT4  Did you feel tired? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
SOCIAL FUNCTIONING 
SF2  During the PAST 4 WEEKS, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)? 
 All of the time Most of the time A good bit of the time 
 Some of the time A little bit of the time None of the time
GENERAL HEALTH 
GH2  I seem to get sick a little easier than other people Definitely true   Mostly true  Don't know Mostly false   Definitely false 
GH3  I am as healthy as anybody I know Definitely true   Mostly true  Don't know Mostly false   Definitely false 
GH4  I expect my health to get worse Definitely true   Mostly true  Don't know Mostly false   Definitely false 
GH5  My health is excellent Definitely true   Mostly true  Don't know Mostly false   Definitely false 
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Abstract Rationale: Survivors of
sepsis syndromes have poor outcomes
for physical and cognitive function.
No investigations of early physical
rehabilitation in the intensive care
unit have specifically targeted pa-
tients with sepsis syndromes.
Objective: To determine whether
early physical rehabilitation improves
physical function and associated out-
comes in patients with sepsis
syndromes. Methods: Fifty critical-
ly ill adults admitted to a general
intensive care unit with sepsis syn-
dromes were recruited into a
prospective double-blinded ran-
domised controlled trial investigating
early physical rehabilitation. Mea-
surements: Primary outcomes of
physical function (acute care index of
function) and self-reported health-re-
lated quality of life were recorded at
ICU discharge and 6 months post-
hospital discharge, respectively. Se-
condary measures included
inflammatory biomarkers; Interleuk-
in-6, Interleukin-10 and tumour
necrosis factor-a, blood lactate, fat-
free muscle mass, exercise capacity,
muscle strength and anxiety. Main
results: A significant increase in
patient self-reported physical function
(81.8 ± 22.2 vs. 60.0 ± 29.4),
p = 0.04) and physical role
(61.4 ± 43.8 vs. 17.1 ± 34.4,
p = 0.005) for the SF-36 at 6 months
was found in the exercise group.
Physical function scores were not
significantly different between
groups. Muscle strength scores were
(51.9 ± 10.5 vs. 47.3 ± 13.6,
p = 0.24) with the standard care
mean Medical Research Council
Muscle Score (MRC)\48/60. The
mean change of Interleukin-10 in-
creased and was significantly higher
in the exercise group (1.8 pg/ml,
180 % vs. 0.9 pg/ml, 90 %,
p = 0.04). There was no significant
difference between groups for lactate,
Interleukin-6, tumour necrosis factor-
a, muscle strength, exercise capacity,
fat-free mass or hospital anxiety.
Conclusion: Implementation of
early physical rehabilitation can im-
prove self-reported physical function
and induce systemic anti-inflamma-
tory effects.
Keywords Physiotherapy 
Critical care  Exercise therapy
Introduction
Sepsis is defined as a powerful systemic response to
severe infection. The incidence of severe sepsis is
estimated to be between 50 and 100 cases per 100,000
people of the population in developed countries [1]. As-
sociated with this disease burden is the cost of ongoing
disability and loss of productivity post-critical illness.
Intensive Care Med (2015) 41:865–874
DOI 10.1007/s00134-015-3763-8 ORIGINAL
Patients with sepsis syndromes have significantly worse
outcomes particularly in the physical and cognitive do-
mains compared to age-matched normal [2] and other
hospitalised patients [3]. A structured rehabilitation
pathway is proposed to prevent these persistent long-term
problems post-ICU discharge [4].
There is emerging evidence that early physical inter-
vention in intensive care unit (ICU) can increase
ventilator-free days, improve peripheral and respiratory
strength, reduce length of ICU and hospital stay [5–7],
and improve long-term physical [8]. There are no ran-
domised prospective trials specifically on the effects of
exercise in humans with sepsis. Animal models of sepsis
have indicated that physical exercise post-sepsis increased
bacterial clearance from blood and organs, decreased the
release of pro- and anti-inflammatory cytokines and im-
proved survival [9]. Additionally, there is evidence for
preconditioning prior to the septic insult with less lung
and distal organ injury occurring following sepsis [10].
Physical training prior to sepsis prevented atrophy, lipid
peroxidation and protein oxidation in the skeletal muscles
of septic rats [11].
Retrospective cohort analysis found that increased
physiotherapy intervention in patients with sepsis resulted
in less ICU mortality [12]. In the absence of prospective
controlled trials specifically investigating early exercise
intervention in sepsis, we aimed to investigate whether
early physical rehabilitation improved physical function
and self-reported health-related quality of life and asso-
ciated secondary outcomes in patients with sepsis
syndromes admitted to ICU.
Materials and methods
A prospective double-blinded randomised controlled trial
[13] (ACTRN 12610000808044) was conducted at a
single quaternary level, university-affiliated, general ICU
at the Royal Brisbane and Women’s Hospital, Brisbane,
Queensland, Australia. Methodology for this trial is de-
tailed in the protocol article [13]. The study was
conducted according to CONSORT guidelines [14]. Par-
ticipants, substitute decision makers, outcome assessors
and health care personnel except treating therapists were
blinded to group allocation.
Study population
Participants C18 years who remained mechanically ven-
tilated C48 h and diagnosed with sepsis [15] (C2 criteria
of a systemic inflammatory response plus proven or
strongly suspected infection), severe sepsis (sepsis plus
organ failure), or septic shock (severe sepsis with
hypotension not responding to fluid management) were
enrolled. Patients with head injuries, burns, spinal in-
juries, or multiple fractured lower limbs and those with
septic shock who were unresponsive to maximal treat-
ment, moribund or had an expected mortality within 48 h
were excluded. Written informed consent was obtained
according to ethical guidelines. The study was approved
by The Human Research Ethics Committee at Royal
Brisbane and Women’s Hospital and the Medical Re-
search Ethics Committee at The University of
Queensland.
Participant age, sex, co-morbidities, admission diag-
noses, acute physiological and chronic health evaluation
(APACHE II) [16], Charlson comorbidity index (CCI)
[17], sequential organ failure assessment (SOFA) [18],
time on mechanical ventilation, ventilator-free days,
length of ICU and hospital stay, readmissions to ICU and
90-day mortality in hospital or home were recorded. En-
rolled participants were randomised into an intervention
and standard care arm by computer generated randomi-
sation http://www.randomization.com, using concealed
allocation (Electronic supplementary material, ESM,
Fig. S1).
ICU physical rehabilitation program
Participants in the intervention arm underwent indi-
vidualised early targeted physical rehabilitation program
prescribed by the ICU research physiotherapist for
30 min, one to two times daily until discharge from the
ICU within 48 h of the diagnosis of sepsis (ESM, Table
S1). Physical rehabilitation strategies included electrical
muscle stimulation (EMS), passive range of motion, ac-
tive range of motion, sitting out of bed, transfers,
ambulation and other mobilisation techniques as appro-
priate. Targeted muscle groups for EMS were vastus
medialis, vastus lateralis, tibialis anterior and brachiora-
dialis. A frequency of 40–45 Hz at 20–25 mA with pulse
duration at 400 ls of 12 s on and 6 s off was used. Par-
ticipants in the standard care group received standard ICU
care which included physical therapy strategies provided
by the ICU physiotherapist. The physical rehabilitation
received by both groups was recorded (Fig. 1). A safety
audit was completed on patients in the intervention group
during treatment.
Primary outcomes
Participants were assessed objectively for physical func-
tion using the acute care index of function (ACIF) [19]
and self-reported health-related quality of life was mea-
sured by the SF-36 medical short-form (SF-36) by
telephone at 6 months post-discharge from hospital [20].
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Secondary outcomes
Secondary measures included exercise capacity using the
physical functional ICU test (PFIT) [21], overall muscle
strength using the Medical Research Council Muscle
Score (MRC) [22] and psychological outcome using the
anxiety subscale of the Hospital Anxiety and Depression
Scale (HADS) [23] on discharge from ICU. Pro- and anti-
inflammatory activity were assessed objectively by
monitoring cytokines; Interleukin-6 (IL-6), Interleukin-10
(IL-10) and tumour necrosis factor-a (TNF-a). Blood
lactate (BL) concentration was assessed to determine
whether exercise was inducing anaerobic glycolysis. Fat-
free mass (FFM) was assessed for lean tissue muscle mass
loss. Methodology for these measures is detailed in the
protocol article [13]. Reliability, validity and respon-
siveness in the ICU [20, 24] and sepsis population
[25, 26] for these measures are specified in the protocol
article [13].
Sample size
Sample size calculations were based on physical function
outcome of ACIF using previously published minimally
clinical important differences and standard deviations
15.4 (SD 17) in an acute care trial [27]. A sample size of
35 per group (total 70) was calculated with an effect size
of 0.7 and 90 % power with a type 1 error rate of 0.05 and
0.025 with Bonferroni adjustment.
Statistical analysis
Data were analysed using intention to treat. Non-normal
data were log-transformed. Data were expressed as mean
[standard deviation (SD)] or median [inter-quartile range
(IQR)]. Single variables were compared using Student’s
t test and dichotomous outcomes were analysed using
a Chi-squared test or Fisher’s exact test as appropriate.
Fig. 1 Total frequency and
duration of physical
rehabilitation received by
participants in intervention and
standard care groups
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A mixed method ANOVA managed missing data and was
used to compare between/within groups at different time
points. If the overall model was significant, multiple
comparisons among pairs of means were analysed with
post hoc Bonferroni correction of the significance level
(p\ 0.05).
Results
Fifty patients (5.2 % of those screened) were recruited
with 26 and 24 participants randomised to the inter-
vention and standard care group, respectively, during
the period December 2010 to August 2012 (ESM,
Fig. S1).
Demographics, ICU and hospital measures
The demographics of participants in the standard care and
intervention groups are reported in Table 1. There were
no significant baseline differences between the groups.
There was no statistical significance between groups for
duration of mechanical ventilation, ventilator-free days,
ICU and hospital length of stay, ICU readmission, ICU
and 90-day mortality and resuscitation (DNR) status
(Table 1).
Adherence
There were no withdrawals during the conduct of the trial.
All participants adhered and remained enrolled in the
study for an average of 11.4 days. Figure 1 describes the
details of the duration and number of episodes of exercise
interventions administered to both groups.
Physical function
A total of 42 participants were assessed for physical
function on discharge from ICU using a t test for inde-
pendent groups. Eight patients were not suitable for
assessment due to death in ICU (n = 4) and for the
presence of delirium or reduced level of consciousness
(n = 4). No differences were found in the physical
function ACIF final scores (61.1 ± 33.1 vs. 55.0 ± 24.4,
p = 0.45) and mobility scores (39.8 ± 38.2 vs.
34.5 ± 27.1, p = 0.67 (Table 2).
Health-related quality of life
Thirty participants completed the SF-36 quality of life
survey at 6 months post-hospital discharge over the
telephone. Sixteen patients were lost to further follow-up
due to death (n = 12), non-contactable (n = 3) or
Table 1 Demographic clinical characteristics and intensive care unit and hospital measures
Intervention (n = 26) Standard care (n = 24) p value
Age (years) 62.5 (30–83) 65.5 (37–85)
Female:male (%) 8 (16 %):18 (36 %) 10 (20 %):14 (28 %)
Weight (kg) 74.50 (44–130) 79 (50–130)
Height (cm) 171.4 (10.1) 170.3 (9.2)
CCI index 3.0 (0–8) 2.0 (0–6)
BMI (kg/m2) 27.9 (17.9–52.6) 28.1 (20.5–36.2)
APACHE II score 28.0 (7.6) 27.0 (6.8)
Sepsis category [n (%)]
Sepsis 1 (3.8) 1 (4.2)
Severe sepsis 6 (23.1) 6 (25)
Septic shock 19 (73.1) 17 (70.8)
SOFA score baseline 11.1 (3.2) 10.5 (2.5)
TOMV (days) 8.0 (4–64) 7.0 (2–30) 0.22a
VFD (days) 20.0 (0–24) 21.0 (0–26) 0.71a
ICU length of stay (days) 12.0 (4–45) 8.5 (3–36) 0.43a
Hospital length of stay (days) 41 (9–158) 45 (14–308) 0.80a
ICU readmission [n (%)] 1 (2) 4 (8) 0.13
ICU mortality [n (%)] 3 (6.0) 1 (2.0) 0.34
90-day-mortality [n (%)] 8 (16) 2 (4) 0.08
DNR status [n (%)] 9 (18) 4 (8) 0.15
Data are median (IQR), mean (SD) or n (%)
CCI Charlson comorbidity index, BMI body mass index, APACHE
acute physiology and chronic health evaluation, SOFA sequential
organ failure assessment, TOMV time on mechanical ventilation,
VFD ventilator-free days, ICU intensive care unit, DNR do not
resuscitate
a Binomial regression, or Chi-squared test, ventilator-free days;
from study day 1 to day 28
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readmitted to hospital (n = 1). An independent t test
comparison between groups found that patients in the
exercise group self-reported a significant quality of life
improvement in the domains of physical function
(81.8 ± 22.2 vs. 60.0 ± 29.4, p = 0.04) and physical
role (61.4 ± 43.8 vs. 17.1 ± 34.4, p = 0.005), compared
to those who received standard care. Patient report of
emotional role (63.6 ± 40.7 vs. 33.3 ± 45.8, p = 0.08),
vitality (45.9 ± 12.0 vs. 39.2 ± 7.7, p = 0.07) and gen-
eral health (50.5 ± 11.9 vs. 41.8 ± 11.3, p = 0.06) all
showed a trend towards statistical significance. Early re-
habilitation did not impact on reports of bodily pain,
social functioning or mental health (Table 3).
Hospital anxiety
Thirty-five participants were able to complete the HAS
assessment at ICU discharge. Fifteen participants were
not successful in testing due to death (n = 4), inability to
converse or delirium (n = 11). A t test for independent
groups found no statistically significant changes between
mean scores with ICU early exercise; however, a Chi-
squared crosstabs found that there was a trend for a
greater number of patients in the intervention group
having low levels of anxiety (25 vs. 14 %, p = 0.09)
(Table 3).
Exercise capacity and muscle strength
A total of 42 participants were tested for exercise capacity
and overall muscle strength at ICU discharge. No differ-
ences were found in ICU exercise capacity using the
interval PFIT score (5.6 ± 2.1 vs. 5.4 ± 1.7, p = 0.61).
Although not statistically significant, the standard care
group recorded a mean MRC score of less than 48/60 for
the MRC scale consistent with the criteria for ICUAW
[28] (Table 2).
Inflammatory biomarkers
Interleukin-6
The pro-inflammatory cytokine; IL-6 was measured on
days 1, 3, 5, and 7 upon initiation of the trial and at ICU
discharge. A reduction in IL-6 mean scores was observed
in the intervention group pre- and post-exercise across
days 1, 3, 5 and 7 but no statistically significant differ-
ences were found between groups. There was a trend
towards significance for mean change from baseline to
ICU discharge where the decrease was greater (5.2 pg/ml,
55 % vs. 20.4 pg/ml 120 %, p = 0.07) (ESM, Table S2)
in the intervention group with a mixed model ANOVA
(Fig. 2).
Interleukin-10
The anti-inflammatory cytokine, Interleukin-10, was
measured on days 1, 3, 5, and 7 and at ICU discharge.
Overall mean change of IL-10 from baseline to ICU
discharge was significantly higher in the intervention
group (1.8 pg/ml, 180 % vs. 0.9 pg/ml, 90 %, p = 0.04)
(ESM, Table S2) than in the standard care group (Fig. 2).
Tumour necrosis factor-a
The pro-inflammatory cytokine, tumour necrosis factor-a,
was also measured on days 1, 3, 5, and 7 and at ICU
discharge. There were statistically significant findings
between groups from baseline to ICU discharge with a
greater percentage decrease in the standard care group
Table 2 Physical function, exercise capacity and muscle strength outcomes at ICU discharge according to study group
Physical function outcomes Intervention (n = 19) Standard care (n = 23) p value
Mean (SD) Mean (SD)
MRC scores (n = 42) 51.9 (10.5) 47.3 (13.6) 0.24
PFIT scores (n = 42) 5.6 (2.1) 5.4 (1.7) 0.61
ACIF final score (n = 42) 61.1 (33.1) 55.0 (24.4) 0.45
Mental status score 79.8 (35.8) 82.7 (31.6) 0.47
Bed mobility score 61.1 (32.8) 61.1 (26.1) 0.99
Transfer score 60.3 (40.1) 62.9 (31.4) 0.81
Mobility score 38.9 (38.2) 34.5 (27.1) 0.67
Data are mean (SD), independent samples t test
MRC medical research council, PFIT physical function ICU test, ACIF acute care index of function
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(2.5 pg/ml, 100 % vs. 2.5 pg/ml, 75 %, p\ 0.01) (Table
S2) (Fig. 2).
Fat-free mass
Percentage fat-free mass was measured at recruitment
(n = 44), week 1 (n = 32) and at ICU discharge
(n = 17). Six patients were ineligible for the use of BIS at
recruitment due to missing a limb, presence of metal
implants or peripheral or generalised oedema. Fat-free
mass increment at week 1 was noted but the groups were
not significantly different (ESM, Fig. S2a). Percentage
changes in fat-free mass showed increments in both
groups at week 1 and reductions at ICU discharge
from baseline (4.4 vs. 2.5 %, -1.2 vs. -5.1 %, p = 0.93)
(ESM, Fig. S2b).
Safety measures
Blood lactate
Blood lactate concentrations were determined pre- and
post-exercise as a safety marker for exercise. Lactate
showed significant effects for time and decreased in both
groups over the course of the week (p = 0.04). It did not
increase post-exercise in the intervention group (ESM,
Table S3).
Table 3 Quality of life and anxiety outcomes according to study group
Quality of life outcome Intervention (n = 11) Standard care (n = 19) p value
Mean (SD) Mean (SD)
SF-36 scores (n = 30)
Physical function 81.8 (22.2) 60.0 (29.4) 0.04*
Role physical 61.4 (43.8) 17.1 (34.4) 0.005**
Bodily pain 70.9 (20.7) 64.7 (22.5) 0.46
General health 50.5 (11.9) 41.8 (11.3) 0.06
Vitality 45.9 (12.0) 39.2 (7.7) 0.07
Social functioning 71.6 (37.1) 73.7 (37.2) 0.88
Role emotional 63.6 (40.7) 33.3 (45.8) 0.08
Mental health 38.6 (11.5) 37.3 (7.4) 0.71
Anxiety outcome Intervention (n = 16) Standard care (n = 19) p value
Mean (SD) Mean (SD)
HAS (n = 35)
Normal 9 (25 %) 5 (14 %) 0.09a
Borderline abnormal 1 (3 %) 6 (17 %)
Abnormal 6 (17 %) 8 (22 %)
Data are mean (SD)
SF-36 short-form 36, HAS hospital anxiety scale
* p\ 0.05, ** p\ 0.01
a Independent t test, or Chi-squared test
Fig. 2 Inflammatory biomarker
changes with early physical
rehabilitation
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Vital signs
As a further measure of safety, arterial blood pressure,
heart rate, respiratory rate and oxygen saturation were
monitored during all sessions of exercise. There were pre-
determined alterations which would define an adverse
event [13]. No session of exercise resulted in an adverse
event.
Discussion
Early physical rehabilitation for critically ill patients with
sepsis resulted in a significant health-related quality of
life improvement in self-reported physical function and
physical role at 6 months post-hospital discharge. In ad-
dition, there were trends towards improvement in
emotional role, vitality and general health and less anxiety
on ICU discharge. There were significantly larger in-
creases in the early exercise group for the anti-
inflammatory cytokine IL-10. There were no significant
effects on physical function, exercise capacity or fat-free
mass on discharge from intensive care.
Previous studies in intensive care have reported posi-
tive outcomes for general patients with a combined
intervention of early rehabilitation [5, 29, 30]. A number
of studies have not shown a difference between groups
[31, 32], but it can be noted that the group of ‘‘standard
care’’ received a high level of exercise due to existing
local practices. Our study differed, in that we investigated
a discrete group of patients with sepsis syndromes. This
group have been shown to have worse physical and
cognitive deficits than other diagnostic groups in ICU, so
there may have been more potential for improvement [2,
3]. Additionally, we provided intervention such as EMS
and passive exercise in the early stage when patients were
sedated and unable to participate in active movement. The
dose of early physical rehabilitation provided in this trial,
i.e. 30 min a day, is a feasible treatment to be delivered in
typical intensive care settings.
Specific studies have been undertaken utilising EMS
with contradictory outcomes [6] with preservation of
muscle mass found in long-stay ICU patients. Studies that
targeted patients with sepsis [33, 34] did not find
preservation of their muscle mass. However, this may
have occurred as sepsis is a systemic inflammatory dis-
ease and exercise lowers overall inflammatory activity,
hence exercising one part of the body with the other leg
serving as a control may not be effective.
Our study included a high proportion of those re-
ceiving EMS or passive exercise when patients were high
acuity, or when sedation produced a decreased level of
co-operation. This was more common early in the ad-
mission; however, some patients deteriorated and passive
manoeuvres were substituted for more active forms of
exercise. We are of the opinion that providing some form
of exercise at these stages as well as more active inter-
ventions produced a higher level of physical function
overall in the later stages as determined from the im-
proved HrQOL. Recent studies using a deeply sedated and
mechanically ventilated experimental ICU rat model [35,
36] found preservation of muscle mass and muscle force
generation after passive mechanical loading.
In addition, a number of factors in sepsis predispose
towards greater potential loss of muscle mass and force
which were reported as secondary measures in this study.
The pro-inflammatory cytokines; Interleukin-6 and tu-
mour necrosis factor-a, are involved in muscle
degradation, myocyte degeneration and muscle atrophy,
inhibition of protein synthesis and apoptosis [37–41].
Significant muscle wasting from bed rest occurs early in
critical illness [42], which results from increased prote-
olytic degradation as well as decreased protein synthesis.
The anti-inflammatory cytokine, Interleukin-10 (IL-10), is
considered to inhibit proteolysis [43]. In this study, the
rate of increase of IL-10 was twice the rate in the exercise
group. Although novel and preliminary, this may con-
tribute to some pertinent information relating to the
mechanism underlying the effect of exercise on the sys-
temic inflammatory response.
The ACIF score was an objective measurement used to
assess basic physical function change at ICU discharge
(short term) and the SF-36 assessed self-reported quality
of life at 6 months (long term) by telephone. As many
subjects were discharged to rural areas, a remote form of
assessment was required at 6 months during which ICU
survivors may exhibit physical- and emotional-related
difficulties [44]. Although the SF-36 indicated increased
self-reported physical function, we could not conclude
that it directly translated into demonstrably improved
physical function, as a physical function assessment or
muscle strength assessment was not performed at
6 months to confirm this. However, a self-perception of
improved physical function would assist in increasing
participation and aid recovery as per the international
classification of functioning, disability and health (ICF)
[45].
Previous studies have found a correlation between
strength and function [26, 46] in general ICU patients;
however, the timing of the assessment in our study, i.e. on
discharge from ICU, may have influenced the results. The
blinded assessor reported that, although able to complete
a simple strength assessment, patients were not able to
complete transfers due to problems with initiation of
movements. Baldwin et al. [47] noted the same difficulties
in a similar population. Deficits in motor control neural
programming may have resulted in adequate strength not
translating to efficient motor functioning, and repeating
the tests at a later date may have shown significance be-
tween groups [48]. Additionally, we did not see a
significant difference in exercise capacity (PFIT)
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consistent with the limitations of this ICU exercise ca-
pacity test [49].
Patients post-sepsis have been reported to have prob-
lems with cognition, anxiety, and post-traumatic
syndromes as well as physical problems. We did not
specifically address these in this study. However, there
was a trend towards fewer patients in the intervention
group reporting severe anxiety and a trend towards a
higher score in the emotional role (SF-36). Exercise has
frequently been reported to lessen anxiety [50–52]. A
recent study has combined both physical and cognitive
interventions with no differences found [32]. Although
early cognitive intervention may aid in improving post-
critical illness outcomes [53], larger numbers may be
required to demonstrate an effect.
Blood lactate concentration was used in the study as a
safety measure to ensure that exercise did not result in
clinically significant anaerobic glycolysis. Pilot data of
other secondary outcome measures of mitochondrial
DNA, muscle oxygenation and microcirculation obtained
during this main randomised trial will be reported in fu-
ture manuscripts.
Limitations
This original study has some limitations. Firstly, the ex-
pected sample size was not reached due to time logistics
for study completion. In addition, some bias may have
been unavoidable in the overall analysis of the HrQOL
outcomes due to the small sample available at 6 months
from early deaths. Basic physical function as measured by
the ACIF score was not assessed at the long-term stage.
Hospital readmission was not monitored, and there was
also a lack of baseline data on physical function, muscle
strength and exercise capacity as is the nature of a critical
care admission.
Conclusion
Early ICU exercise can moderate the detrimental effects
of sepsis. It can improve self-reported quality of life in the
physical domains and induce anti-inflammatory effects.
Further research is required to look at the detailed
mechanisms behind these effects in order to refine and
tailor approaches to physical rehabilitation in the
critically ill.
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Objective: The purpose of this systematic review was to review 
the evidence base for exercise in critically ill patients.
Data Sources and Study Selection: Using keywords critical care 
and physical therapy and related synonyms, randomized con-
trolled trials, meta-analyses, and systematic reviews were identi-
fied through electronic database searches and citation tracking. 
Clinical trials with outcomes of mortality, length of hospital and 
ICU stay, physical function and quality of life, muscle strength, and 
ventilator-free days were included.
Data Extraction and Synthesis: Two reviewers abstracted data 
and assessed quality independently. Effect sizes and 95% confi-
dence intervals were calculated. From 3,126 screened abstracts, 
10 randomized controlled trials and five reviews were found. The 
mean Physiotherapy Evidence Database score was 5.4. Overall 
there was a significant positive effect favoring physical therapy 
for the critically ill to improve the quality of life (g = 0.40, 95% 
confidence interval 0.08, 0.71), physical function (g = 0.46, 95% 
confidence interval 0.13, 0.78), peripheral muscle strength (g = 
0.27, 95% confidence interval 0.02, 0.52), and respiratory muscle 
strength (g = 0.51, 95% confidence interval 0.12, 0.89). Length 
of hospital (g = –0.34, 95% confidence interval –0.53, –0.15) 
and ICU stay (g = –0.34, 95% confidence interval –0.51, –0.18) 
significantly decreased and ventilator-free days increased (g = 
0.38, 95% confidence interval 0.16, 0.59) following physical 
therapy in the ICU. There was no effect on mortality.
Conclusion: Physical therapy in the ICU appears to confer signif-
icant benefit in improving quality of life, physical function, periph-
eral and respiratory muscle strength, increasing ventilator-free 
days, and decreasing hospital and ICU stay. However, further 
controlled trials of better quality and larger sample sizes are 
required to verify the strength of these tentative associations. 
(Crit Care Med 2013; 41:1543–1554)
Key Words: critical care; exercise; intensive care; mobilization; 
physical therapy; review
O
ver the last 20 years, advances in critical care 
management have increased survival following 
intensive care admission (1). While traditionally the 
measure of the quality of critical care has focused on mortality 
outcomes, recently there has been an awareness that functional 
status and health-related quality of life (HRQOL) after critical 
illness are also important (2).
From recent literature and observational studies, it has 
become apparent that survivors of critical illness experience poor 
physical, functional, and cognitive outcomes often lasting for 
years (3–8). This has been termed postintensive care syndrome (2). 
This can result in major impacts on the health and productivity 
of survivors and caregivers, return to work rates, as well as the 
availability of intensive care and hospital beds, surgical waiting 
lists, and health care costs (9).
One aspect of postintensive care syndrome is weakness, 
termed ICU-acquired weakness, may be present in 25% to 
60% of mechanically ventilated patients (10, 11). Although 
the etiology of this weakness is multifactorial and poorly 
understood, evidence suggests that muscle injury from sys-
temic inflammation along with deconditioning from immo-
bilization is responsible (12–14).
As exercise in other populations has been shown to 
improve strength and function, decrease inflammation (15–
17), and affect oxidative stress (18–21), it has been suggested 
that early physical therapy of ICU patients may prevent or 
reverse some physical impairment. There has been a surge 
in interest in this intervention in recent years (22–28), and 
it is important to review the existing studies in this area to 
gauge the quality of evidence and identify research gaps for 
future studies.
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MATERIALS AND METHODS
A systematic review of the published literature was con-
ducted to investigate the effects of ICU physical therapy fol-
lowing critical illness. Although there is increasing published 
literature on this topic, it was decided a priori to restrict and 
to include all prospective controlled 
studies, both randomized controlled 
trials (RCTs) and quasi-RCTs as they 
represent the highest order of clini-
cal trials for evidence-based practice. 
Existing meta-analysis and system-
atic reviews were also included and 
reviewed.
Search Strategy
A comprehensive search strategy of the 
electronic databases Ovid MEDLINE 
(1980 to January 2012), PubMed (1980 
to January 2012), CINAHL (1982 to 
January 2012), and the Cochrane Data-
base (1992 to January 2012) was con-
ducted. The keywords or search terms 
were as follows: (intensive care OR 
critical care) AND (physical therapy 
OR mobilization OR exercise OR phys-
iotherapy OR mobility). For the pur-
pose of this review, we defined physical 
therapy as activities such as positioning, 
stretching, electrical muscle stimula-
tion (EMS), range of motion exercise, 
resistive exercises, ergometry, walking, 
splinting, mobilization activities, and 
aerobic train 1992 to January 2012) 
was conducted. The keywords ing (29). 
The RCTs included were required to 
describe a comparison group that did not receive or mini-
mally received physical therapy in contrast to the intervention 
group. Language limits were set to include English, French, 
Chinese, and Tamil.
TABLE 1. Physiotherapy Evidence Database Quality Scoring of Randomized Controlled Trials
Randomized Controlled Trials
Physiotherapy Evidence Database Categories
Random 
Allocation
Concealed 
Allocation
Baseline 
Similarity
Subject 
Blinding
Therapist 
Blinding
Routsi et al (30) × × √ × ×
Schweickert et al (31) √ √ √ × ×
Burtin et al (32) √ √ × × ×
Muehling et al (34) √ × √ × ×
Muehling et al (33) √ × √ × ×
Chiang et al (35) √ × √ × ×
Porta et al (36) √ × √ × ×
Zanotti et al (37) √ √ × √ ×
Delaney et al (38) √ √ √ × ×
Nava (39) √ × √ × ×
Overall percentage 90 40 80 10 0
√ = Physiotherapy Evidence Database criteria met; × = Physiotherapy Evidence Database criteria not met.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow 
diagram.
Potenally relevant studies 
idenﬁed and screened for 
retrieval (n= 3126)
Studies retrieved for more 
detailed evaluaon (n=101)
Potenally appropriate studies 
to be included in the 
meta-analysis (n=37)
Studies included for
meta-analysis (n=17)
Studies with usable informaon
by outcome included in 
meta-analysis (n=10)
Studies excluded (n=3025)
(Case controls, reviews, pre-post designs, observaonal designs,
retrospecve designs)
Studies excluded based on tle and abstracts (n=64)
(Non-relevant topics e.g. only chest physical therapy)
[Studies excluded based on full text eligibility (n=20)]:
Non-randomized controlled trials (n=5)
Reviews (n=5)
Repeat arcles (n=10)
[Studies excluded based on non-relevant outcomes (n=7)]:
Not ICU physical therapy study (n=1)
No physical therapy intervenon comparison (n=1)
Not an ICU trial (n=3)
Non-usable outcome (n=2)
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Physiotherapy Evidence Database Categories
Physiotherapy 
Evidence Database 
Score
Assessor 
Blinding
Measures of Key  
Outcomes > 85% of 
Subjects
Intention 
to Treat
Between-Group 
Statistical 
Comparison
Point Measures 
and Measures of 
Variability
× × √ √ √ 4
√ √ √ √ √ 8
× × × √ √ 4
× √ √ √ √ 6
× √ × √ √ 5
√ × × √ √ 5
× √ × √ √ 5
√ √ × √ √ 7
× × √ √ √ 6
× × × √ √ 4
30 50 40 100 100  
Figure 2. A,  Meta-analysis and pooled effect sizes (Hedges. g) on physical function, quality of life, muscle strength, ventilator-free days for physical 
therapy or standard care in the ICU. *p ≤ 0.05 and **p ≤ 0.01. B, Meta-analysis and pooled effect sizes (Hedges. g) on length of hospital and intensive 
care stay for physical therapy or standard care in the ICU. *p ≤ 0.05 and **p ≤ 0.01. C, Odds ratio on mortality for physical therapy or standard care in the 
ICU.
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TABLE 2. Summary of Randomized Controlled Trials Investigating ICU Physical Therapy  
in the Critically Ill
Study n Sample Population Control Arm Exercise Intervention Arm
Routsi  
et al (30)
140 Day 2 of admission (Acute 
Physiology and Chronic Health 
Evaluation score ≥ 13)
No sham EMS EMS
Schweickert 
et al (31)
104 Sedated with MV < 72 hr 
(Barthel Index score ≥ 70)
Standard care physiotherapy 
and occupational therapy 
as ordered by primary care 
team
PROM, AROM, transfers, bed mobility, 
sitting up, activities of daily living, sit to 
stand, gait training, early mobilization 
(sedation interrupted)
Burtin  
et al (32)
90 Prolonged ICU stay ≥ 7 d Daily standardized PROM and 
AROM of upper limb and LL 
for 5 d/wk
PROM, AROM, ergometer, ambulation
Muehling  
et al (34)
101 Indications for elective open 
aneurysm repair
Mobilization POD 1 Early mobilization
Muehling  
et al (33)
82 Indications for elective open 
aneurysm repair
Mobilization POD 1 Early mobilization
Chiang  
et al (35)
39 Prolonged MV > 14 d Only verbal encouragement 
for mobilization but not 
routinely performed
Limb strengthening, diaphragmatic 
exercises, bed mobility, transfers, 
standing, ambulation
Porta et al (36) 66 Weaned from MV > 48 to 
 < 96 hr
General physiotherapy 
45 min/d for 6 wk
General physiotherapy (chest 
physiotherapy, PROM, AROM, 
mobilization, ambulation), arm ergometer
Zanotti  
et al (37)
24 30 d bed-bound with chronic 
hypercapnic respiratory failure; 
MV with marked hypotonia  
and atrophy
ALM ALM, EMS to LL
Delaney  
et al (38)
64 Undergoing laparotomy and 
intestinal or rectal resection
Traditional postoperative care Incentive spirometry, sit out of bed, 
ambulation   
Nava (39) 80 Chronic obstructive pulmonary 
disease and episode of acute 
respiratory failure
Standard medical therapy and 
basic ambulation program
PROM, AROM, postural training, cough 
education, respiratory muscle training, 
treadmill walking, ambulation, leg 
ergometer, stair climbing   
EMS฀=฀electrical฀muscle฀stimulation;฀LL฀=฀lower฀limb;฀MV฀=฀mechanical฀ventilation;฀PROM฀=฀passive฀range฀of฀motion;฀AROM฀=฀active฀range฀of฀motion;฀ 
6MWD = 6-min walk distance; POD = postoperative day; ALM = active limb mobilization; IT = incremental test.
Selection Criteria
Clinical trials selected for the meta-analysis were confined 
to those investigating physical therapy within the ICU. Out-
comes of interest were peripheral muscle strength, respi-
ratory muscle strength, physical function, quality of life, 
ventilator-free days, length of stay in hospital and ICU 
in days, and incidence of mortality. In order to calculate 
Hedges. g effect size (g) and 95% confidence intervals (CIs), 
the studies were required to report means, standard devia-
tions, and sample size. To assess eligibility, two investigators 
(G.K., J.P.) independently retrieved and examined the titles 
and abstracts of the studies with a third investigator (R.B.) 
consulted in case of disagreement. To identify additional 
studies, citation-tracking of reference lists of retrieved arti-
cles was conducted. Figure 1 illustrates the article selection 
process.
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Duration/
Frequency/ 
Intensity
Physical Therapy 
Initiation Results and Significant Outcome
Daily: EMS to LL, 55 min 
at 45 Hz
Day 2 of ICU admission ↑ Medical Research Council score (58 vs. 52; p = 0.04)
↑ Ventilator-free days (4 vs. 6 d; p = 0.003)
↓ Weaning period (1 vs. 3 d; p = 0.003)
Physiotherapy and 
occupational therapy:  
daily PROM × 10
Day of enrollment MV < 
72 hr
↑ Return to functional independence (59% vs. 35%; p = 0.02)
↓  Duration of delirium (2 vs. 4 d; p = 0.02)
↑ Ventilator-free days (23.5 vs. 21.1 d; p = 0.05)
Ergometer: 20 min/d, 
ROM: 5 d/wk
On cardiorespiratory 
stability
↑ 6MWD (196 vs. 143m; p < 0.05)
↑ Short Form 36 Questionnaire (21 vs. 15; p < 0.01)
↑ Quadriceps force (2.4 ± 0.6 N kg–1 vs. 2.0 ± 0.8 N kg–1; p = 0.11)
Daily POD 0 ↓ Postoperative ventilation (6.1% vs. 32%; p = 0.002)
↓ Postoperative complications (16% vs. 36%; p = 0.039)
↓ Postoperative hospital stay (10 vs. 11 d; p = 0.016)
Daily POD 0 ↑ Postoperative ventilation in control group (33.3% vs. 5.4%; p = 0.011)
↓ Length of stay in ICU (41 vs. 20 hr)
↑ Rate of postoperative complications (16.2% vs. 35.7%; p = 0.045)
Physical training: 6 wk 
× 5/wk, ROM: 10 × 2 
sets
As early as patients could 
tolerate
↑ Respiratory and limb muscle strength third and sixth week
↑  Total Barthel Index Activity of Daily Living and Functional Independence Measure 
scores intervention group
↑  Functional Independence Measure mobility scale by 80% intervention group (p = 
0.001)
Chest therapy: 15 min 
ROM: 30 min, 
mobilization: 15 min, 
ambulation:  
15 min–graded 
according to level of 
patient activity, upper 
limb cycling: 20 min/d 
× 15 sessions
96 hr after weaning from 
MV
↑ Exercise capacity (7.3 vs. 2.6 W; p = 0.003)
↑ Endurance test (8 vs. 4 min; p = 0.021)
↑  Maximal inspiratory pressure (43 ± 19 cm H
2
O to 52 ± 20 cm H
2
O; p < 0.001) 
(37 ± 14 cm H
2
O to 42 ± 15 cm H
2
O; p = 0.003)
↓  IT workload dyspnea on Borg scale (4.6 ± 2.5 to 3.4 ± 2.7; p = 0.005) (5 ± 3.2 to 
3.5 ± 2.5; p = 0.009)
↓ Exercise capacity peripheral muscle fatigue (6.3 ± 2.5 to 4.1 ± 2.8, p = 0.001)
↓ Endurance test dyspnea on Borg scale (4.7 ± 2.8 to 2.6 ± 2.2, p = 0.007)
↓ Endurance test muscular fatigue on Borg scale (5.6 ± 2.6 to 3.4 ± 2.4; p = 0.002)
ALM/EMS: 5 d/wk × 
4 wk
30 d after bed rest ↑ Muscle strength overall score (1.8 ± 0.7 to 3.4 ± 0.7; p < 0.05)
↑ Muscle strength intervention group score (2.1 ± 1.0 to 1.3 ± 0.8; p = 0.02)
↓ Days transfer from bed to chair score (10.8 ± 2.4 vs. 14.3 ± 2.5; p = 0.001)
Ambulation: 60 m × 5 POD 1 ↓ Length of stay in hospital (5.4 vs. 7.1 d; p = 0.02)
Physical therapy: 30– 
45 min × 2 daily. LL 
exercises: 30 min ×  
2 daily × 3 wk
Within first 24 hr after 
admission
↑ 6MWD (p < 0.001)
↑ Maximal inspiratory pressure intervention group (45–61 cm H
2
O; p < 0.05)
↓ 6MWD heart rate (128–100 beats/min; p < 0.01), dyspnea (p < 0.01)
EMS฀=฀electrical฀muscle฀stimulation;฀LL฀=฀lower฀limb;฀MV฀=฀mechanical฀ventilation;฀PROM฀=฀passive฀range฀of฀motion;฀AROM฀=฀active฀range฀of฀motion;฀
Assessment of Methodological Quality
The quality of the methodological features of the 10 RCTs 
(30–39) were independently assessed and scored using the 
Physiotherapy Evidence Database (PEDro) scale (40). This is 
a reliable instrument for rating quality of RCTs (41), based on 
a 0–10 point scale, with a higher score reflecting well-designed 
trials. The quality of the systematic reviews were independently 
assessed and scored using the Revised Assessment of Multiple 
Systematic Reviews (R-AMSTAR) for grading clinical evidence 
(42). Following independent scoring and assessment of RCTs 
and systematic reviews, both reviewers discussed and verified 
the results. The Cohen kappa (κ) (interobserver reliability) was 
used to assess the agreement between the two investigators (G.K., 
J.P.). Consensus was achieved with open discussion involving the 
third reviewer for the final review process. The quality scoring 
for the included studies is shown in Table 1.
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Data Extraction and Analysis
Two reviewers (G.K., J.P.) independently performed and then 
cross-checked the data with regard to study design, intervention, 
and outcome measures. The parameters of the outcome’s mea-
sures of interest were collected from each RCT and summarized 
(Table 2).
Data were analyzed using Comprehensive Meta-Analysis 
software Version 2.0 (Biostat, Englewood, NJ) (43). To evaluate 
the effects of exercise on continuous outcomes, peripheral and 
respiratory muscle strength, physical function, quality of life, 
ventilator-free days, length of hospital and ICU stay, Hedges. 
g effect size (g), and 95% CI (based on means and standard 
deviations) were calculated between groups receiving physical 
therapy and the control groups at endpoint. Calculated effects 
denoted associations between ICU physical therapy and cor-
responding outcome measures. The strength of the effect sizes 
were interpreted with values less than 0.2 as no effect, more 
than 0.2 as small effect, more than 0.5 as moderate effect, and 
more than 0.8 as large effect (44). Odds ratios were calculated 
for dichotomous data such as mortality comparisons. The data 
were pooled using the fixed effects model; however, when het-
erogeneity was statistically significant (Q statistic, p < 0.001), 
the data were reanalyzed using the random effects model (45). 
Pooled data for overall effect sizes were carefully evaluated due 
to inherent variations in interventions and endpoints. Forest 
plots were constructed for selected outcome measures (Fig. 2).
Based on the criteria of excellence of systematic reviews that 
resulted in the 11 domains examined by R-AMSTAR, the over-
all score on R-AMSTAR was used to assign a grade of systematic 
review quality and clinical relevance with a possible maximum 
score of 44. A conventional cutoff point of 22 was used to indicate 
that on average only two criteria for each of the 11 domains were 
satisfied (42).
RESULTS
Searches from the database identified 3126 articles. Applying 
the exclusion criteria, over 3000 articles were ineligible on the 
basis of being case–control, pre–post, abstract only, observa-
tional and retrospective studies, or narrative reviews. Of the 
TABLE 3. Demographics of Studies Included in the Meta-Analysis
Study
Sample 
Size
Patient Type/Severity/
Illness
Mean Age ± SD/Range, Years, Male:  
Female Ratio, [%]
(Control/
Exercise) Control Exercise Control Exercise
Routsi  
et al (30)
140 (72/68) APACHE II 58 ± 18
49:23 [68:32]
61 ± 19
46:22 [68:32]18 ± 5 18 ± 4
Schweickert  
et al (31)
104 (55/49) APACHE II 54.4 (46.5–66.4)
26:29 [41:59]
57.7 (36.3–69.1) 
26:23 [58:42]19.0 (13.3–23.0) 20.0 (15.8–24.0)
Burtin  
et al (32)
90 (45/45) APACHE II 57 ± 17
26:10 [72:28]
56 ± 16
22:9 [71:29]25 ± 4 26 ± 6
Muehling  
et al (34)
101 (51/50) ASA III 68 (52–84)
47:3 [72:28]
67 (40–81) 
46:3 [94:6]34 32
Muehling  
et al (33)
82 (42/40) ASA III 68 (52–84)
39:3 [93:7]
67 (40–81) 
34:3 [92:8]34 32
Chiang  
et al (35)
39 (19/20) Multisystem failure, n (%) 79 (72.5–82.8)
12:3 [80:20]
75 (63.0–80.3) 
12:5 [71:29]2 (13.3) 2 (1.8)
Porta  
et al (36)
66 (34/32) Long-term mechanical ventilation 72 ± 5
23:11 [68:32]
70 ± 6
22:10 [69:31]
Zanotti et al 
(37)
24 (12/12) Hypercapnic respiratory failure 65 ± 4
8:4 [67:33]
66 ± 8
9:3 [75:25]
Delaney  
et al (38)
64 (33/31) ASA III 42 ± 13
21:12 [64:36]
51 ± 17
21:10 [68:32] 7 12
Nava (39) 80 (20/60) Acute respiratory failure 67 ± 9
38:22 [63:37]
65 ± 6
13:7 [65:35]
LOSICU฀=฀ICU฀length฀of฀stay;฀TOMV฀=฀time฀on฀mechanical฀ventilation;฀PT฀=฀physiotherapy;฀OT฀=฀occupational฀therapy;฀LOSHOSP฀=฀hospital฀length฀of฀stay;฀ 
SICU฀=฀surgical฀ICU;฀FVC฀=฀forced฀vital฀capacity;฀APACHE฀=฀Acute฀Physiology฀and฀Chronic฀Health฀Evaluation;฀ASA฀=฀American฀Society฀of฀Anesthesiologists.
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remaining 101 articles, 37 articles were retained based on title 
and abstract. After review of full content, a further 20 publi-
cations comprising non-randomized trials and reviews were 
excluded. Seventeen RCTs (30–39, 46–52) met the inclusion 
criteria. Seven RCTs (46–52) were then removed from the final 
selection for review; three were not ICU trials (47–49), one was 
not a physical therapy trial (46), one had no physical therapy 
intervention comparisons (50), and two reported non-usable 
information by outcome for this meta-analysis (51, 52).
Methodological Quality
The Kappa level of agreement between reviewers on PEDro 
quality scoring was 0.89. A mean PEDro score of 5.4 (median 
5, range of 4–8) was obtained for the ten RCTs evaluated 
(Table 1). All ten trials (30–39) indicated random allocation 
to treatment group except one trial (30) that did not perform 
true random allocation (90%). All trials reported between-
group statistical comparison and point measures and mea-
sures of variability (100%). Only four trials (31, 32, 37, 38) 
reported concealed allocation (40%). Four trials (30, 31, 34, 
38) performed intention-to-treat analysis (40%), three trials 
(31, 35, 37) reported assessor blinding (30%), and one trial 
(37) reported subject blinding (10%). The difficult problem of 
therapist blinding was apparent as this was not reported in the 
methodology of all the included trials.
Demographics
The patient case mix largely included critically ill patients with 
a range of causes of admission to intensive care. Patient type, 
illness or severity, overall mean age and range in years, sample 
size, gender ratio, type of ICU, type of physical therapy person-
nel, and type of outcome measures were summarized (Table 
3). The total sample size of all ten trials was n = 790 (range 
24–140), after accounting for dropouts. The overall mean age 
for the trials for control versus exercise group was 59.3 versus 
63.6 years. The overall percentage of male:female ratio for con-
trol versus exercise group was 69:31 versus 73:27. Two trials 
recruited patients in mixed ICUs (30, 32), one in a medical unit 
(31), three in surgical units (33, 34, 38), and four in respiratory 
units (35–37, 39).
Intensive Care Type Personnel Outcome Measures
ICU Not mentioned Mechanical ventilation weaning period, LOSICU, Medical Research 
Council, TOMV
Medical ICU PT and OT ICU delirium, hand-grip strength, Barthel Index, mortality, ambulation, 
LOSICU, LOSHOSP, Medical Research Council, TOMV
SICU, medical ICU PT Quadriceps force, hand-grip strength, Berg Balance, Short Form-36 
Questionnaire, LOSICU, LOSHOSP, 6-min walk distance, TOMV
SICU Not mentioned Mortality, postoperative ventilation, postoperative complications, 
perioperative outcomes, LOSICU, LOSHOSP
SICU Not mentioned Mortality, postoperative ventilation, LOSICU, LOSHOSP
Respiratory care center PT Respiratory and peripheral muscle strength, Barthel Index, functional 
independence measure, ambulation, TOMV
Respiratory ICU PT Arm exercise test, inspiratory muscle strength
Respiratory high dependency unit Member of physical 
therapy team
Peripheral muscle strength, cardiorespiratory function, transfer ability
SICU Not mentioned Pain score, McGill Pain Score Questionnaire, Cleveland Clinic Global 
Quality of Life, Short Form-36 Questionnaire
Respiratory ICU Not mentioned Respiratory muscle strength, dyspnea score, LOSICU, forced 
expiratory volume at end of 1st second, forced vital capacity, 
6-min walk distance
LOSICU฀=฀ICU฀length฀of฀stay;฀TOMV฀=฀time฀on฀mechanical฀ventilation;฀PT฀=฀physiotherapy;฀OT฀=฀occupational฀therapy;฀LOSHOSP฀=฀hospital฀length฀of฀stay;฀
SICU฀=฀surgical฀ICU;฀FVC฀=฀forced฀vital฀capacity;฀APACHE฀=฀Acute฀Physiology฀and฀Chronic฀Health฀Evaluation;฀ASA฀=฀American฀Society฀of฀Anesthesiologists.
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TABLE 4. Endpoint Measures of Outcomes Included in the Meta-Analysis
Randomized 
Controlled Trials
Outcome 
Measures 
Tested in 
Meta-Analysis Endpoints
Control Group, 
Mean [SD]/
Median [Range]
Treatment 
Group, Mean 
[SD]/ 
Median [Range]
Significance 
Between 
Groups
Physical function
 Schweickert et al (31) Barthel Index of 
Activities of 
Daily Living 
Score
Hospital DC 55 [0–58] 75 [7.5–95] p = 0.05
 Chiang et al (35) Third and 
sixth week
0.0 [0.0–8.8] 35 [20–55] p < 0.05
Quality of life
 Burtin et al (32) Medical outcomes 
study Short 
Form-36 score
Hospital DC 15 [14–23] 21 [18–23] p < 0.01
 Delaney et al (38) Day 10, 
30, and 
hospital 
DC
66 ± 24.3 64.8 ± 23.4 p > 0.05
Peripheral muscle strength
 Routsi et al (30) Medical Research 
Council score
ICU DC 52 [2–60] 58 [33–60] p < 0.05
 Schweickert et al (31) Hospital DC 48 [0–58] 52 [25–58] p > 0.05
Respiratory muscle strength
 Chiang et al (35) Maximal 
inspiratory 
pressure
Third and 
sixth week
30 cm H
2
O 
[25.0–42.0]
60 cm H
2
O  
[40.5–71.5]
p < 0.05
 Porta et al (36) Not 
mentioned
42 ± 15 cm H
2
O 52 ± 20 cm H
2
O p > 0.05
Ventilator-free days
 Routsi et al (30) Number of ICU 
days without 
mechanical 
ventilation
ICU DC 6 [0–41] 4 [0–16] p < 0.01
 Schweickert et al (31) First 28 
hospital 
days
21.1 [0.0–23.8] 23.5 [7.4–25.6] p = 0.05
 Burtin et al (32) ICU DC 34 30 p > 0.05
Length of hospital stay
 Schweickert et al (31) Number of days 
for length of 
stay in the 
hospital
Hospital DC 12.9 [8.9–19.8] 13.5 [8.0–23.1] p > 0.05
 Burtin et al (32) Hospital DC 40 [28–49] 36 [28–47] p > 0.05
 Muehling et al (34) Hospital DC 11 [8–45] 10 [6–49] p < 0.05
 Muehling et al (33) Hospital DC 11 [8–24] 10 [8–49]
 Delaney et al (38) Hospital DC 7.1 ± 4.8 d 5.4 ± 2.5 p < 0.05
Length of intensive care stay
 Routsi et al (30) Number of d/hr 
for length of 
stay in the ICU
ICU DC 22 d [2–92] 14 d [4–62] p > 0.05
 Schweickert et al (31) ICU DC 79 d [6.1–12.9] 5.9 d [4.5–13.2] p > 0.05
 Burtin et al (32) ICU DC 14 d [8–26] 11 d [5–21] p > 0.05
 Muehling et al (34) ICU DC 32 hr [12–293] 20 hr [14–336] p > 0.05
 Muehling et al (33) ICU DC 41 hr [12–129] 20 hr [14–336]
 Nava et al (39) ICU DC 33.2 ± 11.7 d 38.1 ± 14.3 d p > 0.05
DC = discharge.
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Intervention
Exercise interventions reported in the RCTs covered a wide 
range of techniques. Specifically, physical therapy strategies 
used in the trials varied in type, duration, frequency, and inten-
sity. In some trials patients in the intervention arms received 
a physical therapy package with treatment strategies progress-
ing from passive or active limb mobilization to ambulation 
based on their level of cooperation and strength. In other tri-
als patients received only specific treatment strategies such as 
electrical muscle stimulation or ergometry. Treatments of con-
trol groups varied largely between trials ranging from no sham 
treatment to general or standard physical therapy. Six trials 
(30, 33, 34, 37–39) failed to provide sufficient information on 
the type of physical therapy personnel involved in their stud-
ies, with one trial (37) stating that a member of the physical 
therapy team was involved. Four trials (31, 32, 35, 36) indicated 
that intervention groups received ICU exercise treatments by 
a physical therapist; one of these trials (31) used both physi-
cal and occupational therapy. Endpoint measures of tested out-
comes for the trials were compared at variable time points as 
reported in Table 4.
Effect on Peripheral Muscle Strength
General peripheral muscle strength was measured in five tri-
als (30–32, 35, 37) with the use of the Medical Research 
Council (MRC) scale (0–5) (53), the MRC score (54), or 
hand-held dynamometry. Data were pooled using a fixed 
effects model (Q = 0.46, p = 0.50) from two trials (30, 31) 
that used MRC scores. A small but significant positive effect 
was found for general peripheral muscle strength using the 
MRC score (pooled Hedges g = 0.27; 95% CI, 0.02, 0.52; 
n = 244 [127,117]) following ICU physical therapy (Fig. 2A).
Of the five trials, three (31, 32, 35) specifically used a 
hand-held dynamometer to gauge muscle strength at ICU 
discharge. Quadriceps strength measured using this technique 
indicated significant correlations between changes in lower 
limb strength and ambulation (r = 0.40) in one trial (32). 
The effect size for handgrip strength using this technique was 
calculated from two RCTs (31, 32). Data were pooled using a 
fixed effects model (Q = 0.01, p = 0.93).The effect size analysis 
(pooled Hedges g = 0.07; 95% CI –0.23, 0.38; n = 194 [100, 
94]) revealed no significant effect of physical therapy in criti-
cally ill patients on handgrip strength.
Effect on Respiratory Muscle Strength
Respiratory muscle strength was measured using maximal inspi-
ratory pressures in two trials (35, 36). Data were pooled using a 
fixed effects model (Q = 0.25, p = 0.62). The overall effect size 
on respiratory muscle strength calculated from these two trials 
indicated a significant moderate effect favoring ICU physical 
therapy (pooled Hedges g = 0.51; 95% CI 0.12, 0.89; n = 105 
[53, 52]) (Fig. 2A).
Effect on Physical Function
Two trials (31, 35) reported outcomes using the Barthel Index 
of Activities of Daily Living (55) score as an assessment tool for 
physical function, and pooled effect size was calculated (31, 35). 
Data were pooled using a fixed effects model (Q = 0.44, p = 0.51). 
The overall effect size on physical function outcomes indicated a 
significant small effect, favoring physical therapy for critically ill 
patients (pooled Hedges g = 0.46; 95% CI 0.13, 0.78; n = 143 [74, 
69]) (Fig. 2A).
Effect on Ventilator-Free Days
Effect on mechanical ventilation duration was identified from 
three trials (30–32) reporting number of days alive and breath-
ing without assistance (ventilator-free days) during the length 
of stay in the hospital and ICU during the course of critical 
illness. Data were pooled using a fixed effects model (Q = 1.51, 
p = 0.47). The overall effect size calculated from these three 
trials (30–32) revealed a significant small effect in improving 
ventilator-free days favoring ICU physical therapy (pooled 
Hedges g = 0.38; 95% CI 0.16, 0.59; n = 334 [172, 162]) (Fig. 
2A).
Effect on HRQOL
HRQOL was examined in two trials (32, 38) using the Medical 
Outcomes Study 36-Item Short Form survey score. Data were 
pooled using the fixed effects model (Q = 1.23, p = 0.27). The 
overall effect size for HRQOL calculated from two RCTs (32, 
38) was small but significant favoring ICU physical therapy 
(pooled Hedges g = 0.40; 95% CI 0.08, 0.71; n = 154 [78, 76]) 
(Fig. 2A).
Effect on Length of Hospital Stay
The length of stay in the hospital in number of days follow-
ing ICU physical therapy was examined in five trials (31–34, 
38) with data pooled using a fixed effects model (Q = 4.37, p 
= 0.36). There was a small reduction in the length of hospital 
stay with exercises for the critically ill while in the ICU (pooled 
Hedges g = –0.34; 95% CI –0.53, –0.15; n = 441 [226, 215]) 
(Fig. 2B).
Effect on Length of ICU Stay
Six trials (30–34, 39) were analyzed investigating the length of stay 
measured in number of days in the ICU following ICU physical 
therapy with data pooled using a fixed effects model (Q = 1.44, 
p = 0.92). All studies found a small reduction in ICU length of 
stay and reported a significant small effect (pooled Hedges g = 
–0.34; 95% CI –0.51, –0.18; n = 597 [285, 312]) (Fig. 2B).
As three trials (33, 34, 38) included in this analy-
sis investigated postoperative patients, another sub-
analysis excluding these studies was pooled and it was 
found that the reduction in ICU length of stay (pooled 
Hedges g = –0.31; 95% CI –0.51, –0.12; n = 414 [192,222]) 
remained significant but the effect on hospital length of 
stay was no longer apparent (pooled Hedges g = –0.20; 95% 
CI –0.43,0.13; n = 194 [100, 94]).
Effect on Mortality
Hospital mortality was investigated in three RCTs (31, 32, 39) with 
data pooled using a fixed effects model (Q = 1.71, p = 0.64). There 
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was no effect of ICU physical therapy on mortality (odds ratio, 
1.0; 95% CI 0.54, 1.85; n = 274 [120, 154]) (Fig. 2C).
In summary, there was a significant positive effect favoring ICU 
physical therapy to improve peripheral and respiratory muscle 
strength, quality of life, physical function, increase ventilator-
free days, reduce hospital, and ICU length of stay. However, 
there was no mortality benefit.
Clinical Relevance of Systematic Reviews
Five reviews (56–60) and one narrative review (61) were iden-
tified. The narrative review was excluded in the analysis. While 
the reviews reported search strategies, they were essentially 
narrative reviews with all research designs included, no inde-
pendent assessment, and no scoring or comment on the qual-
ity of the studies.
DISCUSSION
Early physical therapy in intensive care is increasingly recom-
mended (27, 28, 62, 63), and this review has found preliminary 
evidence that there are beneficial effects on muscle strength, 
physical function, HRQOL, ventilator-free days, and lengths of 
stay in the ICU and hospital. While this meta-analysis suggests 
that ICU physical therapy as a “program package” is beneficial, 
further studies are warranted to distinguish the effects of spe-
cific physical therapy strategies and to elucidate the mechanisms 
responsible for effectiveness.
Essentially as the procatabolic nature of acute critical ill-
ness is understood, physical therapy efforts have been directed 
at minimizing proteolysis and increasing protein synthesis. In 
addition to the increase in inflammatory mediators following 
catastrophic illness, an actual proinflammatory state develops 
with bed rest, with increased production of reactive oxygen 
species and a decrease in antioxidative defenses (64). One of 
the theories for the success of early exercise following critical 
illness or trauma is a decrease in the inflammatory load, i.e., a 
decrease in pro- (interleukin-6) and increase in anti- (interleu-
kin-10) inflammatory cytokines (65). Interventions analyzed 
in this study have been shown, in both critically ill and other 
populations to counteract protein catabolism in skeletal mus-
cles (52, 66) and improve microcirculation (51).
Although peripheral muscle strength is regarded as a sur-
rogate measure, weakness has been highly correlated with 
increased duration of mechanical ventilation (54), increased 
length of stay in intensive care, and increased hospital mortal-
ity (67). Maintaining or improving muscle strength was to cor-
relate significantly with functional measures (35).
This meta-analysis also demonstrated that ICU physical 
therapy increased ventilator-free days, which is known to be 
strongly associated with decreases in mortality (68). Overall, 
seven trials (30–34, 38, 39) included in the meta-analysis indi-
cated small effects in either reducing ICU or hospital length of 
stay potentially related to improved muscle strength and func-
tional ability. Length of stay in both the ICU and hospital are 
important performance indicators related to the use of critical 
care resources.
HRQOL represents an important patient-focused outcome 
(69). Upon ICU or hospital discharge, the failure to return to 
premorbid independent function can result in caregiver depen-
dency and associated societal stresses. Despite the use of varied 
exercise protocols including bedside cycling (32) and walking 
(38), overall this meta-analysis showed significant improvements 
in HRQOL of critically ill patients at hospital discharge follow-
ing the implementation of physical therapy in the ICU. Although 
improvements in HRQOL are fundamental, they are not related 
to physical recovery alone as cognitive function can be a contribu-
tor, a factor not tested in this meta-analysis.
Even though this meta-analysis has produced favorable 
findings toward implementation of physical therapy in the 
ICU, clinical trial findings used in the analysis can be consid-
erably critiqued. It is important to note that electrical muscle 
stimulation differs from other physical therapy strategies and 
primarily has a more direct physiological effect. Furthermore, 
blinding was not observed in this study, weakening its findings 
(30). Although ergometry showed improvement in lower limb 
muscle strength (32), delayed endpoint measures may not 
reflect the true effect of ergometry use in the ICU. Sedation 
interruption prior to administering physical therapy is not a 
common ICU practice, which was used in this study (31) may 
have magnified the overall effect size in improving physical 
function and strength and lengths of stay in the hospital and 
ICU. The variability in type, intensity, and duration of inter-
ventions across trials could not allow us to quantitate the pas-
sive or active therapy required to produce the positive effects 
elucidated in this meta-analysis.
Although “early ICU exercise” is still not clearly defined, ini-
tiation of physical therapy or the use of electrical muscle stim-
ulation or passive ranging within a few days of ICU admission 
are strategies performed earlier than the conventional start 
of exercises upon weaning of sedation or mechanical ventila-
tion (51, 52, 70). As physical therapy is a “complex health care 
intervention,” future clinical trials should model, validate, and 
describe exercise interventions using the MRC complex inter-
vention framework (71). This approach will help address the 
safe application of early exercises in critically ill patients espe-
cially in those presenting with sepsis syndromes.
Limitations
This meta-analysis has some limitations. First, there is inherent 
variability of patient case mix in the trials compared and thus fac-
tors such as covariates and risk stratification were not accounted 
for in the overall analysis. This must be taken into account before 
generalizing findings of this review to the critically ill population. 
Second, due to the heterogeneity of outcome measures utilized, 
some meta-analyses comprised only two to three studies. There-
fore, results of these analyses should be considered with caution. 
In addition, the outcome measures within the pooled trials var-
ied in timing and type. Third, the reliability of the overall pooled 
effects also needs to be carefully considered as a wide range of 
interventional measures in terms of type, intensity, and duration 
were used across trials.
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Lastly, the RCTs included in these analyses were not large and 
had a number of methodological shortcomings and reduced 
quality scoring that were not taken into account in the overall 
analysis. Biases within individual studies (e.g., dropouts) were 
acknowledged but not addressed in the actual aggregation of 
data as a sensitivity analysis could not be performed due to 
insufficient information from the trials.
Further Research
Even though it is apparent that ICU physical therapy appears 
to confer benefits, it is imperative that future clinical trials 
investigate physical therapy in the ICU on a larger scale with 
stringent methodological standards to provide conclusive 
evidence on the positive effects of its implementation to the 
critically ill population. It is also important to investigate other 
mechanisms such as the ideal dose and timing of exercise, the 
effect of exercise on specific conditions, and the mechanisms of 
specific interventions.
CONCLUSION
Physical therapy in the ICU can be seen as an important com-
ponent of critical care management. Current evidence suggests 
that ICU physical therapy reduces ICU and hospital lengths of 
stay, increases the number of ventilator-free days, and improves 
peripheral and respiratory muscle strength, physical function, and 
HRQOL. Future research on ICU physical therapy should investi-
gate short-term effects, as well as related long-term outcomes, to 
advocate for the efficacy of early exercise in critical illness.
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he past 10 yr have seen a paradigm shift in sedation 
management in the ICU, with ICUs becoming places 
of“wakefulness” rather than immobility and uncon-
sciousness (1). Less-sedated patients can potentially mobilize 
and participate in rehabilitation, but a complex range of factors 
may limit this including pain, joint stiffness, delirium, neuropa-
thy, and muscle dysfunction (2). Critical illness myopathy has 
been a focus of particular interest and is likely to result from mul-
tiple factors related to inflammation, nutrition, and immobility 
(3, 4). Muscle weakness contributes to the profound fatigue, dis-
ability, and reduced quality of life experienced by many patients 
for months or years following ICU discharge (5, 6).
The biological mechanisms underlying muscle dysfunction 
are a focus of research interest in the hope that novel therapies 
or treatment strategies might reverse or attenuate acute mus-
cle dysfunction, or improve the trajectory of recovery (4, 7). 
Conceptually, one of the simplest and plausible interventions 
is to provide some form of physical therapy. Schweickert et 
al (8) first generated widespread interest in a small random-
ized trial (104 participants) finding a large effect size (24% 
absolute improvement) in an important disability measure 
(return to functional independence). In this issue of Critical 
Care Medicine, Kayambu et al (9) report a systematic review 
and meta-analysis of published trials of physical therapy in 
ICU. Their work is timely because as they point out, “it is 
important to review the existing studies in this area to gauge 
the quality of evidence and identify research gaps for future 
studies.” Strengths of their review include the use of a quality 
assessment tool designed for physical therapy trials, the PEDro 
scale (10), and the calculation of estimated effect sizes using 
Hedges g statistic. They also explored effects on outcomes 
ranging from physiological variables to mortality. The results 
suggest that physical therapy has a positive effect on quality of 
life, physical function, peripheral muscle strength, respiratory 
muscle strength, length of hospital and ICU stay, and duration 
of ventilation, but did not affect mortality. The authors found 
only ten randomized or quasirandomized trials, which used a 
wide variety of interventions and outcome measures. The total 
number of patients was only 790 with individual trials ranging 
from 24 to140 participants; the methodological quality of most 
trials was low. This useful review clearly indicates the need for 
further trials and highlights the importance of design issues to 
ensure internal and external validity. These can usefully be con-
sidered under the “PICO” headings (Population; Intervention; 
Control; Outcome) that underpin most clinical trial questions.
Population
Critically ill populations are inherently heterogeneous with 
wide-ranging admission diagnoses, premorbid conditions, and 
preillness disability. In addition, illness severity at admission 
and the subsequent severity and number of organ failures may 
vary. These issues were inconsistently reported in the reviewed 
studies, and future rehabilitation trials should include measures 
of baseline status that include acute and chronic illnesses and 
ideally preillness disability. This is particularly important when 
considering different patient cohorts and/or interventions 
implemented at different time points during critical illness. For 
example, a young previously fit patient requiring a few hours 
of ventilation is likely to respond differently to a particular 
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rehabilitation intervention compared with an elderly patient 
with chronic obstructive pulmonary disease requiring weeks of 
organ support. These issues could have influenced the negative 
results of some published rehabilitation studies, including 
trials of post-ICU follow-up clinics (11) and posthospital 
discharge exercise programmes (12). A priori stratification 
or clearly defined eligibility criteria may improve external 
generalizability of trial results.
Intervention
A fundamental question is “what is rehabilitation?” Kayambu 
et al focused only on “exercise” rehabilitation, but even this 
simple term included a wide range of different interventions. 
Rehabilitation encompasses many factors including nutrition, 
speech and language therapy, occupational therapy, and psy-
chological interventions, not just physical therapy. In addition, 
the frequency of interventions can vary, and the service model 
through which they are delivered may differ. Importantly, the 
individuals delivering the intervention might be an important 
covariate in relation to training, experience, consistency of 
contact, or subtle factors that could improve patient mood or 
well-being. Rehabilitation is a complex health care interven-
tion; research in this area presents challenges that have not 
previously been widely appreciated in critical care research. 
The Medical Research Council has developed a “complex 
intervention framework,” which makes several recommen-
dations in relation to intervention development and evalu-
ation (13). For example, it is important to carefully develop 
the “construct” comprising the intervention before testing it 
in a trial, often using quantitative and qualitative approaches, 
involving a range of stakeholders, and an iterative process of 
testing. Strong emphasis is placed on describing “process,” in 
other words “what actually happened” in terms of the nature, 
the frequency, and the timing of interventions. This is particu-
larly important in the critically ill because many patients may 
be unable or unwilling to participate in some or all aspects of 
the intervention. Few of the studies reviewed by Kayambu et al 
described the intervention actually delivered in detail. Without 
this information, translating a positive effect into routine prac-
tice is difficult, severely limiting external validity. Similarly, it 
is difficult to know whether a negative result occurred because 
an intervention did not work or was not delivered as intended.
Control Groups
In complex intervention trials, it is equally important to mea-
sure control-group processes. This information is vital to assess 
external validity, particularly for interventions that compare 
the intensity of a treatment or a service reorganization. Very 
few published studies have described control-group treatment 
in sufficient detail.
Outcome
A feature of the studies included in the meta-analyses was the 
large range of outcomes used. Various outcome measures have 
been used to capture quality of life and disability in critical care 
research, few of which were developed or validated specifically 
for this population. It has previously been highlighted that reha-
bilitation should be evaluated across multiple domains (14). 
Ideally, the outcome measures chosen should reflect recommen-
dations in the International Classification of Functioning, Dis-
ability and Health (WHO ICF), which acknowledges separate 
domains relating to body functions and structure, activity, and 
participation (15). Future work to develop and refine outcome 
measures that have sufficient responsiveness and sensitivity, and 
are validated in a critical care population, seems logical before 
undertaking further expensive trials. Input from multiple stake-
holders, especially patients and their families, will be important.
In summary, focusing on rehabilitation interventions that 
improve outcomes beyond short-term mortality is a timely 
step forward for critical care. The assimilated evidence relating 
to physical therapy serves to illustrate the complexity of under-
taking this type of research, and the challenges to be overcome 
in generating externally valid and translatable evidence.
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Early rehabilitation in sepsis: a prospective
randomised controlled trial investigating
functional and physiological outcomes The
i-PERFORM Trial (Protocol Article)
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Abstract
Background: Patients with sepsis syndromes in comparison to general intensive care patients can have worse
outcomes for physical function, quality of life and survival. Early intensive care rehabilitation can improve the
outcome in general Intensive Care Unit (ICU) patients, however no investigations have specifically looked at
patients with sepsis syndromes. The ‘i-PERFORM Trial’ will investigate if early targeted rehabilitation is both safe and
effective in patients with sepsis syndromes admitted to ICU.
Methods/Design: A single-centred blinded randomized controlled trial will be conducted in Brisbane, Australia.
Participants (n = 252) will include those ≥ 18 years, mechanically ventilated for ≥ 48 hours and diagnosed with a
sepsis syndrome. Participants will be randomised to an intervention arm which will undergo an early targeted
rehabilitation program according to the level of arousal, strength and cardiovascular stability and a control group
which will receive normal care.
The primary outcome measures will be physical function tests on discharge from ICU (The Acute Care Index of
Function and The Physical Function ICU Test). Health-related quality of life will be measured using the Short Form-
36 and the psychological component will be tested using The Hospital Anxiety and Depression Scale. Secondary
measures will include inflammatory biomarkers; Interleukin-6, Interleukin-10 and Tumour Necrosis Factor-a,
peripheral blood mitochondrial DNA content and lactate, fat free muscle mass, tissue oxygenation and
microcirculatory flow.
Discussion: The ‘i-PERFORM Trial’ will determine whether early rehabilitation for patients with sepsis is effective at
improving patient outcomes with functional and physiological parameters reflecting long and short-term effects of
early exercise and the safety in its application in critical illness.
Trial Registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12610000808044
Background
Critical Illness and trauma are the primary sources of
intensive care unit admissions. An estimated 2-11% of
these patients require prolonged stays in the ICU which
accounts for 25-45% of total ICU days [1]. Survivors of
intensive care, especially those with prolonged admissions,
may exhibit severe psychological and physical problems
[2] and have a lower health-related quality of life up to
one year following discharge from the hospital [3]. Almost
a quarter of these patients are either admitted with or
develop sepsis i.e. a severe, specific inflammatory response
to infection, during the course of their stay in the ICU
with major immediate and long-term effects on morbidity
and mortality [4]. Patients with sepsis can have a worse
outcome both in terms of overall functioning and mortal-
ity rates [5]. There is evidence that specific decreases in
muscle mass and muscle force occur in sepsis syndromes
caused by a variety of mechanisms [6]. This has major
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effects on the health and productivity of survivors as well
as ultimately impact on the availability of ICU and hospital
beds, surgical waiting lists, health costs and society.
Hypothesising that light to moderate exercise can par-
tially reverse this condition without causing harm to cri-
tically ill patients, several exercise trials conducted in
general intensive care patients have indicated positive
findings that early intervention with exercise is able to
prevent critical illness weakness syndromes, loss of mus-
cle mass, decrease duration of mechanical ventilation,
length of hospital and ICU stay and improve overall qual-
ity of life [7]. Specifically however, it is important to
investigate early rehabilitation in patients with sepsis syn-
dromes as the inflammatory process in sepsis can aggra-
vate and accelerate the rate of muscle wasting in addition
to the immobility associated with the disease in its early
stages. It is equally important to ensure that early exer-
cise in sepsis does not result in oxidative stress or cause
substantial tissue injury potentially worsening the inflam-
matory reaction. The physiological reasons for improve-
ment or adverse effects require investigation (Figure 1).
Sepsis Syndrome
Sepsis is a systemic inflammatory response associated
with an infectious insult. It is the leading cause of death
in critically ill patients and is often associated multi
organ failure [8]. The inflammatory cytokines associated
with sepsis such as Interleukin-6 (IL-6), Interleukin-10
(IL-10) and Interleukin-1b (IL-1b) are found to be corre-
lated with the severity of the disease, the evolution of
organ failure as measured by the SOFA score and
mortality [9]. Physiological responses to inflammation as
described in Table 1 in addition to the presence of a sus-
pected or proven infection has been an internationally
accepted definition for “Sepsis” [8,10]. Increasing sepsis
severity correlates with increasing mortality, rising from
25-30% for severe sepsis to 40-70% for septic shock [11].
Systemic Inflammation and Proteolysis
The aggressive inflammatory process that occurs during
sepsis also affects muscle force, muscle mass and ulti-
mately physical function [12,13]. Persistent elevation of
circulating levels of Interleukin-6 (IL-6) have been
known to infiltrate myocytes with inflammatory factors
such as prostaglandins leading to proteolysis, myocyte
degeneration, and muscle atrophy [14]. Tumour Necro-
sis factor-a (TNF-a) overexpression in sepsis is linked
to the development of cachexia [15] through endothelial
dysfunction, leading to myocyte apoptosis, reduction in
skeletal muscle mass, weakness and myopathy. It has
been hypothesised that the prevention of excessive
release of pro-inflammatory cytokines [15], and activa-
tion of proteolytic pathways leading to limitation of
free-radical generation [16] may inhibit the catabolic
skeletal muscle changes in sepsis [17] and thus critical
illness weakness syndromes.
Inflammatory Biomarkers and Exercise
Interleukin-10 (IL-10); an anti-inflammatory cytokine is
thought to inhibit proteolysis [18] while low levels have
been postulated to lead to excessive inflammation and
muscle damage [19]. IL-10 is known to attenuate the
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Figure 1 Impact of delayed ICU rehabilitation in early sepsis. This diagram illustrates the sequential impact of delayed rehabilitation for
patients with sepsis as a result of the inflammatory processes and the detrimental short and long-term outcomes.
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synthesis of TNF-a surface receptor and its suppressive
effects may be beneficial in pathology that results from
inflammatory dysregulation such as in sepsis.
A number of studies [20-22] in healthy and other dis-
eased populations; such as in chronic heart failure, have
shown that aerobic and resisted exercise alters pro-
inflammatory cytokines specifically decreasing IL-6 and
TNF-a and increasing IL-10. Simple physical exercises
such as repetitive passive muscle stretches have been
shown to decrease pro-inflammatory cytokine (IL-6),
increase anti-inflammatory cytokine (IL-10) and
improve the IL-10/TNF-a ratio in chronic critically ill
patients [23]. The use of electrical muscle stimulation
on major muscle groups has been shown to attenuate
the production of TNF-a [24]. It is therefore important
to investigate the effect of exercise on IL-10 in sepsis.
Our pilot study tested 20 patients with sepsis syndromes
randomised into a treatment (proactive rehabilitation) and
a control group. The trial demonstrated significant
decreases (-7.2%) in the percentage fat free mass in the
control group with no decreases in the intervention group.
Significant increases in IL-10 (mean difference 12.1 [SE
+/- 2.1], p < 0.01) were found in the treatment group.
Clinically relevant findings from this study indicate early
exercise reduces loss of muscle mass in sepsis [25].
Oxidative stress
Oxygen-derived free radicals play an important role in
the development and progression of disease in critically
ill patients resulting in increases in the level of Reactive
Oxygen Species (ROS) [26] or decreases in antioxidant
defences [27] causing oxidative stress [28]. ROS can play
a pivotal role in stimulating the inflammatory system by
causing an increase in cytokines (e.g. Interleukins and
TNF-a). Both cytokines and ROS can enter the circula-
tion and mediate systemic inflammatory responses
linked with clinical conditions [29] which are inter-
related in causing muscle proteolysis resulting in the
induction of sepsis-induced myopathy [6].
In patients with sepsis, antioxidant depletion has been
found to be associated with mitochondrial dysfunction
where oxidative stress generates bioenergetic failure [30]
which may affect changes in mitochondrial DNA (mtDNA)
quantity [31], as well as increase mutations or deletions.
This has been hypothesised to be part of the mechanism
underlying multiple organ failure and death [32,33].
Oxidative stress also acts as an atrophic stimulus in an
unloaded muscle [34] promoting wasting by modifying
redox-sensitive processes in its muscle fibres such as dur-
ing periods of disuse in locomotor skeletal muscles [35]
and the unloaded diaphragm during prolonged mechani-
cal ventilation [36,37]. Currently, however, there is no
published data on the effects of exercise on oxidative
stress on the critically ill population particularly in sepsis.
Illness Severity
Hyperlactaemia is a marker of illness severity in sepsis
[38,39]. During early sepsis, perturbation of glycolytic
mechanisms can occur. In septic shock, high concentra-
tions of circulating adrenaline can derive large quantities
of lactate out of skeletal muscles, overwhelming lactate
clearance mechanisms with resultant, hyperlactaemia
[40,41]. The effect of light exercise on lactate clearance
mechanisms in early sepsis remains to be investigated.
Microcirculation and Muscle Oxygenation
Sepsis impairs microcirculatory function causing tissue
hypoxia [42]. This, combined with blood flow diversion
from less important tissues to vital organs [43] promotes
decreased muscular oxygen extraction [44]. However,
the use of electrical stimulation [45] on major muscle
groups and a physical exercise rehabilitation program in
chronic heart failure patients [46] have demonstrated
short-term beneficial systemic effects on microcircula-
tion. The effect of early activity on microcirculation in
patients with sepsis should be further investigated.
Early Rehabilitation may Modulate Detrimental Effects of
Sepsis
The roles of pro-inflammatory cytokines, mitochondrial
changes and muscle proteolysis in causing sepsis-
induced myopathy in critically ill patients are
Table 1 Criteria for SIRS and Sepsis syndromes (modified from Dellinger et al [57])
Syndrome Criteria Mortality
Systemic inflammatory response syndrome (SIRS) any
two or more of the following criteria
▪ HR>90 bpm
▪ RR>20/min or PaCO2< 32 mmHg
▪ WCC< 4 × 109 cells/L or > 12 × 109 cells/L or > 10% immature bands 12,000
▪ T>38°C or <36°C
Sepsis ▪ SIRS + proven infection 15%
Severe sepsis ▪ Sepsis + failure of one or more organs 20%
Septic shock ▪ Severe sepsis + cardiovascular failure despite adequate fluid resuscitation
(usually SABP <90 mmHg or >40 mmHg from baseline)
45%
HR; Heart rate, RR; Respiratory Rate; WCC; White Cell Count; T; Temperature, SIRS; Systemic Inflammatory Response Syndrome, SABP; Systolic Arterial Blood
Pressure.
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hypothesised from animal models [6,14]. It is postulated
that exercise can modulate cytokine levels [47], ROS
production [48] and ATP levels [49] in patients with
sepsis. In conjunction with an early mobility protocol,
ambulation during mechanical ventilation in the early
stages of critical illness is becoming widely practiced
[50-52], especially with interruption of sedation [53-55].
Conservatively, simple passive movements [56] and neu-
romuscular electrical stimulation [45] as a precursor to
active mobilisation can induce microcirculatory changes
that may attenuate the anti-inflammatory effects in early
sepsis.
Overall, early rehabilitation in critical illness seems to
show reduced time on the ventilator, improved quality
of life and reduced hospital and ICU stay [7] but this is
not specific to sepsis. Furthermore, the short-term sys-
temic effects of exercise for ICU patients remain highly
speculative and debatable. The impact of exercise in the
early stages of critical illness on effects such as oxidative
stress and microcirculatory alterations have been unex-
plored and speculated from other populations. Exploring
these physiological factors in response to exercise can
contribute to determining the safety of early rehabilita-
tion in sepsis.
Hypotheses and Aims
The primary research hypothesis of the “i-PERFORM
Trial” is that patients with defined sepsis syndromes [57]
in the ICU who participate in an early targeted rehabilita-
tion program will have improved physical function and
an improved quality of life. The secondary hypotheses is
that there will be systemic effects underlying primary
improvements which will include; increased fat free mass;
decreased pro-inflammatory and increased anti-inflam-
matory cytokines; increased peripheral blood mitochon-
drial DNA content and reduced blood lactate levels; and
improved tissue oxygenation and microcirculation flow.
Methods/Design
Methods and Design
The i-PERFORM Trial is a prospective double blinded
randomised controlled trial (RCT) in patients with sep-
sis syndromes randomised into an early rehabilitation
intervention arm or a control arm during the course of
ICU stay. All outcomes will be measured by a blinded
assessor from the research team. This study is being
conducted in a quaternary level general Intensive Care
Unit at the Royal Brisbane and Women’s Hospital
(RBWH), Brisbane, Queensland, Australia. The Human
Research Ethics Committee at RBWH and the Medical
Research Ethics Committee at The University of
Queensland have approved this study. The study proto-
col is registered with the Australian New Zealand Clini-
cal Trials Registry (ANZCTR). Figure 2 illustrates the
methodology design for this RCT through recommenda-
tions from CONSORT (Consolidated Standards of
Reporting Trials) Statement.
Inclusion Criteria
To be eligible for recruitment in the study, participants
must be aged 18 years and above; ventilated for ≥ 48
hours; diagnosed with a sepsis syndrome or have a high
clinical suspicion of sepsis [57]. Patients with head inju-
ries, burns, spinal injuries, and multiple fractured lower
limbs requiring specific rehabilitation regimes and
patients with septic shock who are unresponsive to max-
imal treatment and those who are moribund or have an
expected mortality within 48 hours will be excluded.
Recruitment, Randomisation and Blinding
Eligible patients will be identified and consent will be
sought by the chief and principal investigators, with next
of kin or substitute decision maker. Participants recruited
will be randomized into control and intervention arms
using computer generated randomization; http://www.
randomization.com/. The randomization sequence will
be generated and re-identifiable serial numbers will be
assigned by a research personnel not involved in the
study. They will be concealed from consent designee
research staff for group allocation to prevent selection
bias and protected by an electronic password. Partici-
pants, substitute decision makers and outcome assessors
will be blinded to group allocation to avoid influence
over treatment effect. Blinding of the treating phy-
siotherapist and health care providers cannot be ensured
due to the nature of the research intervention.
Demographics
Patient demographic information will be collected at base-
line (recruitment) and ICU and hospital discharge and will
include; age, gender, primary reason for readmission to
ICU, Acute Physiological and Chronic Health Evaluation
II (APACHE II)[58], Sequential Organ Failure Assessment
(SOFA) score [59], Charlson Comorbidity Index [60], time
on mechanical ventilation, length of ICU and hospital stay,
readmissions to ICU and 90-day mortality.
Intervention Arm
Participants randomised to the intervention arm of the
trial will undergo a specific targeted rehabilitation pro-
gram prescribed by the treating ICU physiotherapist for
30 minutes, one to two times daily until discharge from
the ICU within 48 hours of the diagnosis of sepsis
(Early Intervention Arm). The rehabilitation program
will comprise of passive or active range of motion exer-
cises, resistive exercises, electrical muscle stimulation to
major muscle groups, leg or arm ergometry, sitting out
of bed, tilt table therapy and ambulation with assistance.
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The rehabilitation strategy for the participants in the
intervention arm has been carefully planned with con-
sideration for different levels of cardiovascular stability,
ability of the patient to co-operate, and existing evidence
regarding rehabilitation techniques and mobilisation
strategies in intensive care. It will be administered and
progressed by the discretion of the physiotherapist,
according to individual acuity of illness and level of co-
operation as based on the Ramsay sedation score which
will account for the intervention progression stages. If
the patient deteriorates, a lower level of activity will be
given. Table 2 summarises the intervention strategies.
Control Arm
Participants allocated to the control arm will receive
standard ICU care. The participants randomised to this
group will not receive active rehabilitation from the
research team, i.e. will not be given targeted exercises
early in their disease process upon recruitment. However,
they will continue to receive simple and less regular
mobilisation activities from other sources, as part of the
usual ICU care such as sitting out of bed or ambulation
immediately prior to discharge from the unit. The time
involved in these activities and the type of activities per-
formed will be recorded and compared between groups.
Safety and Withdrawal criteria
A safety audit will be completed on patients in the reha-
bilitation group to monitor any adverse events [61] dur-
ing rehabilitation. Data will be gathered from the
patient’s IntelliVue bedside monitor MP70 (Phillips)
every 10 seconds and printed out for 10 minutes prior,
during and post rehabilitation. The intra-arterial line
will be zeroed 10 minutes prior to exercise. A withdra-
wal criterion with a checklist of adverse events will be
used for the clinical decision of withdrawal or modifica-
tion of exercise intervention.
Primary Outcome Measures
All primary outcomes will be measured at baseline
(recruitment) and at ICU discharge and quality of life at
6 months post hospital discharge. The primary outcome
Figure 2 Research methodology sequence diagram. The inclusion criteria are as follows: Age ≥ 18 yrs and remain ventilated for ≥ 48 hours;
present with documented sepsis or high clinical suspicion of sepsis. Patients with head injuries, burns, spinal injuries, and multiple fractured
lower limbs, those with septic shock unresponsive to treatment, moribund or with expected mortality within 48 hours will be excluded.
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measures will report the level of physical functioning
and quality of life (long-term effects) of the participants.
Physical function will be measured using the Acute Care
Index of Function (ACIF) and the Physical Function
ICU Test (PFIT).
The ACIF will essentially rate simple physical function
(transfer bed to chair, sit to stand independently) of the
patient on leaving the ICU [62]. The PFIT is a newly
developed clinical tool for testing functional strength
and endurance capacity in ICU patients. It consists of a
battery of tests assessing endurance, muscle strength,
cardiovascular capacity and functional ability which are
domain representative of physical function and specific
for the use of higher functional assessment in the criti-
cally ill [63]. These have been chosen as corresponding
measuring instruments as they have demonstrated relia-
bility, validity and responsiveness in the ICU population
[63,64].
Quality of life will be measured using the Short Form-
36 (SF-36) Health Survey Questionnaire. Information
from the next of kin will be used to provide proxy
scores which have been demonstrated to have good
reliability and validity [65].
The constructs of psychological well being will be
measured using the anxiety subscale of the Hospital
Anxiety and Depression Scale (HADS) as psychological
wellbeing is known to be highly correlated to functional
physical outcomes [66].
Secondary Outcome Measures
The secondary outcome measures will report on the phy-
siological factors (short-term effects) illustrating underly-
ing mechanisms of early intervention undertaken in the
study. Blood samples (8 ml) will be obtained from the
patients’ arterial line, for the analysis of cytokines, blood
lactate and mtDNA levels pre and post intervention dur-
ing the trial. All blood samples taken will be centrifuged
(Spintron GT-25E/LL, Australia) for 15 minutes at 3000
rpm, within 20 minutes of collection. Plasma from the
whole blood for the cytokine analysis and peripheral
blood mononuclear cells (PBMC) forming the buffy coat
pellet for DNA isolation will be stored at -80°C.
Inflammatory Biomarkers
Biomarkers will be measured before intervention and 30
minutes post intervention daily (week 1) and thereafter
twice weekly (till ICU discharge). The acute inflamma-
tory response of early exercise in sepsis will be mea-
sured by changes in levels of pro-inflammatory
cytokines (IL-6 and TNF-a) and anti-inflammatory cyto-
kine (IL-10). IL-6, IL-10 and TNF-a will be measured
Table 2 Intervention Strategies for early targeted rehabilitation for the critically ill.
Ramsay Sedation
Scale
Stages of
exercise
progression
Conditions Type of Intervention Recommended Exercise
Prescription
6-4 Stage 1 Sedated Passive Range of Motion with stretch reflex to upper
and lower limbs
30 Mins/day
Electrical Muscle Stimulation to major muscle groups 30 Mins/day
3-2 Stage 2 Inotropic
Dependence
Active Range of Motion/Lightly resisted with upper and
lower limb
10 Mins × 2/day
Electrical Muscle Stimulation to major muscle groups 30 Mins/day
Sitting up in Bed with assistance as tolerated 30 Mins × 2/day
Sitting on Edge of Bed 10 Mins × 2/day
2 Stage 3 Weight Active Range of Motion/Lightly resisted with upper and
lower limb
10 Mins × 2/day
Bearing Electrical Muscle Stimulation to major muscle groups 30 Mins/day
Muscle Strength Sitting On Edge of Bed 10 Mins × 2/day
Grade < 3 Sitting Out of Bed with assistance 60 Mins × 2/day
Lower Limb Ergometry 15 Mins × 2/day
Tilt Table Therapy 30 Mins/day
2 Stage 4 Weight Active Range of Motion/Lightly resisted with upper and
lower limb
10 Mins × 2/day
Bearing Electrical muscle stimulation to major muscle groups 30 Mins/day
Muscle Strength Sitting On Edge of Bed 10 Mins/day
Grade > 3 Sitting Out of Bed 30 Mins/day
Upper Limb Ergometry (low level resistance) 15 Mins/day
Lower Limb Ergometry 15 Mins × 2/day
Ambulation with assistive device and therapist 30 Mins × 2/day
The Intervention strategies act as a guide for the execution of early exercises for the patients with sepsis syndromes based on the level of alertness according to
the Ramsay Sedation Scale
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from plasma samples with the Milliplex cytokine panels
from Millipore (Billerica, MA, USA) using a Luminex
100 assay, with inter and intra-assay CV < 7%.
Muscle Mass
Fat free mass will account for muscle mass (lean tissue)
measured at baseline (week 0) and weekly thereafter (till
ICU discharge) using the Multi-Frequency Bioelectrical
Impedance Spectroscopy (BIS) Machine (ImpediMed
SFB7, ImpediMed Ltd, Brisbane, Australia). Measure-
ments will be taken at a standardised time of the day as
practicable for validity [67] and at standardised anatomi-
cal landmarks for reproducibility of results [68]. Pairs of
gel electrodes will be placed on the hand and foot on
the right side of the body with the participant positioned
in supine. ICU monitoring will continue during mea-
surement without interference [69]. An estimate will be
made of the critically ill patients’ fluid balance. Urinary
catheters will be emptied, prior to measurement. If sub-
jects are known to have ascites, a pleural effusion or a
renal replacement therapy, measurements will not be
done. Percentage fat free mass will be measured in tri-
plicate and analysed to reflect if proteolysis had
occurred and resulted in the loss of muscle mass [70].
Oxidative Stress Markers
Oxidative stress will be determined through changes in
mitochondrial DNA levels. Mitochondrial DNA copy
number in the PBMC will be measured by determining
relative amounts of mitochondrial to nuclear DNA
using quantitative real-time PCR. Mitochondrial DNA
(mtDNA) levels in the peripheral blood will be mea-
sured at baseline (week 0) and weekly thereafter (till
ICU discharge). Total DNA from the blood sample will
be extracted from the buffycoat using a DNA Analysis
Kit (Machery Nagel Blood XL, Germany) and mtDNA
quantity will be analysed using SYBR Green Master Mix
Real Time PCR kit (Applied Biosystems, Warrington,
United Kingdom). Triplicate analysis of blood samples
will be conducted and trends of longitudinal increases
in mitochondrial DNA levels will be reported.
Illness Severity
Blood lactate levels will be measured before intervention
and 30 minutes post intervention with arterial blood
using a standard benchtop Arterial Blood Gas Analyser
(ABL 700 Series gas Machines, RADIOMETER, Copen-
hagen, Denmark). Lactate concentration trends will be
used to analyse lactate clearance rates [71] as a marker
of illness severity.
Muscle oxygenation and Microcirculation
Muscle oxygenation and microcirculatory changes will
be measured using the Near Infrared Oxygenation
(NIR0) Monitor and the Orthogonal Polarization Spec-
tral (OPS) Microscan respectively.
Muscle (tissue) oxygenation will be measured pre and
post intervention daily using the NIRO (NIRO-200,
Hamamatsu, Japan) with a probe placed on a peripheral
muscle to detect levels of muscle oxygenation (StO2)
following acute exercise [72]. Muscle oxygen consump-
tion will be further analysed through induced ischemia
and active hyperaemia [73]. A pneumatic cuff will be
placed above the elbow and inflated to 50 mmHg above
the patient’s systolic blood pressure and the occlusion
will be retained for 3 minutes inducing local ischemia.
StO2 will be recorded continuously for 3 minutes before,
during and after arterial occlusion [44].
Improvements in microcirculation following acute
exercise will be measured pre and post intervention ses-
sion once weekly using the OPS MicroScan (Microvision
Medical Inc, Wallingford, PA, USA) with a non-invasive
probe placed in the sub-lingual space to detect func-
tional capillary density and blood flow velocity as indica-
tors of microcirculatory function [74] using video
images. Five video sequences per patient will be graded
by 3 independent observers and assigned a flow velocity
score to each of the 4 quadrants of each image [75].
Capillary density will be calculated using superimposed
calibrated grid of vertical and horizontal lines on the
images of number of small (< 20 μm) vessels crossing
the lines of the grid divided by the total length of the
lines, yielding the number of small vessels per milli-
metre [76]. An average of these 5 readings will be calcu-
lated for discrete capillary density value for each time
point at which imaging was performed.
Confounding Variables
Critical illness neuropathy and myopathy is a possible
feature of critically ill patients. Formal tests to estab-
lish critical illness neuropathy or myopathy can be
painful, invasive, time consuming and expensive [6].
Such formal diagnosis may not implicate any pertinent
findings in this trial. Basic physiotherapy assessment
muscle testing done as part of regular intervention
assessment using the Medical Research Council or
Manual Muscle Test will detect any possible develop-
ment of weakness without requirements for formal
diagnosis and is accepted as configuration of critical
illness polyneuromyopathy [77].
Sample size
Clinically important difference and the standard devia-
tion estimates used in our sample size calculations were
based on a previous clinical trial [64]. Sample size was
calculated using the ACIF [62] for hypothesis testing
with a type I error rate of 0.05 and 0.025 with Bonfer-
roni adjustment and type II error rate of 0.20 (80%
power). A minimum of 35 per group (70 total) is
required to detect a minimum clinical difference (effect
size) of 0.7 for physical functional outcomes which will
yield clinically significant results for the main hypothesis
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achievable by intervention. Projection of the sample size
after adjusting for attrition or withdrawal rates, partici-
pation refusals and possible death due to sepsis; based
on admission and mortality rates in the RBWH ICU,
126 patients per group (252 in total) will be required.
A smaller number of patients will undergo mtDNA,
tissue oxygenation and microcirculatory measurements
as these will be tested as pilot investigations. To test
these secondary hypotheses, a minimum of 58 per group
is required to detect a minimum clinical difference of
0.8 for clinically significant changes in mitochondrial
DNA [78], a minimum 91 per group is required to
detect a clinical difference of 0.4 and 59 per group is
required to detect a minimum clinical difference of 0.7
for clinically significant changes in tissue oxygenation
[45] and microcirculation [46] respectively, all corrected
for with Bonferroni adjustment of 0.025.
Data Management and Statistical Analysis
A baseline comparison using both student t-tests and
chi-square for equal proportions of demographic data
will be done between groups at enrolment. Data will
be analyzed using SPSS Version 17.0. The distribution,
range of scores and heterogeneity will be examined for
participants in both groups. Mean changes scores,
standard deviations and 95% confidence intervals will
be calculated and specific analysis detailed under each
outcome measure will be performed. Repeated mea-
sures, between/within analysis of variance (ANOVA)
will be performed to investigate for the main effects of
time and group. Post hoc analyses will then be per-
formed to ascertain where the differences occur. A
Bonferroni correction will be used as the post hoc
measure as there are multiple outcome measures. Ana-
lysis will be by both intention-to-treat and per-proto-
col method. Any violations of the protocol will be
noted. Statistical significance will be set at p < 0.05
and p < 0.025(two-tailed). All efforts will be taken to
avoid missing data but if it occurs a carry forward
imputation will be done and linear mixed modelling
will be used for overall analysis. Reasons for loss of fol-
low up will be recorded.
Discussion
The i-PERFORM Trial is an original study in investigat-
ing early rehabilitation in patients presenting with sepsis
syndromes. Fully powered to be a larger trial from the
pilot study, this RCT has been modified to include
detailed and intensive interventional measures and
further outcome measures; SF-36, PFIT, blood lactate,
mitochondrial DNA, muscle oxygenation and microcir-
culation dynamics.
Controversies still exist with regards to the implemen-
tation of early exercise in critically ill patients despite
growing evidence in the literature [7,79]. Introducing
early rehabilitation in patients with sepsis syndromes is
challenging and the direct physiological implications are
unknown. Novel findings from the i-PERFORM Trial
involving physiological markers of oxidative stress and
microcirculation will translate better understanding of
the short-term systemic effects of early exercise in criti-
cal illness. The mechanisms and associations between
early exercise and the inflammatory effects of sepsis
explored in this trial will implicate on future rehabilita-
tion management of patients with sepsis in intensive
care units.
Key Messages
• The i-PERFORM RCT will determine whether
early targeted rehabilitation will achieve a higher
functional level and an improved quality of life in
patients with sepsis.
• Participants in the intervention arm will receive
early, targeted, individualised rehabilitation program
comprising of passive, active and resisted exercises,
electrical stimulation to major lower limb muscles,
sitting out of bed with exercises and tilt-tabling to
improve orthostatic reflexes, ergometry exercises for
upper and lower limbs and ambulation.
• Physical functional capacity, quality of life, psycho-
logical wellbeing, inflammatory biomarkers, oxidative
stress markers, illness severity, muscle oxygenation
and microcirculation will be assessed using standard
instruments at specific times before, during and after
exercise sessions.
• Short-term systemic findings from early rehabilita-
tion in sepsis will be novel and will translate better
understanding of the acute effects of early exercise
in critical illness.
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Narrative Review
Early exercise and attenuation of myopathy in
the patient with sepsis in ICU
Jennifer D. Paratz, Geetha Kayambu
Burns, Trauma and Critical Care Research Centre, School of Medicine, The University of Queensland, Australia
Background: Many survivors of severe illness and intensive care admission have decreased quality of life of
which decreased physical recovery plays a major part. Those with sepsis syndromes in particular have been
shown to have increased mortality and poor quality of life compared to other survivors in intensive care.
Objectives: This review aimed to discuss mechanics of myopathy in sepsis and examine the evidence that
these are able to be prevented by early activity in intensive care.
Major findings: There are a number of exercise trials conducted in general intensive care patients. These
have positive findings indicating that early intervention with exercise is able to prevent critical illness
weakness syndromes, and loss of muscle mass, decrease duration of mechanical ventilation, length of
hospital and intensive care unit (ICU) stay and improve overall quality of life. Specific changes and
mechanisms responsible for decreases in muscle force and muscle mass in sepsis syndromes and
possible interventions are discussed. As many of these findings are extrapolated from animal studies, there
is a need for further research into mechanisms of myopathy in intensive care patients.
Conclusions: Controlled clinical trials need to be conducted specifically on patients with sepsis syndromes.
Longer term outcomes such as health related quality of life, mortality, duration of ventilation and length of
ICU stay are important to investigate. It is also important to identify specific effects of exercise on the
mechanisms of myopathy in sepsis. Once this has been proven, research needs to be undertaken so
specific levels of exercise can be safely recommended.
Keywords: Intensive care units, Critical care, Critical illness, Sepsis, Exercise therapy, Rehabilitation, Muscle weakness, Myopathy, Early ambulation
Introduction
Patients can be admitted to intensive care for a variety
of reasons; the two overall main causes are major
injury or severe infection and subsequent organ
failure. As a result of both the initial insult, subsequent
immobilization and other iatrogenic factors, the
critically ill survivor can become extremely catabolic
and have impaired function on discharge. Certain
diseases e.g. sepsis syndromes can particularly cause
myopathy and impaired functional status.
Sepsis is a complex series of linked inflammatory
and haemostatic alterations which may occur in
response to infection. This can range from systemic
inflammatory response to organ dysfunction to
multiple organ failure.1 Sepsis may develop from an
infective source anywhere in the body with common
sites including the lung, sinuses, urinary tract,
invasive lines and the abdomen. Approximately
12% of admissions to intensive care unit (ICU) are
for sepsis and a further 20% will develop sepsis,2
which has major immediate and long-term effects on
morbidity and mortality. Table 1 illustrates the
severity of the response, the definition of sepsis
syndromes and the predicted mortality. Sepsis
syndromes are defined according to severity and level
of systemic involvement. It is important to know and
understand these in order to plan an appropriate
management strategy for the patient.
Medical Management of Sepsis Syndromes
In 2004, a consensus conference of intensivists and
infectious diseases physicians developed a manage-
ment plan termed ‘surviving sepsis’.3 This consensus
management plan for sepsis (www.survivingsepsis.
com) initially improved overall mortality figures.
However, in recent years as patients have developed
more co-morbidities and resistant organisms emerge,
the incidence and mortality of sepsis has worsened.4
The management plan consists of the following
strategies listed in Table 2.
Aggressive fluid loading and administration of
vasopressors¡inotropes titrated against the patient’s
response is important in the early stage. Rapid
restoration of fluid not only modulates infection but
also decreases the need for vasopressor therapy.5 A
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survival benefit has been found6 in maximizing
overall oxygen delivery to the body (i.e. ensuring
there is both adequate cardiac output and pulmonary
gas exchange and ensuring equal oxygen demand and
consumption), so observance of this in our manage-
ment plans and any exercise is important. This
approach is called early goal directed therapy.6
The patient in the early stage of severe sepsis or
septic shock is therefore being intensively fluid
loaded, potentially with high level of vasoactive
support, intensive haemodynamic monitoring, a
number of invasive lines and often renal replacement
therapy. A high level of respiratory support with
advanced modes of ventilation, e.g. high frequency
oscillation and/or nitric oxide is often in situ. If the
physiotherapist is to intervene at this early stage,
there are a number of precautions, which need to be
taken along with an appreciation of the pathophy-
siology, the severity of the sepsis and the goals of
management at that stage. The patient’s condition
can fluctuate from second to second, therefore a very
high degree of interpretation of invasive monitoring
and continual assessment needs to be undertaken.
Outcomes of Critically Ill Patients
Studies investigating the quality of life of critically ill
patients on discharge from hospital have found severe
psychological and physical problems.7,8 Overall ICU
survivors have been found to have a lower health
related quality of life than an age matched general
population one year after discharge from hospital.8
This has a major impact on the health and
productivity of survivors as well as the impact on
the availability of ICU and hospital beds, surgical
waiting lists and health costs. Independent predictors
of ICU acquired weakness and impaired functional
performance are length of stay, aminoglycosides,
hyperglycaemia, neuromuscular blocking agents,
corticosteroids and duration of mechanical ventila-
tion.9 However, sepsis specifically has a hazard ratio
of 5.7 increased chance of death twelve months post
ICU discharge and is the largest diagnostic group of
non-survivors in ICU.10 ICU patients specifically
with sepsis can have a worse functional outcome with
incomplete recovery in physical function, general
health and role-physical.11,12
Musculoskeletal Effects of Sepsis
An explanation of the poorer functional outcomes of
patients with sepsis, may be the increased rate of ICU
acquired weakness (ICUAW), occurring in 10–70% of
patients13,14 of this population. These weakness syn-
dromes can involve both respiratory and peripheral
muscles.15 ICUAW has been shown to result in
increased duration of mechanical ventilation, difficulty
in weaning, an increased length of stay in intensive care,
increased rate of nosocomial infections, functional
impairment post ICU discharge, poor quality of life16
and increased mortality.17 While ICUAW can occur in
a variety of critically ill patients, there is substantial
evidence that sepsis syndromes directly cause severe
myopathy through a variety of mechanisms.
Over a three week period an average of 16% of
total body protein can be lost in patients with
sepsis,18 mainly in the skeletal tissue, with the greatest
atrophy in the contractile myosin filaments.19 It has
been shown in experimental model animals that
decreases in muscle force generating capacity can
occur well before and in the absence of decreases in
muscle mass. These decreases in contractile perfor-
mance have been shown to occur within hours of the
toxin being administered; illustrating that it is not
only the effect of immobility causing weakness in
muscles post sepsis.20 It has been demonstrated21 in
these animal models that both inflammation and
immobility will lead to muscle weakness with the two
factors having a synergistic effect.
Table 1 Criteria for SIRS and sepsis syndromes (modified from Dellinger et al.3)
Syndrome Criteria Mortality
Systemic inflammatory response
syndrome (SIRS) any two or more
of the following criteria
& HR.90 bpm
& RR.20/minute or PaCO2,32 mmHg
& WCC.12 0006109/L
& T.38uC
Sepsis & SIRSzproven infection 15%
Severe sepsis & Sepsiszfailure of one or more organs 20%
Septic shock & Severe sepsiszcardiovascular failure despite adequate fluid
resuscitation (usually SABP,90 mmHg or .40 mmHg from baseline.
45%
Table 2 Management for sepsis syndromes (modified
from Dellinger et al.3)
Management strategies for sepsis
N Early recognition
N Early haemodynamic resuscitation and continued support
N Early and adequate antibiotic therapy
N Source control
N Tight glycaemic control
N Protective mechanical ventilation
N ¡Corticosteroids (refractory vasopressors dependent shock)
N ¡Drotecogin alpha (APACHE II.25)
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What actually causes these abnormalities in both
muscle contractile force and cross-sectional area? A
major factor appears to be systemic inflammation.
This increase in cytokines is part of an immune
response to sepsis, with secondary effects on organs
causing tissue damage and dysfunction. There is now
a link between pro-inflammatory cytokines and
skeletal muscle weakness and wasting. There is further
evidence that cytokines can cause increased produc-
tion of free radical species which can result in sepsis
induced myopathy. The proinflammatory cytokines
Interleukins-1alpha and -1beta, Interleukin-6 (IL-6)
and Tumour necrosis factor alpha are implicated in
muscle degradation, myocyte degeneration andmuscle
atrophy, inhibition of protein synthesis and apoptosis
demonstrated in animal models to result in loss
of muscle mass and contractile force.21 However
Interleukin-10 (IL-10) is an anti-inflammatory cyto-
kine and is thought to inhibit proteolysis.22
Importantly this cytokine is increased during exercise.
The actual immobility also plays a major part
through decreased muscle protein synthesis and
proteolysis. Decreased muscle protein synthesis,
evident through urinary nitrogen excretion, occurs
after hours of immobility. Proteolysis, i.e. increased
breakdown of muscle tissue, occurs through three
major pathways: the calcium dependent calpains, the
lysosomal proteinases, and the ubiquitin proteasome
system. Although the process of proteolysis is
multifactorial it is interesting that Ca2z uptake
and content in limb skeletal muscles are increased
during sepsis and this process is inherently involved
in proteolysis.23 Proteolytic activity via the ubiquitin
proteasome system, which degrades the major
contractile proteins, has also been shown to be
higher in patients with sepsis compared with healthy
controls.24 A bioenergetic abnormality is strongly
suspected as a major mechanism of both multiple
organ failure and skeletal muscle impairment. There
is usually impaired oxygen utilization in septic
patients which implicates nitric oxide mediated
inhibition of the mitochondrial respiratory chain.25
Mitochondrial dysfunction occurs in both respira-
tory and limb muscles; however, the concentration
of energy rich phosphates, e.g. ATP and creatinine
phosphate, is maintained in respiratory muscles. It
has been suggested that this sparing of respiratory
muscles is due to the constant stretch from the
ventilator.15,25
It is also important to emphasize that muscles are
not inactive partners during this time of immobility
but appear to work in a bidirectional role to
inflammatory signalling.26 An actual proinflamma-
tory state develops with bed rest, with increased
production of reactive oxygen species, and a decrease
in anti-oxidative defences. Immobile muscles are
therefore likely to cause even more acute as well as
long-term deleterious effects to the patient.
Initially, a great deal of this knowledge and/or
supposition of the pathophysiological mechanism of
muscle dysfunction in sepsis was based on animal
studies. The human studies available, while demon-
strating alterations in signalling pathways that were
purported to control protein synthesis and proteo-
lysis, were based on data from healthy subjects and
those in diseased populations other than sepsis.27
However, there is an emerging body of knowledge on
the mechanism of myopathy post sepsis.25,26,28,29
Further work aims to elucidate the exact mechan-
isms(s) occurring in sepsis in order to target these
causes. While pharmacological means have been
suggested, exercise in other diseased populations,
e.g. heart failure, has been demonstrated to reduce
proinflammatory parameters27 and there are excellent
justifications and pathophysiological bases to further
explore this as a mechanism.
Is there Any Evidence that Early Activity within
ICU is Safe or Beneficial?
Early mobility and upright positioning within ICU
has been an accepted component of management in a
number of countries for quite a few years.30,31 This
has led to difficulty in conducting well controlled
trials to demonstrate safety and benefit, due to the
ethical dilemma of utilizing a control group.
However, recently there has been a plethora of
articles warning of the risks of sedation and
immobilization and the advisability of early mobili-
zation32–37 and a number of publications demonstrat-
ing safety and efficacy in a general ICU population.
Bailey et al.38 completed 1449 activity events in 103
critically ill patients and demonstrated ,1% adverse
events. Two major controlled trials39,40 have been
conducted in centres where mobility was not pre-
viously utilized and provided level 1 evidence that
that the addition of early mobility was safe and
beneficial. Schweickert et al.39 found that the addition
of targeted exercises to ICU patients at 72 hours
resulted in increased return to functional indepen-
dence, decrease in time of delirium, and increase in
ventilator free days. Burtin et al.40 did not introduce
passive or active exercise until return of cardiovas-
cular stability but was able to demonstrate improved
quadriceps strength and increased six minute walk
distance at hospital discharge and improved quality
of life as shown by the SF36.
As respiratory muscles are affected as well, as
shown by the extended time on MV and difficulty
weaning, these muscles have also been targeted. A
randomized controlled trial on ventilated patients in
early respiratory failure was conducted,41 but found
no difference in weaning or reintubation rate and
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actually found that the intervention group had
decreased respiratory muscle strength by the end of
the trial. Caruso41 suggested a number of mechan-
isms as to why the training was not effective, and
suggested the lack of feasibility of muscular training
in critically ill patients, overtraining, fatigue, or even
the short duration/low load of the proposed training
programme. Interestingly he comments that critically
ill patients present with a decrease of the resting
potential of muscle membranes, loss of the sodium–
potassium gradient, and increase of the cytosolic
calcium, leading to decreased muscle and nerve
contractility, proteolysis, and mitochondrial density
reduction and these alterations may prevent effective
strength or endurance training in critically ill
patients. These are the issues involved in deciding
whether to intervene with exercise during sepsis and
there may be differences in targeting peripheral and
not respiratory muscles.
Along with trials on early mobilization have been
similar studies on the efficacy of interruption of
sedation. Decreases in the duration of mechanical
ventilation,42 length of hospital and ICU stay, and
mortality were found and increased time spent on
spontaneous modes of ventilation43 have been found.
This relatively new approach to sedation has enabled
rehabilitation to proceed earlier and more effectively.
A number of studies conducted within ICU have
targeted the patients at a slightly later stage, i.e. well
after weakness was evident providing electrical muscle
stimulation (EMS)44 on admission to ‘step down’
intensive care unit45 and on weaning from mechanical
ventilation46 and after MV for 14 days.47 The inter-
vention group demonstrated increased strength,44,47
increased endurance capacity,46 increased respiratory
muscle strength,45 and improved function.44,45,47
Therefore, benefits have been shown in a general
population of ICU patient but the question remains
as to whether myopathy can be prevented particularly
in patients with sepsis syndromes. How early can this
intervention take place?
Specific Trials on Exercise in the Early Stage of
Admission to ICU
The priorities for a patient in early severe respiratory
failure, sepsis or septic shock are support and
recovery from organ failure including respiratory,
cardiovascular and renal. These patients are often on
high levels of support including vasoactive support
for the cardiovascular system, mechanical ventilation
modes such as renal replacement therapy. It therefore
seems counter intuitive to discuss or recommend
exercise at this stage. However, as discussed, muscu-
loskeletal effects of sepsis occur almost immediately
following the toxin and if prevention of loss of muscle
mass is to occur, intervention must occur early.
There is limited but promising evidence in early
sepsis syndromes that early intervention can limit the
loss of muscle force or mass. In five patients with
severe respiratory failure requiring neuromuscular
blockade, continuous passive movement of one limb
prevented protein degradation in one limb, while the
contra-lateral control limb continued to lose muscle
mass.48
This area has also been investigated using animal
models. In a paralyzed rat model,49 it was shown that
repetitive passive stretch was able to induce induction
of messenger ribonucleuic acid and c-fos in immobi-
lized subjects.
A pilot trial50 investigated the effect of early exercise
specifically in patients diagnosed with severe sepsis or
septic shock.1 Twenty patients were randomized to
control or intervention with the intervention group
receiving at least 30 minutes of passive movement,
stretch reflex, assisted or active exercise according to
their level of co-operation. Most patients were heavily
sedated, and on high levels of vasopressor and
ventilatory support. However, at the end of the first
week the control group had lost 7.2% of fat free mass
with no decrease in the intervention group.
Inflammatory levels had also altered with significant
decreases in IL-6 and a significant increase in IL-10 in
the intervention group. From this pilot data, a larger
trial has been initiated examining longer term quality
of life measures (ACTRN 12610000808044).
Winkelman et al.51 investigated the effects on pro
(IL-6) and anti (IL-10) inflammatory cytokines of
light exercise in critically ill patients. It was shown
that exercise produced a trend in decreasing IL-6 and
increasing IL-10 thus potentially preventing proteo-
lysis. However, further developments require mon-
itoring as too high a release of IL-10 can result in
immunosuppressive properties.22
An additional method of intervention which is
particularly useful in immobilized patients is EMS. A
number of trials in humans have demonstrated
beneficial effects inducing prevention of critical illness
polyneuropathy and myopathy (defined by muscle
strength)52 loss of muscle mass53 (defined by ultra-
sound) improvement in microcirculation54 and less
catabolism55 (defined by excretion of nitrogen,
creatinine, 3-methyl histidine).
These studies were small and underpowered how-
ever they are promising in providing a signal that
myopathy in sepsis syndromes can be prevented.
Is there any link between any of these changes and
musculoskeletal changes in sepsis? A number of
studies have shown that aerobic and resisted exercise
in healthy and other diseased populations, for
example chronic heart failure, alters proinflammatory
cytokines.27 The studies by Paratz et al.50 and
Winkelman et al.51 are therefore important as they
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demonstrate that exercise in critically ill patients is
able to alter these inflammatory markers and act at a
systemic level. Passive movements appear to retard
proteolysis at a local level as studies demonstrated a
decrease in muscle wasting48 and decreased loss of
lean muscle mass.50
EMS demonstrated improvements at a microcircu-
latory level as shown by an increased oxygen
consumption and reperfusion rate. Gerovasili54
attributed this to an improvement in mitochondrial
function as he postulated that a bioenergetic pathway
may have been activated during the exercise session.
He also postulated that the improvement may have
been due to an effect on inflammatory mediators.
Although only one study above50 specifically
investigated early exercise in patients with sepsis
syndromes, the remaining above studies all included a
mixed ICU population. In the study by Schweickert
et al.39 86 and 82% in the intervention and control
group respectively had criteria for sepsis. However,
these trials indicate that early intervention can be
provided at this stage and the significant benefits
achieved relate well to specific problems causing
myopathy in patients with sepsis.
Outcome Measures
Identification of the efficacy of physical interventions
in sepsis can be gauged with a variety of measures
both short and long-term. These can be grouped as
measures of strength, preservation of muscle mass,
inflammatory levels, oxidative stress, the effect on
microcirculation, functional tests and quality of life
measures. It is also important to investigate whether
the intervention is safe.
Evidence of Safety
Consistent with the concept of Primum non nocere,
the important question remains whether providing
exercise at this early stage is safe. Although existing
studies have commented on the lack of adverse
changes in cardiovascular and respiratory para-
meters, there is also a concern as to the effect of
exercise on bioenergetics and oxidative stress.
In a discussion on sepsis and myopathy, particu-
larly with regard to sarcolemmal injury, the authors
pose the question23 as to whether exercising patients
with damaged muscles, i.e. patients with sepsis could
propagate muscle inflammation and injury or delay
recovery. However, the effects of exercise on cyto-
kines and free radical generation in muscle following
exercise have been based on healthy normals under-
taking exhausting and fatiguing levels of activity.56
As stated previously, light or moderate exercise can
be considered to be an antioxidant.57 Measures of
oxidative stress could be monitored to ensure that
exercise is not detrimental to the bioenergetic
system.57
A clinical measurement that may be of interest is
central venous oxygen saturation (SvO2 or ScvO2), an
indicator of possible global tissue hypoxia.58 This is
closely measured during resuscitation of the patient
using early goal directed therapy and monitors the
patient’s oxygen delivery to the tissues, i.e. balance of
oxygen delivery and oxygen consumption. For
example, if the patient’s SvO2 decreased to abnormal
levels (,60%) this may indicate that O2 supply was
insufficient or O2 demand had increased. This can
lead to anaerobic metabolism, lactate production and
oxygen debt, which have been implicated in further
multi-organ failure and increased mortality.58 This
could conceivably occur if exercise was instituted
when the patient was too hypoxaemic or relatively
hypovolaemic. If this particular monitor is in situ it is
an easy parameter for the clinical physiotherapist to
observe and could also assist researchers to demon-
strate that early intervention is safe.
Outcome Measures Indicating Benefit
Short term measures are often termed ‘surrogate’
outcomes, as although they may indicate improve-
ment, they do not indicate long-term benefit to the
patient. However, these measures often assist in
explaining the effect of the intervention, are useful
for the clinician and can contribute in small trials to
establishing efficacy and safety.
Measures of strength, and lean muscle mass
A measure of maximal skeletal force, i.e. strength is
often used to investigate the efficacy of an interven-
tion. A major problem with patients is lack of co-
operation in the early stage of ICU admission, so
non-volitional measurements for strength and/or
endurance are often utilized, such as an evoked
(stimulated) muscle force. Studies have suggested that
the adductor pollicis muscle will predict weakness of
both upper airway as well as peripheral muscles and
is much more susceptible to a decrease in muscle
strength, so this muscle is often targeted as a
reference point.20,59 This muscle is composed primar-
ily of Type I fibres and shows a high degree of
immobilization induced atrophy, but the recovery to
normal values of shortening velocity is faster.
As the patient becomes more co-operative, a
maximum voluntary contraction force using a cate-
gorized scale, the Medical Research Council (MRC)
score, grading the muscle from 0 to 5 is often used.
However, this can be subjective and non-linear, as
grade 4 may span a large range of strength.59 In one
study, excellent inter-rater reliability was found60 in
using manual muscle tests to grade muscles in
survivors of critical illness. However, the ‘assessors’
in this study, who were from a variety of health
professional backgrounds, underwent intensive train-
ing in using the MRC scale prior to assessment, so
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reliability between operators for this measurement
cannot be automatically assumed. A more objective
measurement may be the dynamometer or myometer
as it provides a quantitative measurement of volun-
tary contraction strength; however, it has been
claimed that it is less suitable for assessing strength
of very weak muscles (grade 1–3).59 In addition, age
and gender adjusted values must be considered then
interpreting the results.
To document whether the patient had an actual
critical illness weakness syndrome, a variety of formal
electrodiagnostic tests have been used. However
recently a number of studies have quoted a value
derived from the MRC score (,48/60)52,61 as defining
critical illness weakness syndrome. If this is to be
accepted it emphasises that the validity and inter-
rater reliability of the MRC must be ensured and
further research undertaken.
Respiratory muscle strength (maximal inspiratory
pressure) can also be measured to assess the effect of
intervention. This should be completed with standard
protocol from the American Thoracic Society.62
Levels of fat free mass to investigate the level of
lean muscle tissue are also important. There are
various bioimpedance devices specifically developed
to record these measures in intensive care patients.
Bioelectrical impedance analysis can have problems
differentiating oedema from fat mass, which could
potentially be a problem in ICU patients; however,
the vector method can differentiate between oedema
and other body tissues.63 An index of whether muscle
wasting has altered can be completed by measuring
catabolism, i.e. urinary excretion of nitrogen, 3-
methyl histidine and creatinine. Ultrasound has been
used to assess the cross sectional area of muscles
following interventional trials53 and has been shown
to have very good intra- and interobserver reprodu-
cibility.64
Measures of inflammation
Levels of cytokines have been measured to inves-
tigate whether early intervention can reverse
pro-inflammatory cytokines and increase levels of
anti-inflammatory cytokines.50,51 These measures
provide excellent confirmation that exercise is having
an effect on the inflammatory state, but need to take
into account diurnal variations and large variations
between subjects. Further research is also required to
ascertain whether these changes result in long-term
meaningful outcomes.
Measures of delirium, anxiety and depression
The time in delirium has been documented as an
outcome measure.42,43 This is important as the length
of time spent in delirium can correlate with adverse
psychological outcomes, insomnia and nightmares
post discharge. In addition, incidence of delirium has
been shown to predict longer hospital stay65 and
mortality.66 Levels of depression and anxiety can also
be measured on ICU or hospital discharge. The
hospital anxiety and depression scale is a widely used
instrument in the acute care setting with demon-
strated validity, reliability and sensitive to change
during the course of the disease and responsive to
therapeutic intervention.67 It is feasible that these
outcomes could be affected by early activity and
mobilization.
Measures of function and quality of life
Functional tests in current studies have included the
functional independence measure47 and the Barthel
index47 but could also include the Physical Function
ICU Test),68 a recently developed tool to measure
endurance, strength, cardiovascular capacity and
functional level. The Physical Function ICU Test
demonstrated good reliability and was responsive to
change.68 The six minute walking distance (6 MWD)
has also been utilized to demonstrate benefit in
several trials.40,45
Quality of life measures have included Medical
Outcome Study Short Form-36 (SF-36) which has
been demonstrated to have reliability, responsiveness,
construct and criterion validity and is responsive to
clinical improvement in an ICU population.69
Additionally it has been shown to be reliable when
next of kin’s estimates are used to construct an
estimate of the patient’s quality of life,70 so a pre ICU
score can be constructed.
Long-term measures often require larger numbers
of patients, although it is important to investigate
whether early intervention results in longer term
improvements.
Quality adjusted life years, as well as economic
issues, e.g. utilization of health funds post hospital
discharge, mortality, length of time on mechanical
ventilation, ICU and hospital stay, ventilator free
days and weaning success are important measures
and relate to overall health resource issues as well as
individual patients’ improvement. These have been
examined in a number of studies on critically ill
patients but not necessarily sepsis. While important
measures, there can be high rate of variability
implying that large numbers of patients are required
to provide adequate power for the study.
Conclusion and Future Challenges
There has been preliminary evidence to support that
muscles in sepsis show dramatic decreases in contractile
force and mass. It is queried whether light to moderate
exercise or substitutes (e.g. EMS) can partially reverse
this condition without causing harm to these critically
ill patients and so decrease duration of mechanical
ventilation, decrease length of stay, and improve overall
functional outcome. There is preliminary evidence in
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patients with sepsis that varying methods of delivering
exercise, e.g. EMS, CPM, passive movement are
effective and safe in preventing a degree of myopathy
that is often present in these patients. Larger trials need
to be undertaken in this population examining long-
term meaningful outcomes. In addition it needs to be
proven that these interventions are not harmful. Once
this has been proven, research needs to be undertaken
so specific levels of exercise can be safely recommended.
References
1 Vincent JL, Korkut HA. Defining sepsis. Clin Chest Med
2008;29:585–90.
2 Brun-Buisson C, Doyon F, Carlett J. Incidence, risk factors,
and outcome of severe sepsis and septic shock in adults. A
multicentre prospective study in intensive care in adults. JAMA
1995;274:968–74.
3 Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM,
Jaeschke R, et al. Surviving sepsis campaign: international
guidelines for management of severe sepsis and septic shock:
Intensive Care Med 2008;34:17–60.
4 Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid
increase in hospitalization and mortality rates for severe sepsis
in the United States: a trend analysis from 1993–2003. Crit Care
Med 2007;35:1244–50.
5 Hillman K, Bishop G. Infection. In: Hillman K, Bishop G,
editors. Clinical intensive care and acute medicine. 2nd ed.
Cambridge: Cambridge University Press; 2004. p. 149–98.
6 Rivers EP, Coba V, Visbal A, Whitmill M, Amponsah D.
Management of sepsis: early resuscitation. Clin Chest Med
2008;29:689–704.
7 Rimachi R, Vincent JL, Brimouille S. Survival and quality of
life after prolonged intensive care unit stay. Anesth Intensive
Care 2007;35:62–7.
8 Pettila V, Kaarlola A, Makelainen A. Health related quality of
life of multiple organ dysfunction patients after one year after
intensive care. Intensive Care Med 2000;26:1473–9.
9 Garnarcho-Montero J, Madrazo-Osuna J, Garcia-Garmendia
JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A,
et al. Critical illness polyneuropathy: risk factors and clinical
consequences. A cohort study in septic patients. Intensive Care
Med 2001;27:1288–96.
10 Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E,
Lee KY, et al. Determinants of long-term survival after
intensive care. Crit Care Med 2008;26:1523–30.
11 Hofhuis JG, Spronk PE, van Stel HF, Schrijvers AJ, Rommes
JH, Bakker J. The impact of severe sepsis on health related
quality of life: a long term follow-up study. Anesth Analg
2008;107:1957–64.
12 Winters BD, Eberlein M, Leung J, Needham DM, Pronovost
PJ, Sevransky JE. Long term mortality and quality of life in
sepsis: a systematic review. Crit Care Med 2010;38:1276–83.
13 Khan J, Harrison TB, Rich MM. Early development of critical
illness myopathy in patients with severe sepsis. Neurology
2006;67:1421–5.
14 Tennila A, Salmi T, Pettila V. Early signs of critical illness poly
neuropathy in ICU patients with systemic inflammatory
response syndrome or sepsis. Intensive Care Med 2000;26:
1360–3.
15 Prentice CE, Paratz JD, Bersten AD. Differences in the degree
of respiratory and peripheral muscle impairment are evident on
clinical, electrophysiological and biopsy testing in critically ill
adults: a quantitative systematic review. Crit Care
Resuscitation 2010;12:111–20.
16 De Jonghe B, Lacherade JC, Durand MC, Sharshar T. Critical
illness neuromuscular syndromes. Crit Care Clinics 2007;23:55–
69.
17 Ali NA, O’Brien JM, Hoffman SP, Phillips G, Garland A,
Finley JC, et al. Acquired weakness, handgrip strength and
mortality in critically ill patients. Am J Respir Crit Care Med
2008;178:262–8.
18 Finn PJ, Plank LD, Clark MA. Progressive cellular dehydration
and proteolysis in critically ill patients. Lancet 1996;347;654–6.
19 Helliwell TR, Griffiths RD, McCelland P, Palmer TEA, Bone
JM. Muscle fibre atrophy in critically ill patients is associated
with the loss of myosin filaments and the presence of lysosomal
enzymes and ubiquitin. Neuropathol Appl Neurobiol
1998;24:507–17.
20 Eikermann M, Koch G, Gerwig M. Muscle force and fatigue in
patients with sepsis and multi-organ failure. Intensive Care
Med 2006;32:251–9.
21 Fink H, Helming M, Unterbuchner, Lenz A, Neff F, Martyn
JAJ, et al. Systemic inflammatory response syndrome increases
immobility-induced neuromuscular weakness. Crit Care Med
2008;36:910–6.
22 Oberholzer A, Oberholzer C, Modlawer LL. IL-10: a complex
role in the pathogenesis of sepsis syndromes and its potential as
an anti-inflammatory drug. Crit Care Med 2002;30:S58–63.
23 Callahan LA, Supinski GS. Sepsis-induced myopathy. Crit
Care Med 2009;37:S354–67.
24 Klaude M, Frederiksson K, Tjader I, Hammarvist F, Ahlmans
B, Rooyackers O, et al. Proteasome proteolytic activity in
skeletal muscle is increased in patients with sepsis. Clin Sci
2007;112:499–506.
25 Fredriksson K, Rooyacckers O. Mitochondrial function in
sepsis: respiratory muscle versus leg muscle. Crit Care Med
2007;35:S449–53.
26 Lightfoot A, McArdle A, Griffiths RD. Muscle in defense. Crit
Care Med 2009;37:S384–90.
27 Gielen S, Adams V, Mobius-Winkler S. Anti-inflammatory
effects of exercise training in the skeletal muscles of patients
with chronic heart failure. J Am Coll Cardiol 2003;42:861–8.
28 Fredriksson K, Tajader I, Keller P, Petrovic N, Ahlman B,
Scheele C, et al. Dysregulation of mitochondrial dynamics and
the muscle transcriptome in ICU Patients suffering from sepsis
induced multiple organ failure. PLoS One 2008;3:e3686.
29 Greenhaff PL, Karagounis LG, Peirce N, Simpson EJ, Hazell
M, Layfield R, et al. Disassociation between the effects of
amino acids and insulin in signalling, ubiquitin ligases and
protein turnover in human muscle. Am J Physiol Endocrinol
Metab 2008;295:E595–604.
30 Norrenberg M, Vincent JL. A profile of European intensive
care unit physiotherapists. European Society Intensive Care
Medicine. Intensive Care Med 2000;26:988–94.
31 Chang A, Hodges P, Boots R, Paratz J. Standing with
assistance of a tilt table in intensive care: a survey of
Australian physiotherapy practice. Aust J Physiother
2004;50:51–4.
32 Morris PE. Moving our critically ill patients: mobility barriers
and benefits. Crit Care Clin 2007;23:1–20.
33 Bailey PP, Miller RR, Clemmer TP. Culture of early mobility in
mechanically ventilated patients. Crit Care Clin 2009;37:S429.
34 Stiller K. Safety issues that should be considered when
mobilising critically ill patients. Crit Care Clin 2007;23:35–53.
35 Kress JP. Clinical trials of early mobilization of critically ill
patients. Crit Care Med 2009;37:S442–7.
36 Chambers MA, Moylan JS, Reid MB. Physical inactivity and
muscle weakness in the critically ill. Crit Care Med 2009:37:
S337–46.
37 Bower RG. Consequences of bed rest. Crit Care Med 2009:
37:S422–8.
38 Bailey P, Thomsen GE, Spuhler VJ, Blair R, Jewkes J, Bezdjian
L, et al. Early activity is feasible and safe in respiratory failure
patients. Crit Care Med 2007;35:139–45.
39 Schweickert WM, Pohlman MC, Pohlman AS, Nigos C, Pawlik
AJ, Esbrook CL. Early physical and occupational therapy in
mechanically ventilated, critically ill patients: a randomised
controlled trial. Lancet 2009;373:1874–82.
40 Burtin C, Clerckx B, Robbeets C, Ferdinande P, Langer D,
Troosters T, et al. Early exercise in critically ill patients
enhances short-term functional recovery. Crit Care Med
2009;37:2499–505.
41 Caruso P, Denari SD, Ruiz SA, Bernal KG, Manfrin GM,
Friedrich C, et al. Inspiratory muscle training is ineffective in
mechanically ventilated critically ill patients. Clinics (Sao
Paulo) 2005;60:479–84.
42 Kress JP, Pohlman AS, O’Connor MF, Hall JB. Daily
interruption of sedative infusions in critically ill patients
undergoing mechanical ventilation. N Engl J Med 2000;342:
1471–7.
43 Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert
WD, Pun BT, et al. Efficacy and safety of a paired sedation and
ventilator weaning protocol for mechanically ventilated patients
in intensive care (Awakening and Breathing Controlled trial): a
randomized controlled trial. Lancet 2008;371:126–34.
Paratz and Kayambu Early exercise and attenuation of myopathy in the patient with sepsis
64 Physical Therapy Reviews 2011 VOL. 16 NO. 1
Pu
bl
ish
ed
 b
y 
M
an
ey
 P
ub
lis
hi
ng
 (c
) W
. S
. M
an
ey
 &
 S
on
 Li
mi
ted
44 Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle
strength training in bed-bound patients with COPD receiving
mechanical ventilation. Chest 2003;124:292–6.
45 Nava S. Rehabilitation of patients admitted to a respiratory
intensive care unit. Arch Phys Med Rehabil 1998;79:849–54.
46 Porta R, Vitacca M, Gile LS, Clini E. Supported arm training
in patients recently weaned from mechanical ventilation. Chest
2005;128:2511–20.
47 Chiang LL, Wang LY, Wu HD, Wu YT. Effects of physical
training on functional status in patients with prolonged
mechanical ventilation. Phys Ther 2006;86:1271–81.
48 Griffiths RD, Palmer TE, Helliwell T, MacLennan P,
MacMillan RR. Effect of passive stretching on the wasting of
muscle in the critically ill. Nutrition 1995;1:428–32.
49 Ikeda S, Yoshida A. Induction of myogenin messenger
ribonucleic acid in rat skeletal muscle after 1 hour of passive
repetitive stretching. Arch Phys Med Rehabil 2004;85:166–7.
50 Paratz JD, Thomas PJ, Chang AT, Boots RJ. Early exercise in
sepsis attenuates inflammation and loss of muscle mass. 2009 e-AJP
Vol. 55(4), supp. Available from: http://www.physiotherapy.asn.au/
images/AJP/Documents/abstracts%202009.pdf.
51 Winkelman C, Higgins PA, Chen YJ, Levine AD. Cytokines in
chronically ill patients after activity and rest. Bio Res Nurs
2007;8:261–271.
52 Routsi C, Gerovasili V, Vasileiadis I, Karatzanos E, Pitsolois T,
Tripodaki ES, et al. Electrical muscle stimulation prevents
critical illness polyneuropathy: a randomized parallel interven-
tion trial. Crit Care 2010;14:R74. Available from: http://
ccforum.com/content/14/2/R74.
53 Gerovasili V, Stefanidis K, Vitzilaios K, Karatzanous E, Politis
P, Koroneus A, et al. Electrical muscle stimulation preserves the
muscle mass of critically ill patients: a randomized study. Crit
Care 2009;13:R161. Available from: http://ccforum.com/content/
13/5/R161; accessed 10 Feb 2011.
54 Gerovasili V, Tripodaki E, Karatzanous E, Pitsolis T, Markaki
V, Zervakis D, et al. Short term systemic effect of electrical
muscle stimulation in critically ill patients. Chest 2009;136:
1249–56.
55 Bouletreau P, Patricot MC, Saudin F, Guiraud M, Mathian B.
Effects of intermittent electrical stimulations on muscle
catabolism in intensive care patients. JPEN 1987:11:552–5.
56 Fisher-Wellman K, Bloomer RJ. Acute exercise and oxidative
stress: a 30 year history. Dynamic Med 2009;8:1–25.
57 Gomez-Cabrera MC, Domenech E, Vina J. Moderate exercise
is an antioxidant: upregulation of antioxidant genes by training.
Free Radic Biol Med 2008;15:126–13.
58 Rivers EP, Ander DS, Powell D. Central venous oxygen
saturation in the critically ill patient. Curr Opin Crit Care
2001;7:204–11.
59 Bittner EA, Martyn JA, George E, Frontera WR, Eikermann
M. Measurement of muscle strength in the intensive care unit.
Crit Care Med 2009;37:S321–30.
60 Fan E, Ciesla ND, Trong AD, Bhoopathi V, Zeger SL,
Needham DM. Inter-rater reliability of manual muscle strength
testing in ICU survivors and simulated patients. Intensive Care
Med 2010;36:1038–43
61 Brunello AG, Haemggi M, Wigger O, Porta F, Takala J, Jakob
SM. Usefulness of a clinical diagnosis of ICU- acquired paresis
to predict outcome in patients with SIRS and acute respiratory
failure. Intensive Care Med 2010;36:66–74.
62 Green M, Road J, Sieck GC, Similowski T. ATS/ERS
statement on respiratory muscle testing: tests of respiratory
muscle strength. Am J Respir Crit Care Med 2002;166:518–624.
63 Cornish, BH, Ward LC, Thomas BJ, Jebb SA, Elia, M.
Evaluation of multiple frequency bioelectrical impedance and
Cole-Cole analysis for the assessment of body water volumes in
healthy humans. Eur J Clin Nutr 1996;50;159–64.
64 Campbell IT, Watt T, Withers D, England R, Sukmar S,
Keegan MA, et al. Muscle thickness measured with ultrasound
may be an indicator of lean tissue wasting in multiple organ
failure in the presence of edema. Am J Clin Nutr 1995;62:533–9.
65 Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC,
Ely EW. Intensive care delirium is an independent predictor of
longer hospital stay: a prospective analysis of 261 non-
ventilated patients. Crit Care 2005;R375–381.
66 Ely EW, Shintani A, Truman B, Speroff T, Gordon SM,
Harrell FE, et al. Delirium as a predictor of mortality in
mechanically ventilated patients in the intensive care unit.
JAMA 2004;291;1753–62.
67 Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of
the Hospital and Anxiety Depression Scale: an updated review.
J Psychosom Res 2002;52:69–77.
68 Skinner EH, Berney S, Warrillow S, Denehy L. Development of
a physical outcome measure (PFIT) and a pilot exercise training
protocol for use in intensive care. Crit Care Resusc
2009;11:110–15.
69 Heyland DK, Hopman W, Coo H. Long term health related
quality of life in survivors of sepsis, Short Form 36: a valid and
reliable measure of health related quality of life. Crit Care Med
2001;28:3599–605.
70 Rogers J, Ridley S, Chrispin P. Reliability of the next of kins’
estimates of critically ill patients; quality of life. Anaesthesia
1997;52:1137–43.
Paratz and Kayambu Early exercise and attenuation of myopathy in the patient with sepsis
Physical Therapy Reviews 2011 VOL. 16 NO. 1 65
